STUDYID,SUBJID,RAND,TREATXT,TRTCD,PCREFID,CNTNRID,PCDT,PCTM,VISIT,PCTPT,PCORRES,PCORRESU,PKACOM,PKCOML,PCSPEC,PKTERM,PCCAT,PCNAM,PCANMETH,PCMETHOD,PCLLOQ,PCLLOQU,PCSPID,ASSAYRUN,ASSAYDT
C1071040,10681001,1,PF-06863135,T,6514526668,6.51453E+11,20210209,11:30,CYCLE1_DAY1,0 H,<0.500,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 12,1RSYC,26-Oct-21
C1071040,10681001,1,PF-06863135,T,6514526668,6.51453E+11,20210209,18:45,CYCLE1_DAY1,6 H,30.71922081,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 13,11RSYC,2-Nov-21
C1071040,10681001,1,PF-06863135,T,6514526671,6.51453E+11,20210216,9:12,CYCLE1_DAY8,0 H,884.5256799,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 14,11RSYC,2-Nov-21
C1071040,10681001,1,PF-06863135,T,6514526671,6.51453E+11,20210216,16:30,CYCLE1_DAY8,6 H,327.3161609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 15,12RSYC,2-Nov-21
C1071040,10681001,1,PF-06863135,T,6514526673,6.51453E+11,20210223,11:20,CYCLE1_DAY15,0 H,851.6107698,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 16,1RSYC,26-Oct-21
C1071040,10681001,1,PF-06863135,T,6514526675,6.51453E+11,20210302,10:08,CYCLE1_DAY22,0 H,924.473617,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 17,1RSYC,26-Oct-21
C1071040,10681001,1,PF-06863135,T,6514526676,6.51453E+11,20210309,11:00,CYCLE2_DAY1,0 H,198.4857578,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 18,1RSYC,26-Oct-21
C1071040,10681001,1,PF-06863135,T,6515768046,6.51577E+11,20210406,14:04,CYCLE3_DAY1,0 H,856.8659803,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 19,12RSYC,2-Nov-21
C1071040,10681001,1,PF-06863135,T,6515337610,6.51534E+11,20210504,12:00,CYCLE4_DAY1,0 H,792.2798825,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 20,12RSYC,2-Nov-21
C1071040,10681001,1,PF-06863135,T,6517472556,6.51747E+11,20210727,13:56,CYCLE7_DAY1,0 H,637.3261739,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 21,12RSYC,2-Nov-21
C1071040,10681001,1,PF-06863135,T,6517472564,6.51747E+11,20211102,11:09,CYCLE10_DAY1,0 H,577.0884619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 678,64RSYC,3-May-22
C1071040,10681001,1,PF-06863135,T,6518807395,6.51881E+11,20220111,11:36,CYCLE13_DAY1,0 H,960.2219825,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1611,97RSYC,12-May-22
C1071040,10681001,1,PF-06863135,T,6518807393,6.51881E+11,20220405,11:49,CYCLE16_DAY1,0 H,2.971705169,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1921,123RSYC,29-Jul-22
C1071040,10681001,1,PF-06863135,T,6521317289,6.52132E+11,20221213,11:17,CYCLE25_DAY1,0 H,993.8557852,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2127,139RSYC,22-Mar-23
C1071040,10681001,1,PF-06863135,T,6521699933,6.5217E+11,20230307,10:43,CYCLE28_DAY1,0 H,238.4126488,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2202,141RSYC,17-May-23
C1071040,10681001,1,PF-06863135,T,6523611270,6.52361E+11,20230810,11:51,END_OF_TRT,,448.911335,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2288,147RSYC,29-Feb-24
C1071040,10681002,2,PF-06863135,T,6514526669,6.51453E+11,20210302,11:00,CYCLE1_DAY1,0 H,38.98008151,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 22,1RSYC,26-Oct-21
C1071040,10681002,2,PF-06863135,T,6514526669,6.51453E+11,20210302,18:30,CYCLE1_DAY1,6 H,154.0108121,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 23,11RSYC,2-Nov-21
C1071040,10681002,2,PF-06863135,T,6514526670,6.51453E+11,20210309,9:31,CYCLE1_DAY8,0 H,981.2292948,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 24,11RSYC,2-Nov-21
C1071040,10681002,2,PF-06863135,T,6514526670,6.51453E+11,20210309,17:31,CYCLE1_DAY8,6 H,725.3575273,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 25,12RSYC,2-Nov-21
C1071040,10681002,2,PF-06863135,T,6514526672,6.51453E+11,20210316,9:56,CYCLE1_DAY15,0 H,654.9339315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 26,1RSYC,26-Oct-21
C1071040,10681002,2,PF-06863135,T,6515768043,6.51577E+11,20210323,10:05,CYCLE1_DAY22,0 H,711.3533077,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 27,1RSYC,26-Oct-21
C1071040,10681002,2,PF-06863135,T,6515784458,6.51578E+11,20210330,10:29,CYCLE2_DAY1,0 H,762.6739429,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 28,1RSYC,26-Oct-21
C1071040,10681002,2,PF-06863135,T,6515784461,6.51578E+11,20210427,9:42,CYCLE3_DAY1,0 H,426.1647844,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 29,12RSYC,2-Nov-21
C1071040,10681002,2,PF-06863135,T,6515784462,6.51578E+11,20210601,10:06,CYCLE4_DAY1,0 H,4.292904145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 30,141RSYC,17-May-23
C1071040,10031001,3,PF-06863135,T,6514857230,6.51486E+11,20210322,11:53,CYCLE1_DAY1,0 H,81.0995994,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 31,119RSYC,27-Jul-22
C1071040,10031001,3,PF-06863135,T,6514857230,6.51486E+11,20210322,19:01,CYCLE1_DAY1,6 H,824.3972823,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 32,122RSYC,29-Jul-22
C1071040,10031001,3,PF-06863135,T,6515792892,6.51579E+11,20210401,12:50,CYCLE1_DAY8,0 H,380.353872,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 33,11RSYC,2-Nov-21
C1071040,10031001,3,PF-06863135,T,6515792892,6.51579E+11,20210401,19:20,CYCLE1_DAY8,6 H,478.8590598,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 34,12RSYC,2-Nov-21
C1071040,10031001,3,PF-06863135,T,6514020347,6.51402E+11,20210407,10:46,CYCLE1_DAY15,0 H,220.114739,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 35,2RSYC,27-Oct-21
C1071040,10031001,3,PF-06863135,T,6515792899,6.51579E+11,20210414,11:49,CYCLE1_DAY22,0 H,540.0883915,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 36,2RSYC,27-Oct-21
C1071040,10031001,3,PF-06863135,T,6514020351,6.51402E+11,20210421,13:10,CYCLE2_DAY1,0 H,946.569358,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 37,2RSYC,27-Oct-21
C1071040,10031001,3,PF-06863135,T,6515792911,6.51579E+11,20210616,17:56,CYCLE4_DAY1,0 H,198.9490135,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 38,2RSYC,27-Oct-21
C1071040,10031001,3,PF-06863135,T,6517889683,6.51789E+11,20210908,9:45,CYCLE7_DAY1,0 H,506.4480567,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 174,6RSYC,29-Oct-21
C1071040,10071001,4,PF-06863135,T,6514020370,6.51402E+11,20210325,10:50,CYCLE1_DAY1,0 H,806.1309078,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 39,2RSYC,27-Oct-21
C1071040,10071001,4,PF-06863135,T,6514020370,6.51402E+11,20210325,17:30,CYCLE1_DAY1,6 H,933.4276863,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 40,11RSYC,2-Nov-21
C1071040,10071001,4,PF-06863135,T,6514020372,6.51402E+11,20210401,11:00,CYCLE1_DAY8,0 H,2.359339185,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 41,11RSYC,2-Nov-21
C1071040,10071001,4,PF-06863135,T,6514020372,6.51402E+11,20210401,17:25,CYCLE1_DAY8,6 H,868.5023327,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 42,12RSYC,2-Nov-21
C1071040,10071001,4,PF-06863135,T,6514020373,6.51402E+11,20210408,10:50,CYCLE1_DAY15,0 H,868.4917898,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 43,2RSYC,27-Oct-21
C1071040,10071001,4,PF-06863135,T,6514020376,6.51402E+11,20210415,14:00,CYCLE1_DAY22,0 H,334.3230882,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 44,2RSYC,27-Oct-21
C1071040,10071001,4,PF-06863135,T,6514020378,6.51402E+11,20210422,14:15,CYCLE2_DAY1,0 H,999.5577648,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 45,2RSYC,27-Oct-21
C1071040,10071001,4,PF-06863135,T,6515768699,6.51577E+11,20210519,13:45,CYCLE3_DAY1,0 H,742.2096314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 46,12RSYC,2-Nov-21
C1071040,10071001,4,PF-06863135,T,6515808065,6.51581E+11,20210617,14:00,CYCLE4_DAY1,0 H,392.6663034,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 47,2RSYC,27-Oct-21
C1071040,10071001,4,PF-06863135,T,6516303733,6.5163E+11,20210909,9:20,CYCLE7_DAY1,0 H,847.4358993,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 161,6RSYC,29-Oct-21
C1071040,10071001,4,PF-06863135,T,6518265669,6.51827E+11,20211202,11:30,CYCLE10_DAY1,0 H,481.6973163,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1092,107RSYC,24-May-22
C1071040,10071001,4,PF-06863135,T,6518265671,6.51827E+11,20220224,11:30,CYCLE13_DAY1,0 H,104.6500929,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1885,109RSYC,25-May-22
C1071040,10071001,4,PF-06863135,T,6520930827,6.52093E+11,20220811,11:08,CYCLE19_DAY1,0 H,977.4906168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2074,129RSYC,21-Oct-22
C1071040,10071001,4,PF-06863135,T,6520930824,6.52093E+11,20221103,8:52,CYCLE22_DAY1,0 H,956.7304089,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2137,139RSYC,22-Mar-23
C1071040,10071001,4,PF-06863135,T,6520930826,6.52093E+11,20230126,11:18,CYCLE25_DAY1,0 H,17.07020284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2214,142RSYC,18-May-23
C1071040,10071001,4,PF-06863135,T,6521740467,6.52174E+11,20230420,11:18,CYCLE28_DAY1,0 H,854.3542828,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2243,143RSYC,27-Nov-23
C1071040,10071001,4,PF-06863135,T,6521740464,6.52174E+11,20230713,11:32,CYCLE31_DAY1,0 H,496.1794071,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2289,145RSYC,4-Jan-24
C1071040,10071001,4,PF-06863135,T,6524291345,6.52429E+11,20231228,11:34,CYCLE37_DAY1,0 H,241.6438836,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2320,148RSYC,27-Mar-24
C1071040,10071001,4,PF-06863135,T,6518265672,6.51827E+11,20220608,10:25,UNPL,9001 H,797.8655359,NG/ML,,Visit revised from C16D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2005,115RSYC,25-Jul-22
C1071040,10191002,5,PF-06863135,T,6517246477,6.51725E+11,20210712,11:20,CYCLE1_DAY1,0 H,39.13188736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 48,2RSYC,27-Oct-21
C1071040,10191002,5,PF-06863135,T,6517246477,6.51725E+11,20210712,18:35,CYCLE1_DAY1,6 H,230.8428885,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 49,11RSYC,2-Nov-21
C1071040,10191002,5,PF-06863135,T,6514020417,6.51402E+11,20210719,10:54,CYCLE1_DAY8,0 H,296.82302,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 50,11RSYC,2-Nov-21
C1071040,10191002,5,PF-06863135,T,6514020417,6.51402E+11,20210719,17:10,CYCLE1_DAY8,6 H,551.5698489,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 51,12RSYC,2-Nov-21
C1071040,10191002,5,PF-06863135,T,6517418458,6.51742E+11,20210727,11:03,CYCLE1_DAY15,0 H,637.9001668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 52,2RSYC,27-Oct-21
C1071040,10191002,5,PF-06863135,T,6517418463,6.51742E+11,20210803,11:01,CYCLE1_DAY22,0 H,620.941926,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 53,2RSYC,27-Oct-21
C1071040,10191002,5,PF-06863135,T,6517418466,6.51742E+11,20210810,14:50,CYCLE2_DAY1,0 H,209.1731831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 54,2RSYC,27-Oct-21
C1071040,10191002,5,PF-06863135,T,6517418472,6.51742E+11,20210907,13:01,CYCLE3_DAY1,0 H,870.8370609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 171,6RSYC,29-Oct-21
C1071040,10191002,5,PF-06863135,T,6517246394,6.51725E+11,20211005,11:57,CYCLE4_DAY1,0 H,748.4652684,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 279,14RSYC,15-Nov-21
C1071040,10191002,5,PF-06863135,T,6517418479,6.51742E+11,20211228,9:17,CYCLE7_DAY1,0 H,726.4705505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 965,65RSYC,3-May-22
C1071040,10191002,5,PF-06863135,T,6518807116,6.51881E+11,20220322,10:45,CYCLE10_DAY1,0 H,821.6923331,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1890,87RSYC,13-May-22
C1071040,10191002,5,PF-06863135,T,6518807118,6.51881E+11,20220614,10:34,CYCLE13_DAY1,0 H,672.3130336,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2007,115RSYC,25-Jul-22
C1071040,10191002,5,PF-06863135,T,6520491233,6.52049E+11,20220906,11:18,CYCLE16_DAY1,0 H,510.8415888,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2077,131RSYC,9-Nov-22
C1071040,10191002,5,PF-06863135,T,6520491234,6.52049E+11,20221130,10:23,CYCLE19_DAY1,0 H,492.8389934,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2128,139RSYC,22-Mar-23
C1071040,10191002,5,PF-06863135,T,6521907800,6.52191E+11,20230221,10:32,CYCLE22_DAY1,0 H,2.365466343,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2203,141RSYC,17-May-23
C1071040,10191002,5,PF-06863135,T,6521907798,6.52191E+11,20230518,13:22,CYCLE25_DAY1,0 H,787.5492519,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2244,145RSYC,4-Jan-24
C1071040,10191002,5,PF-06863135,T,6521907801,6.52191E+11,20230718,11:56,END_OF_TRT,,561.2621897,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2280,145RSYC,4-Jan-24
C1071040,10191002,5,PF-06863135,T,6517246397,6.51725E+11,20210713,12:35,CYCLE1_DAY1,24 H,352.0899213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 55,11RSYC,2-Nov-21
C1071040,10191002,5,PF-06863135,T,6517418482,6.51742E+11,20210715,10:12,CYCLE1_DAY4,0 H,125.1630329,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 56,13RSYC,15-Nov-21
C1071040,10191002,5,PF-06863135,T,6517246497,6.51725E+11,20210716,12:20,CYCLE1_DAY4,24 H,413.329992,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 57,12RSYC,2-Nov-21
C1071040,10981001,6,PF-06863135,T,6517246478,6.51725E+11,20210719,10:30,CYCLE1_DAY1,0 H,441.0094547,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 58,2RSYC,27-Oct-21
C1071040,10981001,6,PF-06863135,T,6517246478,6.51725E+11,20210719,20:30,CYCLE1_DAY1,6 H,946.3719044,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 59,2RSYC,27-Oct-21
C1071040,10981001,6,PF-06863135,T,6516326701,6.51633E+11,20210727,9:30,CYCLE1_DAY8,0 H,650.6394622,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 60,12RSYC,2-Nov-21
C1071040,10981001,6,PF-06863135,T,6516326701,6.51633E+11,20210727,16:30,CYCLE1_DAY8,6 H,344.0223553,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 61,3RSYC,28-Oct-21
C1071040,10981001,6,PF-06863135,T,6517246482,6.51725E+11,20210802,11:10,CYCLE1_DAY15,0 H,512.0516973,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 62,3RSYC,28-Oct-21
C1071040,10981001,6,PF-06863135,T,6517769668,6.51777E+11,20210809,11:05,CYCLE1_DAY22,0 H,387.6684532,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 63,3RSYC,28-Oct-21
C1071040,10981001,6,PF-06863135,T,6517769674,6.51777E+11,20210816,11:45,CYCLE2_DAY1,0 H,290.2921462,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 64,3RSYC,28-Oct-21
C1071040,10981001,6,PF-06863135,T,6517769676,6.51777E+11,20210913,11:00,CYCLE3_DAY1,0 H,865.1971903,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 194,7RSYC,29-Oct-21
C1071040,10981001,6,PF-06863135,T,6517768789,6.51777E+11,20211011,11:04,CYCLE4_DAY1,0 H,13.70405901,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 341,16RSYC,16-Nov-21
C1071040,10981001,6,PF-06863135,T,6517246506,6.51725E+11,20210721,14:44,UNPL,9003 H,825.0551385,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 65,11RSYC,2-Nov-21
C1071040,10981001,6,PF-06863135,T,6517246494,6.51725E+11,20210720,14:30,CYCLE1_DAY1,24 H,795.4737079,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 66,3RSYC,28-Oct-21
C1071040,10981001,6,PF-06863135,T,6517246496,6.51725E+11,20210722,6:25,CYCLE1_DAY4,0 H,72.98321416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 67,3RSYC,28-Oct-21
C1071040,10981001,6,PF-06863135,T,6517246498,6.51725E+11,20210724,11:00,CYCLE1_DAY4,24 H,932.6289511,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 68,3RSYC,28-Oct-21
C1071040,10981002,7,PF-06863135,T,6516326700,6.51633E+11,20210723,10:56,CYCLE1_DAY1,0 H,114.8519783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 69,3RSYC,28-Oct-21
C1071040,10981002,7,PF-06863135,T,6516326700,6.51633E+11,20210723,19:48,CYCLE1_DAY1,6 H,577.6513252,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 70,3RSYC,28-Oct-21
C1071040,10981002,7,PF-06863135,T,6517769660,6.51777E+11,20210730,8:25,CYCLE1_DAY8,0 H,930.4619258,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 71,3RSYC,28-Oct-21
C1071040,10981002,7,PF-06863135,T,6517769660,6.51777E+11,20210802,18:30,CYCLE1_DAY8,6 H,655.1144452,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 72,3RSYC,28-Oct-21
C1071040,10981002,7,PF-06863135,T,6517769666,6.51777E+11,20210812,9:36,CYCLE1_DAY15,0 H,225.2485564,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 73,3RSYC,28-Oct-21
C1071040,10981002,7,PF-06863135,T,6517246507,6.51725E+11,20210817,17:12,END_OF_TRT,,672.7553498,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 74,3RSYC,28-Oct-21
C1071040,10981002,7,PF-06863135,T,6517560594,6.51756E+11,20210724,11:40,CYCLE1_DAY1,24 H,761.1316628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 75,3RSYC,28-Oct-21
C1071040,10981002,7,PF-06863135,T,6517560596,6.51756E+11,20210726,11:57,CYCLE1_DAY4,0 H,110.7089825,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 76,3RSYC,28-Oct-21
C1071040,10981002,7,PF-06863135,T,6517560598,6.51756E+11,20210727,13:43,CYCLE1_DAY4,24 H,386.7068313,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 77,3RSYC,28-Oct-21
C1071040,10031005,8,PF-06863135,T,6516580385,6.51658E+11,20210802,12:32,CYCLE1_DAY1,0 H,398.6884631,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 78,3RSYC,28-Oct-21
C1071040,10031005,8,PF-06863135,T,6516580385,6.51658E+11,20210802,18:59,CYCLE1_DAY1,6 H,64.59937573,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 79,3RSYC,28-Oct-21
C1071040,10031005,8,PF-06863135,T,6517889669,6.51789E+11,20210812,10:50,CYCLE1_DAY8,0 H,353.5060768,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 80,3RSYC,28-Oct-21
C1071040,10031005,8,PF-06863135,T,6517889669,6.51789E+11,20210812,17:00,CYCLE1_DAY8,6 H,910.961424,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 81,3RSYC,28-Oct-21
C1071040,10031005,8,PF-06863135,T,6517473942,6.51747E+11,20210803,14:10,CYCLE1_DAY1,24 H,249.5104645,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 82,3RSYC,28-Oct-21
C1071040,10031005,8,PF-06863135,T,6517473943,6.51747E+11,20210806,9:30,CYCLE1_DAY4,0 H,805.9913184,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 83,3RSYC,28-Oct-21
C1071040,10031005,8,PF-06863135,T,6517473952,6.51747E+11,20210807,9:35,CYCLE1_DAY4,24 H,63.35799895,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 84,3RSYC,28-Oct-21
C1071040,10191004,9,PF-06863135,T,6517418450,6.51742E+11,20210802,9:36,CYCLE1_DAY1,0 H,776.4707758,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 85,3RSYC,28-Oct-21
C1071040,10191004,9,PF-06863135,T,6517418450,6.51742E+11,20210802,17:10,CYCLE1_DAY1,6 H,795.5331451,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 86,3RSYC,28-Oct-21
C1071040,10191004,9,PF-06863135,T,6517418457,6.51742E+11,20210809,9:28,CYCLE1_DAY8,0 H,220.7947731,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 87,12RSYC,2-Nov-21
C1071040,10191004,9,PF-06863135,T,6517418457,6.51742E+11,20210809,17:15,CYCLE1_DAY8,6 H,428.5091481,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 88,3RSYC,28-Oct-21
C1071040,10191004,9,PF-06863135,T,6517418459,6.51742E+11,20210816,8:40,CYCLE1_DAY15,0 H,35.16510768,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 89,3RSYC,28-Oct-21
C1071040,10191004,9,PF-06863135,T,6517246387,6.51725E+11,20210823,9:10,CYCLE1_DAY22,0 H,541.1907299,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 172,6RSYC,29-Oct-21
C1071040,10191004,9,PF-06863135,T,6517418467,6.51742E+11,20210830,8:50,CYCLE2_DAY1,0 H,615.9415025,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 173,6RSYC,29-Oct-21
C1071040,10191004,9,PF-06863135,T,6517246393,6.51725E+11,20211025,10:19,CYCLE4_DAY1,0 H,919.425621,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 517,25RSYC,22-Apr-22
C1071040,10191004,9,PF-06863135,T,6517418481,6.51742E+11,20220117,9:30,CYCLE7_DAY1,0 H,724.8854429,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1610,97RSYC,12-May-22
C1071040,10191004,9,PF-06863135,T,6518807117,6.51881E+11,20220411,9:39,CYCLE10_DAY1,0 H,871.7418045,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1922,123RSYC,29-Jul-22
C1071040,10191004,9,PF-06863135,T,6520491237,6.52049E+11,20220705,10:31,CYCLE13_DAY1,0 H,950.4692152,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2027,128RSYC,21-Oct-22
C1071040,10191004,9,PF-06863135,T,6520491231,6.52049E+11,20220926,10:05,CYCLE16_DAY1,0 H,510.9036442,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2107,131RSYC,9-Nov-22
C1071040,10191004,9,PF-06863135,T,6521907799,6.52191E+11,20221219,9:32,CYCLE19_DAY1,0 H,849.7480365,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2171,140RSYC,22-Mar-23
C1071040,10191004,9,PF-06863135,T,6521907796,6.52191E+11,20230313,10:19,CYCLE22_DAY1,0 H,950.3572403,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2204,141RSYC,17-May-23
C1071040,10191004,9,PF-06863135,T,6522691980,6.52269E+11,20230605,10:30,CYCLE25_DAY1,0 H,166.9682314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2261,144RSYC,27-Nov-23
C1071040,10191004,9,PF-06863135,T,6522691972,6.52269E+11,20230828,10:29,CYCLE28_DAY1,0 H,261.0933491,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2300,147RSYC,29-Feb-24
C1071040,10191004,9,PF-06863135,T,6517246398,6.51725E+11,20210803,11:15,CYCLE1_DAY1,24 H,946.0966537,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 90,3RSYC,28-Oct-21
C1071040,10191004,9,PF-06863135,T,6517418484,6.51742E+11,20210805,8:24,CYCLE1_DAY4,0 H,348.7153549,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 91,4RSYC,28-Oct-21
C1071040,10191004,9,PF-06863135,T,6517418487,6.51742E+11,20210806,11:05,CYCLE1_DAY4,24 H,74.05717177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 92,12RSYC,2-Nov-21
C1071040,10681004,10,PF-06863135,T,6517472543,6.51747E+11,20210802,14:55,CYCLE1_DAY1,0 H,594.7425215,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 93,4RSYC,28-Oct-21
C1071040,10681004,10,PF-06863135,T,6517472543,6.51747E+11,20210802,20:40,CYCLE1_DAY1,6 H,918.4231689,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 94,4RSYC,28-Oct-21
C1071040,10681004,10,PF-06863135,T,6517763953,6.51776E+11,20210812,17:25,END_OF_TRT,,721.4859817,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 95,4RSYC,28-Oct-21
C1071040,10681004,10,PF-06863135,T,6517260791,6.51726E+11,20210803,14:56,CYCLE1_DAY1,24 H,826.6650592,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 96,4RSYC,28-Oct-21
C1071040,10681004,10,PF-06863135,T,6517472561,6.51747E+11,20210805,8:30,CYCLE1_DAY4,0 H,978.3149392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 97,4RSYC,28-Oct-21
C1071040,10681004,10,PF-06863135,T,6517763951,6.51776E+11,20210806,11:30,CYCLE1_DAY4,24 H,386.6010487,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 98,4RSYC,28-Oct-21
C1071040,10821001,11,PF-06863135,T,6603295436,6.6033E+11,20210809,15:45,CYCLE1_DAY1,0 H,139.5787358,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1,1RSYC,26-Oct-21
C1071040,10821001,11,PF-06863135,T,6603295436,6.6033E+11,20210809,22:10,CYCLE1_DAY1,6 H,598.6653966,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2,11RSYC,2-Nov-21
C1071040,10821001,11,PF-06863135,T,6603295460,6.6033E+11,20210816,19:25,UNPL,9001 H,367.5403624,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 3,1RSYC,26-Oct-21
C1071040,10821001,11,PF-06863135,T,6603295452,6.6033E+11,20210810,14:30,CYCLE1_DAY1,24 H,938.8377559,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 4,11RSYC,2-Nov-21
C1071040,10821001,11,PF-06863135,T,6603295454,6.6033E+11,20210812,18:20,CYCLE1_DAY4,0 H,921.1094037,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 5,11RSYC,2-Nov-21
C1071040,10821001,11,PF-06863135,T,6603295456,6.6033E+11,20210813,19:02,CYCLE1_DAY4,24 H,822.4699408,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 6,11RSYC,2-Nov-21
C1071040,10771001,12,PF-06863135,T,6517246446,6.51725E+11,20210806,13:05,CYCLE1_DAY1,0 H,215.8657167,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 185,7RSYC,29-Oct-21
C1071040,10771001,12,PF-06863135,T,6517246446,6.51725E+11,20210806,20:10,CYCLE1_DAY1,6 H,227.9534937,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 184,7RSYC,29-Oct-21
C1071040,10771001,12,PF-06863135,T,6517246448,6.51725E+11,20210813,10:00,CYCLE1_DAY8,0 H,763.6867025,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 187,12RSYC,2-Nov-21
C1071040,10771001,12,PF-06863135,T,6517246448,6.51725E+11,20210813,17:20,CYCLE1_DAY8,6 H,631.6693406,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 186,7RSYC,29-Oct-21
C1071040,10771001,12,PF-06863135,T,6517643718,6.51764E+11,20210819,10:20,CYCLE1_DAY15,0 H,292.0869031,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 192,7RSYC,29-Oct-21
C1071040,10771001,12,PF-06863135,T,6517246452,6.51725E+11,20210825,10:38,CYCLE1_DAY22,0 H,77.18760643,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 188,7RSYC,29-Oct-21
C1071040,10771001,12,PF-06863135,T,6517246453,6.51725E+11,20210908,10:52,CYCLE2_DAY1,0 H,768.0535364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 189,7RSYC,29-Oct-21
C1071040,10771001,12,PF-06863135,T,6517246455,6.51725E+11,20211006,11:34,CYCLE3_DAY1,0 H,564.4667369,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 280,14RSYC,15-Nov-21
C1071040,10771001,12,PF-06863135,T,6517775846,6.51778E+11,20211103,11:50,UNPL,9001 H,291.0175114,NG/ML,,Visit revised; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 910,20RSYC,19-Apr-22
C1071040,10771001,12,PF-06863135,T,6517246461,6.51725E+11,20210807,14:10,CYCLE1_DAY1,24 H,369.9011543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 190,7RSYC,29-Oct-21
C1071040,10771001,12,PF-06863135,T,6517246464,6.51725E+11,20210809,12:20,CYCLE1_DAY4,0 H,980.7920067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 191,7RSYC,29-Oct-21
C1071040,10771001,12,PF-06863135,T,6517775855,6.51778E+11,20210810,14:55,CYCLE1_DAY4,24 H,546.9467488,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 193,7RSYC,29-Oct-21
C1071040,10031004,13,PF-06863135,T,6516580382,6.51658E+11,20210809,10:50,CYCLE1_DAY1,0 H,74.9618255,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 99,4RSYC,28-Oct-21
C1071040,10031004,13,PF-06863135,T,6516580382,6.51658E+11,20210809,18:15,CYCLE1_DAY1,6 H,924.3496533,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 100,4RSYC,28-Oct-21
C1071040,10031004,13,PF-06863135,T,6517751580,6.51775E+11,20211004,10:58,CYCLE3_DAY1,0 H,395.4610102,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 332,16RSYC,16-Nov-21
C1071040,10031004,13,PF-06863135,T,6517751588,6.51775E+11,20211101,13:40,CYCLE4_DAY1,0 H,81.84830489,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 590,27RSYC,21-Apr-22
C1071040,10031004,13,PF-06863135,T,6517889684,6.51789E+11,20210810,12:27,CYCLE1_DAY1,24 H,871.4049878,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 102,4RSYC,28-Oct-21
C1071040,10031004,13,PF-06863135,T,6517889686,6.51789E+11,20210811,16:15,CYCLE1_DAY4,0 H,899.0638012,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 103,4RSYC,28-Oct-21
C1071040,10031004,13,PF-06863135,T,6517889689,6.51789E+11,20210812,16:57,CYCLE1_DAY4,24 H,552.5580711,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 101,4RSYC,28-Oct-21
C1071040,11171001,14,PF-06863135,T,6517764044,6.51776E+11,20210809,10:23,CYCLE1_DAY1,0 H,719.5642221,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 104,4RSYC,28-Oct-21
C1071040,11171001,14,PF-06863135,T,6517764044,6.51776E+11,20210809,17:23,CYCLE1_DAY1,6 H,139.1122038,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 105,9RSYC,1-Nov-21
C1071040,11171001,14,PF-06863135,T,6517764048,6.51776E+11,20210818,9:25,CYCLE1_DAY8,0 H,495.4913007,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 106,12RSYC,2-Nov-21
C1071040,11171001,14,PF-06863135,T,6517764048,6.51776E+11,20210818,17:50,CYCLE1_DAY8,6 H,205.187412,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 107,4RSYC,28-Oct-21
C1071040,11171001,14,PF-06863135,T,6517433559,6.51743E+11,20210826,9:41,CYCLE1_DAY15,0 H,984.6507975,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 196,7RSYC,29-Oct-21
C1071040,11171001,14,PF-06863135,T,6517433562,6.51743E+11,20210902,9:30,CYCLE1_DAY22,0 H,325.9654388,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 195,7RSYC,29-Oct-21
C1071040,11171001,14,PF-06863135,T,6517433563,6.51743E+11,20210909,13:33,CYCLE2_DAY1,0 H,976.7133339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 197,7RSYC,29-Oct-21
C1071040,11171001,14,PF-06863135,T,6518158468,6.51816E+11,20211007,9:00,CYCLE3_DAY1,0 H,0.291528846,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 352,17RSYC,17-Nov-21
C1071040,11171001,14,PF-06863135,T,6518158472,6.51816E+11,20211104,10:41,CYCLE4_DAY1,0 H,253.3036852,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 604,27RSYC,21-Apr-22
C1071040,11171001,14,PF-06863135,T,6517764069,6.51776E+11,20220127,9:20,CYCLE7_DAY1,0 H,169.3978874,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1724,72RSYC,7-May-22
C1071040,11171001,14,PF-06863135,T,6518390144,6.51839E+11,20220421,8:04,CYCLE10_DAY1,0 H,330.5552987,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1983,114RSYC,25-Jul-22
C1071040,11171001,14,PF-06863135,T,6518390143,6.51839E+11,20220714,8:45,CYCLE13_DAY1,0 H,640.5594156,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2093,127RSYC,19-Oct-22
C1071040,11171001,14,PF-06863135,T,6517764086,6.51776E+11,20220912,7:30,END_OF_TRT,,393.6527224,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2100,132RSYC,10-Nov-22
C1071040,11171001,14,PF-06863135,T,6517433571,6.51743E+11,20210810,11:15,CYCLE1_DAY1,24 H,881.418887,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 108,4RSYC,28-Oct-21
C1071040,11171001,14,PF-06863135,T,6517433573,6.51743E+11,20210812,6:28,CYCLE1_DAY4,0 H,466.3177469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 109,4RSYC,28-Oct-21
C1071040,11171001,14,PF-06863135,T,6517433575,6.51743E+11,20210813,11:45,CYCLE1_DAY4,24 H,145.4933295,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 110,4RSYC,28-Oct-21
C1071040,11171002,15,PF-06863135,T,6517764040,6.51776E+11,20210809,10:30,CYCLE1_DAY1,0 H,550.5824872,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 111,4RSYC,28-Oct-21
C1071040,11171002,15,PF-06863135,T,6517764040,6.51776E+11,20210809,17:30,CYCLE1_DAY1,6 H,278.8828737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 112,4RSYC,28-Oct-21
C1071040,11171002,15,PF-06863135,T,6517764047,6.51776E+11,20210816,8:40,CYCLE1_DAY8,0 H,38.0359079,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 113,12RSYC,2-Nov-21
C1071040,11171002,15,PF-06863135,T,6517764047,6.51776E+11,20210816,17:36,CYCLE1_DAY8,6 H,72.61645107,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 114,4RSYC,28-Oct-21
C1071040,11171002,15,PF-06863135,T,6517433560,6.51743E+11,20210825,9:40,CYCLE1_DAY15,0 H,650.4766053,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 199,7RSYC,29-Oct-21
C1071040,11171002,15,PF-06863135,T,6517433561,6.51743E+11,20210901,10:12,CYCLE1_DAY22,0 H,126.641553,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 198,7RSYC,29-Oct-21
C1071040,11171002,15,PF-06863135,T,6517764062,6.51776E+11,20210908,12:20,CYCLE2_DAY1,0 H,983.6273813,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 200,7RSYC,29-Oct-21
C1071040,11171002,15,PF-06863135,T,6518158467,6.51816E+11,20211006,9:25,CYCLE3_DAY1,0 H,865.1094649,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 351,17RSYC,17-Nov-21
C1071040,11171002,15,PF-06863135,T,6518158471,6.51816E+11,20211102,10:37,CYCLE4_DAY1,0 H,929.7807275,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 603,27RSYC,21-Apr-22
C1071040,11171002,15,PF-06863135,T,6517764089,6.51776E+11,20211123,9:24,END_OF_TRT,,338.7080409,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 906,86RSYC,13-May-22
C1071040,11171002,15,PF-06863135,T,6517764071,6.51776E+11,20210810,11:20,CYCLE1_DAY1,24 H,554.6272185,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 115,4RSYC,28-Oct-21
C1071040,11171002,15,PF-06863135,T,6517764076,6.51776E+11,20210812,6:34,CYCLE1_DAY4,0 H,57.88740324,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 116,4RSYC,28-Oct-21
C1071040,11171002,15,PF-06863135,T,6517433576,6.51743E+11,20210813,11:30,CYCLE1_DAY4,24 H,435.9972806,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 117,12RSYC,2-Nov-21
C1071040,10031006,16,PF-06863135,T,6517751563,6.51775E+11,20210816,10:35,CYCLE1_DAY1,0 H,662.5590279,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 118,4RSYC,28-Oct-21
C1071040,10031006,16,PF-06863135,T,6517751563,6.51775E+11,20210816,17:36,CYCLE1_DAY1,6 H,710.3303154,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 119,4RSYC,28-Oct-21
C1071040,10031006,16,PF-06863135,T,6517889668,6.51789E+11,20210825,11:20,CYCLE1_DAY8,0 H,228.7074378,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 179,12RSYC,2-Nov-21
C1071040,10031006,16,PF-06863135,T,6517889668,6.51789E+11,20210825,17:02,CYCLE1_DAY8,6 H,914.848947,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 178,6RSYC,29-Oct-21
C1071040,10031006,16,PF-06863135,T,6517751571,6.51775E+11,20210901,16:35,CYCLE1_DAY15,0 H,88.42726324,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 175,6RSYC,29-Oct-21
C1071040,10031006,16,PF-06863135,T,6517751572,6.51775E+11,20210908,13:16,CYCLE1_DAY22,0 H,663.0228102,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 176,6RSYC,29-Oct-21
C1071040,10031006,16,PF-06863135,T,6517751576,6.51775E+11,20210915,10:10,CYCLE2_DAY1,0 H,816.2780278,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 177,6RSYC,29-Oct-21
C1071040,10031006,16,PF-06863135,T,6517751585,6.51775E+11,20211110,14:44,CYCLE4_DAY1,0 H,685.4306657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 901,20RSYC,19-Apr-22
C1071040,10031006,16,PF-06863135,T,6517260610,6.51726E+11,20210817,11:30,CYCLE1_DAY1,24 H,219.1756678,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 120,5RSYC,28-Oct-21
C1071040,10031006,16,PF-06863135,T,6517889687,6.51789E+11,20210820,14:00,CYCLE1_DAY4,0 H,269.3654872,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1086,67RSYC,8-May-22
C1071040,10031006,16,PF-06863135,T,6517889688,6.51789E+11,20210821,12:45,CYCLE1_DAY4,24 H,368.5714213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1087,87RSYC,13-May-22
C1071040,10021001,17,PF-06863135,T,6603324910,6.60332E+11,20210816,9:25,CYCLE1_DAY1,0 H,338.360556,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 7,1RSYC,26-Oct-21
C1071040,10021001,17,PF-06863135,T,6603324910,6.60332E+11,20210816,16:26,CYCLE1_DAY1,6 H,436.7042455,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 8,11RSYC,2-Nov-21
C1071040,10021001,17,PF-06863135,T,6603324913,6.60332E+11,20210823,13:15,CYCLE1_DAY8,0 H,107.5247689,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 132,12RSYC,2-Nov-21
C1071040,10021001,17,PF-06863135,T,6603324913,6.60332E+11,20210823,20:00,CYCLE1_DAY8,6 H,196.2829693,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 133,5RSYC,28-Oct-21
C1071040,10021001,17,PF-06863135,T,6603324915,6.60332E+11,20210830,12:52,CYCLE1_DAY15,0 H,575.40644,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 134,5RSYC,28-Oct-21
C1071040,10021001,17,PF-06863135,T,6603324917,6.60332E+11,20210906,10:00,CYCLE1_DAY22,0 H,373.4738062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 135,5RSYC,28-Oct-21
C1071040,10021001,17,PF-06863135,T,6603324919,6.60332E+11,20210913,12:50,CYCLE2_DAY1,0 H,492.5560742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 136,5RSYC,28-Oct-21
C1071040,10021001,17,PF-06863135,T,6603324921,6.60332E+11,20211013,13:40,CYCLE3_DAY1,0 H,507.1139795,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 236,13RSYC,15-Nov-21
C1071040,10021001,17,PF-06863135,T,6603324923,6.60332E+11,20211110,14:40,CYCLE4_DAY1,0 H,74.10309128,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 813,34RSYC,24-Apr-22
C1071040,10021001,17,PF-06863135,T,6603324924,6.60332E+11,20220202,11:35,CYCLE7_DAY1,0 H,847.7731608,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1582,59RSYC,1-May-22
C1071040,10021001,17,PF-06863135,T,6603839288,6.60384E+11,20220427,12:25,CYCLE10_DAY1,0 H,493.7705132,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2002,115RSYC,25-Jul-22
C1071040,10021001,17,PF-06863135,T,6603324933,6.60332E+11,20220720,12:30,CYCLE13_DAY1,0 H,383.9995589,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2066,132RSYC,10-Nov-22
C1071040,10021001,17,PF-06863135,T,6604204206,6.6042E+11,20221012,12:45,CYCLE16_DAY1,0 H,771.4849143,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2114,131RSYC,9-Nov-22
C1071040,10021001,17,PF-06863135,T,6604204199,6.6042E+11,20230105,11:45,CYCLE19_DAY1,0 H,751.5482861,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2185,141RSYC,17-May-23
C1071040,10021001,17,PF-06863135,T,6604204200,6.6042E+11,20230329,11:10,CYCLE22_DAY1,0 H,740.4856008,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2234,143RSYC,27-Nov-23
C1071040,10021001,17,PF-06863135,T,6604608949,6.60461E+11,20230913,12:38,CYCLE28_DAY1,0 H,223.7902568,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2335,148RSYC,27-Mar-24
C1071040,10021001,17,PF-06863135,T,6604777912,6.60478E+11,20231206,14:30,CYCLE31_DAY1,0 H,816.9557126,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2336,148RSYC,27-Mar-24
C1071040,10021001,17,PF-06863135,T,6604777916,6.60478E+11,20240228,13:40,CYCLE34_DAY1,0 H,,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071040,10021001,17,PF-06863135,T,6603324937,6.60332E+11,20210820,20:18,UNPL,9002 H,365.7903163,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 137,5RSYC,28-Oct-21
C1071040,10021001,17,PF-06863135,T,6603324926,6.60332E+11,20210817,9:27,CYCLE1_DAY1,24 H,340.1353156,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 9,11RSYC,2-Nov-21
C1071040,10021001,17,PF-06863135,T,6603324929,6.60332E+11,20210819,9:35,CYCLE1_DAY4,0 H,892.4792658,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 10,11RSYC,2-Nov-21
C1071040,10021001,17,PF-06863135,T,6603324931,6.60332E+11,20210820,9:20,CYCLE1_DAY4,24 H,541.6959517,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 11,11RSYC,2-Nov-21
C1071040,11171003,18,PF-06863135,T,6517764042,6.51776E+11,20210816,10:11,CYCLE1_DAY1,0 H,340.3194359,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 121,5RSYC,28-Oct-21
C1071040,11171003,18,PF-06863135,T,6517764042,6.51776E+11,20210816,17:28,CYCLE1_DAY1,6 H,223.0333401,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 122,9RSYC,1-Nov-21
C1071040,11171003,18,PF-06863135,T,6517764046,6.51776E+11,20210823,8:26,CYCLE1_DAY8,0 H,31.76471278,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 123,12RSYC,2-Nov-21
C1071040,11171003,18,PF-06863135,T,6517764046,6.51776E+11,20210823,17:10,CYCLE1_DAY8,6 H,472.6693926,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 124,5RSYC,28-Oct-21
C1071040,11171003,18,PF-06863135,T,6517764050,6.51776E+11,20210830,10:40,CYCLE1_DAY15,0 H,250.0819453,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 201,7RSYC,29-Oct-21
C1071040,11171003,18,PF-06863135,T,6517764058,6.51776E+11,20210907,10:40,CYCLE1_DAY22,0 H,578.9853583,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 202,7RSYC,29-Oct-21
C1071040,11171003,18,PF-06863135,T,6517764063,6.51776E+11,20210915,12:22,CYCLE2_DAY1,0 H,654.9034414,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 203,7RSYC,29-Oct-21
C1071040,11171003,18,PF-06863135,T,6517433565,6.51743E+11,20211015,9:10,CYCLE3_DAY1,0 H,252.2769876,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 545,26RSYC,22-Apr-22
C1071040,11171003,18,PF-06863135,T,6517764068,6.51776E+11,20211110,11:57,CYCLE4_DAY1,0 H,337.1915407,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 596,27RSYC,21-Apr-22
C1071040,11171003,18,PF-06863135,T,6517433570,6.51743E+11,20220202,8:24,CYCLE7_DAY1,0 H,531.0264545,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1725,72RSYC,7-May-22
C1071040,11171003,18,PF-06863135,T,6517764088,6.51776E+11,20220331,13:54,END_OF_TRT,,593.1234702,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1923,123RSYC,29-Jul-22
C1071040,11171003,18,PF-06863135,T,6517433572,6.51743E+11,20210817,11:02,CYCLE1_DAY1,24 H,411.0454013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 125,5RSYC,28-Oct-21
C1071040,11171003,18,PF-06863135,T,6517764077,6.51776E+11,20210819,11:19,CYCLE1_DAY4,0 H,47.86799662,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 126,5RSYC,28-Oct-21
C1071040,11171003,18,PF-06863135,T,6517764082,6.51776E+11,20210820,11:02,CYCLE1_DAY4,24 H,528.8553283,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 204,7RSYC,29-Oct-21
C1071040,11171005,19,PF-06863135,T,6517433556,6.51743E+11,20210816,10:31,CYCLE1_DAY1,0 H,791.6699355,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 127,5RSYC,28-Oct-21
C1071040,11171005,19,PF-06863135,T,6517433556,6.51743E+11,20210816,17:32,CYCLE1_DAY1,6 H,847.6640616,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 128,9RSYC,1-Nov-21
C1071040,11171005,19,PF-06863135,T,6517764045,6.51776E+11,20210823,7:50,CYCLE1_DAY8,0 H,133.7566851,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 205,12RSYC,2-Nov-21
C1071040,11171005,19,PF-06863135,T,6517764045,6.51776E+11,20210823,18:15,CYCLE1_DAY8,6 H,256.9815782,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 129,5RSYC,28-Oct-21
C1071040,11171005,19,PF-06863135,T,6517764053,6.51776E+11,20210901,10:12,CYCLE1_DAY15,0 H,461.7311096,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 206,7RSYC,29-Oct-21
C1071040,11171005,19,PF-06863135,T,6517764057,6.51776E+11,20210907,10:15,CYCLE1_DAY22,0 H,984.0655986,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 207,7RSYC,29-Oct-21
C1071040,11171005,19,PF-06863135,T,6518158469,6.51816E+11,20211011,8:50,CYCLE3_DAY1,0 H,69.07363949,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 353,17RSYC,17-Nov-21
C1071040,11171005,19,PF-06863135,T,6517433586,6.51743E+11,20211108,11:25,END_OF_TRT,,75.72526021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 546,86RSYC,13-May-22
C1071040,11171005,19,PF-06863135,T,6517764073,6.51776E+11,20210817,10:50,CYCLE1_DAY1,24 H,589.2851487,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 130,5RSYC,28-Oct-21
C1071040,11171005,19,PF-06863135,T,6517764078,6.51776E+11,20210819,11:18,CYCLE1_DAY4,0 H,640.0772911,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 131,5RSYC,28-Oct-21
C1071040,11171005,19,PF-06863135,T,6517764081,6.51776E+11,20210820,11:22,CYCLE1_DAY4,24 H,88.57767666,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 208,7RSYC,29-Oct-21
C1071040,10071002,20,PF-06863135,T,6517472394,6.51747E+11,20210824,12:45,CYCLE1_DAY1,0 H,292.0321037,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 163,6RSYC,29-Oct-21
C1071040,10071002,20,PF-06863135,T,6517472394,6.51747E+11,20210824,18:50,CYCLE1_DAY1,6 H,320.1711758,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 162,9RSYC,1-Nov-21
C1071040,10071002,20,PF-06863135,T,6517472396,6.51747E+11,20210903,9:50,CYCLE1_DAY8,0 H,723.8099147,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 164,6RSYC,29-Oct-21
C1071040,10071002,20,PF-06863135,T,6517472396,6.51747E+11,20210903,16:31,CYCLE1_DAY8,6 H,605.8777813,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 165,6RSYC,29-Oct-21
C1071040,10071002,20,PF-06863135,T,6517472399,6.51747E+11,20210913,7:50,CYCLE1_DAY15,0 H,755.0744715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 166,6RSYC,29-Oct-21
C1071040,10071002,20,PF-06863135,T,6517472401,6.51747E+11,20210923,8:10,CYCLE1_DAY22,0 H,256.6266619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 167,6RSYC,29-Oct-21
C1071040,10071002,20,PF-06863135,T,6517472403,6.51747E+11,20210930,8:30,CYCLE2_DAY1,0 H,121.6087641,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 292,15RSYC,16-Nov-21
C1071040,10071002,20,PF-06863135,T,6517472405,6.51747E+11,20211104,8:10,CYCLE3_DAY1,0 H,787.4992346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 551,26RSYC,22-Apr-22
C1071040,10071002,20,PF-06863135,T,6517472408,6.51747E+11,20220217,8:40,CYCLE7_DAY1,0 H,379.1833957,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1598,96RSYC,12-May-22
C1071040,10071002,20,PF-06863135,T,6517472417,6.51747E+11,20220520,9:43,CYCLE10_DAY1,0 H,301.1039934,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1967,114RSYC,25-Jul-22
C1071040,10071002,20,PF-06863135,T,6518265670,6.51827E+11,20220812,8:40,CYCLE13_DAY1,0 H,610.3764224,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2075,129RSYC,21-Oct-22
C1071040,10071002,20,PF-06863135,T,6520930829,6.52093E+11,20221104,8:01,CYCLE16_DAY1,0 H,982.6076579,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2138,139RSYC,22-Mar-23
C1071040,10071002,20,PF-06863135,T,6521740462,6.52174E+11,20230127,7:52,CYCLE19_DAY1,0 H,129.26901,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2215,142RSYC,18-May-23
C1071040,10071002,20,PF-06863135,T,6521740465,6.52174E+11,20230421,7:55,CYCLE22_DAY1,0 H,688.3552233,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2245,143RSYC,27-Nov-23
C1071040,10071002,20,PF-06863135,T,6521740463,6.52174E+11,20230714,8:51,CYCLE25_DAY1,0 H,945.6250545,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2290,145RSYC,4-Jan-24
C1071040,10071002,20,PF-06863135,T,6523543385,6.52354E+11,20231229,9:17,CYCLE31_DAY1,0 H,498.4993013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2322,148RSYC,27-Mar-24
C1071040,10071002,20,PF-06863135,T,6520344352,6.52034E+11,20211203,8:10,UNPL,9001 H,418.2526543,NG/ML,,Received as 6517472406-02,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 992,66RSYC,3-May-22
C1071040,10071002,20,PF-06863135,T,6517472411,6.51747E+11,20210825,11:45,CYCLE1_DAY1,24 H,307.4484555,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 168,11RSYC,2-Nov-21
C1071040,10071002,20,PF-06863135,T,6517472412,6.51747E+11,20210830,14:00,CYCLE1_DAY4,0 H,260.3804311,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 169,6RSYC,29-Oct-21
C1071040,10071002,20,PF-06863135,T,6517472415,6.51747E+11,20210831,12:25,CYCLE1_DAY4,24 H,675.0149944,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 170,6RSYC,29-Oct-21
C1071040,10381001,21,PF-06863135,T,6603349515,6.60335E+11,20210830,9:13,CYCLE1_DAY1,0 H,582.1443244,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 138,5RSYC,28-Oct-21
C1071040,10381001,21,PF-06863135,T,6603349515,6.60335E+11,20210830,17:40,CYCLE1_DAY1,6 H,863.9029786,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 139,5RSYC,28-Oct-21
C1071040,10381001,21,PF-06863135,T,6603349517,6.60335E+11,20210906,13:34,CYCLE1_DAY8,0 H,978.9484059,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 140,12RSYC,2-Nov-21
C1071040,10381001,21,PF-06863135,T,6603349517,6.60335E+11,20210906,20:05,CYCLE1_DAY8,6 H,777.0871799,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 141,5RSYC,28-Oct-21
C1071040,10381001,21,PF-06863135,T,6603349519,6.60335E+11,20210914,13:32,CYCLE1_DAY15,0 H,51.62996469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 142,5RSYC,28-Oct-21
C1071040,10381001,21,PF-06863135,T,6603349520,6.60335E+11,20210921,13:54,CYCLE1_DAY22,0 H,708.4278775,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 143,5RSYC,28-Oct-21
C1071040,10381001,21,PF-06863135,T,6603349525,6.60335E+11,20211026,13:10,CYCLE3_DAY1,0 H,348.2902349,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 617,90RSYC,11-May-22
C1071040,10381001,21,PF-06863135,T,6603349527,6.60335E+11,20211123,13:07,CYCLE4_DAY1,0 H,486.028071,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 814,34RSYC,24-Apr-22
C1071040,10381001,21,PF-06863135,T,6603349528,6.60335E+11,20220216,8:45,CYCLE7_DAY1,0 H,472.2367515,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1589,59RSYC,1-May-22
C1071040,10381001,21,PF-06863135,T,6603682808,6.60368E+11,20220518,10:50,CYCLE10_DAY1,0 H,313.6983506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2004,115RSYC,25-Jul-22
C1071040,10381001,21,PF-06863135,T,6604047970,6.60405E+11,20220810,11:45,CYCLE13_DAY1,0 H,999.5221642,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2068,129RSYC,21-Oct-22
C1071040,10381001,21,PF-06863135,T,6603682806,6.60368E+11,20221102,12:20,CYCLE16_DAY1,0 H,211.6328583,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2150,139RSYC,22-Mar-23
C1071040,10381001,21,PF-06863135,T,6604047975,6.60405E+11,20230125,10:30,CYCLE19_DAY1,0 H,908.0899145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2187,141RSYC,17-May-23
C1071040,10381001,21,PF-06863135,T,6604254033,6.60425E+11,20230712,8:30,CYCLE25_DAY1,0 H,419.320467,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2270,144RSYC,27-Nov-23
C1071040,10381001,21,PF-06863135,T,6604594756,6.60459E+11,20231004,8:58,CYCLE28_DAY1,0 H,880.9459115,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2313,147RSYC,29-Feb-24
C1071040,10381001,21,PF-06863135,T,6605017953,6.60502E+11,20240110,11:40,END_OF_TRT,,164.4781336,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2337,152RSYC,9-Apr-24
C1071040,10381001,21,PF-06863135,T,6603349531,6.60335E+11,20210831,12:10,CYCLE1_DAY1,24 H,950.4429955,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 144,5RSYC,28-Oct-21
C1071040,10381001,21,PF-06863135,T,6603349532,6.60335E+11,20210902,12:20,CYCLE1_DAY4,0 H,32.56849984,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 145,5RSYC,28-Oct-21
C1071040,10381001,21,PF-06863135,T,6603349534,6.60335E+11,20210903,13:30,CYCLE1_DAY4,24 H,478.2069559,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 146,5RSYC,28-Oct-21
C1071040,10821003,22,PF-06863135,T,6603295435,6.6033E+11,20210906,13:40,CYCLE1_DAY1,0 H,558.2138848,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 147,5RSYC,28-Oct-21
C1071040,10821003,22,PF-06863135,T,6603295435,6.6033E+11,20210906,20:15,CYCLE1_DAY1,6 H,783.8186896,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 148,5RSYC,28-Oct-21
C1071040,10821003,22,PF-06863135,T,6603295437,6.6033E+11,20210913,12:21,CYCLE1_DAY8,0 H,915.813474,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 149,5RSYC,28-Oct-21
C1071040,10821003,22,PF-06863135,T,6603295437,6.6033E+11,20210913,19:50,CYCLE1_DAY8,6 H,656.5809448,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 150,6RSYC,29-Oct-21
C1071040,10821003,22,PF-06863135,T,6603295439,6.6033E+11,20210920,13:45,CYCLE1_DAY15,0 H,473.8538772,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 232,21RSYC,20-Apr-22
C1071040,10821003,22,PF-06863135,T,6603295441,6.6033E+11,20210930,13:05,CYCLE1_DAY22,0 H,130.8823187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 233,13RSYC,15-Nov-21
C1071040,10821003,22,PF-06863135,T,6603295459,6.6033E+11,20210908,18:45,UNPL,9001 H,254.8842185,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 151,11RSYC,2-Nov-21
C1071040,10821003,22,PF-06863135,T,6603295451,6.6033E+11,20210907,14:15,CYCLE1_DAY1,24 H,738.4149083,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 152,6RSYC,29-Oct-21
C1071040,10821003,22,PF-06863135,T,6603295453,6.6033E+11,20210910,12:20,CYCLE1_DAY4,0 H,0.348968489,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 153,6RSYC,29-Oct-21
C1071040,10821003,22,PF-06863135,T,6603295455,6.6033E+11,20210911,12:50,CYCLE1_DAY4,24 H,778.3509387,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 154,6RSYC,29-Oct-21
C1071040,10071003,23,PF-06863135,T,6517472395,6.51747E+11,20210930,12:10,CYCLE1_DAY1,0 H,925.3033187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 291,15RSYC,16-Nov-21
C1071040,10071003,23,PF-06863135,T,6517472395,6.51747E+11,20210930,18:20,CYCLE1_DAY1,6 H,91.12610882,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 290,15RSYC,16-Nov-21
C1071040,10071003,23,PF-06863135,T,6517472397,6.51747E+11,20211019,9:15,CYCLE1_DAY8,0 H,266.993289,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 548,26RSYC,22-Apr-22
C1071040,10071003,23,PF-06863135,T,6517472397,6.51747E+11,20211019,15:55,CYCLE1_DAY8,6 H,975.7593555,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 547,26RSYC,22-Apr-22
C1071040,10071003,23,PF-06863135,T,6517472398,6.51747E+11,20211025,11:05,CYCLE1_DAY15,0 H,793.0449954,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 549,26RSYC,22-Apr-22
C1071040,10071003,23,PF-06863135,T,6517472402,6.51747E+11,20211101,8:40,CYCLE2_DAY1,0 H,560.2750368,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 550,26RSYC,22-Apr-22
C1071040,10071003,23,PF-06863135,T,6517472404,6.51747E+11,20211129,8:25,CYCLE3_DAY1,0 H,759.1554911,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 991,66RSYC,3-May-22
C1071040,10071003,23,PF-06863135,T,6517472407,6.51747E+11,20211227,9:00,CYCLE4_DAY1,0 H,879.5811165,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 993,66RSYC,3-May-22
C1071040,10071003,23,PF-06863135,T,6517472425,6.51747E+11,20220124,8:25,END_OF_TRT,,827.9011641,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1599,110RSYC,25-May-22
C1071040,10071003,23,PF-06863135,T,6517472410,6.51747E+11,20211001,12:15,CYCLE1_DAY1,24 H,479.7935213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 293,15RSYC,16-Nov-21
C1071040,10071003,23,PF-06863135,T,6517472413,6.51747E+11,20211015,11:00,CYCLE1_DAY4,0 H,71.70218637,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 294,15RSYC,16-Nov-21
C1071040,10071003,23,PF-06863135,T,6517472414,6.51747E+11,20211016,10:30,CYCLE1_DAY4,24 H,818.0099962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 295,15RSYC,16-Nov-21
C1071040,11211001,24,PF-06863135,T,6801650268,6.80165E+11,20210913,9:04,CYCLE1_DAY1,0 H,458.355223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 209,7RSYC,29-Oct-21
C1071040,11211001,24,PF-06863135,T,6801650268,6.80165E+11,20210913,18:40,CYCLE1_DAY1,6 H,278.5830809,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 210,8RSYC,29-Oct-21
C1071040,11211001,24,PF-06863135,T,6801650270,6.80165E+11,20210921,8:55,CYCLE1_DAY8,0 H,142.9778381,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 211,12RSYC,2-Nov-21
C1071040,11211001,24,PF-06863135,T,6801650271,6.80165E+11,20211013,9:00,CYCLE2_DAY1,0 H,370.780426,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 650,110RSYC,25-May-22
C1071040,11211001,24,PF-06863135,T,6801703038,6.8017E+11,20211111,9:25,CYCLE3_DAY1,0 H,531.7895709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 670,30RSYC,22-Apr-22
C1071040,11211001,24,PF-06863135,T,6801703039,6.8017E+11,20211209,9:15,CYCLE4_DAY1,0 H,769.6722967,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 959,65RSYC,3-May-22
C1071040,11211001,24,PF-06863135,T,6801793351,6.80179E+11,20220303,11:30,CYCLE7_DAY1,0 H,407.8818197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1874,80RSYC,4-May-22
C1071040,11211001,24,PF-06863135,T,6801697216,6.8017E+11,20220525,10:20,CYCLE10_DAY1,0 H,266.8954049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1963,114RSYC,25-Jul-22
C1071040,11211001,24,PF-06863135,T,6802000328,6.802E+11,20220818,9:50,CYCLE13_DAY1,0 H,794.7744667,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2073,129RSYC,21-Oct-22
C1071040,11211001,24,PF-06863135,T,6802000329,6.802E+11,20221110,8:45,CYCLE16_DAY1,0 H,969.0364266,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2159,140RSYC,22-Mar-23
C1071040,11211001,24,PF-06863135,T,6802110620,6.80211E+11,20230202,9:10,CYCLE19_DAY1,0 H,,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071040,11211001,24,PF-06863135,T,6802110621,6.80211E+11,20230427,10:45,CYCLE22_DAY1,0 H,574.6624436,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2254,145RSYC,4-Jan-24
C1071040,11211001,24,PF-06863135,T,6802330963,6.80233E+11,20230720,10:10,CYCLE25_DAY1,0 H,196.9086569,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2271,145RSYC,4-Jan-24
C1071040,11211001,24,PF-06863135,T,6802351832,6.80235E+11,20231012,9:00,CYCLE28_DAY1,0 H,742.1224192,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2314,147RSYC,29-Feb-24
C1071040,11211001,24,PF-06863135,T,6801650286,6.80165E+11,20210915,10:40,UNPL,9001 H,258.24977,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 212,8RSYC,29-Oct-21
C1071040,11211001,24,PF-06863135,T,6802024260,6.80202E+11,20211013,17:40,UNPL,9002 H,163.9860546,NG/ML,9,Received as 6801650271-05,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071040,11211001,24,PF-06863135,T,6801650280,6.80165E+11,20210914,11:25,CYCLE1_DAY1,24 H,58.98821821,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 213,8RSYC,29-Oct-21
C1071040,11211001,24,PF-06863135,T,6801650282,6.80165E+11,20210916,8:35,CYCLE1_DAY4,0 H,545.9386306,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 214,8RSYC,29-Oct-21
C1071040,11211001,24,PF-06863135,T,6801650284,6.80165E+11,20210917,12:00,CYCLE1_DAY4,24 H,329.2112891,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 215,8RSYC,29-Oct-21
C1071040,10031007,25,PF-06863135,T,6517889667,6.51789E+11,20210914,11:27,CYCLE1_DAY1,0 H,686.0528179,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1084,41RSYC,26-Apr-22
C1071040,10031007,25,PF-06863135,T,6517889667,6.51789E+11,20210914,18:00,CYCLE1_DAY1,6 H,462.3843224,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1083,41RSYC,26-Apr-22
C1071040,10031007,25,PF-06863135,T,6517751566,6.51775E+11,20210921,10:55,CYCLE1_DAY8,0 H,796.9685803,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 182,12RSYC,2-Nov-21
C1071040,10031007,25,PF-06863135,T,6517751566,6.51775E+11,20210921,16:27,CYCLE1_DAY8,6 H,944.3245323,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 181,7RSYC,29-Oct-21
C1071040,10031007,25,PF-06863135,T,6517751569,6.51775E+11,20210928,12:43,CYCLE1_DAY15,0 H,139.7489411,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 331,16RSYC,16-Nov-21
C1071040,10031007,25,PF-06863135,T,6517751583,6.51775E+11,20211109,11:43,CYCLE3_DAY1,0 H,385.3721698,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 589,27RSYC,21-Apr-22
C1071040,10031007,25,PF-06863135,T,6515337624,6.51534E+11,20211207,10:45,CYCLE4_DAY1,0 H,425.3280126,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1924,123RSYC,29-Jul-22
C1071040,10031007,25,PF-06863135,T,6519134606,6.51913E+11,20221108,12:55,END_OF_TRT,,694.4112671,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2139,139RSYC,22-Mar-23
C1071040,10031007,25,PF-06863135,T,6517260611,6.51726E+11,20210916,12:15,CYCLE1_DAY4,0 H,405.9316792,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 962,65RSYC,3-May-22
C1071040,10031007,25,PF-06863135,T,6517473951,6.51747E+11,20210917,13:40,CYCLE1_DAY4,24 H,933.1635784,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 180,7RSYC,29-Oct-21
C1071040,11081002,26,PF-06863135,T,6801650151,6.80165E+11,20210914,10:10,CYCLE1_DAY1,0 H,448.9704629,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 216,8RSYC,29-Oct-21
C1071040,11081002,26,PF-06863135,T,6801650151,6.80165E+11,20210914,19:12,CYCLE1_DAY1,6 H,947.3502306,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 217,9RSYC,1-Nov-21
C1071040,11081002,26,PF-06863135,T,6801650153,6.80165E+11,20210921,10:50,CYCLE1_DAY8,0 H,433.2388456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 218,12RSYC,2-Nov-21
C1071040,11081002,26,PF-06863135,T,6801650153,6.80165E+11,20210921,19:55,CYCLE1_DAY8,6 H,616.1814613,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 219,8RSYC,29-Oct-21
C1071040,11081002,26,PF-06863135,T,6801650155,6.80165E+11,20210928,9:05,CYCLE1_DAY15,0 H,378.2087582,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 220,8RSYC,29-Oct-21
C1071040,11081002,26,PF-06863135,T,6801650157,6.80165E+11,20211005,10:15,CYCLE1_DAY22,0 H,674.0486521,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 247,13RSYC,15-Nov-21
C1071040,11081002,26,PF-06863135,T,6801650159,6.80165E+11,20211012,11:56,CYCLE2_DAY1,0 H,729.4906037,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 248,13RSYC,15-Nov-21
C1071040,11081002,26,PF-06863135,T,6801701817,6.8017E+11,20211109,11:25,CYCLE3_DAY1,0 H,932.8883284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 669,30RSYC,22-Apr-22
C1071040,11081002,26,PF-06863135,T,6801701819,6.8017E+11,20211207,10:40,CYCLE4_DAY1,0 H,288.5353549,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 950,65RSYC,3-May-22
C1071040,11081002,26,PF-06863135,T,6801790622,6.80179E+11,20220301,11:00,CYCLE7_DAY1,0 H,513.0829779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1590,110RSYC,25-May-22
C1071040,11081002,26,PF-06863135,T,6801701821,6.8017E+11,20220524,11:08,CYCLE10_DAY1,0 H,70.89499671,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1960,114RSYC,25-Jul-22
C1071040,11081002,26,PF-06863135,T,6801893000,6.80189E+11,20220816,10:42,CYCLE13_DAY1,0 H,966.799923,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2069,129RSYC,21-Oct-22
C1071040,11081002,26,PF-06863135,T,6801958743,6.80196E+11,20221108,10:56,CYCLE16_DAY1,0 H,468.3494392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2151,139RSYC,22-Mar-23
C1071040,11081002,26,PF-06863135,T,6802068779,6.80207E+11,20230131,10:49,CYCLE19_DAY1,0 H,875.5333899,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2201,141RSYC,17-May-23
C1071040,11081002,26,PF-06863135,T,6802135340,6.80214E+11,20230425,10:40,CYCLE22_DAY1,0 H,938.10902,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2253,143RSYC,27-Nov-23
C1071040,11081002,26,PF-06863135,T,6802256363,6.80226E+11,20230718,10:52,CYCLE25_DAY1,0 H,823.2440916,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2272,144RSYC,27-Nov-23
C1071040,11081002,26,PF-06863135,T,6802256365,6.80226E+11,20231010,10:47,CYCLE28_DAY1,0 H,63.97180201,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2315,147RSYC,29-Feb-24
C1071040,11081002,26,PF-06863135,T,6802408401,6.80241E+11,20240109,11:00,CYCLE31_DAY1,0 H,286.0069968,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2338,148RSYC,27-Mar-24
C1071040,11081002,26,PF-06863135,T,6801650169,6.80165E+11,20210916,9:50,UNPL,9001 H,52.34384296,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 221,11RSYC,2-Nov-21
C1071040,11081002,26,PF-06863135,T,6801650163,6.80165E+11,20210915,13:07,CYCLE1_DAY1,24 H,609.6146461,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 222,8RSYC,29-Oct-21
C1071040,11081002,26,PF-06863135,T,6801650165,6.80165E+11,20210917,10:39,CYCLE1_DAY4,0 H,30.39333812,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 223,8RSYC,29-Oct-21
C1071040,11081002,26,PF-06863135,T,6801650167,6.80165E+11,20210918,13:20,CYCLE1_DAY4,24 H,923.7604905,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 224,13RSYC,15-Nov-21
C1071040,10821005,27,PF-06863135,T,6603459530,6.60346E+11,20210920,16:40,CYCLE1_DAY1,0 H,214.3679043,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 155,6RSYC,29-Oct-21
C1071040,10821005,27,PF-06863135,T,6603459530,6.60346E+11,20210920,22:40,CYCLE1_DAY1,6 H,645.1955943,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 156,6RSYC,29-Oct-21
C1071040,10821005,27,PF-06863135,T,6603459541,6.60346E+11,20210921,16:45,CYCLE1_DAY1,24 H,121.3274517,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 240,13RSYC,15-Nov-21
C1071040,10821005,27,PF-06863135,T,6603459544,6.60346E+11,20210923,15:40,CYCLE1_DAY4,0 H,352.1071744,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 241,13RSYC,15-Nov-21
C1071040,10821005,27,PF-06863135,T,6603459547,6.60346E+11,20210924,16:57,CYCLE1_DAY4,24 H,869.6374707,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 242,13RSYC,15-Nov-21
C1071040,10031008,28,PF-06863135,T,6517889666,6.51789E+11,20210920,11:20,CYCLE1_DAY1,0 H,800.8611462,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 183,7RSYC,29-Oct-21
C1071040,10031008,28,PF-06863135,T,6517751567,6.51775E+11,20210929,11:40,CYCLE1_DAY8,0 H,770.3524822,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 330,16RSYC,16-Nov-21
C1071040,10031008,28,PF-06863135,T,6517751567,6.51775E+11,20210929,17:30,CYCLE1_DAY8,6 H,270.9349562,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 329,16RSYC,16-Nov-21
C1071040,10031008,28,PF-06863135,T,6517889671,6.51789E+11,20211006,12:55,CYCLE1_DAY15,0 H,112.7395994,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 346,16RSYC,16-Nov-21
C1071040,10031008,28,PF-06863135,T,6516580398,6.51658E+11,20211013,13:00,CYCLE1_DAY22,0 H,344.8060188,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 278,14RSYC,15-Nov-21
C1071040,10031008,28,PF-06863135,T,6517889674,6.51789E+11,20211020,15:50,CYCLE2_DAY1,0 H,75.90018545,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 347,16RSYC,16-Nov-21
C1071040,10031008,28,PF-06863135,T,6517889678,6.51789E+11,20211117,10:45,CYCLE3_DAY1,0 H,204.1878991,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 911,20RSYC,19-Apr-22
C1071040,10031008,28,PF-06863135,T,6518620858,6.51862E+11,20211215,17:30,CYCLE4_DAY1,0 H,271.06852,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1925,123RSYC,29-Jul-22
C1071040,10031008,28,PF-06863135,T,6516580425,6.51658E+11,20220309,15:20,CYCLE7_DAY1,0 H,929.4377189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2009,115RSYC,25-Jul-22
C1071040,10031008,28,PF-06863135,T,6519134616,6.51913E+11,20220601,18:00,CYCLE10_DAY1,0 H,121.9783084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2010,115RSYC,25-Jul-22
C1071040,10031008,28,PF-06863135,T,6519134614,6.51913E+11,20221116,16:17,CYCLE16_DAY1,0 H,619.790129,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2140,139RSYC,22-Mar-23
C1071040,10031008,28,PF-06863135,T,6521762368,6.52176E+11,20230206,15:10,CYCLE19_DAY1,0 H,650.6805883,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2217,142RSYC,18-May-23
C1071040,10031008,28,PF-06863135,T,6522244541,6.52224E+11,20230503,15:36,CYCLE22_DAY1,0 H,89.29716529,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2281,144RSYC,27-Nov-23
C1071040,10031008,28,PF-06863135,T,6524705277,6.52471E+11,,,,,907.8558408,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2323,148RSYC,27-Mar-24
C1071040,10031008,28,PF-06863135,T,6517473947,6.51747E+11,20210923,10:56,CYCLE1_DAY4,0 H,449.6688572,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 296,15RSYC,16-Nov-21
C1071040,10031008,28,PF-06863135,T,6517260614,6.51726E+11,20210924,10:37,CYCLE1_DAY4,24 H,20.28234699,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 964,65RSYC,3-May-22
C1071040,10101002,29,PF-06863135,T,6517559654,6.51756E+11,20210928,10:44,CYCLE1_DAY1,0 H,351.8976474,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 303,15RSYC,16-Nov-21
C1071040,10101002,29,PF-06863135,T,6517559654,6.51756E+11,20210928,17:37,CYCLE1_DAY1,6 H,223.7733263,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 302,15RSYC,16-Nov-21
C1071040,10101002,29,PF-06863135,T,6517559655,6.51756E+11,20211006,8:16,CYCLE1_DAY8,0 H,233.0445488,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 305,15RSYC,16-Nov-21
C1071040,10101002,29,PF-06863135,T,6517559655,6.51756E+11,20211006,15:02,CYCLE1_DAY8,6 H,765.5412462,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 304,15RSYC,16-Nov-21
C1071040,10101002,29,PF-06863135,T,6517559658,6.51756E+11,20211013,8:22,CYCLE1_DAY15,0 H,849.3485217,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 309,15RSYC,16-Nov-21
C1071040,10101002,29,PF-06863135,T,6518459660,6.51846E+11,20211124,10:50,CYCLE3_DAY1,0 H,452.4744393,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 679,30RSYC,22-Apr-22
C1071040,10101002,29,PF-06863135,T,6518877338,6.51888E+11,20211220,11:45,CYCLE4_DAY1,0 H,846.6712064,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1167,104RSYC,22-May-22
C1071040,10101002,29,PF-06863135,T,6519690726,6.51969E+11,20220316,9:20,CYCLE7_DAY1,0 H,315.6544165,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1891,87RSYC,13-May-22
C1071040,10101002,29,PF-06863135,T,6517559676,6.51756E+11,20220608,10:51,CYCLE10_DAY1,0 H,599.9976275,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2008,115RSYC,25-Jul-22
C1071040,10101002,29,PF-06863135,T,6520726026,6.52073E+11,20220831,0:00,CYCLE13_DAY1,0 H,772.801267,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2078,129RSYC,21-Oct-22
C1071040,10101002,29,PF-06863135,T,6520726028,6.52073E+11,20221123,0:00,CYCLE16_DAY1,0 H,10.77665831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2129,139RSYC,22-Mar-23
C1071040,10101002,29,PF-06863135,T,6521315623,6.52132E+11,20230215,9:51,CYCLE19_DAY1,0 H,856.2379784,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2190,141RSYC,17-May-23
C1071040,10101002,29,PF-06863135,T,6521315621,6.52132E+11,20230508,12:20,CYCLE22_DAY1,0 H,76.67672605,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2246,143RSYC,27-Nov-23
C1071040,10101002,29,PF-06863135,T,6524471823,6.52447E+11,20240117,10:16,CYCLE31_DAY1,0 H,60.22990622,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2354,148RSYC,27-Mar-24
C1071040,10101002,29,PF-06863135,T,6521205060,6.52121E+11,20211110,11:16,UNPL,9001 H,944.4739077,NG/ML,,Received as 6517559662-07,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 563,26RSYC,22-Apr-22
C1071040,10101002,29,PF-06863135,T,6517559670,6.51756E+11,20210929,11:30,CYCLE1_DAY1,24 H,465.7203087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 312,15RSYC,16-Nov-21
C1071040,10101002,29,PF-06863135,T,6517559672,6.51756E+11,20211001,10:50,CYCLE1_DAY4,0 H,904.6521059,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 314,15RSYC,16-Nov-21
C1071040,10101002,29,PF-06863135,T,6517559673,6.51756E+11,20211002,10:50,CYCLE1_DAY4,24 H,797.2662262,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 315,15RSYC,16-Nov-21
C1071040,10541001,30,PF-06863135,T,6216170878,6.21617E+11,20210921,10:10,CYCLE1_DAY1,0 H,816.3574682,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 157,6RSYC,29-Oct-21
C1071040,10541001,30,PF-06863135,T,6216170880,6.21617E+11,20210927,10:19,CYCLE1_DAY8,0 H,586.1118983,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 158,6RSYC,29-Oct-21
C1071040,10541001,30,PF-06863135,T,6216170882,6.21617E+11,20211004,9:20,CYCLE1_DAY15,0 H,200.032364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 365,17RSYC,17-Nov-21
C1071040,10541001,30,PF-06863135,T,6216170885,6.21617E+11,20211011,7:50,CYCLE1_DAY22,0 H,802.9020747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 366,17RSYC,17-Nov-21
C1071040,10541001,30,PF-06863135,T,6216170886,6.21617E+11,20211018,8:30,CYCLE2_DAY1,0 H,36.70149081,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 367,17RSYC,17-Nov-21
C1071040,10541001,30,PF-06863135,T,6216170888,6.21617E+11,20211115,8:30,CYCLE3_DAY1,0 H,812.5713245,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 698,31RSYC,23-Apr-22
C1071040,10541001,30,PF-06863135,T,6216170890,6.21617E+11,20211213,8:40,CYCLE4_DAY1,0 H,668.9030149,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1275,89RSYC,11-May-22
C1071040,10541001,30,PF-06863135,T,6216170909,6.21617E+11,20220217,10:50,END_OF_TRT,,839.4527111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1771,87RSYC,13-May-22
C1071040,10541001,30,PF-06863135,T,6216170895,6.21617E+11,20210922,11:25,CYCLE1_DAY1,24 H,298.1864164,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 159,6RSYC,29-Oct-21
C1071040,10541001,30,PF-06863135,T,6216170896,6.21617E+11,20210923,12:05,CYCLE1_DAY4,0 H,914.9576109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 160,6RSYC,29-Oct-21
C1071040,10541001,30,PF-06863135,T,6216170898,6.21617E+11,20210924,12:30,CYCLE1_DAY4,24 H,982.0187482,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1770,71RSYC,7-May-22
C1071040,10101001,31,PF-06863135,T,6518332217,6.51833E+11,20210927,10:32,CYCLE1_DAY1,0 H,386.4522509,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 361,17RSYC,17-Nov-21
C1071040,10101001,31,PF-06863135,T,6518332217,6.51833E+11,20210927,16:00,CYCLE1_DAY1,6 H,795.9305245,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 360,17RSYC,17-Nov-21
C1071040,10101001,31,PF-06863135,T,6517559656,6.51756E+11,20211005,8:32,CYCLE1_DAY8,0 H,252.5648036,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 307,15RSYC,16-Nov-21
C1071040,10101001,31,PF-06863135,T,6517559656,6.51756E+11,20211005,17:47,CYCLE1_DAY8,6 H,756.5377258,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 306,15RSYC,16-Nov-21
C1071040,10101001,31,PF-06863135,T,6517559657,6.51756E+11,20211012,8:26,CYCLE1_DAY15,0 H,387.2045499,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 308,15RSYC,16-Nov-21
C1071040,10101001,31,PF-06863135,T,6517559660,6.51756E+11,20211019,7:54,CYCLE1_DAY22,0 H,387.8097951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 310,15RSYC,16-Nov-21
C1071040,10101001,31,PF-06863135,T,6517559661,6.51756E+11,20211025,8:26,CYCLE2_DAY1,0 H,63.13724191,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 562,26RSYC,22-Apr-22
C1071040,10101001,31,PF-06863135,T,6517559664,6.51756E+11,20211122,8:53,CYCLE3_DAY1,0 H,914.4305745,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 879,19RSYC,19-Apr-22
C1071040,10101001,31,PF-06863135,T,6518877339,6.51888E+11,20211220,8:30,CYCLE4_DAY1,0 H,386.7009622,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1168,104RSYC,22-May-22
C1071040,10101001,31,PF-06863135,T,6519690725,6.51969E+11,20220314,8:48,CYCLE7_DAY1,0 H,203.2441113,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1892,81RSYC,4-May-22
C1071040,10101001,31,PF-06863135,T,6517559675,6.51756E+11,20220829,0:00,CYCLE13_DAY1,0 H,286.7466201,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2079,129RSYC,21-Oct-22
C1071040,10101001,31,PF-06863135,T,6518806985,6.51881E+11,20221121,8:42,CYCLE16_DAY1,0 H,551.6375836,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2169,140RSYC,22-Mar-23
C1071040,10101001,31,PF-06863135,T,6520726024,6.52073E+11,20230215,9:25,CYCLE19_DAY1,0 H,279.6577485,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2191,141RSYC,17-May-23
C1071040,10101001,31,PF-06863135,T,6522542260,6.52254E+11,20230508,8:45,CYCLE22_DAY1,0 H,389.4812187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2247,143RSYC,27-Nov-23
C1071040,10101001,31,PF-06863135,T,6522542261,6.52254E+11,20230731,8:26,CYCLE25_DAY1,0 H,506.9996388,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2291,145RSYC,4-Jan-24
C1071040,10101001,31,PF-06863135,T,6524145854,6.52415E+11,20240115,7:57,CYCLE31_DAY1,0 H,942.9012962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2355,148RSYC,27-Mar-24
C1071040,10101001,31,PF-06863135,T,6522365006,6.52237E+11,20221219,8:51,UNPL,9001 H,976.6733456,NG/ML,,Received as 6520726027-02,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2192,141RSYC,17-May-23
C1071040,10101001,31,PF-06863135,T,6517559669,6.51756E+11,20210928,10:17,CYCLE1_DAY1,24 H,24.62821113,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 311,15RSYC,16-Nov-21
C1071040,10101001,31,PF-06863135,T,6517559671,6.51756E+11,20211001,9:55,CYCLE1_DAY4,0 H,810.6363649,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 313,15RSYC,16-Nov-21
C1071040,10101001,31,PF-06863135,T,6517559674,6.51756E+11,20211002,10:16,CYCLE1_DAY4,24 H,462.8749894,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 316,15RSYC,16-Nov-21
C1071040,11111002,32,PF-06863135,T,6801650368,6.80165E+11,20210927,9:50,CYCLE1_DAY1,0 H,333.3449459,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 270,14RSYC,15-Nov-21
C1071040,11111002,32,PF-06863135,T,6801650368,6.80165E+11,20210927,19:01,CYCLE1_DAY1,6 H,28.48037632,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 271,14RSYC,15-Nov-21
C1071040,11111002,32,PF-06863135,T,6801650369,6.80165E+11,20211005,9:00,CYCLE1_DAY8,0 H,409.957637,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 273,14RSYC,15-Nov-21
C1071040,11111002,32,PF-06863135,T,6801650369,6.80165E+11,20211005,18:00,CYCLE1_DAY8,6 H,130.5167456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 272,14RSYC,15-Nov-21
C1071040,11111002,32,PF-06863135,T,6801650371,6.80165E+11,20211012,9:15,CYCLE1_DAY15,0 H,270.104084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 274,14RSYC,15-Nov-21
C1071040,11111002,32,PF-06863135,T,6801650373,6.80165E+11,20211018,10:37,CYCLE1_DAY22,0 H,422.9125686,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 275,14RSYC,15-Nov-21
C1071040,11111002,32,PF-06863135,T,6801650388,6.80165E+11,20211027,9:45,END_OF_TRT,,269.0013295,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 668,64RSYC,3-May-22
C1071040,11111002,32,PF-06863135,T,6801650379,6.80165E+11,20210928,13:05,CYCLE1_DAY1,24 H,11.57986418,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 225,8RSYC,29-Oct-21
C1071040,11111002,32,PF-06863135,T,6801650399,6.80165E+11,20211001,8:35,CYCLE1_DAY4,0 H,453.2152485,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 277,14RSYC,15-Nov-21
C1071040,11111002,32,PF-06863135,T,6801650383,6.80165E+11,20211002,11:40,CYCLE1_DAY4,24 H,331.6048293,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 276,14RSYC,15-Nov-21
C1071040,11091001,33,PF-06863135,T,6801650191,6.80165E+11,20210927,9:45,CYCLE1_DAY1,0 H,558.5942399,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 226,21RSYC,20-Apr-22
C1071040,11091001,33,PF-06863135,T,6801650191,6.80165E+11,20210927,20:58,CYCLE1_DAY1,6 H,326.0708823,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 227,8RSYC,29-Oct-21
C1071040,11091001,33,PF-06863135,T,6801650192,6.80165E+11,20211004,10:05,CYCLE1_DAY8,0 H,130.6217461,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 253,13RSYC,15-Nov-21
C1071040,11091001,33,PF-06863135,T,6801650192,6.80165E+11,20211005,21:30,CYCLE1_DAY8,6 H,195.1437307,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 252,13RSYC,15-Nov-21
C1071040,11091001,33,PF-06863135,T,6801650194,6.80165E+11,20211012,8:50,CYCLE1_DAY15,0 H,609.7509467,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 256,13RSYC,15-Nov-21
C1071040,11091001,33,PF-06863135,T,6801650196,6.80165E+11,20211019,13:10,CYCLE1_DAY22,0 H,805.9166686,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 258,13RSYC,15-Nov-21
C1071040,11091001,33,PF-06863135,T,6801650198,6.80165E+11,20211026,12:50,CYCLE2_DAY1,0 H,661.9938879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 637,29RSYC,22-Apr-22
C1071040,11091001,33,PF-06863135,T,6801709454,6.80171E+11,20211124,11:22,CYCLE3_DAY1,0 H,311.7890681,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 838,35RSYC,25-Apr-22
C1071040,11091001,33,PF-06863135,T,6801709455,6.80171E+11,20211221,11:25,CYCLE4_DAY1,0 H,908.28502,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 954,65RSYC,3-May-22
C1071040,11091001,33,PF-06863135,T,6801812297,6.80181E+11,20220315,11:00,CYCLE7_DAY1,0 H,307.4601318,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1873,80RSYC,4-May-22
C1071040,11091001,33,PF-06863135,T,6801893157,6.80189E+11,20220607,10:55,CYCLE10_DAY1,0 H,924.7293327,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2016,115RSYC,25-Jul-22
C1071040,11091001,33,PF-06863135,T,6801962917,6.80196E+11,20220830,10:54,CYCLE13_DAY1,0 H,293.6323799,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2071,129RSYC,21-Oct-22
C1071040,11091001,33,PF-06863135,T,6802045271,6.80205E+11,20221122,10:55,CYCLE16_DAY1,0 H,851.2334133,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2152,139RSYC,22-Mar-23
C1071040,11091001,33,PF-06863135,T,6801962918,6.80196E+11,20221208,11:20,END_OF_TRT,,923.0147177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2160,140RSYC,22-Mar-23
C1071040,11091001,33,PF-06863135,T,6801650208,6.80165E+11,20210929,8:40,UNPL,9001 H,532.6092738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 228,8RSYC,29-Oct-21
C1071040,11091001,33,PF-06863135,T,6801650202,6.80165E+11,20210928,15:15,CYCLE1_DAY1,24 H,836.722646,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 229,8RSYC,29-Oct-21
C1071040,11091001,33,PF-06863135,T,6801650204,6.80165E+11,20210930,9:53,CYCLE1_DAY4,0 H,681.2233395,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 230,8RSYC,29-Oct-21
C1071040,11091001,33,PF-06863135,T,6801650206,6.80165E+11,20211001,15:15,CYCLE1_DAY4,24 H,29.5285479,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 261,14RSYC,15-Nov-21
C1071040,10791001,34,PF-06863135,T,6216170981,6.21617E+11,20210927,14:15,CYCLE1_DAY1,0 H,534.3769087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 371,17RSYC,17-Nov-21
C1071040,10791001,34,PF-06863135,T,6216170981,6.21617E+11,20210927,20:55,CYCLE1_DAY1,6 H,114.9901109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 370,17RSYC,17-Nov-21
C1071040,10791001,34,PF-06863135,T,6216170982,6.21617E+11,20211004,14:24,CYCLE1_DAY8,0 H,243.0725585,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 372,17RSYC,17-Nov-21
C1071040,10791001,34,PF-06863135,T,6216170985,6.21617E+11,20211011,15:07,CYCLE1_DAY15,0 H,518.2653075,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 375,17RSYC,17-Nov-21
C1071040,10791001,34,PF-06863135,T,6216843014,6.21684E+11,20211018,14:27,CYCLE1_DAY22,0 H,857.5129124,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 396,18RSYC,17-Nov-21
C1071040,10791001,34,PF-06863135,T,6216170988,6.21617E+11,20211025,17:30,CYCLE2_DAY1,0 H,769.6557085,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 416,21RSYC,20-Apr-22
C1071040,10791001,34,PF-06863135,T,6217031634,6.21703E+11,20211124,17:24,CYCLE3_DAY1,0 H,234.7339247,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 767,33RSYC,24-Apr-22
C1071040,10791001,34,PF-06863135,T,6217184137,6.21718E+11,20211223,14:18,CYCLE4_DAY1,0 H,680.8771084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1521,97RSYC,12-May-22
C1071040,10791001,34,PF-06863135,T,6216170994,6.21617E+11,20220315,12:48,CYCLE7_DAY1,0 H,898.7803955,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1879,80RSYC,4-May-22
C1071040,10791001,34,PF-06863135,T,6216171003,6.21617E+11,20220615,14:57,CYCLE10_DAY1,0 H,782.1714978,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2041,128RSYC,21-Oct-22
C1071040,10791001,34,PF-06863135,T,6217178487,6.21718E+11,20220914,13:21,CYCLE13_DAY1,0 H,595.2093781,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2102,132RSYC,10-Nov-22
C1071040,10791001,34,PF-06863135,T,6219244642,6.21924E+11,20221209,17:50,CYCLE16_DAY1,0 H,105.8062419,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2182,141RSYC,17-May-23
C1071040,10791001,34,PF-06863135,T,6219947540,6.21995E+11,20230302,14:20,CYCLE19_DAY1,0 H,883.7679862,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2212,143RSYC,27-Nov-23
C1071040,10791001,34,PF-06863135,T,6219947539,6.21995E+11,20230525,13:20,CYCLE22_DAY1,0 H,209.089879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2256,144RSYC,27-Nov-23
C1071040,10791001,34,PF-06863135,T,6219947542,6.21995E+11,20230824,13:15,CYCLE25_DAY1,0 H,383.9803681,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2294,145RSYC,4-Jan-24
C1071040,10791001,34,PF-06863135,T,6219244645,6.21924E+11,20240229,14:49,CYCLE31_DAY1,0 H,520.347647,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2366,152RSYC,9-Apr-24
C1071040,10791001,34,PF-06863135,T,6216170997,6.21617E+11,20210928,13:57,CYCLE1_DAY1,24 H,408.8410564,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 377,17RSYC,17-Nov-21
C1071040,10791001,34,PF-06863135,T,6216170999,6.21617E+11,20210930,14:33,CYCLE1_DAY4,0 H,862.807264,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 379,17RSYC,17-Nov-21
C1071040,10791001,34,PF-06863135,T,6216171001,6.21617E+11,20211001,14:44,CYCLE1_DAY4,24 H,126.9872723,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 381,18RSYC,17-Nov-21
C1071040,10071005,35,PF-06863135,T,6518157745,6.51816E+11,20211005,12:10,CYCLE1_DAY1,0 H,721.141505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 349,16RSYC,16-Nov-21
C1071040,10071005,35,PF-06863135,T,6518157745,6.51816E+11,20211005,18:15,CYCLE1_DAY1,6 H,223.9208813,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 348,16RSYC,16-Nov-21
C1071040,10071005,35,PF-06863135,T,6518265654,6.51827E+11,20211015,10:45,CYCLE1_DAY8,0 H,298.657084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 355,17RSYC,17-Nov-21
C1071040,10071005,35,PF-06863135,T,6518265654,6.51827E+11,20211015,17:30,CYCLE1_DAY8,6 H,373.6681117,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 354,17RSYC,17-Nov-21
C1071040,10071005,35,PF-06863135,T,6518418506,6.51842E+11,20211021,9:00,CYCLE1_DAY15,0 H,963.2888134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 609,90RSYC,11-May-22
C1071040,10071005,35,PF-06863135,T,6518418507,6.51842E+11,20211027,11:10,CYCLE1_DAY22,0 H,320.4937439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 610,90RSYC,11-May-22
C1071040,10071005,35,PF-06863135,T,6518157746,6.51816E+11,20211105,9:50,CYCLE2_DAY1,0 H,14.32832126,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 602,27RSYC,21-Apr-22
C1071040,10071005,35,PF-06863135,T,6518265659,6.51827E+11,20211203,11:45,CYCLE3_DAY1,0 H,32.38364565,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1091,67RSYC,8-May-22
C1071040,10071005,35,PF-06863135,T,6518265662,6.51827E+11,20211230,10:22,CYCLE4_DAY1,0 H,780.1553187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1600,96RSYC,12-May-22
C1071040,10071005,35,PF-06863135,T,6518265664,6.51827E+11,20220324,10:12,CYCLE7_DAY1,0 H,117.3589043,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1926,123RSYC,29-Jul-22
C1071040,10071005,35,PF-06863135,T,6517472416,6.51747E+11,20220616,10:00,CYCLE10_DAY1,0 H,139.8118331,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2006,115RSYC,25-Jul-22
C1071040,10071005,35,PF-06863135,T,6520930825,6.52093E+11,20220908,9:50,CYCLE13_DAY1,0 H,497.6478071,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2076,129RSYC,21-Oct-22
C1071040,10071005,35,PF-06863135,T,6520930828,6.52093E+11,20221201,10:00,CYCLE16_DAY1,0 H,166.0246308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2130,139RSYC,22-Mar-23
C1071040,10071005,35,PF-06863135,T,6521240600,6.52124E+11,20230106,10:02,END_OF_TRT,,774.4103987,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2168,140RSYC,22-Mar-23
C1071040,10071005,35,PF-06863135,T,6518157753,6.51816E+11,20211006,13:03,CYCLE1_DAY1,24 H,926.5666289,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 350,17RSYC,17-Nov-21
C1071040,10071005,35,PF-06863135,T,6518265665,6.51827E+11,20211011,12:00,CYCLE1_DAY4,0 H,150.2015268,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 356,17RSYC,17-Nov-21
C1071040,10071005,35,PF-06863135,T,6518265668,6.51827E+11,20211012,11:45,CYCLE1_DAY4,24 H,883.2871719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 357,17RSYC,17-Nov-21
C1071040,11091002,36,PF-06863135,T,6801650190,6.80165E+11,20210930,9:50,CYCLE1_DAY1,0 H,38.94464242,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 231,8RSYC,29-Oct-21
C1071040,11091002,36,PF-06863135,T,6801650190,6.80165E+11,20210930,17:40,CYCLE1_DAY1,6 H,751.6778966,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 251,18RSYC,17-Nov-21
C1071040,11091002,36,PF-06863135,T,6801650193,6.80165E+11,20211007,10:25,CYCLE1_DAY8,0 H,527.2349657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 255,13RSYC,15-Nov-21
C1071040,11091002,36,PF-06863135,T,6801650193,6.80165E+11,20211007,17:35,CYCLE1_DAY8,6 H,901.2673939,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 254,13RSYC,15-Nov-21
C1071040,11091002,36,PF-06863135,T,6801650195,6.80165E+11,20211014,10:10,END_OF_TRT,,227.0953871,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 257,13RSYC,15-Nov-21
C1071040,11091002,36,PF-06863135,T,6801650203,6.80165E+11,20211001,11:23,CYCLE1_DAY1,24 H,986.6548594,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 259,13RSYC,15-Nov-21
C1071040,11091002,36,PF-06863135,T,6801650205,6.80165E+11,20211004,6:55,CYCLE1_DAY4,0 H,32.20237308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 260,14RSYC,15-Nov-21
C1071040,11091002,36,PF-06863135,T,6801650207,6.80165E+11,20211005,11:34,CYCLE1_DAY4,24 H,77.39123728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 262,14RSYC,15-Nov-21
C1071040,11241001,37,PF-06863135,T,6801650307,6.80165E+11,20211004,10:08,CYCLE1_DAY1,0 H,921.2183902,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 263,14RSYC,15-Nov-21
C1071040,11241001,37,PF-06863135,T,6801650307,6.80165E+11,20211004,16:39,CYCLE1_DAY1,6 H,471.9268623,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 264,18RSYC,17-Nov-21
C1071040,11241001,37,PF-06863135,T,6801650309,6.80165E+11,20211011,11:12,CYCLE1_DAY8,0 H,806.4293974,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 266,14RSYC,15-Nov-21
C1071040,11241001,37,PF-06863135,T,6801650309,6.80165E+11,20211011,17:55,CYCLE1_DAY8,6 H,647.4460169,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 265,14RSYC,15-Nov-21
C1071040,11241001,37,PF-06863135,T,6801650313,6.80165E+11,20211025,10:10,CYCLE1_DAY22,0 H,723.128818,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 656,29RSYC,22-Apr-22
C1071040,11241001,37,PF-06863135,T,6801650328,6.80165E+11,20211101,11:05,END_OF_TRT,,480.7971963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 661,86RSYC,13-May-22
C1071040,11241001,37,PF-06863135,T,6801650319,6.80165E+11,20211005,10:10,CYCLE1_DAY1,24 H,436.9688846,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 267,14RSYC,15-Nov-21
C1071040,11241001,37,PF-06863135,T,6801650321,6.80165E+11,20211007,10:39,CYCLE1_DAY4,0 H,643.5821903,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 268,14RSYC,15-Nov-21
C1071040,11241001,37,PF-06863135,T,6801650323,6.80165E+11,20211008,11:32,CYCLE1_DAY4,24 H,943.0817241,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 269,18RSYC,17-Nov-21
C1071040,10981003,38,PF-06863135,T,6517769657,6.51777E+11,20211004,10:20,CYCLE1_DAY1,0 H,266.0563682,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 343,16RSYC,16-Nov-21
C1071040,10981003,38,PF-06863135,T,6517769657,6.51777E+11,20211004,21:15,CYCLE1_DAY1,6 H,364.6131786,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 342,16RSYC,16-Nov-21
C1071040,10981003,38,PF-06863135,T,6517769662,6.51777E+11,20211011,8:50,CYCLE1_DAY8,0 H,704.3113708,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 345,16RSYC,16-Nov-21
C1071040,10981003,38,PF-06863135,T,6517769662,6.51777E+11,20211011,13:56,CYCLE1_DAY8,6 H,990.313191,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 344,16RSYC,16-Nov-21
C1071040,10981003,38,PF-06863135,T,6517768773,6.51777E+11,20211020,9:20,CYCLE1_DAY15,0 H,601.0037126,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 340,16RSYC,16-Nov-21
C1071040,10981003,38,PF-06863135,T,6517768774,6.51777E+11,20211027,8:33,CYCLE1_DAY22,0 H,252.6741696,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 597,27RSYC,21-Apr-22
C1071040,10981003,38,PF-06863135,T,6517769672,6.51777E+11,20211103,8:50,CYCLE2_DAY1,0 H,56.37838689,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 600,27RSYC,21-Apr-22
C1071040,10981003,38,PF-06863135,T,6517769678,6.51777E+11,20211130,8:50,CYCLE3_DAY1,0 H,303.7523693,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1082,41RSYC,26-Apr-22
C1071040,10981003,38,PF-06863135,T,6517769686,6.51777E+11,20211229,9:35,CYCLE4_DAY1,0 H,441.7797134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1717,72RSYC,7-May-22
C1071040,10981003,38,PF-06863135,T,6517769690,6.51777E+11,20220324,9:00,CYCLE7_DAY1,0 H,960.3654078,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1927,123RSYC,29-Jul-22
C1071040,10981003,38,PF-06863135,T,6518807318,6.51881E+11,20220615,9:28,CYCLE10_DAY1,0 H,230.7670481,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2034,128RSYC,21-Oct-22
C1071040,10981003,38,PF-06863135,T,6520972522,6.52097E+11,20220923,9:20,CYCLE13_DAY1,0 H,21.49443651,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2111,131RSYC,9-Nov-22
C1071040,10981003,38,PF-06863135,T,6521653169,6.52165E+11,20221228,8:20,CYCLE16_DAY1,0 H,305.032086,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2173,140RSYC,22-Mar-23
C1071040,10981003,38,PF-06863135,T,6520972524,6.52097E+11,20230324,9:10,CYCLE19_DAY1,0 H,366.7980631,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2222,142RSYC,18-May-23
C1071040,10981003,38,PF-06863135,T,6522845154,6.52285E+11,20230613,8:41,CYCLE22_DAY1,0 H,163.8964783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2262,144RSYC,27-Nov-23
C1071040,10981003,38,PF-06863135,T,6524724652,6.52472E+11,20240103,9:25,CYCLE28_DAY1,0 H,120.6842795,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2324,148RSYC,27-Mar-24
C1071040,10981003,38,PF-06863135,T,6517755820,6.51776E+11,20211005,15:25,CYCLE1_DAY1,24 H,72.2360386,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 333,16RSYC,16-Nov-21
C1071040,10981003,38,PF-06863135,T,6517755822,6.51776E+11,20211007,12:05,CYCLE1_DAY4,0 H,713.2712349,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 334,16RSYC,16-Nov-21
C1071040,10981003,38,PF-06863135,T,6517755828,6.51776E+11,20211008,11:00,CYCLE1_DAY4,24 H,118.6029212,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 335,16RSYC,16-Nov-21
C1071040,10671003,39,PF-06863135,T,6517433455,6.51743E+11,20211004,11:45,CYCLE1_DAY1,0 H,228.4546935,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 283,14RSYC,15-Nov-21
C1071040,10671003,39,PF-06863135,T,6517433455,6.51743E+11,20211004,18:35,CYCLE1_DAY1,6 H,689.962016,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 282,18RSYC,17-Nov-21
C1071040,10671003,39,PF-06863135,T,6517433457,6.51743E+11,20211011,9:25,CYCLE1_DAY8,0 H,130.7409598,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 284,14RSYC,15-Nov-21
C1071040,10671003,39,PF-06863135,T,6517433457,6.51743E+11,20211011,17:07,CYCLE1_DAY8,6 H,866.6707678,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 531,25RSYC,22-Apr-22
C1071040,10671003,39,PF-06863135,T,6517433460,6.51743E+11,20211018,11:00,CYCLE1_DAY15,0 H,525.2355668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 285,14RSYC,15-Nov-21
C1071040,10671003,39,PF-06863135,T,6518354391,6.51835E+11,20211025,9:11,CYCLE1_DAY22,0 H,564.0813615,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 607,90RSYC,11-May-22
C1071040,10671003,39,PF-06863135,T,6518354392,6.51835E+11,20211101,10:21,CYCLE2_DAY1,0 H,244.3778646,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 608,90RSYC,11-May-22
C1071040,10671003,39,PF-06863135,T,6517433465,6.51743E+11,20211129,10:33,CYCLE3_DAY1,0 H,286.2728126,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 967,65RSYC,3-May-22
C1071040,10671003,39,PF-06863135,T,6517433472,6.51743E+11,20211005,12:35,CYCLE1_DAY1,24 H,6.498634047,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 286,14RSYC,15-Nov-21
C1071040,10671003,39,PF-06863135,T,6517433474,6.51743E+11,20211007,11:43,CYCLE1_DAY4,0 H,84.81688301,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 287,14RSYC,15-Nov-21
C1071040,10671003,39,PF-06863135,T,6517433476,6.51743E+11,20211008,13:05,CYCLE1_DAY4,24 H,883.4963044,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 288,14RSYC,15-Nov-21
C1071040,10351001,40,PF-06863135,T,6216407870,6.21641E+11,20211015,9:15,CYCLE1_DAY1,0 H,473.9401456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 383,18RSYC,17-Nov-21
C1071040,10351001,40,PF-06863135,T,6216407870,6.21641E+11,20211015,16:15,CYCLE1_DAY1,6 H,523.573028,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 382,18RSYC,17-Nov-21
C1071040,10351001,40,PF-06863135,T,6215033391,6.21503E+11,20211025,10:30,CYCLE1_DAY8,0 H,667.3067103,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 402,21RSYC,20-Apr-22
C1071040,10351001,40,PF-06863135,T,6215033391,6.21503E+11,20211025,16:30,CYCLE1_DAY8,6 H,489.8729871,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 401,21RSYC,20-Apr-22
C1071040,10351001,40,PF-06863135,T,6216407874,6.21641E+11,20211101,8:15,CYCLE1_DAY15,0 H,535.7928768,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 428,88RSYC,11-May-22
C1071040,10351001,40,PF-06863135,T,6217091593,6.21709E+11,20211108,10:24,CYCLE1_DAY22,0 H,422.1009119,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 507,24RSYC,20-Apr-22
C1071040,10351001,40,PF-06863135,T,6216407878,6.21641E+11,20211115,10:06,CYCLE2_DAY1,0 H,296.2375174,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 429,88RSYC,11-May-22
C1071040,10351001,40,PF-06863135,T,6216407885,6.21641E+11,20211016,10:15,CYCLE1_DAY1,24 H,709.1679509,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 384,18RSYC,17-Nov-21
C1071040,10351001,40,PF-06863135,T,6216407888,6.21641E+11,20211018,9:28,CYCLE1_DAY4,0 H,652.2814805,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 385,18RSYC,17-Nov-21
C1071040,10351001,40,PF-06863135,T,6216407890,6.21641E+11,20211019,10:37,CYCLE1_DAY4,24 H,856.4949707,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 386,18RSYC,17-Nov-21
C1071040,10771002,41,PF-06863135,T,6517643711,6.51764E+11,20211005,13:00,CYCLE1_DAY1,0 H,306.461487,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 326,16RSYC,16-Nov-21
C1071040,10771002,41,PF-06863135,T,6517643711,6.51764E+11,20211005,20:30,CYCLE1_DAY1,6 H,817.3035399,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 325,16RSYC,16-Nov-21
C1071040,10771002,41,PF-06863135,T,6517643714,6.51764E+11,20211015,2:53,CYCLE1_DAY8,0 H,592.6404657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 892,19RSYC,19-Apr-22
C1071040,10771002,41,PF-06863135,T,6517643714,6.51764E+11,20211015,19:45,CYCLE1_DAY8,6 H,144.3704693,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 891,19RSYC,19-Apr-22
C1071040,10771002,41,PF-06863135,T,6517246450,6.51725E+11,20211021,7:55,CYCLE1_DAY15,0 H,48.82409718,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 842,35RSYC,25-Apr-22
C1071040,10771002,41,PF-06863135,T,6517529121,6.51753E+11,20211027,8:40,CYCLE1_DAY22,0 H,65.62478255,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 872,19RSYC,19-Apr-22
C1071040,10771002,41,PF-06863135,T,6517775835,6.51778E+11,20211101,11:34,CYCLE2_DAY1,0 H,6.39983709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 909,20RSYC,19-Apr-22
C1071040,10771002,41,PF-06863135,T,6517246469,6.51725E+11,20211012,13:40,UNPL,9001 H,35.98348087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 281,14RSYC,15-Nov-21
C1071040,10771002,41,PF-06863135,T,6517643721,6.51764E+11,20211006,14:35,CYCLE1_DAY1,24 H,66.34684229,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 327,16RSYC,16-Nov-21
C1071040,10771002,41,PF-06863135,T,6517643725,6.51764E+11,20211009,8:15,CYCLE1_DAY4,0 H,755.7508544,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2126,137RSYC,18-Nov-22
C1071040,10771002,41,PF-06863135,T,6517756053,6.51776E+11,20211010,9:30,CYCLE1_DAY4,24 H,860.3688582,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 336,16RSYC,16-Nov-21
C1071040,10151001,42,PF-06863135,T,6517560122,6.51756E+11,20211013,8:25,CYCLE1_DAY1,0 H,561.4516313,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 317,15RSYC,16-Nov-21
C1071040,10151001,42,PF-06863135,T,6517560124,6.51756E+11,20211020,9:45,CYCLE1_DAY8,0 H,28.59507684,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 320,16RSYC,16-Nov-21
C1071040,10151001,42,PF-06863135,T,6517560124,6.51756E+11,20211020,16:35,CYCLE1_DAY8,6 H,588.0260602,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 319,15RSYC,16-Nov-21
C1071040,10151001,42,PF-06863135,T,6517560126,6.51756E+11,20211027,10:20,CYCLE1_DAY15,0 H,56.86894016,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 578,27RSYC,21-Apr-22
C1071040,10151001,42,PF-06863135,T,6517560128,6.51756E+11,20211103,10:20,CYCLE1_DAY22,0 H,127.9043914,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 580,27RSYC,21-Apr-22
C1071040,10151001,42,PF-06863135,T,6517560130,6.51756E+11,20211110,10:30,CYCLE2_DAY1,0 H,293.2959744,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 582,27RSYC,21-Apr-22
C1071040,10151001,42,PF-06863135,T,6517560133,6.51756E+11,20211208,13:02,CYCLE3_DAY1,0 H,217.4779215,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1050,40RSYC,26-Apr-22
C1071040,10151001,42,PF-06863135,T,6517560135,6.51756E+11,20220105,11:01,CYCLE4_DAY1,0 H,275.0678627,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1660,100RSYC,23-May-22
C1071040,10151001,42,PF-06863135,T,6517560137,6.51756E+11,20220330,11:00,CYCLE7_DAY1,0 H,906.6309534,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1928,123RSYC,29-Jul-22
C1071040,10151001,42,PF-06863135,T,6523756324,6.52376E+11,20230828,11:50,UNPL,9001 H,540.9488667,NG/ML,,Visit revised from C25D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2303,147RSYC,29-Feb-24
C1071040,10151001,42,PF-06863135,T,6517560139,6.51756E+11,20211014,17:00,CYCLE1_DAY1,24 H,289.7115586,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 321,16RSYC,16-Nov-21
C1071040,10151001,42,PF-06863135,T,6517560141,6.51756E+11,20211015,16:30,CYCLE1_DAY4,0 H,705.295764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 323,16RSYC,16-Nov-21
C1071040,10111001,43,PF-06863135,T,6517559759,6.51756E+11,20211014,11:50,CYCLE1_DAY1,0 H,921.6335998,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 568,26RSYC,22-Apr-22
C1071040,10111001,43,PF-06863135,T,6517559759,6.51756E+11,20211014,19:57,CYCLE1_DAY1,6 H,849.5466558,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 567,26RSYC,22-Apr-22
C1071040,10111001,43,PF-06863135,T,6517559760,6.51756E+11,20211022,8:50,CYCLE1_DAY8,0 H,812.6348039,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 570,26RSYC,22-Apr-22
C1071040,10111001,43,PF-06863135,T,6517559760,6.51756E+11,20211022,18:15,CYCLE1_DAY8,6 H,938.3529778,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 569,26RSYC,22-Apr-22
C1071040,10111001,43,PF-06863135,T,6517559762,6.51756E+11,20211028,9:20,CYCLE1_DAY15,0 H,399.8751635,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 571,26RSYC,22-Apr-22
C1071040,10111001,43,PF-06863135,T,6517559764,6.51756E+11,20211103,8:30,CYCLE1_DAY22,0 H,178.6342178,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 572,86RSYC,13-May-22
C1071040,10111001,43,PF-06863135,T,6514526586,6.51453E+11,20211109,8:33,CYCLE2_DAY1,0 H,333.6247197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 839,64RSYC,3-May-22
C1071040,10111001,43,PF-06863135,T,6517559769,6.51756E+11,20211206,11:00,CYCLE3_DAY1,0 H,937.8058798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1031,40RSYC,26-Apr-22
C1071040,10111001,43,PF-06863135,T,6517559774,6.51756E+11,20211015,12:50,CYCLE1_DAY1,24 H,406.4246322,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 573,26RSYC,22-Apr-22
C1071040,10111001,43,PF-06863135,T,6517559776,6.51756E+11,20211018,9:45,CYCLE1_DAY4,0 H,722.5068028,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 574,26RSYC,22-Apr-22
C1071040,10111001,43,PF-06863135,T,6517559779,6.51756E+11,20211019,12:55,CYCLE1_DAY4,24 H,795.9744066,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 575,86RSYC,13-May-22
C1071040,10101003,44,PF-06863135,T,6518332216,6.51833E+11,20211012,11:30,CYCLE1_DAY1,0 H,851.415972,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 359,17RSYC,17-Nov-21
C1071040,10101003,44,PF-06863135,T,6518332216,6.51833E+11,20211012,18:00,CYCLE1_DAY1,6 H,937.2821666,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 358,17RSYC,17-Nov-21
C1071040,10101003,44,PF-06863135,T,6517559677,6.51756E+11,20211022,8:00,CYCLE1_DAY8,0 H,575.4125924,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 564,26RSYC,22-Apr-22
C1071040,10101003,44,PF-06863135,T,6517559677,6.51756E+11,20211022,16:15,CYCLE1_DAY8,6 H,713.9085653,NG/ML,,Received as 6517559679-08,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 565,86RSYC,13-May-22
C1071040,10101003,44,PF-06863135,T,6518558183,6.51856E+11,20211105,9:04,CYCLE1_DAY22,0 H,12.72600265,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 611,90RSYC,11-May-22
C1071040,10101003,44,PF-06863135,T,6518706283,6.51871E+11,20211112,12:50,CYCLE2_DAY1,0 H,230.1670397,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 935,36RSYC,25-Apr-22
C1071040,10101003,44,PF-06863135,T,6518877335,6.51888E+11,20211210,8:33,CYCLE3_DAY1,0 H,993.5586924,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1166,104RSYC,22-May-22
C1071040,10101003,44,PF-06863135,T,6518877340,6.51888E+11,20220107,8:19,CYCLE4_DAY1,0 H,782.4252469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1612,97RSYC,12-May-22
C1071040,10101003,44,PF-06863135,T,6519690724,6.51969E+11,20220401,8:13,CYCLE7_DAY1,0 H,474.2927908,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1929,122RSYC,29-Jul-22
C1071040,10101003,44,PF-06863135,T,6518806983,6.51881E+11,20220624,8:20,CYCLE10_DAY1,0 H,27.2949525,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2028,131RSYC,9-Nov-22
C1071040,10101003,44,PF-06863135,T,6520726025,6.52073E+11,20220916,0:00,CYCLE13_DAY1,0 H,295.7921406,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2098,132RSYC,10-Nov-22
C1071040,10101003,44,PF-06863135,T,6520726030,6.52073E+11,20221216,10:14,UNPL,9001 H,555.0590612,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2131,139RSYC,22-Mar-23
C1071040,10101003,44,PF-06863135,T,6518459661,6.51846E+11,20211013,12:00,CYCLE1_DAY1,24 H,467.4132558,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 362,17RSYC,17-Nov-21
C1071040,10101003,44,PF-06863135,T,6518499635,6.5185E+11,20211015,10:35,CYCLE1_DAY4,0 H,806.1843236,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 363,17RSYC,17-Nov-21
C1071040,10101003,44,PF-06863135,T,6518499636,6.5185E+11,20211016,12:22,CYCLE1_DAY4,24 H,313.3031762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 364,17RSYC,17-Nov-21
C1071040,10021002,45,PF-06863135,T,6603324911,6.60332E+11,20211011,9:09,CYCLE1_DAY1,0 H,813.7378503,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 234,18RSYC,17-Nov-21
C1071040,10021002,45,PF-06863135,T,6603324911,6.60332E+11,20211011,16:09,CYCLE1_DAY1,6 H,193.2529923,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 235,13RSYC,15-Nov-21
C1071040,10021002,45,PF-06863135,T,6603529935,6.60353E+11,20211018,9:25,CYCLE1_DAY8,0 H,498.7088562,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 244,13RSYC,15-Nov-21
C1071040,10021002,45,PF-06863135,T,6603529935,6.60353E+11,20211018,15:09,CYCLE1_DAY8,6 H,700.7071108,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 243,13RSYC,15-Nov-21
C1071040,10021002,45,PF-06863135,T,6603529938,6.60353E+11,20211025,9:10,CYCLE1_DAY15,0 H,888.2938519,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 629,64RSYC,3-May-22
C1071040,10021002,45,PF-06863135,T,6603529940,6.60353E+11,20211101,9:10,CYCLE1_DAY22,0 H,890.9070229,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 630,64RSYC,3-May-22
C1071040,10021002,45,PF-06863135,T,6603563110,6.60356E+11,20211108,11:00,CYCLE2_DAY1,0 H,7.843614471,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 820,35RSYC,25-Apr-22
C1071040,10021002,45,PF-06863135,T,6603529946,6.60353E+11,20211206,10:10,CYCLE3_DAY1,0 H,91.78182035,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 942,65RSYC,3-May-22
C1071040,10021002,45,PF-06863135,T,6603529947,6.60353E+11,20220105,9:49,CYCLE4_DAY1,0 H,830.081168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1583,59RSYC,1-May-22
C1071040,10021002,45,PF-06863135,T,6603529950,6.60353E+11,20220330,9:45,CYCLE7_DAY1,0 H,89.05439718,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1917,122RSYC,29-Jul-22
C1071040,10021002,45,PF-06863135,T,6603578688,6.60358E+11,20220620,8:55,CYCLE10_DAY1,0 H,540.6196567,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2024,132RSYC,10-Nov-22
C1071040,10021002,45,PF-06863135,T,6603839290,6.60384E+11,20220912,10:25,CYCLE13_DAY1,0 H,930.7691703,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2115,131RSYC,9-Nov-22
C1071040,10021002,45,PF-06863135,T,6604204202,6.6042E+11,20221205,9:00,CYCLE16_DAY1,0 H,836.5479848,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2161,140RSYC,22-Mar-23
C1071040,10021002,45,PF-06863135,T,6604204197,6.6042E+11,20230227,10:45,CYCLE19_DAY1,0 H,615.0659298,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2208,142RSYC,18-May-23
C1071040,10021002,45,PF-06863135,T,6604608948,6.60461E+11,20230522,10:50,CYCLE22_DAY1,0 H,719.9843984,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2252,143RSYC,27-Nov-23
C1071040,10021002,45,PF-06863135,T,6604608946,6.60461E+11,20230828,10:35,CYCLE25_DAY1,0 H,956.4879374,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2339,149RSYC,27-Mar-24
C1071040,10021002,45,PF-06863135,T,6604608947,6.60461E+11,20231120,12:00,CYCLE28_DAY1,0 H,633.1098612,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2340,148RSYC,27-Mar-24
C1071040,10021002,45,PF-06863135,T,6604777913,6.60478E+11,20240212,10:25,CYCLE31_DAY1,0 H,669.3337239,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2359,152RSYC,9-Apr-24
C1071040,10021002,45,PF-06863135,T,6603324927,6.60332E+11,20211012,9:25,CYCLE1_DAY1,24 H,714.2879906,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 237,13RSYC,15-Nov-21
C1071040,10021002,45,PF-06863135,T,6603324928,6.60332E+11,20211014,9:55,CYCLE1_DAY4,0 H,600.5014439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 238,13RSYC,15-Nov-21
C1071040,10021002,45,PF-06863135,T,6603324930,6.60332E+11,20211015,9:35,CYCLE1_DAY4,24 H,103.1159254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 239,13RSYC,15-Nov-21
C1071040,10481001,46,PF-06863135,T,6216407971,6.21641E+11,20211012,17:10,CYCLE1_DAY1,0 H,191.049798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 434,76RSYC,4-May-22
C1071040,10481001,46,PF-06863135,T,6216407971,6.21641E+11,20211012,23:10,CYCLE1_DAY1,6 H,108.7712657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 433,88RSYC,11-May-22
C1071040,10481001,46,PF-06863135,T,6216407973,6.21641E+11,20211019,10:05,CYCLE1_DAY8,0 H,710.5724464,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 438,88RSYC,11-May-22
C1071040,10481001,46,PF-06863135,T,6216407973,6.21641E+11,20211019,16:00,CYCLE1_DAY8,6 H,220.9103651,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 437,88RSYC,11-May-22
C1071040,10481001,46,PF-06863135,T,6216407976,6.21641E+11,20211026,9:30,CYCLE1_DAY15,0 H,220.315258,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 439,88RSYC,11-May-22
C1071040,10481001,46,PF-06863135,T,6216856431,6.21686E+11,20211102,9:00,CYCLE1_DAY22,0 H,304.3834926,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 477,23RSYC,20-Apr-22
C1071040,10481001,46,PF-06863135,T,6216408001,6.21641E+11,20211111,10:55,END_OF_TRT,,819.0296118,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 710,64RSYC,3-May-22
C1071040,10481001,46,PF-06863135,T,6216407987,6.21641E+11,20211013,17:10,CYCLE1_DAY1,24 H,689.1448724,NG/ML,9; Tube received empty,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 440,,
C1071040,10481001,46,PF-06863135,T,6216407989,6.21641E+11,20211015,11:55,CYCLE1_DAY4,0 H,440.7071039,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 442,88RSYC,11-May-22
C1071040,10481001,46,PF-06863135,T,6216407991,6.21641E+11,20211016,12:00,CYCLE1_DAY4,24 H,978.0489973,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 443,88RSYC,11-May-22
C1071040,10031009,47,PF-06863135,T,6517751561,6.51775E+11,20211012,11:27,CYCLE1_DAY1,0 H,540.3920325,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1068,41RSYC,26-Apr-22
C1071040,10031009,47,PF-06863135,T,6517751561,6.51775E+11,20211012,18:00,CYCLE1_DAY1,6 H,443.1317903,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1067,41RSYC,26-Apr-22
C1071040,10031009,47,PF-06863135,T,6517751564,6.51775E+11,20211020,10:35,CYCLE1_DAY8,0 H,344.9129288,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 588,27RSYC,21-Apr-22
C1071040,10031009,47,PF-06863135,T,6517751564,6.51775E+11,20211020,17:30,CYCLE1_DAY8,6 H,254.4758867,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 587,27RSYC,21-Apr-22
C1071040,10031009,47,PF-06863135,T,6517472379,6.51747E+11,20211013,10:35,CYCLE1_DAY1,24 H,10.27589528,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 988,66RSYC,3-May-22
C1071040,10031009,47,PF-06863135,T,6517260612,6.51726E+11,20211014,12:35,CYCLE1_DAY4,0 H,227.907583,NG/ML,,Visit revised from C1D8 and Time Point updated; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2011,126RSYC,1-Aug-22
C1071040,10031009,47,PF-06863135,T,6517260613,6.51726E+11,20211015,12:30,CYCLE1_DAY4,24 H,204.7630213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 963,65RSYC,3-May-22
C1071040,11041001,48,PF-06863135,T,6216725274,6.21673E+11,20211013,12:00,CYCLE1_DAY1,0 H,880.0160597,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 451,76RSYC,4-May-22
C1071040,11041001,48,PF-06863135,T,6216725274,6.21673E+11,20211013,22:00,CYCLE1_DAY1,6 H,606.5796958,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 450,88RSYC,11-May-22
C1071040,11041001,48,PF-06863135,T,6216923991,6.21692E+11,20211021,15:10,CYCLE1_DAY8,0 H,196.5482018,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 484,23RSYC,20-Apr-22
C1071040,11041001,48,PF-06863135,T,6216923991,6.21692E+11,20211022,1:20,CYCLE1_DAY8,6 H,136.8816918,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 483,23RSYC,20-Apr-22
C1071040,11041001,48,PF-06863135,T,6216923998,6.21692E+11,20211029,13:00,CYCLE1_DAY15,0 H,162.5369543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1418,57RSYC,30-Apr-22
C1071040,11041001,48,PF-06863135,T,6216924001,6.21692E+11,20211108,12:00,CYCLE1_DAY22,0 H,794.983161,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 746,32RSYC,23-Apr-22
C1071040,11041001,48,PF-06863135,T,6216924046,6.21692E+11,20211116,15:40,END_OF_TRT,,729.9958629,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1425,108RSYC,24-May-22
C1071040,11041001,48,PF-06863135,T,6216725290,6.21673E+11,20211014,16:00,CYCLE1_DAY1,24 H,714.9574575,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 452,89RSYC,11-May-22
C1071040,11041001,48,PF-06863135,T,6216725293,6.21673E+11,20211018,14:00,CYCLE1_DAY4,0 H,693.054699,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 454,89RSYC,11-May-22
C1071040,11041001,48,PF-06863135,T,6216725294,6.21673E+11,20211019,16:20,CYCLE1_DAY4,24 H,278.3908337,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 387,18RSYC,17-Nov-21
C1071040,10791002,49,PF-06863135,T,6216170980,6.21617E+11,20211013,12:18,CYCLE1_DAY1,0 H,657.5342005,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 369,17RSYC,17-Nov-21
C1071040,10791002,49,PF-06863135,T,6216170980,6.21617E+11,20211013,19:21,CYCLE1_DAY1,6 H,709.0733188,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 368,17RSYC,17-Nov-21
C1071040,10791002,49,PF-06863135,T,6216170983,6.21617E+11,20211019,14:48,CYCLE1_DAY8,0 H,907.6648251,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 374,17RSYC,17-Nov-21
C1071040,10791002,49,PF-06863135,T,6216170983,6.21617E+11,20211019,21:07,CYCLE1_DAY8,6 H,647.0929267,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 373,17RSYC,17-Nov-21
C1071040,10791002,49,PF-06863135,T,6216843012,6.21684E+11,20211028,16:18,CYCLE1_DAY15,0 H,915.9024929,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 473,23RSYC,20-Apr-22
C1071040,10791002,49,PF-06863135,T,6216170996,6.21617E+11,20211014,14:12,CYCLE1_DAY1,24 H,17.82590224,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 376,17RSYC,17-Nov-21
C1071040,10791002,49,PF-06863135,T,6216170998,6.21617E+11,20211015,14:15,CYCLE1_DAY4,0 H,686.5449046,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 378,17RSYC,17-Nov-21
C1071040,10791002,49,PF-06863135,T,6216171000,6.21617E+11,20211016,14:34,CYCLE1_DAY4,24 H,118.3310769,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 380,18RSYC,17-Nov-21
C1071040,10151002,50,PF-06863135,T,6517560123,6.51756E+11,20211015,16:30,CYCLE1_DAY1,0 H,846.4160796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 318,15RSYC,16-Nov-21
C1071040,10151002,50,PF-06863135,T,6517560125,6.51756E+11,20211022,9:30,CYCLE1_DAY8,0 H,619.7995605,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 577,27RSYC,21-Apr-22
C1071040,10151002,50,PF-06863135,T,6517560125,6.51756E+11,20211022,15:24,CYCLE1_DAY8,6 H,653.2738898,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 576,27RSYC,21-Apr-22
C1071040,10151002,50,PF-06863135,T,6517560127,6.51756E+11,20211029,10:50,CYCLE1_DAY15,0 H,496.2173791,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 579,27RSYC,21-Apr-22
C1071040,10151002,50,PF-06863135,T,6517560129,6.51756E+11,20211105,10:25,CYCLE1_DAY22,0 H,308.6523505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 581,27RSYC,21-Apr-22
C1071040,10151002,50,PF-06863135,T,6517560131,6.51756E+11,20211112,10:09,CYCLE2_DAY1,0 H,755.0038283,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 886,19RSYC,19-Apr-22
C1071040,10151002,50,PF-06863135,T,6517560132,6.51756E+11,20211210,10:38,CYCLE3_DAY1,0 H,980.8255569,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1049,40RSYC,26-Apr-22
C1071040,10151002,50,PF-06863135,T,6519170849,6.51917E+11,20220107,10:30,CYCLE4_DAY1,0 H,205.9358078,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1661,100RSYC,23-May-22
C1071040,10151002,50,PF-06863135,T,6520320365,6.52032E+11,20220623,10:34,CYCLE10_DAY1,0 H,530.9032342,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2033,128RSYC,21-Oct-22
C1071040,10151002,50,PF-06863135,T,6517560152,6.51756E+11,20220707,11:00,END_OF_TRT,,546.0085422,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2032,128RSYC,21-Oct-22
C1071040,10151002,50,PF-06863135,T,6517560140,6.51756E+11,20211018,13:15,CYCLE1_DAY4,0 H,521.0757623,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 322,16RSYC,16-Nov-21
C1071040,10151002,50,PF-06863135,T,6517560142,6.51756E+11,20211019,14:05,CYCLE1_DAY4,24 H,373.1416806,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 324,16RSYC,16-Nov-21
C1071040,10791004,51,PF-06863135,T,6216840408,6.21684E+11,20211014,13:28,CYCLE1_DAY1,0 H,214.0273525,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 467,23RSYC,20-Apr-22
C1071040,10791004,51,PF-06863135,T,6216840408,6.21684E+11,20211014,20:08,CYCLE1_DAY1,6 H,669.15178,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 466,23RSYC,20-Apr-22
C1071040,10791004,51,PF-06863135,T,6216843010,6.21684E+11,20211021,13:33,CYCLE1_DAY8,0 H,416.2209958,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 472,23RSYC,20-Apr-22
C1071040,10791004,51,PF-06863135,T,6216843010,6.21684E+11,20211021,19:23,CYCLE1_DAY8,6 H,177.4766583,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 471,23RSYC,20-Apr-22
C1071040,10791004,51,PF-06863135,T,6216170984,6.21617E+11,20211028,14:30,CYCLE1_DAY15,0 H,750.4597889,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 415,21RSYC,20-Apr-22
C1071040,10791004,51,PF-06863135,T,6216843015,6.21684E+11,20211104,13:22,CYCLE1_DAY22,0 H,252.304058,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 474,23RSYC,20-Apr-22
C1071040,10791004,51,PF-06863135,T,6216170989,6.21617E+11,20211111,14:00,CYCLE2_DAY1,0 H,239.1529574,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 702,64RSYC,3-May-22
C1071040,10791004,51,PF-06863135,T,6217142537,6.21714E+11,20211216,13:20,CYCLE3_DAY1,0 H,925.3504836,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1467,54RSYC,30-Apr-22
C1071040,10791004,51,PF-06863135,T,6217031636,6.21703E+11,20220113,13:35,CYCLE4_DAY1,0 H,272.149486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1811,92RSYC,12-May-22
C1071040,10791004,51,PF-06863135,T,6217031638,6.21703E+11,20220407,13:19,CYCLE7_DAY1,0 H,222.5103046,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1912,123RSYC,29-Jul-22
C1071040,10791004,51,PF-06863135,T,6219244643,6.21924E+11,20221222,14:21,CYCLE16_DAY1,0 H,433.071112,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2183,141RSYC,17-May-23
C1071040,10791004,51,PF-06863135,T,6219244641,6.21924E+11,20230316,15:45,CYCLE19_DAY1,0 H,539.956334,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2213,142RSYC,18-May-23
C1071040,10791004,51,PF-06863135,T,6219244644,6.21924E+11,20230608,9:53,CYCLE22_DAY1,0 H,63.82881604,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2257,144RSYC,27-Nov-23
C1071040,10791004,51,PF-06863135,T,6219947541,6.21995E+11,20230829,14:00,CYCLE25_DAY1,0 H,761.3462217,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2311,147RSYC,29-Feb-24
C1071040,10791004,51,PF-06863135,T,6219947543,6.21995E+11,20240222,13:38,CYCLE31_DAY1,0 H,241.3074758,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2367,153RSYC,10-Apr-24
C1071040,10791004,51,PF-06863135,T,6216840412,6.21684E+11,20211015,14:07,CYCLE1_DAY1,24 H,717.2547148,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 394,18RSYC,17-Nov-21
C1071040,10791004,51,PF-06863135,T,6216840413,6.21684E+11,20211018,14:00,CYCLE1_DAY4,0 H,729.0895117,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 395,18RSYC,17-Nov-21
C1071040,10791004,51,PF-06863135,T,6216840410,6.21684E+11,20211019,14:00,CYCLE1_DAY4,24 H,569.3461427,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 393,18RSYC,17-Nov-21
C1071040,11171006,52,PF-06863135,T,6517764043,6.51776E+11,20211018,11:25,CYCLE1_DAY1,0 H,62.11514772,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 338,16RSYC,16-Nov-21
C1071040,11171006,52,PF-06863135,T,6517764043,6.51776E+11,20211018,17:32,CYCLE1_DAY1,6 H,576.0545699,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 337,16RSYC,16-Nov-21
C1071040,11171006,52,PF-06863135,T,6517433558,6.51743E+11,20211025,10:50,CYCLE1_DAY8,0 H,9.646018516,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 544,25RSYC,22-Apr-22
C1071040,11171006,52,PF-06863135,T,6517433558,6.51743E+11,20211025,16:47,CYCLE1_DAY8,6 H,866.1681563,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 543,25RSYC,22-Apr-22
C1071040,11171006,52,PF-06863135,T,6517764054,6.51776E+11,20211102,9:42,CYCLE1_DAY15,0 H,130.7598803,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 594,27RSYC,21-Apr-22
C1071040,11171006,52,PF-06863135,T,6517764059,6.51776E+11,20211108,9:03,CYCLE1_DAY22,0 H,128.285378,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 595,27RSYC,21-Apr-22
C1071040,11171006,52,PF-06863135,T,6517764064,6.51776E+11,20211115,12:05,CYCLE2_DAY1,0 H,912.9730658,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 903,20RSYC,19-Apr-22
C1071040,11171006,52,PF-06863135,T,6517433585,6.51743E+11,20211122,8:32,END_OF_TRT,,35.78054539,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 848,107RSYC,24-May-22
C1071040,11171006,52,PF-06863135,T,6517764070,6.51776E+11,20211019,10:30,CYCLE1_DAY1,24 H,253.2354176,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 339,16RSYC,16-Nov-21
C1071040,11171006,52,PF-06863135,T,6517433574,6.51743E+11,20211021,9:42,CYCLE1_DAY4,0 H,576.9642895,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 289,14RSYC,15-Nov-21
C1071040,11171006,52,PF-06863135,T,6518011622,6.51801E+11,20211022,9:20,CYCLE1_DAY4,24 H,304.6117601,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 601,27RSYC,21-Apr-22
C1071040,10321001,53,PF-06863135,T,6517509070,6.51751E+11,20211015,11:52,CYCLE1_DAY1,0 H,921.6886461,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 298,15RSYC,16-Nov-21
C1071040,10321001,53,PF-06863135,T,6517509070,6.51751E+11,20211015,19:24,CYCLE1_DAY1,6 H,132.1330618,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 297,15RSYC,16-Nov-21
C1071040,10321001,53,PF-06863135,T,6517509073,6.51751E+11,20211022,11:41,CYCLE1_DAY8,0 H,322.6399915,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 557,26RSYC,22-Apr-22
C1071040,10321001,53,PF-06863135,T,6517509073,6.51751E+11,20211022,17:46,CYCLE1_DAY8,6 H,93.57609871,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 556,26RSYC,22-Apr-22
C1071040,10321001,53,PF-06863135,T,6517509074,6.51751E+11,20211028,14:41,CYCLE1_DAY15,0 H,757.3230194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 558,26RSYC,22-Apr-22
C1071040,10321001,53,PF-06863135,T,6517509077,6.51751E+11,20211104,8:33,CYCLE1_DAY22,0 H,151.8564341,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 559,26RSYC,22-Apr-22
C1071040,10321001,53,PF-06863135,T,6517509078,6.51751E+11,20211110,11:25,CYCLE2_DAY1,0 H,200.266299,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 869,19RSYC,19-Apr-22
C1071040,10321001,53,PF-06863135,T,6518150043,6.51815E+11,20211209,11:55,CYCLE3_DAY1,0 H,237.0031634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1090,67RSYC,8-May-22
C1071040,10321001,53,PF-06863135,T,6518150044,6.51815E+11,20220106,11:56,CYCLE4_DAY1,0 H,732.6456001,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1630,85RSYC,10-May-22
C1071040,10321001,53,PF-06863135,T,6517559966,6.51756E+11,20220331,14:24,CYCLE7_DAY1,0 H,645.5871444,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1930,123RSYC,29-Jul-22
C1071040,10321001,53,PF-06863135,T,6517559974,6.51756E+11,20220627,12:55,CYCLE10_DAY1,0 H,444.170888,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2030,128RSYC,21-Oct-22
C1071040,10321001,53,PF-06863135,T,6518807506,6.51881E+11,20220919,9:21,CYCLE13_DAY1,0 H,699.2568623,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2099,132RSYC,10-Nov-22
C1071040,10321001,53,PF-06863135,T,6519136799,6.51914E+11,20221128,11:33,END_OF_TRT,,459.5772141,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2132,139RSYC,22-Mar-23
C1071040,10321001,53,PF-06863135,T,6517509082,6.51751E+11,20211016,13:35,CYCLE1_DAY1,24 H,22.66779349,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 299,15RSYC,16-Nov-21
C1071040,10321001,53,PF-06863135,T,6517509084,6.51751E+11,20211018,12:51,CYCLE1_DAY4,0 H,571.8788306,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 300,15RSYC,16-Nov-21
C1071040,10321001,53,PF-06863135,T,6517509086,6.51751E+11,20211019,13:41,CYCLE1_DAY4,24 H,875.9187796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 301,15RSYC,16-Nov-21
C1071040,11021001,54,PF-06863135,T,6216756800,6.21676E+11,20211018,14:05,CYCLE1_DAY1,0 H,401.5336162,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 390,18RSYC,17-Nov-21
C1071040,11021001,54,PF-06863135,T,6216756800,6.21676E+11,20211018,20:00,CYCLE1_DAY1,6 H,232.0677395,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1384,100RSYC,23-May-22
C1071040,11021001,54,PF-06863135,T,6217023832,6.21702E+11,20211102,19:10,CYCLE1_DAY15,0 H,760.0464592,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 505,24RSYC,20-Apr-22
C1071040,11021001,54,PF-06863135,T,6217136144,6.21714E+11,20211108,15:50,CYCLE1_DAY22,0 H,828.5732067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 509,24RSYC,20-Apr-22
C1071040,11021001,54,PF-06863135,T,6217023837,6.21702E+11,20211115,17:00,CYCLE2_DAY1,0 H,343.8150589,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 757,33RSYC,24-Apr-22
C1071040,11021001,54,PF-06863135,T,6217142695,6.21714E+11,20211216,15:00,END_OF_TRT,,982.4486322,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1469,109RSYC,25-May-22
C1071040,11021001,54,PF-06863135,T,6216756811,6.21676E+11,20211019,14:27,CYCLE1_DAY1,24 H,747.4806429,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 391,18RSYC,17-Nov-21
C1071040,11021001,54,PF-06863135,T,6216756814,6.21676E+11,20211021,14:45,CYCLE1_DAY4,0 H,841.755154,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 461,23RSYC,20-Apr-22
C1071040,11021001,54,PF-06863135,T,6216756816,6.21676E+11,20211022,16:05,CYCLE1_DAY4,24 H,872.1407231,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 463,23RSYC,20-Apr-22
C1071040,11041002,55,PF-06863135,T,6216923990,6.21692E+11,20211018,11:00,CYCLE1_DAY1,0 H,51.862528,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 482,23RSYC,20-Apr-22
C1071040,11041002,55,PF-06863135,T,6216923990,6.21692E+11,20211019,0:30,CYCLE1_DAY1,6 H,931.5849352,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 481,23RSYC,20-Apr-22
C1071040,11041002,55,PF-06863135,T,6216923994,6.21692E+11,20211025,10:30,CYCLE1_DAY8,0 H,725.2155588,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 486,24RSYC,20-Apr-22
C1071040,11041002,55,PF-06863135,T,6216923994,6.21692E+11,20211025,17:45,CYCLE1_DAY8,6 H,602.9977444,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 485,24RSYC,20-Apr-22
C1071040,11041002,55,PF-06863135,T,6216923995,6.21692E+11,20211102,11:45,CYCLE1_DAY15,0 H,913.1586833,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 487,24RSYC,20-Apr-22
C1071040,11041002,55,PF-06863135,T,6216924002,6.21692E+11,20211108,12:40,CYCLE1_DAY22,0 H,113.3849123,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 488,24RSYC,20-Apr-22
C1071040,11041002,55,PF-06863135,T,6216725284,6.21673E+11,20211214,10:42,CYCLE3_DAY1,0 H,19.52681306,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1377,84RSYC,10-May-22
C1071040,11041002,55,PF-06863135,T,6216725304,6.21673E+11,20220113,12:45,END_OF_TRT,,357.9435858,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1756,109RSYC,25-May-22
C1071040,11041002,55,PF-06863135,T,6216725291,6.21673E+11,20211019,18:30,CYCLE1_DAY1,24 H,300.7183628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 453,89RSYC,11-May-22
C1071040,11041002,55,PF-06863135,T,6216924029,6.21692E+11,20211021,6:00,CYCLE1_DAY4,0 H,29.40848981,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 490,24RSYC,20-Apr-22
C1071040,11041002,55,PF-06863135,T,6216924033,6.21692E+11,20211022,13:45,CYCLE1_DAY4,24 H,67.17381007,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 493,24RSYC,20-Apr-22
C1071040,10121001,56,PF-06863135,T,6517433306,6.51743E+11,20211019,8:58,CYCLE1_DAY1,0 H,637.1752412,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 522,25RSYC,22-Apr-22
C1071040,10121001,56,PF-06863135,T,6517433306,6.51743E+11,20211019,16:12,CYCLE1_DAY1,6 H,747.3445114,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 521,25RSYC,22-Apr-22
C1071040,10121001,56,PF-06863135,T,6517433308,6.51743E+11,20211026,9:55,CYCLE1_DAY8,0 H,851.6020702,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 524,25RSYC,22-Apr-22
C1071040,10121001,56,PF-06863135,T,6517433308,6.51743E+11,20211026,15:55,CYCLE1_DAY8,6 H,448.5687959,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 523,25RSYC,22-Apr-22
C1071040,10121001,56,PF-06863135,T,6518019676,6.51802E+11,20220426,11:32,END_OF_TRT,,5.480968744,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1982,114RSYC,25-Jul-22
C1071040,10121001,56,PF-06863135,T,6517433322,6.51743E+11,20211020,11:35,CYCLE1_DAY1,24 H,40.43336223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 526,107RSYC,24-May-22
C1071040,10121001,56,PF-06863135,T,6517433323,6.51743E+11,20211021,12:10,CYCLE1_DAY4,0 H,181.7314299,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 527,109RSYC,25-May-22
C1071040,10121001,56,PF-06863135,T,6517433326,6.51743E+11,20211022,11:25,CYCLE1_DAY4,24 H,777.9809884,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 530,25RSYC,22-Apr-22
C1071040,11081003,57,PF-06863135,T,6801650152,6.80165E+11,20211019,9:55,CYCLE1_DAY1,0 H,624.5386465,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 245,13RSYC,15-Nov-21
C1071040,11081003,57,PF-06863135,T,6801650152,6.80165E+11,20211019,20:10,CYCLE1_DAY1,6 H,129.1942794,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 246,13RSYC,15-Nov-21
C1071040,11081003,57,PF-06863135,T,6801650154,6.80165E+11,20211026,10:00,CYCLE1_DAY8,0 H,897.7200858,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 632,64RSYC,3-May-22
C1071040,11081003,57,PF-06863135,T,6801650154,6.80165E+11,20211026,19:35,CYCLE1_DAY8,6 H,228.7266109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 631,64RSYC,3-May-22
C1071040,11081003,57,PF-06863135,T,6801650156,6.80165E+11,20211102,8:40,CYCLE1_DAY15,0 H,713.1624226,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 633,64RSYC,3-May-22
C1071040,11081003,57,PF-06863135,T,6801650158,6.80165E+11,20211109,9:35,CYCLE1_DAY22,0 H,900.7767838,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 634,64RSYC,3-May-22
C1071040,11081003,57,PF-06863135,T,6801650160,6.80165E+11,20211116,9:45,CYCLE2_DAY1,0 H,36.43311006,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 635,29RSYC,22-Apr-22
C1071040,11081003,57,PF-06863135,T,6801650172,6.80165E+11,20211210,11:20,END_OF_TRT,,635.9583486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 951,86RSYC,13-May-22
C1071040,11081003,57,PF-06863135,T,6801650164,6.80165E+11,20211020,14:35,CYCLE1_DAY1,24 H,102.4505813,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 249,13RSYC,15-Nov-21
C1071040,11081003,57,PF-06863135,T,6801650166,6.80165E+11,20211022,8:40,CYCLE1_DAY4,0 H,925.0656737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 250,13RSYC,15-Nov-21
C1071040,11081003,57,PF-06863135,T,6801650168,6.80165E+11,20211023,12:58,CYCLE1_DAY4,24 H,142.188064,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 636,29RSYC,22-Apr-22
C1071040,11021002,58,PF-06863135,T,6216756799,6.21676E+11,20211020,13:05,CYCLE1_DAY1,0 H,974.1437814,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 389,18RSYC,17-Nov-21
C1071040,11021002,58,PF-06863135,T,6216756799,6.21676E+11,20211020,19:00,CYCLE1_DAY1,6 H,224.1795694,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 388,18RSYC,17-Nov-21
C1071040,11021002,58,PF-06863135,T,6216756801,6.21676E+11,20211027,17:20,CYCLE1_DAY8,0 H,583.1552798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 459,23RSYC,20-Apr-22
C1071040,11021002,58,PF-06863135,T,6216756801,6.21676E+11,20211027,23:20,CYCLE1_DAY8,6 H,500.3255486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 458,23RSYC,20-Apr-22
C1071040,11021002,58,PF-06863135,T,6217023831,6.21702E+11,20211103,16:30,CYCLE1_DAY15,0 H,734.9396849,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 504,24RSYC,20-Apr-22
C1071040,11021002,58,PF-06863135,T,6217118740,6.21712E+11,20211110,12:10,CYCLE1_DAY22,0 H,674.1708009,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1452,54RSYC,30-Apr-22
C1071040,11021002,58,PF-06863135,T,6217170460,6.21717E+11,20211117,15:10,CYCLE2_DAY1,0 H,194.3296524,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 795,34RSYC,24-Apr-22
C1071040,11021002,58,PF-06863135,T,6217136148,6.21714E+11,20211215,15:35,CYCLE3_DAY1,0 H,511.8280005,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1465,54RSYC,30-Apr-22
C1071040,11021002,58,PF-06863135,T,6217142692,6.21714E+11,20220105,13:50,END_OF_TRT,,990.7053969,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1834,86RSYC,13-May-22
C1071040,11021002,58,PF-06863135,T,6216756812,6.21676E+11,20211021,13:15,CYCLE1_DAY1,24 H,989.9134881,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 392,18RSYC,17-Nov-21
C1071040,11021002,58,PF-06863135,T,6216756813,6.21676E+11,20211022,15:35,CYCLE1_DAY4,0 H,697.971637,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 460,23RSYC,20-Apr-22
C1071040,10171001,60,PF-06863135,T,6215033337,6.21503E+11,20211021,14:57,CYCLE1_DAY1,0 H,834.0949287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 398,21RSYC,20-Apr-22
C1071040,10171001,60,PF-06863135,T,6215033337,6.21503E+11,20211021,22:00,CYCLE1_DAY1,6 H,76.97743571,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 397,21RSYC,20-Apr-22
C1071040,10171001,60,PF-06863135,T,6216407831,6.21641E+11,20211109,11:30,END_OF_TRT,,60.22845543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 705,64RSYC,3-May-22
C1071040,10171001,60,PF-06863135,T,6216407817,6.21641E+11,20211022,16:00,CYCLE1_DAY1,24 H,333.5939235,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 419,21RSYC,20-Apr-22
C1071040,10171001,60,PF-06863135,T,6216407820,6.21641E+11,20211027,12:00,CYCLE1_DAY4,0 H,354.9028246,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 422,21RSYC,20-Apr-22
C1071040,10171001,60,PF-06863135,T,6216407821,6.21641E+11,20211028,15:03,CYCLE1_DAY4,24 H,490.2307591,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 423,21RSYC,20-Apr-22
C1071040,10791005,61,PF-06863135,T,6216840407,6.21684E+11,20211021,17:45,CYCLE1_DAY1,0 H,261.9970277,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 465,23RSYC,20-Apr-22
C1071040,10791005,61,PF-06863135,T,6216840407,6.21684E+11,20211021,23:48,CYCLE1_DAY1,6 H,106.8218326,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 464,23RSYC,20-Apr-22
C1071040,10791005,61,PF-06863135,T,6216170987,6.21617E+11,20211111,13:49,CYCLE1_DAY22,0 H,159.1560362,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 701,31RSYC,23-Apr-22
C1071040,10791005,61,PF-06863135,T,6216843016,6.21684E+11,20211118,14:14,CYCLE2_DAY1,0 H,250.6389269,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 737,32RSYC,23-Apr-22
C1071040,10791005,61,PF-06863135,T,6216171011,6.21617E+11,20211210,12:17,END_OF_TRT,,266.5699458,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1291,108RSYC,24-May-22
C1071040,10791005,61,PF-06863135,T,6216840409,6.21684E+11,20211022,16:00,CYCLE1_DAY1,24 H,564.5856998,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 468,23RSYC,20-Apr-22
C1071040,10791005,61,PF-06863135,T,6216840415,6.21684E+11,20211025,17:09,CYCLE1_DAY4,0 H,829.7301997,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 469,23RSYC,20-Apr-22
C1071040,10791005,61,PF-06863135,T,6216840418,6.21684E+11,20211026,17:21,CYCLE1_DAY4,24 H,611.3601336,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 470,23RSYC,20-Apr-22
C1071040,10901001,62,PF-06863135,T,6517433521,6.51743E+11,20211025,14:35,CYCLE1_DAY1,0 H,568.338444,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 536,25RSYC,22-Apr-22
C1071040,10901001,62,PF-06863135,T,6517433521,6.51743E+11,20211025,21:35,CYCLE1_DAY1,6 H,59.87095036,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 535,25RSYC,22-Apr-22
C1071040,10901001,62,PF-06863135,T,6517433523,6.51743E+11,20211101,16:15,CYCLE1_DAY8,0 H,815.0196604,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 538,25RSYC,22-Apr-22
C1071040,10901001,62,PF-06863135,T,6517433523,6.51743E+11,20211101,22:32,CYCLE1_DAY8,6 H,532.4073073,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 537,25RSYC,22-Apr-22
C1071040,10901001,62,PF-06863135,T,6517433526,6.51743E+11,20211108,14:58,CYCLE1_DAY15,0 H,595.9604607,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 539,25RSYC,22-Apr-22
C1071040,10901001,62,PF-06863135,T,6517433538,6.51743E+11,20211026,15:54,CYCLE1_DAY1,24 H,847.3234438,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 540,25RSYC,22-Apr-22
C1071040,10901001,62,PF-06863135,T,6517433539,6.51743E+11,20211028,12:18,CYCLE1_DAY4,0 H,182.3269306,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 541,25RSYC,22-Apr-22
C1071040,10901001,62,PF-06863135,T,6517433541,6.51743E+11,20211029,15:30,CYCLE1_DAY4,24 H,147.3171568,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 542,86RSYC,13-May-22
C1071040,10031010,63,PF-06863135,T,6516580384,6.51658E+11,20211025,10:35,CYCLE1_DAY1,0 H,281.2258379,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 512,24RSYC,20-Apr-22
C1071040,10031010,63,PF-06863135,T,6516580384,6.51658E+11,20211025,17:45,CYCLE1_DAY1,6 H,653.5932288,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 511,24RSYC,20-Apr-22
C1071040,10031010,63,PF-06863135,T,6516580386,6.51658E+11,20211103,11:50,CYCLE1_DAY8,0 H,771.1598819,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 514,24RSYC,20-Apr-22
C1071040,10031010,63,PF-06863135,T,6516580386,6.51658E+11,20211103,17:30,CYCLE1_DAY8,6 H,692.2654935,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 513,24RSYC,20-Apr-22
C1071040,10031010,63,PF-06863135,T,6517751570,6.51775E+11,20211110,17:12,CYCLE1_DAY15,0 H,291.6361709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1069,41RSYC,26-Apr-22
C1071040,10031010,63,PF-06863135,T,6518620863,6.51862E+11,20211026,10:40,CYCLE1_DAY1,24 H,186.693197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 615,90RSYC,11-May-22
C1071040,10031010,63,PF-06863135,T,6518620865,6.51862E+11,20211027,10:43,CYCLE1_DAY4,0 H,535.5695622,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1123,94RSYC,12-May-22
C1071040,10031010,63,PF-06863135,T,6517473948,6.51747E+11,20211028,10:51,CYCLE1_DAY4,24 H,246.1657821,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1008,39RSYC,26-Apr-22
C1071040,11241002,64,PF-06863135,T,6801650308,6.80165E+11,20211025,10:29,CYCLE1_DAY1,0 H,599.5260766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 651,29RSYC,22-Apr-22
C1071040,11241002,64,PF-06863135,T,6801650308,6.80165E+11,20211025,16:53,CYCLE1_DAY1,6 H,988.9100204,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 652,29RSYC,22-Apr-22
C1071040,11241002,64,PF-06863135,T,6801650310,6.80165E+11,20211101,10:13,CYCLE1_DAY8,0 H,982.7712316,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 654,29RSYC,22-Apr-22
C1071040,11241002,64,PF-06863135,T,6801650310,6.80165E+11,20211101,16:31,CYCLE1_DAY8,6 H,562.0579941,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 653,29RSYC,22-Apr-22
C1071040,11241002,64,PF-06863135,T,6801650312,6.80165E+11,20211110,14:15,CYCLE1_DAY15,0 H,338.1159184,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 655,29RSYC,22-Apr-22
C1071040,11241002,64,PF-06863135,T,6801700252,6.8017E+11,20211116,14:32,CYCLE1_DAY22,0 H,831.6814589,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 831,64RSYC,3-May-22
C1071040,11241002,64,PF-06863135,T,6801650316,6.80165E+11,20211124,14:39,CYCLE2_DAY1,0 H,406.9069816,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 829,35RSYC,25-Apr-22
C1071040,11241002,64,PF-06863135,T,6801700259,6.8017E+11,20211221,12:49,CYCLE3_DAY1,0 H,584.706462,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 960,65RSYC,3-May-22
C1071040,11241002,64,PF-06863135,T,6801700262,6.8017E+11,20220118,14:47,CYCLE4_DAY1,0 H,831.7121119,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1597,96RSYC,12-May-22
C1071040,11241002,64,PF-06863135,T,6801805147,6.80181E+11,20220412,14:50,CYCLE7_DAY1,0 H,987.7793678,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1918,122RSYC,29-Jul-22
C1071040,11241002,64,PF-06863135,T,6801913233,6.80191E+11,20220705,14:24,CYCLE10_DAY1,0 H,1.241145767,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2026,131RSYC,9-Nov-22
C1071040,11241002,64,PF-06863135,T,6801913234,6.80191E+11,20220927,14:08,CYCLE13_DAY1,0 H,269.2187763,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2120,134RSYC,11-Nov-22
C1071040,11241002,64,PF-06863135,T,6802054682,6.80205E+11,20221220,15:07,CYCLE16_DAY1,0 H,16.23499745,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2162,143RSYC,27-Nov-23
C1071040,11241002,64,PF-06863135,T,6802054683,6.80205E+11,20230315,14:18,CYCLE19_DAY1,0 H,4.359593831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2209,142RSYC,18-May-23
C1071040,11241002,64,PF-06863135,T,6802232421,6.80223E+11,20230606,14:45,CYCLE22_DAY1,0 H,662.8474247,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2273,144RSYC,27-Nov-23
C1071040,11241002,64,PF-06863135,T,6802232422,6.80223E+11,20230829,13:55,CYCLE25_DAY1,0 H,464.0763096,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2299,147RSYC,29-Feb-24
C1071040,11241002,64,PF-06863135,T,6802432310,6.80243E+11,20231121,13:25,CYCLE28_DAY1,0 H,268.0167087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2341,148RSYC,27-Mar-24
C1071040,11241002,64,PF-06863135,T,6802432311,6.80243E+11,20240213,14:40,CYCLE31_DAY1,0 H,243.4723546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2360,153RSYC,10-Apr-24
C1071040,11241002,64,PF-06863135,T,6801650325,6.80165E+11,20211027,11:35,UNPL,9001 H,432.9558728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 660,64RSYC,3-May-22
C1071040,11241002,64,PF-06863135,T,6801650320,6.80165E+11,20211026,11:22,CYCLE1_DAY1,24 H,48.25869021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 657,29RSYC,22-Apr-22
C1071040,11241002,64,PF-06863135,T,6801650322,6.80165E+11,20211029,10:22,CYCLE1_DAY4,0 H,501.4880844,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 658,29RSYC,22-Apr-22
C1071040,11241002,64,PF-06863135,T,6801650324,6.80165E+11,20211030,11:20,CYCLE1_DAY4,24 H,862.7017946,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 659,29RSYC,22-Apr-22
C1071040,10961001,65,PF-06863135,T,6215349420,6.21535E+11,20211025,11:00,CYCLE1_DAY1,0 H,519.2023496,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 404,21RSYC,20-Apr-22
C1071040,10961001,65,PF-06863135,T,6215349420,6.21535E+11,20211025,20:15,CYCLE1_DAY1,6 H,464.2740525,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 403,21RSYC,20-Apr-22
C1071040,10961001,65,PF-06863135,T,6216170914,6.21617E+11,20211104,16:00,CYCLE1_DAY8,0 H,17.64411114,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 700,31RSYC,23-Apr-22
C1071040,10961001,65,PF-06863135,T,6216170914,6.21617E+11,20211104,22:15,CYCLE1_DAY8,6 H,27.77642009,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 699,31RSYC,23-Apr-22
C1071040,10961001,65,PF-06863135,T,6215349424,6.21535E+11,20211112,15:25,CYCLE1_DAY15,0 H,95.72736031,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 694,30RSYC,22-Apr-22
C1071040,10961001,65,PF-06863135,T,6215349426,6.21535E+11,20211122,14:00,CYCLE1_DAY22,0 H,872.7537045,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 695,30RSYC,22-Apr-22
C1071040,10961001,65,PF-06863135,T,6216170920,6.21617E+11,20211201,13:58,CYCLE2_DAY1,0 H,750.1254184,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1276,89RSYC,11-May-22
C1071040,10961001,65,PF-06863135,T,6216170922,6.21617E+11,20211227,10:20,CYCLE3_DAY1,0 H,213.1723051,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1783,71RSYC,7-May-22
C1071040,10961001,65,PF-06863135,T,6216170924,6.21617E+11,20220124,9:40,CYCLE4_DAY1,0 H,212.3080709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1784,71RSYC,7-May-22
C1071040,10961001,65,PF-06863135,T,6218290587,6.21829E+11,20220419,12:00,CYCLE7_DAY1,0 H,770.9450288,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1913,123RSYC,29-Jul-22
C1071040,10961001,65,PF-06863135,T,6217142393,6.21714E+11,20220711,11:00,CYCLE10_DAY1,0 H,332.4459265,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2040,128RSYC,21-Oct-22
C1071040,10961001,65,PF-06863135,T,6216170943,6.21617E+11,20220725,9:00,END_OF_TRT,,275.6807706,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2053,132RSYC,10-Nov-22
C1071040,10961001,65,PF-06863135,T,6216170928,6.21617E+11,20211026,14:15,CYCLE1_DAY1,24 H,66.99788425,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 412,107RSYC,24-May-22
C1071040,10961001,65,PF-06863135,T,6216170930,6.21617E+11,20211028,14:00,CYCLE1_DAY4,0 H,589.7233695,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 413,21RSYC,20-Apr-22
C1071040,10961001,65,PF-06863135,T,6216170933,6.21617E+11,20211029,14:15,CYCLE1_DAY4,24 H,934.4443964,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 414,21RSYC,20-Apr-22
C1071040,10171002,66,PF-06863135,T,6215033338,6.21503E+11,20211025,12:38,CYCLE1_DAY1,0 H,558.8036676,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 400,21RSYC,20-Apr-22
C1071040,10171002,66,PF-06863135,T,6215033338,6.21503E+11,20211025,19:44,CYCLE1_DAY1,6 H,696.2321853,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 399,21RSYC,20-Apr-22
C1071040,10171002,66,PF-06863135,T,6216407803,6.21641E+11,20211108,13:05,CYCLE1_DAY8,0 H,716.6475287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 418,21RSYC,20-Apr-22
C1071040,10171002,66,PF-06863135,T,6216407803,6.21641E+11,20211108,19:20,CYCLE1_DAY8,6 H,556.8020112,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 417,21RSYC,20-Apr-22
C1071040,10171002,66,PF-06863135,T,6216407806,6.21641E+11,20211115,12:00,CYCLE1_DAY15,0 H,792.7192146,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 703,31RSYC,23-Apr-22
C1071040,10171002,66,PF-06863135,T,6216407807,6.21641E+11,20211122,11:17,CYCLE1_DAY22,0 H,623.8279226,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 704,31RSYC,23-Apr-22
C1071040,10171002,66,PF-06863135,T,6216407816,6.21641E+11,20220420,11:01,CYCLE7_DAY1,0 H,865.138879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1990,114RSYC,25-Jul-22
C1071040,10171002,66,PF-06863135,T,6217142268,6.21714E+11,20220711,10:10,CYCLE10_DAY1,0 H,619.4232276,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2038,128RSYC,21-Oct-22
C1071040,10171002,66,PF-06863135,T,6219335461,6.21934E+11,20221004,16:11,CYCLE13_DAY1,0 H,370.8350181,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2122,131RSYC,9-Nov-22
C1071040,10171002,66,PF-06863135,T,6221257540,6.22126E+11,20231128,8:25,CYCLE28_DAY1,0 H,252.8845405,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2346,151RSYC,8-Apr-24
C1071040,10171002,66,PF-06863135,T,6222063119,6.22206E+11,20240219,8:24,CYCLE31_DAY1,0 H,960.3613112,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2363,152RSYC,9-Apr-24
C1071040,10171002,66,PF-06863135,T,6216407809,6.21641E+11,20211221,14:50,UNPL,9001 H,186.9056154,NG/ML,,Visit revised from C2D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1292,84RSYC,10-May-22
C1071040,10171002,66,PF-06863135,T,6219335460,6.21934E+11,20230327,11:30,UNPL,9002 H,822.6835802,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2227,145RSYC,4-Jan-24
C1071040,10171002,66,PF-06863135,T,6216407818,6.21641E+11,20211026,14:10,CYCLE1_DAY1,24 H,869.0667232,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 420,21RSYC,20-Apr-22
C1071040,10171002,66,PF-06863135,T,6216407819,6.21641E+11,20211103,15:08,CYCLE1_DAY4,0 H,117.3353015,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 421,21RSYC,20-Apr-22
C1071040,10171002,66,PF-06863135,T,6216407822,6.21641E+11,20211104,14:00,CYCLE1_DAY4,24 H,911.7767652,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 424,21RSYC,20-Apr-22
C1071040,10461001,67,PF-06863135,T,6216756763,6.21676E+11,20211109,9:45,CYCLE1_DAY1,0 H,692.0951668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 456,23RSYC,20-Apr-22
C1071040,10461001,67,PF-06863135,T,6216756763,6.21676E+11,20211109,18:00,CYCLE1_DAY1,6 H,173.4501357,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 455,23RSYC,20-Apr-22
C1071040,10461001,67,PF-06863135,T,6216756764,6.21676E+11,20211118,10:40,CYCLE1_DAY8,0 H,262.8766977,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 731,32RSYC,23-Apr-22
C1071040,10461001,67,PF-06863135,T,6216756764,6.21676E+11,20211118,19:00,CYCLE1_DAY8,6 H,949.420155,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 730,32RSYC,23-Apr-22
C1071040,10461001,67,PF-06863135,T,6216756767,6.21676E+11,20211124,10:50,CYCLE1_DAY15,0 H,286.8810997,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1380,84RSYC,10-May-22
C1071040,10461001,67,PF-06863135,T,6216756769,6.21676E+11,20211201,10:50,CYCLE1_DAY22,0 H,706.7492161,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1382,84RSYC,10-May-22
C1071040,10461001,67,PF-06863135,T,6217283546,6.21728E+11,20211208,9:30,CYCLE2_DAY1,0 H,183.6551496,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1565,58RSYC,1-May-22
C1071040,10461001,67,PF-06863135,T,6217233434,6.21723E+11,20220105,6:00,CYCLE3_DAY1,0 H,768.450217,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1812,92RSYC,12-May-22
C1071040,10461001,67,PF-06863135,T,6217233437,6.21723E+11,20220202,10:47,CYCLE4_DAY1,0 H,659.0226418,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1813,92RSYC,12-May-22
C1071040,10461001,67,PF-06863135,T,6217647292,6.21765E+11,20220504,10:20,CYCLE7_DAY1,0 H,142.2848822,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2001,115RSYC,25-Jul-22
C1071040,10461001,67,PF-06863135,T,6217647302,6.21765E+11,20220727,9:50,CYCLE10_DAY1,0 H,844.9211049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2058,132RSYC,10-Nov-22
C1071040,10461001,67,PF-06863135,T,6219611638,6.21961E+11,20230118,10:45,CYCLE16_DAY1,0 H,820.1977139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2200,141RSYC,17-May-23
C1071040,10461001,67,PF-06863135,T,6219611636,6.21961E+11,20230712,9:45,CYCLE22_DAY1,0 H,189.826641,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2276,144RSYC,27-Nov-23
C1071040,10461001,67,PF-06863135,T,6220331901,6.22033E+11,20231004,11:35,CYCLE25_DAY1,0 H,423.53473,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2316,147RSYC,29-Feb-24
C1071040,10461001,67,PF-06863135,T,6220331903,6.22033E+11,20231227,9:55,CYCLE28_DAY1,0 H,239.3734338,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2368,152RSYC,9-Apr-24
C1071040,10461001,67,PF-06863135,T,6216756774,6.21676E+11,20211110,11:10,CYCLE1_DAY1,24 H,835.2065259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 457,23RSYC,20-Apr-22
C1071040,10461001,67,PF-06863135,T,6216756776,6.21676E+11,20211115,13:00,CYCLE1_DAY4,0 H,246.2928448,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 733,32RSYC,23-Apr-22
C1071040,10461001,67,PF-06863135,T,6216756779,6.21676E+11,20211116,15:10,CYCLE1_DAY4,24 H,923.903331,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 736,32RSYC,23-Apr-22
C1071040,10561001,68,PF-06863135,T,6216408039,6.21641E+11,20211025,13:00,CYCLE1_DAY1,0 H,25.86172237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 446,76RSYC,4-May-22
C1071040,10561001,68,PF-06863135,T,6216408039,6.21641E+11,20211025,20:15,CYCLE1_DAY1,6 H,113.3227506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 445,88RSYC,11-May-22
C1071040,10561001,68,PF-06863135,T,6216898572,6.2169E+11,20211103,9:40,CYCLE1_DAY8,0 H,334.7455508,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 480,23RSYC,20-Apr-22
C1071040,10561001,68,PF-06863135,T,6216898572,6.2169E+11,20211103,20:50,CYCLE1_DAY8,6 H,36.07051077,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 479,23RSYC,20-Apr-22
C1071040,10561001,68,PF-06863135,T,6217026143,6.21703E+11,20211116,10:00,CYCLE1_DAY22,0 H,770.6603707,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 766,33RSYC,24-Apr-22
C1071040,10561001,68,PF-06863135,T,6216408048,6.21641E+11,20211125,9:15,CYCLE2_DAY1,0 H,161.5113608,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 713,31RSYC,23-Apr-22
C1071040,10561001,68,PF-06863135,T,6217026165,6.21703E+11,20211223,14:05,CYCLE3_DAY1,0 H,50.06302881,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1432,57RSYC,30-Apr-22
C1071040,10561001,68,PF-06863135,T,6216898587,6.2169E+11,20220119,13:00,CYCLE4_DAY1,0 H,642.024756,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1773,71RSYC,7-May-22
C1071040,10561001,68,PF-06863135,T,6216408053,6.21641E+11,20220414,10:40,CYCLE7_DAY1,0 H,356.0516437,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1914,123RSYC,29-Jul-22
C1071040,10561001,68,PF-06863135,T,6218590825,6.21859E+11,20220706,10:50,CYCLE10_DAY1,0 H,173.6597833,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2039,128RSYC,21-Oct-22
C1071040,10561001,68,PF-06863135,T,6219498866,6.2195E+11,20230316,10:50,CYCLE19_DAY1,0 H,558.3726162,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2210,142RSYC,18-May-23
C1071040,10561001,68,PF-06863135,T,6220036098,6.22004E+11,20230608,9:40,CYCLE22_DAY1,0 H,761.4855952,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2258,147RSYC,29-Feb-24
C1071040,10561001,68,PF-06863135,T,6220036108,6.22004E+11,20230831,12:30,CYCLE25_DAY1,0 H,695.5576757,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2308,148RSYC,27-Mar-24
C1071040,10561001,68,PF-06863135,T,6222181789,6.22218E+11,20240215,9:15,CYCLE31_DAY1,0 H,718.7045067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2361,152RSYC,9-Apr-24
C1071040,10561001,68,PF-06863135,T,6219498868,6.2195E+11,20230105,9:40,UNPL,9001 H,832.0572985,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2178,140RSYC,22-Mar-23
C1071040,10561001,68,PF-06863135,T,6216408056,6.21641E+11,20211026,14:15,CYCLE1_DAY1,24 H,732.0707648,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 447,88RSYC,11-May-22
C1071040,10561001,68,PF-06863135,T,6216408058,6.21641E+11,20211028,13:30,CYCLE1_DAY4,0 H,433.438161,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 448,88RSYC,11-May-22
C1071040,10561001,68,PF-06863135,T,6216408060,6.21641E+11,20211029,14:30,CYCLE1_DAY4,24 H,52.01754735,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 449,88RSYC,11-May-22
C1071040,10981004,69,PF-06863135,T,6516326699,6.51633E+11,20211025,9:17,CYCLE1_DAY1,0 H,908.242836,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 841,35RSYC,25-Apr-22
C1071040,10981004,69,PF-06863135,T,6516326699,6.51633E+11,20211025,18:07,CYCLE1_DAY1,6 H,223.7022087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 840,35RSYC,25-Apr-22
C1071040,10981004,69,PF-06863135,T,6517769661,6.51777E+11,20211102,9:25,CYCLE1_DAY8,0 H,527.7065272,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 599,27RSYC,21-Apr-22
C1071040,10981004,69,PF-06863135,T,6517769661,6.51777E+11,20211102,17:35,CYCLE1_DAY8,6 H,515.4897764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 598,27RSYC,21-Apr-22
C1071040,10981004,69,PF-06863135,T,6517769663,6.51777E+11,20211109,9:42,CYCLE1_DAY15,0 H,245.2305143,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 907,20RSYC,19-Apr-22
C1071040,10981004,69,PF-06863135,T,6517769670,6.51777E+11,20211118,8:45,CYCLE1_DAY22,0 H,187.9105448,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 908,20RSYC,19-Apr-22
C1071040,10981004,69,PF-06863135,T,6517768779,6.51777E+11,20211124,9:37,CYCLE2_DAY1,0 H,125.8647257,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1075,41RSYC,26-Apr-22
C1071040,10981004,69,PF-06863135,T,6517768782,6.51777E+11,20211223,9:50,CYCLE3_DAY1,0 H,346.7733159,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1076,41RSYC,26-Apr-22
C1071040,10981004,69,PF-06863135,T,6517768786,6.51777E+11,20220120,9:09,CYCLE4_DAY1,0 H,249.0853273,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1718,72RSYC,7-May-22
C1071040,10981004,69,PF-06863135,T,6517769688,6.51777E+11,20220412,9:14,CYCLE7_DAY1,0 H,484.4516942,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1931,122RSYC,29-Jul-22
C1071040,10981004,69,PF-06863135,T,6518807319,6.51881E+11,20220706,9:25,CYCLE10_DAY1,0 H,184.837133,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2035,128RSYC,21-Oct-22
C1071040,10981004,69,PF-06863135,T,6520972525,6.52097E+11,20220928,10:54,CYCLE13_DAY1,0 H,486.4370131,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2112,131RSYC,9-Nov-22
C1071040,10981004,69,PF-06863135,T,6521653170,6.52165E+11,20221227,11:10,CYCLE16_DAY1,0 H,931.0043257,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2174,140RSYC,22-Mar-23
C1071040,10981004,69,PF-06863135,T,6521653171,6.52165E+11,20230322,10:44,CYCLE19_DAY1,0 H,892.7183645,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2223,142RSYC,18-May-23
C1071040,10981004,69,PF-06863135,T,6522845153,6.52285E+11,20230614,12:00,CYCLE22_DAY1,0 H,916.5568316,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2263,144RSYC,27-Nov-23
C1071040,10981004,69,PF-06863135,T,6524724651,6.52472E+11,20231218,12:10,CYCLE28_DAY1,0 H,56.08094462,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2325,148RSYC,27-Mar-24
C1071040,10981004,69,PF-06863135,T,6517755819,6.51776E+11,20211026,10:35,CYCLE1_DAY1,24 H,520.4227306,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 591,27RSYC,21-Apr-22
C1071040,10981004,69,PF-06863135,T,6517755824,6.51776E+11,20211029,6:19,CYCLE1_DAY4,0 H,856.0690813,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 592,27RSYC,21-Apr-22
C1071040,10981004,69,PF-06863135,T,6517755826,6.51776E+11,20211030,13:00,CYCLE1_DAY4,24 H,925.4958411,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 593,27RSYC,21-Apr-22
C1071040,10401001,70,PF-06863135,T,6518161422,6.51816E+11,20211026,10:25,CYCLE1_DAY1,0 H,755.6340667,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 606,63RSYC,2-May-22
C1071040,10401001,70,PF-06863135,T,6518161422,6.51816E+11,20211026,16:22,CYCLE1_DAY1,6 H,955.2910468,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 605,89RSYC,11-May-22
C1071040,10401001,70,PF-06863135,T,6517560297,6.51756E+11,20211105,8:46,CYCLE1_DAY8,0 H,325.7664265,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 888,19RSYC,19-Apr-22
C1071040,10401001,70,PF-06863135,T,6517560297,6.51756E+11,20211105,15:16,CYCLE1_DAY8,6 H,541.2750771,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 887,19RSYC,19-Apr-22
C1071040,10401001,70,PF-06863135,T,6517560298,6.51756E+11,20211112,10:57,CYCLE1_DAY15,0 H,158.4818657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 889,19RSYC,19-Apr-22
C1071040,10401001,70,PF-06863135,T,6517560300,6.51756E+11,20211119,12:10,CYCLE1_DAY22,0 H,849.0454195,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 890,19RSYC,19-Apr-22
C1071040,10401001,70,PF-06863135,T,6517560303,6.51756E+11,20211125,11:47,CYCLE2_DAY1,0 H,156.0084406,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1051,40RSYC,26-Apr-22
C1071040,10401001,70,PF-06863135,T,6517560305,6.51756E+11,20211223,11:10,CYCLE3_DAY1,0 H,48.16266703,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1052,40RSYC,26-Apr-22
C1071040,10401001,70,PF-06863135,T,6517560307,6.51756E+11,20220121,9:08,CYCLE4_DAY1,0 H,326.9352566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1721,72RSYC,7-May-22
C1071040,10401001,70,PF-06863135,T,6517560308,6.51756E+11,20220414,11:00,CYCLE7_DAY1,0 H,420.0973142,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1932,123RSYC,29-Jul-22
C1071040,10401001,70,PF-06863135,T,6517560317,6.51756E+11,20220706,10:05,CYCLE10_DAY1,0 H,246.118397,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2036,131RSYC,9-Nov-22
C1071040,10401001,70,PF-06863135,T,6520956318,6.52096E+11,20221005,13:00,CYCLE13_DAY1,0 H,246.519961,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2113,134RSYC,11-Nov-22
C1071040,10401001,70,PF-06863135,T,6523034191,6.52303E+11,20230614,8:28,CYCLE22_DAY1,0 H,678.37267,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2264,144RSYC,27-Nov-23
C1071040,10401001,70,PF-06863135,T,6521647797,6.52165E+11,20230907,9:29,CYCLE25_DAY1,0 H,424.5086843,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2305,147RSYC,29-Feb-24
C1071040,10401001,70,PF-06863135,T,6524124731,6.52412E+11,20231130,12:29,CYCLE28_DAY1,0 H,343.4601815,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2326,148RSYC,27-Mar-24
C1071040,10401001,70,PF-06863135,T,6524124733,6.52412E+11,20240306,12:14,CYCLE31_DAY1,0 H,946.3129259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2372,152RSYC,9-Apr-24
C1071040,10401001,70,PF-06863135,T,6517560319,6.51756E+11,20211029,10:48,UNPL,9001 H,569.6844865,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 586,27RSYC,21-Apr-22
C1071040,10401001,70,PF-06863135,T,6521647796,6.52165E+11,20230125,10:29,UNPL,9002 H,592.4523882,NG/ML,,Visit revised from C16D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2205,141RSYC,17-May-23
C1071040,10401001,70,PF-06863135,T,6517560311,6.51756E+11,20211027,10:20,CYCLE1_DAY1,24 H,252.2442574,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 583,27RSYC,21-Apr-22
C1071040,10401001,70,PF-06863135,T,6517560312,6.51756E+11,20211101,10:40,CYCLE1_DAY4,0 H,408.3116957,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 584,27RSYC,21-Apr-22
C1071040,10401001,70,PF-06863135,T,6517560315,6.51756E+11,20211102,11:58,CYCLE1_DAY4,24 H,204.8510557,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 585,86RSYC,13-May-22
C1071040,10191007,71,PF-06863135,T,6517246381,6.51725E+11,20211026,8:59,CYCLE1_DAY1,0 H,229.3807181,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 516,25RSYC,22-Apr-22
C1071040,10191007,71,PF-06863135,T,6517246381,6.51725E+11,20211026,19:30,CYCLE1_DAY1,6 H,277.562526,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 515,25RSYC,22-Apr-22
C1071040,10191007,71,PF-06863135,T,6517246493,6.51725E+11,20211027,13:30,CYCLE1_DAY1,24 H,171.1720723,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 518,63RSYC,2-May-22
C1071040,10481005,72,PF-06863135,T,6216407972,6.21641E+11,20211029,11:00,CYCLE1_DAY1,0 H,646.1676011,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 436,76RSYC,4-May-22
C1071040,10481005,72,PF-06863135,T,6216407972,6.21641E+11,20211029,17:00,CYCLE1_DAY1,6 H,36.87595106,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 435,88RSYC,11-May-22
C1071040,10481005,72,PF-06863135,T,6216856419,6.21686E+11,20211105,9:00,CYCLE1_DAY8,0 H,234.0033158,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 476,23RSYC,20-Apr-22
C1071040,10481005,72,PF-06863135,T,6216856419,6.21686E+11,20211105,15:20,CYCLE1_DAY8,6 H,863.8774631,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 475,23RSYC,20-Apr-22
C1071040,10481005,72,PF-06863135,T,6216856423,6.21686E+11,20211112,8:55,CYCLE1_DAY15,0 H,489.2683538,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 738,32RSYC,23-Apr-22
C1071040,10481005,72,PF-06863135,T,6216407977,6.21641E+11,20211119,9:25,CYCLE1_DAY22,0 H,482.2388326,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1306,49RSYC,29-Apr-22
C1071040,10481005,72,PF-06863135,T,6216856440,6.21686E+11,20211126,11:15,CYCLE2_DAY1,0 H,95.39405409,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1400,95RSYC,13-May-22
C1071040,10481005,72,PF-06863135,T,6216856453,6.21686E+11,20211223,10:00,CYCLE3_DAY1,0 H,856.7427772,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1401,95RSYC,13-May-22
C1071040,10481005,72,PF-06863135,T,6217184393,6.21718E+11,20220120,8:30,CYCLE4_DAY1,0 H,141.3080361,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1749,91RSYC,11-May-22
C1071040,10481005,72,PF-06863135,T,6217142723,6.21714E+11,20220707,9:00,CYCLE10_DAY1,0 H,832.8963301,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2037,128RSYC,21-Oct-22
C1071040,10481005,72,PF-06863135,T,6217142722,6.21714E+11,20220929,10:40,CYCLE13_DAY1,0 H,869.9435276,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2121,131RSYC,9-Nov-22
C1071040,10481005,72,PF-06863135,T,6219283083,6.21928E+11,20221222,9:30,CYCLE16_DAY1,0 H,574.9944028,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2177,140RSYC,22-Mar-23
C1071040,10481005,72,PF-06863135,T,6219283082,6.21928E+11,20230316,9:30,CYCLE19_DAY1,0 H,938.4163306,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2226,142RSYC,18-May-23
C1071040,10481005,72,PF-06863135,T,6219283081,6.21928E+11,20230608,9:00,CYCLE22_DAY1,0 H,634.4068392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2259,144RSYC,27-Nov-23
C1071040,10481005,72,PF-06863135,T,6220027062,6.22003E+11,20230831,8:57,CYCLE25_DAY1,0 H,448.6009981,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2307,147RSYC,29-Feb-24
C1071040,10481005,72,PF-06863135,T,6220027063,6.22003E+11,20231123,12:21,CYCLE28_DAY1,0 H,256.9179855,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2347,148RSYC,27-Mar-24
C1071040,10481005,72,PF-06863135,T,6221581756,6.22158E+11,20240214,9:15,CYCLE31_DAY1,0 H,707.4986111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2364,152RSYC,9-Apr-24
C1071040,10481005,72,PF-06863135,T,6222579039,6.22258E+11,20240228,8:05,END_OF_TRT,,603.2891441,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2369,152RSYC,9-Apr-24
C1071040,10481005,72,PF-06863135,T,6218548367,6.21855E+11,20220428,9:30,UNPL,9001 H,13.95026644,NG/ML,,Received as 6216407986-09,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2163,141RSYC,17-May-23
C1071040,10481005,72,PF-06863135,T,6216407988,6.21641E+11,20211030,11:00,CYCLE1_DAY1,24 H,687.9043876,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 441,88RSYC,11-May-22
C1071040,10481005,72,PF-06863135,T,6216856467,6.21686E+11,20211101,12:20,CYCLE1_DAY4,0 H,248.3186974,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 478,23RSYC,20-Apr-22
C1071040,10481005,72,PF-06863135,T,6216407992,6.21641E+11,20211102,12:20,CYCLE1_DAY4,24 H,521.1262469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 444,88RSYC,11-May-22
C1071040,10101004,73,PF-06863135,T,6517559653,6.51756E+11,20211029,10:57,CYCLE1_DAY1,0 H,121.3264681,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 561,26RSYC,22-Apr-22
C1071040,10101004,73,PF-06863135,T,6517559653,6.51756E+11,20211029,18:17,CYCLE1_DAY1,6 H,241.2116207,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 560,26RSYC,22-Apr-22
C1071040,10101004,73,PF-06863135,T,6518706277,6.51871E+11,20211106,13:59,CYCLE1_DAY8,0 H,15.76890376,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 616,90RSYC,11-May-22
C1071040,10101004,73,PF-06863135,T,6518558181,6.51856E+11,20211112,10:43,CYCLE1_DAY15,0 H,831.7415824,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 915,20RSYC,19-Apr-22
C1071040,10101004,73,PF-06863135,T,6517559659,6.51756E+11,20211119,10:00,CYCLE1_DAY22,0 H,494.8604061,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 878,19RSYC,19-Apr-22
C1071040,10101004,73,PF-06863135,T,6518922660,6.51892E+11,20211126,10:16,CYCLE2_DAY1,0 H,927.0353402,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 680,30RSYC,22-Apr-22
C1071040,10101004,73,PF-06863135,T,6517559680,6.51756E+11,20211030,12:07,CYCLE1_DAY1,24 H,16.32472968,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 566,26RSYC,22-Apr-22
C1071040,10101004,73,PF-06863135,T,6518558186,6.51856E+11,20211101,10:45,CYCLE1_DAY4,0 H,298.0356364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 612,90RSYC,11-May-22
C1071040,10101004,73,PF-06863135,T,6518558188,6.51856E+11,20211102,14:20,CYCLE1_DAY4,24 H,507.7064809,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 613,90RSYC,11-May-22
C1071040,10121002,74,PF-06863135,T,6517433305,6.51743E+11,20211101,8:20,CYCLE1_DAY1,0 H,299.991113,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 520,25RSYC,22-Apr-22
C1071040,10121002,74,PF-06863135,T,6517433305,6.51743E+11,20211101,16:00,CYCLE1_DAY1,6 H,201.7476352,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 519,25RSYC,22-Apr-22
C1071040,10121002,74,PF-06863135,T,6517433307,6.51743E+11,20211109,10:35,CYCLE1_DAY8,0 H,62.34512321,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 844,35RSYC,25-Apr-22
C1071040,10121002,74,PF-06863135,T,6517433307,6.51743E+11,20211109,16:35,CYCLE1_DAY8,6 H,378.383168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 843,35RSYC,25-Apr-22
C1071040,10121002,74,PF-06863135,T,6517433310,6.51743E+11,20211116,8:10,CYCLE1_DAY15,0 H,988.5839321,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 845,35RSYC,25-Apr-22
C1071040,10121002,74,PF-06863135,T,6517433311,6.51743E+11,20211123,10:03,CYCLE1_DAY22,0 H,555.0695284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 966,65RSYC,3-May-22
C1071040,10121002,74,PF-06863135,T,6518019666,6.51802E+11,20211130,10:15,CYCLE2_DAY1,0 H,740.2354096,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1088,67RSYC,8-May-22
C1071040,10121002,74,PF-06863135,T,6517433316,6.51743E+11,20211229,9:00,CYCLE3_DAY1,0 H,262.9751659,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1628,85RSYC,10-May-22
C1071040,10121002,74,PF-06863135,T,6517433318,6.51743E+11,20220127,9:25,CYCLE4_DAY1,0 H,660.7466058,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1629,85RSYC,10-May-22
C1071040,10121002,74,PF-06863135,T,6518019671,6.51802E+11,20220420,11:20,CYCLE7_DAY1,0 H,354.0000171,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1933,123RSYC,29-Jul-22
C1071040,10121002,74,PF-06863135,T,6517433328,6.51743E+11,20220714,10:30,CYCLE10_DAY1,0 H,624.1707729,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2029,131RSYC,9-Nov-22
C1071040,10121002,74,PF-06863135,T,6520915406,6.52092E+11,20221007,10:15,CYCLE13_DAY1,0 H,40.80932149,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2108,134RSYC,11-Nov-22
C1071040,10121002,74,PF-06863135,T,6520915405,6.52092E+11,20221229,9:25,CYCLE16_DAY1,0 H,280.0099843,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2170,140RSYC,22-Mar-23
C1071040,10121002,74,PF-06863135,T,6520915407,6.52092E+11,20230321,10:00,CYCLE19_DAY1,0 H,855.3824445,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2219,142RSYC,18-May-23
C1071040,10121002,74,PF-06863135,T,6523311141,6.52331E+11,20230615,9:45,CYCLE22_DAY1,0 H,22.46451478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2265,144RSYC,27-Nov-23
C1071040,10121002,74,PF-06863135,T,6523311142,6.52331E+11,20230907,10:20,CYCLE25_DAY1,0 H,965.3521547,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2301,147RSYC,29-Feb-24
C1071040,10121002,74,PF-06863135,T,6523737982,6.52374E+11,20231130,10:15,CYCLE28_DAY1,0 H,847.3925217,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2327,148RSYC,27-Mar-24
C1071040,10121002,74,PF-06863135,T,6523737988,6.52374E+11,20231212,8:20,END_OF_TRT,,624.9156405,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2328,149RSYC,27-Mar-24
C1071040,10121002,74,PF-06863135,T,6517433321,6.51743E+11,20211102,10:30,CYCLE1_DAY1,24 H,97.52889763,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 525,107RSYC,24-May-22
C1071040,10121002,74,PF-06863135,T,6517433324,6.51743E+11,20211104,13:15,CYCLE1_DAY4,0 H,541.2053531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 528,25RSYC,22-Apr-22
C1071040,10121002,74,PF-06863135,T,6517433325,6.51743E+11,20211105,11:50,CYCLE1_DAY4,24 H,930.8416591,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 529,25RSYC,22-Apr-22
C1071040,11021003,75,PF-06863135,T,6217023822,6.21702E+11,20211028,19:15,CYCLE1_DAY1,0 H,827.2556707,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 499,24RSYC,20-Apr-22
C1071040,11021003,75,PF-06863135,T,6217023822,6.21702E+11,20211029,0:30,CYCLE1_DAY1,6 H,993.2892247,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 498,24RSYC,20-Apr-22
C1071040,11021003,75,PF-06863135,T,6217023825,6.21702E+11,20211109,20:30,CYCLE1_DAY8,0 H,658.5525121,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 503,24RSYC,20-Apr-22
C1071040,11021003,75,PF-06863135,T,6217023825,6.21702E+11,20211110,2:50,CYCLE1_DAY8,6 H,298.6859924,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 502,24RSYC,20-Apr-22
C1071040,11021003,75,PF-06863135,T,6217170434,6.21717E+11,20211116,14:00,CYCLE1_DAY15,0 H,770.5615925,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 790,34RSYC,24-Apr-22
C1071040,11021003,75,PF-06863135,T,6217170449,6.21717E+11,20211123,12:30,CYCLE1_DAY22,0 H,936.4843567,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 794,34RSYC,24-Apr-22
C1071040,11021003,75,PF-06863135,T,6217170457,6.21717E+11,20211130,10:30,CYCLE2_DAY1,0 H,888.9107611,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1507,56RSYC,30-Apr-22
C1071040,11021003,75,PF-06863135,T,6217023844,6.21702E+11,20211228,11:40,CYCLE3_DAY1,0 H,528.5204396,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1835,93RSYC,12-May-22
C1071040,11021003,75,PF-06863135,T,6217417531,6.21742E+11,20220125,11:30,CYCLE4_DAY1,0 H,946.4600302,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1836,93RSYC,12-May-22
C1071040,11021003,75,PF-06863135,T,6217170495,6.21717E+11,20220419,12:15,CYCLE7_DAY1,0 H,8.986934237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1915,123RSYC,29-Jul-22
C1071040,11021003,75,PF-06863135,T,6218223703,6.21822E+11,20220601,12:30,END_OF_TRT,,293.8134628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2019,115RSYC,25-Jul-22
C1071040,11021003,75,PF-06863135,T,6217023853,6.21702E+11,20211102,14:00,CYCLE1_DAY4,0 H,96.73948347,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 506,24RSYC,20-Apr-22
C1071040,11021003,75,PF-06863135,T,6216756815,6.21676E+11,20211103,14:10,CYCLE1_DAY4,24 H,957.7579256,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 462,23RSYC,20-Apr-22
C1071040,11021004,76,PF-06863135,T,6217023821,6.21702E+11,20211108,17:00,CYCLE1_DAY1,0 H,171.4074485,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 497,24RSYC,20-Apr-22
C1071040,11021004,76,PF-06863135,T,6217023821,6.21702E+11,20211108,23:00,CYCLE1_DAY1,6 H,694.1717815,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 496,24RSYC,20-Apr-22
C1071040,11021004,76,PF-06863135,T,6217184362,6.21718E+11,20211115,15:50,CYCLE1_DAY8,0 H,648.4720299,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 802,34RSYC,24-Apr-22
C1071040,11021004,76,PF-06863135,T,6217184362,6.21718E+11,20211115,22:00,CYCLE1_DAY8,6 H,610.2250245,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 801,34RSYC,24-Apr-22
C1071040,11021004,76,PF-06863135,T,6217170435,6.21717E+11,20211122,15:00,CYCLE1_DAY15,0 H,668.2678998,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 791,34RSYC,24-Apr-22
C1071040,11021004,76,PF-06863135,T,6217170446,6.21717E+11,20211129,13:00,CYCLE1_DAY22,0 H,622.6170624,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1501,55RSYC,30-Apr-22
C1071040,11021004,76,PF-06863135,T,6217170459,6.21717E+11,20211206,13:30,CYCLE2_DAY1,0 H,623.8368841,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1508,56RSYC,30-Apr-22
C1071040,11021004,76,PF-06863135,T,6217023846,6.21702E+11,20220103,14:30,CYCLE3_DAY1,0 H,434.3550254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1837,93RSYC,12-May-22
C1071040,11021004,76,PF-06863135,T,6217170486,6.21717E+11,20220131,16:25,CYCLE4_DAY1,0 H,567.8797229,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1838,93RSYC,12-May-22
C1071040,11021004,76,PF-06863135,T,6217170501,6.21717E+11,20220425,14:58,CYCLE7_DAY1,0 H,624.1918834,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1997,115RSYC,25-Jul-22
C1071040,11021004,76,PF-06863135,T,6218384029,6.21838E+11,20220719,14:50,CYCLE10_DAY1,0 H,541.9583764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2103,132RSYC,10-Nov-22
C1071040,11021004,76,PF-06863135,T,6218384031,6.21838E+11,20221010,14:40,CYCLE13_DAY1,0 H,955.4670808,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2124,131RSYC,9-Nov-22
C1071040,11021004,76,PF-06863135,T,6217136150,6.21714E+11,20211109,17:00,CYCLE1_DAY1,24 H,703.3568853,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 510,24RSYC,20-Apr-22
C1071040,11021004,76,PF-06863135,T,6217023851,6.21702E+11,20211110,16:15,CYCLE1_DAY4,0 H,794.2612616,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 759,33RSYC,24-Apr-22
C1071040,11021005,77,PF-06863135,T,6217023823,6.21702E+11,20211108,18:10,CYCLE1_DAY1,0 H,274.0097909,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 501,24RSYC,20-Apr-22
C1071040,11021005,77,PF-06863135,T,6217023823,6.21702E+11,20211109,0:30,CYCLE1_DAY1,6 H,523.8203391,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 500,24RSYC,20-Apr-22
C1071040,11021005,77,PF-06863135,T,6217023826,6.21702E+11,20211115,16:50,CYCLE1_DAY8,0 H,852.1939153,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 752,32RSYC,23-Apr-22
C1071040,11021005,77,PF-06863135,T,6217170433,6.21717E+11,20211122,15:30,CYCLE1_DAY15,0 H,264.6030556,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 789,34RSYC,24-Apr-22
C1071040,11021005,77,PF-06863135,T,6217170443,6.21717E+11,20211129,15:10,CYCLE1_DAY22,0 H,292.1728491,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1500,55RSYC,30-Apr-22
C1071040,11021005,77,PF-06863135,T,6217170456,6.21717E+11,20211206,15:30,CYCLE2_DAY1,0 H,415.8167517,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1506,56RSYC,30-Apr-22
C1071040,11021005,77,PF-06863135,T,6217142696,6.21714E+11,20220103,14:10,END_OF_TRT,,240.5298148,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1839,86RSYC,13-May-22
C1071040,11021005,77,PF-06863135,T,6217118743,6.21712E+11,20211109,18:25,CYCLE1_DAY1,24 H,824.3523404,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 508,24RSYC,20-Apr-22
C1071040,11021005,77,PF-06863135,T,6217023850,6.21702E+11,20211110,13:45,CYCLE1_DAY4,0 H,108.7290932,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 758,33RSYC,24-Apr-22
C1071040,11021006,78,PF-06863135,T,6217023820,6.21702E+11,20211109,17:10,CYCLE1_DAY1,0 H,496.7716186,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 495,24RSYC,20-Apr-22
C1071040,11021006,78,PF-06863135,T,6217023820,6.21702E+11,20211109,23:15,CYCLE1_DAY1,6 H,762.9218766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 494,24RSYC,20-Apr-22
C1071040,11021006,78,PF-06863135,T,6217023827,6.21702E+11,20211116,17:50,CYCLE1_DAY8,0 H,337.0475558,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 754,32RSYC,23-Apr-22
C1071040,11021006,78,PF-06863135,T,6217023827,6.21702E+11,20211117,0:00,CYCLE1_DAY8,6 H,127.1915993,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 753,32RSYC,23-Apr-22
C1071040,11021006,78,PF-06863135,T,6217170440,6.21717E+11,20211123,12:30,CYCLE1_DAY15,0 H,109.8626068,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 793,34RSYC,24-Apr-22
C1071040,11021006,78,PF-06863135,T,6217170448,6.21717E+11,20211130,13:30,CYCLE1_DAY22,0 H,768.33978,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1502,55RSYC,30-Apr-22
C1071040,11021006,78,PF-06863135,T,6217170461,6.21717E+11,20211207,12:30,CYCLE2_DAY1,0 H,184.726389,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1509,56RSYC,30-Apr-22
C1071040,11021006,78,PF-06863135,T,6217170478,6.21717E+11,20220104,9:50,CYCLE3_DAY1,0 H,492.9701172,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1840,93RSYC,12-May-22
C1071040,11021006,78,PF-06863135,T,6217170492,6.21717E+11,20220201,10:55,CYCLE4_DAY1,0 H,183.6417958,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1841,93RSYC,12-May-22
C1071040,11021006,78,PF-06863135,T,6217170502,6.21717E+11,20220426,10:50,CYCLE7_DAY1,0 H,510.1417112,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1998,115RSYC,25-Jul-22
C1071040,11021006,78,PF-06863135,T,6217142672,6.21714E+11,20220719,14:55,CYCLE10_DAY1,0 H,891.3630288,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2064,132RSYC,10-Nov-22
C1071040,11021006,78,PF-06863135,T,6218384030,6.21838E+11,20221011,10:45,CYCLE13_DAY1,0 H,509.0043824,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2125,131RSYC,9-Nov-22
C1071040,11021006,78,PF-06863135,T,6217136153,6.21714E+11,20211110,17:15,CYCLE1_DAY1,24 H,579.3834287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 786,34RSYC,24-Apr-22
C1071040,11021006,78,PF-06863135,T,6217184363,6.21718E+11,20211112,17:50,CYCLE1_DAY4,0 H,813.1010096,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 803,34RSYC,24-Apr-22
C1071040,11021006,78,PF-06863135,T,6217136154,6.21714E+11,20211113,18:15,CYCLE1_DAY4,24 H,246.9729479,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 787,34RSYC,24-Apr-22
C1071040,11021007,79,PF-06863135,T,6217184361,6.21718E+11,20211115,13:30,CYCLE1_DAY1,0 H,191.1919059,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 800,34RSYC,24-Apr-22
C1071040,11021007,79,PF-06863135,T,6217184361,6.21718E+11,20211115,20:10,CYCLE1_DAY1,6 H,857.7777855,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 799,34RSYC,24-Apr-22
C1071040,11021007,79,PF-06863135,T,6217233479,6.21723E+11,20211122,16:30,CYCLE1_DAY8,0 H,843.9215493,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 810,64RSYC,3-May-22
C1071040,11021007,79,PF-06863135,T,6217233479,6.21723E+11,20211122,23:00,CYCLE1_DAY8,6 H,779.6068495,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 809,34RSYC,24-Apr-22
C1071040,11021007,79,PF-06863135,T,6217170436,6.21717E+11,20211129,15:30,CYCLE1_DAY15,0 H,117.0926774,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1496,55RSYC,30-Apr-22
C1071040,11021007,79,PF-06863135,T,6217170512,6.21717E+11,20211116,13:00,CYCLE1_DAY1,24 H,923.8236599,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1515,56RSYC,30-Apr-22
C1071040,11021007,79,PF-06863135,T,6217233481,6.21723E+11,20211118,15:00,CYCLE1_DAY4,0 H,469.0712781,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1545,58RSYC,1-May-22
C1071040,11021007,79,PF-06863135,T,6217184366,6.21718E+11,20211119,15:30,CYCLE1_DAY4,24 H,706.383611,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1523,56RSYC,30-Apr-22
C1071040,10821007,80,PF-06863135,T,6603459531,6.60346E+11,20211101,12:55,CYCLE1_DAY1,0 H,916.8584158,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 619,63RSYC,2-May-22
C1071040,10821007,80,PF-06863135,T,6603459531,6.60346E+11,20211101,19:40,CYCLE1_DAY1,6 H,367.745577,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 620,90RSYC,11-May-22
C1071040,10821007,80,PF-06863135,T,6603491873,6.60349E+11,20211108,9:40,CYCLE1_DAY8,0 H,427.8089111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 625,64RSYC,3-May-22
C1071040,10821007,80,PF-06863135,T,6603491873,6.60349E+11,20211108,16:20,CYCLE1_DAY8,6 H,254.9036051,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 624,64RSYC,3-May-22
C1071040,10821007,80,PF-06863135,T,6603459535,6.60346E+11,20211115,11:20,CYCLE1_DAY15,0 H,298.8318417,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 621,90RSYC,11-May-22
C1071040,10821007,80,PF-06863135,T,6603541506,6.60354E+11,20211122,12:10,END_OF_TRT,,988.0523264,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 818,107RSYC,24-May-22
C1071040,10821007,80,PF-06863135,T,6603505731,6.60351E+11,20211103,2:10,UNPL,9001 H,381.4660416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 627,107RSYC,24-May-22
C1071040,10821007,80,PF-06863135,T,6603491879,6.60349E+11,20211103,17:30,UNPL,9002 H,808.961553,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 626,107RSYC,24-May-22
C1071040,10821007,80,PF-06863135,T,6603505732,6.60351E+11,20211105,15:25,UNPL,9003 H,890.7974465,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 628,107RSYC,24-May-22
C1071040,10821007,80,PF-06863135,T,6603459540,6.60346E+11,20211102,13:45,CYCLE1_DAY1,24 H,939.8051625,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 622,64RSYC,3-May-22
C1071040,10821007,80,PF-06863135,T,6603451262,6.60345E+11,20211104,15:20,CYCLE1_DAY4,0 H,178.0678956,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 618,90RSYC,11-May-22
C1071040,10821007,80,PF-06863135,T,6603459546,6.60346E+11,20211105,16:50,CYCLE1_DAY4,24 H,557.7381284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 623,64RSYC,3-May-22
C1071040,11111003,81,PF-06863135,T,6801708299,6.80171E+11,20211101,10:30,CYCLE1_DAY1,0 H,350.0705755,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 672,30RSYC,22-Apr-22
C1071040,11111003,81,PF-06863135,T,6801708299,6.80171E+11,20211101,20:38,CYCLE1_DAY1,6 H,400.4770295,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 673,30RSYC,22-Apr-22
C1071040,11111003,81,PF-06863135,T,6801650370,6.80165E+11,20211108,9:15,CYCLE1_DAY8,0 H,242.354007,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 663,29RSYC,22-Apr-22
C1071040,11111003,81,PF-06863135,T,6801650370,6.80165E+11,20211108,18:30,CYCLE1_DAY8,6 H,149.2726165,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 662,29RSYC,22-Apr-22
C1071040,11111003,81,PF-06863135,T,6801650372,6.80165E+11,20211115,10:00,CYCLE1_DAY15,0 H,620.7978879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 664,29RSYC,22-Apr-22
C1071040,11111003,81,PF-06863135,T,6801650374,6.80165E+11,20211122,9:55,CYCLE1_DAY22,0 H,358.2689009,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 830,35RSYC,25-Apr-22
C1071040,11111003,81,PF-06863135,T,6801650376,6.80165E+11,20211129,10:25,CYCLE2_DAY1,0 H,706.7085755,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 940,65RSYC,3-May-22
C1071040,11111003,81,PF-06863135,T,6801697214,6.8017E+11,20211227,11:30,CYCLE3_DAY1,0 H,32.14507682,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 958,65RSYC,3-May-22
C1071040,11111003,81,PF-06863135,T,6801697215,6.8017E+11,20220124,10:55,CYCLE4_DAY1,0 H,374.8293829,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1596,96RSYC,12-May-22
C1071040,11111003,81,PF-06863135,T,6801828108,6.80183E+11,20220418,9:50,CYCLE7_DAY1,0 H,374.2338096,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1919,123RSYC,29-Jul-22
C1071040,11111003,81,PF-06863135,T,6801891347,6.80189E+11,20220711,9:25,CYCLE10_DAY1,0 H,543.8845019,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2025,132RSYC,10-Nov-22
C1071040,11111003,81,PF-06863135,T,6801944848,6.80194E+11,20221003,9:40,END_OF_TRT,,952.3136166,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2119,131RSYC,9-Nov-22
C1071040,11111003,81,PF-06863135,T,6801650380,6.80165E+11,20211102,14:38,CYCLE1_DAY1,24 H,442.0956393,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 665,29RSYC,22-Apr-22
C1071040,11111003,81,PF-06863135,T,6801650382,6.80165E+11,20211104,9:05,CYCLE1_DAY4,0 H,12.26155587,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 666,30RSYC,22-Apr-22
C1071040,11111003,81,PF-06863135,T,6801650384,6.80165E+11,20211105,12:40,CYCLE1_DAY4,24 H,439.7772086,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 667,30RSYC,22-Apr-22
C1071040,10351002,82,PF-06863135,T,6216407869,6.21641E+11,20211101,11:38,CYCLE1_DAY1,0 H,771.8639341,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 426,76RSYC,4-May-22
C1071040,10351002,82,PF-06863135,T,6216407869,6.21641E+11,20211101,21:30,CYCLE1_DAY1,6 H,453.5434421,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 425,88RSYC,11-May-22
C1071040,10351002,82,PF-06863135,T,6216407872,6.21641E+11,20211111,8:32,CYCLE1_DAY8,0 H,462.107652,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 427,88RSYC,11-May-22
C1071040,10351002,82,PF-06863135,T,6216407873,6.21641E+11,20211118,8:50,CYCLE1_DAY15,0 H,877.5057197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 706,31RSYC,23-Apr-22
C1071040,10351002,82,PF-06863135,T,6217091592,6.21709E+11,20211124,9:15,CYCLE1_DAY22,0 H,835.0785906,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 783,33RSYC,24-Apr-22
C1071040,10351002,82,PF-06863135,T,6216407877,6.21641E+11,20211201,9:25,CYCLE2_DAY1,0 H,175.1962927,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1297,49RSYC,29-Apr-22
C1071040,10351002,82,PF-06863135,T,6216407899,6.21641E+11,20211208,12:10,END_OF_TRT,,930.9196416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1298,108RSYC,24-May-22
C1071040,10351002,82,PF-06863135,T,6216407886,6.21641E+11,20211102,13:35,CYCLE1_DAY1,24 H,119.5088215,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 430,88RSYC,11-May-22
C1071040,10351002,82,PF-06863135,T,6216407887,6.21641E+11,20211104,8:15,CYCLE1_DAY4,0 H,776.5842188,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 431,88RSYC,11-May-22
C1071040,10351002,82,PF-06863135,T,6216407889,6.21641E+11,20211105,9:45,CYCLE1_DAY4,24 H,776.1290063,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 432,88RSYC,11-May-22
C1071040,10931001,83,PF-06863135,T,6517472607,6.51747E+11,20211101,15:37,CYCLE1_DAY1,0 H,433.6547134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 553,26RSYC,22-Apr-22
C1071040,10931001,83,PF-06863135,T,6517472607,6.51747E+11,20211101,22:45,CYCLE1_DAY1,6 H,274.572643,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 552,26RSYC,22-Apr-22
C1071040,10931001,83,PF-06863135,T,6517472609,6.51747E+11,20211108,14:35,CYCLE1_DAY8,0 H,377.1241116,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 857,36RSYC,25-Apr-22
C1071040,10931001,83,PF-06863135,T,6517472609,6.51747E+11,20211108,20:01,CYCLE1_DAY8,6 H,24.92743206,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 856,36RSYC,25-Apr-22
C1071040,10931001,83,PF-06863135,T,6517472610,6.51747E+11,20211115,9:23,CYCLE1_DAY15,0 H,721.8904011,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 858,36RSYC,25-Apr-22
C1071040,10931001,83,PF-06863135,T,6518778274,6.51878E+11,20211201,14:30,CYCLE2_DAY1,0 H,193.4965258,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1147,107RSYC,24-May-22
C1071040,10931001,83,PF-06863135,T,6518934245,6.51893E+11,20220126,13:35,CYCLE4_DAY1,0 H,116.7721004,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1708,72RSYC,7-May-22
C1071040,10931001,83,PF-06863135,T,6517472623,6.51747E+11,20211102,16:45,CYCLE1_DAY1,24 H,951.0823548,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 554,26RSYC,22-Apr-22
C1071040,10931001,83,PF-06863135,T,6517472625,6.51747E+11,20211104,11:50,CYCLE1_DAY4,0 H,812.9146084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 555,26RSYC,22-Apr-22
C1071040,10931001,83,PF-06863135,T,6517472626,6.51747E+11,20211105,11:50,CYCLE1_DAY4,24 H,813.3571838,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 861,36RSYC,25-Apr-22
C1071040,10541002,84,PF-06863135,T,6216170879,6.21617E+11,20211102,10:00,CYCLE1_DAY1,0 H,67.10211714,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 406,21RSYC,20-Apr-22
C1071040,10541002,84,PF-06863135,T,6216170879,6.21617E+11,20211102,18:30,CYCLE1_DAY1,6 H,366.2954263,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 405,21RSYC,20-Apr-22
C1071040,10541002,84,PF-06863135,T,6216170881,6.21617E+11,20211108,9:00,CYCLE1_DAY8,0 H,789.613639,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 408,21RSYC,20-Apr-22
C1071040,10541002,84,PF-06863135,T,6216170881,6.21617E+11,20211108,17:50,CYCLE1_DAY8,6 H,378.6388617,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 407,21RSYC,20-Apr-22
C1071040,10541002,84,PF-06863135,T,6216170883,6.21617E+11,20211115,9:21,CYCLE1_DAY15,0 H,391.6551619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 696,31RSYC,23-Apr-22
C1071040,10541002,84,PF-06863135,T,6216170884,6.21617E+11,20211122,9:10,CYCLE1_DAY22,0 H,400.6469684,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 697,31RSYC,23-Apr-22
C1071040,10541002,84,PF-06863135,T,6216170887,6.21617E+11,20211129,9:40,CYCLE2_DAY1,0 H,506.9516531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1274,89RSYC,11-May-22
C1071040,10541002,84,PF-06863135,T,6216170889,6.21617E+11,20211227,9:20,END_OF_TRT,,818.0627194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1772,71RSYC,7-May-22
C1071040,10541002,84,PF-06863135,T,6216170894,6.21617E+11,20211103,12:30,CYCLE1_DAY1,24 H,620.4076037,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 409,21RSYC,20-Apr-22
C1071040,10541002,84,PF-06863135,T,6216170897,6.21617E+11,20211104,9:40,CYCLE1_DAY4,0 H,414.0311321,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 410,21RSYC,20-Apr-22
C1071040,10541002,84,PF-06863135,T,6216170899,6.21617E+11,20211105,12:30,CYCLE1_DAY4,24 H,973.8495592,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 411,21RSYC,20-Apr-22
C1071040,11101003,85,PF-06863135,T,6801650229,6.80165E+11,20211104,10:25,CYCLE1_DAY1,0 H,1.200975753,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 638,29RSYC,22-Apr-22
C1071040,11101003,85,PF-06863135,T,6801650229,6.80165E+11,20211104,16:08,CYCLE1_DAY1,6 H,918.1203038,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 639,29RSYC,22-Apr-22
C1071040,11101003,85,PF-06863135,T,6801650231,6.80165E+11,20211111,10:12,CYCLE1_DAY8,0 H,908.9037899,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 643,29RSYC,22-Apr-22
C1071040,11101003,85,PF-06863135,T,6801650231,6.80165E+11,20211111,15:50,CYCLE1_DAY8,6 H,162.4397478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 642,29RSYC,22-Apr-22
C1071040,11101003,85,PF-06863135,T,6801650233,6.80165E+11,20211117,15:45,CYCLE1_DAY15,0 H,236.3364099,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 826,35RSYC,25-Apr-22
C1071040,11101003,85,PF-06863135,T,6801650235,6.80165E+11,20211124,13:25,CYCLE1_DAY22,0 H,143.3231343,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 828,35RSYC,25-Apr-22
C1071040,11101003,85,PF-06863135,T,6801650237,6.80165E+11,20211201,13:15,CYCLE2_DAY1,0 H,233.0457508,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 956,65RSYC,3-May-22
C1071040,11101003,85,PF-06863135,T,6801747726,6.80175E+11,20211228,11:00,CYCLE3_DAY1,0 H,159.1725122,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 957,65RSYC,3-May-22
C1071040,11101003,85,PF-06863135,T,6801747727,6.80175E+11,20220126,11:36,CYCLE4_DAY1,0 H,447.9376253,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1595,59RSYC,1-May-22
C1071040,11101003,85,PF-06863135,T,6801650250,6.80165E+11,20220401,11:35,END_OF_TRT,,299.7872234,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1920,123RSYC,29-Jul-22
C1071040,11101003,85,PF-06863135,T,6801650241,6.80165E+11,20211105,10:05,CYCLE1_DAY1,24 H,802.5553672,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 644,29RSYC,22-Apr-22
C1071040,11101003,85,PF-06863135,T,6801650243,6.80165E+11,20211108,15:18,CYCLE1_DAY4,0 H,358.2753805,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 646,29RSYC,22-Apr-22
C1071040,11101003,85,PF-06863135,T,6801650245,6.80165E+11,20211109,14:10,CYCLE1_DAY4,24 H,318.1763555,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 648,29RSYC,22-Apr-22
C1071040,11041003,86,PF-06863135,T,6216923989,6.21692E+11,20211104,12:30,CYCLE1_DAY1,0 H,452.7907386,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1758,91RSYC,11-May-22
C1071040,11041003,86,PF-06863135,T,6216923993,6.21692E+11,20211115,16:30,CYCLE1_DAY8,0 H,601.9002415,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 744,32RSYC,23-Apr-22
C1071040,11041003,86,PF-06863135,T,6216923993,6.21692E+11,20211115,23:35,CYCLE1_DAY8,6 H,6.621257059,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 743,32RSYC,23-Apr-22
C1071040,11041003,86,PF-06863135,T,6216725279,6.21673E+11,20211123,8:50,CYCLE1_DAY15,0 H,843.0928482,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 725,31RSYC,23-Apr-22
C1071040,11041003,86,PF-06863135,T,6216725280,6.21673E+11,20211129,15:00,CYCLE1_DAY22,0 H,469.1253189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1376,84RSYC,10-May-22
C1071040,11041003,86,PF-06863135,T,6216924003,6.21692E+11,20211206,11:00,CYCLE2_DAY1,0 H,229.5496713,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1420,57RSYC,30-Apr-22
C1071040,11041003,86,PF-06863135,T,6216725285,6.21673E+11,20220104,12:15,CYCLE3_DAY1,0 H,570.2597106,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1757,91RSYC,11-May-22
C1071040,11041003,86,PF-06863135,T,6216924045,6.21692E+11,20220111,11:47,END_OF_TRT,,404.3414418,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1759,109RSYC,25-May-22
C1071040,11041003,86,PF-06863135,T,6216924028,6.21692E+11,20211105,18:20,CYCLE1_DAY1,24 H,248.8097762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 748,32RSYC,23-Apr-22
C1071040,11041003,86,PF-06863135,T,6216924032,6.21692E+11,20211108,12:00,CYCLE1_DAY4,0 H,386.486125,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 492,24RSYC,20-Apr-22
C1071040,11041003,86,PF-06863135,T,6216924034,6.21692E+11,20211109,16:15,CYCLE1_DAY4,24 H,317.1920018,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 749,32RSYC,23-Apr-22
C1071040,10151003,87,PF-06863135,T,6518602938,6.5186E+11,20211110,13:50,CYCLE1_DAY1,0 H,460.7565367,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 614,63RSYC,2-May-22
C1071040,10151003,87,PF-06863135,T,6518842175,6.51884E+11,20211118,9:20,CYCLE1_DAY8,0 H,243.9468418,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 938,65RSYC,3-May-22
C1071040,10151003,87,PF-06863135,T,6518842175,6.51884E+11,20211118,16:05,CYCLE1_DAY8,6 H,762.3858238,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 937,64RSYC,3-May-22
C1071040,10151003,87,PF-06863135,T,6518842176,6.51884E+11,20211124,9:30,CYCLE1_DAY15,0 H,384.8339286,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1164,104RSYC,22-May-22
C1071040,10151003,87,PF-06863135,T,6518602944,6.5186E+11,20211201,9:29,CYCLE1_DAY22,0 H,708.5293238,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1114,67RSYC,8-May-22
C1071040,10151003,87,PF-06863135,T,6517560136,6.51756E+11,20220426,11:45,CYCLE7_DAY1,0 H,809.3109657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1980,114RSYC,25-Jul-22
C1071040,10151003,87,PF-06863135,T,6521544923,6.52154E+11,20230321,11:08,CYCLE19_DAY1,0 H,873.7434152,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2206,145RSYC,4-Jan-24
C1071040,10151003,87,PF-06863135,T,6521544920,6.52154E+11,20230615,11:05,CYCLE22_DAY1,0 H,559.4388282,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2266,147RSYC,29-Feb-24
C1071040,10151003,87,PF-06863135,T,6518602952,6.5186E+11,20211111,15:00,CYCLE1_DAY1,24 H,803.7588685,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 923,20RSYC,19-Apr-22
C1071040,10151003,87,PF-06863135,T,6518602955,6.5186E+11,20211112,13:00,CYCLE1_DAY4,0 H,301.4571134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 924,20RSYC,19-Apr-22
C1071040,11041004,88,PF-06863135,T,6216923987,6.21692E+11,20211105,15:00,CYCLE1_DAY1,0 H,945.8167843,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1413,96RSYC,12-May-22
C1071040,11041004,88,PF-06863135,T,6216923987,6.21692E+11,20211105,22:30,CYCLE1_DAY1,6 H,283.8405859,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1412,108RSYC,24-May-22
C1071040,11041004,88,PF-06863135,T,6216725277,6.21673E+11,20211112,12:50,CYCLE1_DAY8,0 H,459.7384278,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 724,31RSYC,23-Apr-22
C1071040,11041004,88,PF-06863135,T,6216725277,6.21673E+11,20211113,0:45,CYCLE1_DAY8,6 H,312.6758324,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 723,31RSYC,23-Apr-22
C1071040,11041004,88,PF-06863135,T,6216923997,6.21692E+11,20211118,15:20,CYCLE1_DAY15,0 H,323.9262703,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 745,32RSYC,23-Apr-22
C1071040,11041004,88,PF-06863135,T,6216924048,6.21692E+11,20211124,19:30,END_OF_TRT,,534.6637704,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1760,109RSYC,25-May-22
C1071040,11041004,88,PF-06863135,T,6216924027,6.21692E+11,20211106,16:30,CYCLE1_DAY1,24 H,288.6730896,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 489,24RSYC,20-Apr-22
C1071040,11041004,88,PF-06863135,T,6216924031,6.21692E+11,20211108,11:40,CYCLE1_DAY4,0 H,778.8964539,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 491,24RSYC,20-Apr-22
C1071040,11041004,88,PF-06863135,T,6216924036,6.21692E+11,20211109,14:00,CYCLE1_DAY4,24 H,986.6299539,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 750,32RSYC,23-Apr-22
C1071040,10741001,89,PF-06863135,T,6518693890,6.51869E+11,20211109,13:26,CYCLE1_DAY1,0 H,969.7719115,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 930,36RSYC,25-Apr-22
C1071040,10741001,89,PF-06863135,T,6518693890,6.51869E+11,20211109,20:05,CYCLE1_DAY1,6 H,102.3477121,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 929,36RSYC,25-Apr-22
C1071040,10741001,89,PF-06863135,T,6518693891,6.51869E+11,20211119,11:40,CYCLE1_DAY8,0 H,542.584335,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 932,36RSYC,25-Apr-22
C1071040,10741001,89,PF-06863135,T,6518693891,6.51869E+11,20211119,22:45,CYCLE1_DAY8,6 H,227.2286201,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 931,36RSYC,25-Apr-22
C1071040,10741001,89,PF-06863135,T,6517472579,6.51747E+11,20211129,9:35,CYCLE1_DAY15,0 H,275.9950534,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 997,39RSYC,26-Apr-22
C1071040,10741001,89,PF-06863135,T,6517472581,6.51747E+11,20211208,15:10,CYCLE1_DAY22,0 H,247.4778609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1968,122RSYC,29-Jul-22
C1071040,10741001,89,PF-06863135,T,6517472583,6.51747E+11,20211215,12:00,CYCLE2_DAY1,0 H,96.42831965,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 998,39RSYC,26-Apr-22
C1071040,10741001,89,PF-06863135,T,6519029238,6.51903E+11,20220113,15:00,CYCLE3_DAY1,0 H,558.4623578,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1654,100RSYC,23-May-22
C1071040,10741001,89,PF-06863135,T,6517472604,6.51747E+11,20220119,13:24,END_OF_TRT,,678.0536036,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1653,100RSYC,23-May-22
C1071040,10741001,89,PF-06863135,T,6518693897,6.51869E+11,20211110,14:41,CYCLE1_DAY1,24 H,729.2317623,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1131,94RSYC,12-May-22
C1071040,10741001,89,PF-06863135,T,6518693899,6.51869E+11,20211112,8:30,CYCLE1_DAY4,0 H,191.0100067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 933,36RSYC,25-Apr-22
C1071040,10741001,89,PF-06863135,T,6518693902,6.51869E+11,20211113,10:30,CYCLE1_DAY4,24 H,864.2473646,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 934,36RSYC,25-Apr-22
C1071040,10801001,90,PF-06863135,T,6517433488,6.51743E+11,20211108,10:59,CYCLE1_DAY1,0 H,488.3519091,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 533,25RSYC,22-Apr-22
C1071040,10801001,90,PF-06863135,T,6517433488,6.51743E+11,20211108,16:47,CYCLE1_DAY1,6 H,703.0744614,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 532,25RSYC,22-Apr-22
C1071040,10801001,90,PF-06863135,T,6517433490,6.51743E+11,20211115,9:58,CYCLE1_DAY8,0 H,487.1419704,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 973,66RSYC,3-May-22
C1071040,10801001,90,PF-06863135,T,6517433490,6.51743E+11,20211115,16:09,CYCLE1_DAY8,6 H,635.0274408,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 972,66RSYC,3-May-22
C1071040,10801001,90,PF-06863135,T,6518789963,6.51879E+11,20211122,13:36,CYCLE1_DAY15,0 H,460.2694113,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 936,64RSYC,3-May-22
C1071040,10801001,90,PF-06863135,T,6517433494,6.51743E+11,20211129,13:16,CYCLE1_DAY22,0 H,53.90266866,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 975,66RSYC,3-May-22
C1071040,10801001,90,PF-06863135,T,6517433495,6.51743E+11,20211207,10:13,CYCLE2_DAY1,0 H,582.0031777,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 976,66RSYC,3-May-22
C1071040,10801001,90,PF-06863135,T,6517433518,6.51743E+11,20220104,11:35,END_OF_TRT,,901.8712091,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1649,100RSYC,23-May-22
C1071040,10801001,90,PF-06863135,T,6517433504,6.51743E+11,20211109,9:00,CYCLE1_DAY1,24 H,475.1973152,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 534,107RSYC,24-May-22
C1071040,10801001,90,PF-06863135,T,6517433505,6.51743E+11,20211111,15:25,CYCLE1_DAY4,0 H,380.9875346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 846,36RSYC,25-Apr-22
C1071040,10801001,90,PF-06863135,T,6517433508,6.51743E+11,20211112,14:25,CYCLE1_DAY4,24 H,53.97337167,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 847,36RSYC,25-Apr-22
C1071040,10021003,91,PF-06863135,T,6603529933,6.60353E+11,20211108,8:40,CYCLE1_DAY1,0 H,684.1518821,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 815,34RSYC,24-Apr-22
C1071040,10021003,91,PF-06863135,T,6603529933,6.60353E+11,20211108,19:07,CYCLE1_DAY1,6 H,221.1689793,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 816,35RSYC,25-Apr-22
C1071040,10021003,91,PF-06863135,T,6603529936,6.60353E+11,20211115,13:38,CYCLE1_DAY8,0 H,983.8516829,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 817,35RSYC,25-Apr-22
C1071040,10021003,91,PF-06863135,T,6603551414,6.60355E+11,20211122,13:20,CYCLE1_DAY15,0 H,853.3556363,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 819,35RSYC,25-Apr-22
C1071040,10021003,91,PF-06863135,T,6603529939,6.60353E+11,20211129,13:43,CYCLE1_DAY22,0 H,480.9199165,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 943,65RSYC,3-May-22
C1071040,10021003,91,PF-06863135,T,6603546714,6.60355E+11,20211206,10:55,CYCLE2_DAY1,0 H,470.853953,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 944,65RSYC,3-May-22
C1071040,10021003,91,PF-06863135,T,6603529945,6.60353E+11,20220105,14:15,CYCLE3_DAY1,0 H,649.6916416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1584,59RSYC,1-May-22
C1071040,10021003,91,PF-06863135,T,6603529948,6.60353E+11,20220201,14:17,CYCLE4_DAY1,0 H,165.8186011,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1585,59RSYC,1-May-22
C1071040,10021003,91,PF-06863135,T,6603324925,6.60332E+11,20220426,14:09,CYCLE7_DAY1,0 H,727.407968,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2003,122RSYC,29-Jul-22
C1071040,10021003,91,PF-06863135,T,6603839289,6.60384E+11,20220719,13:56,CYCLE10_DAY1,0 H,530.3421363,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2067,129RSYC,21-Oct-22
C1071040,10021003,91,PF-06863135,T,6603578700,6.60358E+11,20221011,14:16,CYCLE13_DAY1,0 H,547.5350195,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2116,131RSYC,9-Nov-22
C1071040,10021003,91,PF-06863135,T,6604204198,6.6042E+11,20230103,13:22,CYCLE16_DAY1,0 H,568.57239,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2186,141RSYC,17-May-23
C1071040,10021003,91,PF-06863135,T,6604204201,6.6042E+11,20230328,12:50,CYCLE19_DAY1,0 H,65.07813494,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2235,142RSYC,18-May-23
C1071040,10021003,91,PF-06863135,T,6604204203,6.6042E+11,20230621,13:00,CYCLE22_DAY1,0 H,984.1293817,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2255,143RSYC,27-Nov-23
C1071040,10021003,91,PF-06863135,T,6604608950,6.60461E+11,20230912,13:05,CYCLE25_DAY1,0 H,309.3130973,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071040,10021003,91,PF-06863135,T,6604608951,6.60461E+11,20231205,12:20,CYCLE28_DAY1,0 H,615.7992252,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2342,148RSYC,27-Mar-24
C1071040,10021003,91,PF-06863135,T,6604777914,6.60478E+11,20240227,13:01,CYCLE31_DAY1,0 H,835.5004281,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071040,10021003,91,PF-06863135,T,6603563111,6.60356E+11,20211109,11:00,CYCLE1_DAY1,24 H,999.914251,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 821,35RSYC,25-Apr-22
C1071040,10021003,91,PF-06863135,T,6603563112,6.60356E+11,20211111,10:10,CYCLE1_DAY4,0 H,739.5776385,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 822,35RSYC,25-Apr-22
C1071040,10021003,91,PF-06863135,T,6603563113,6.60356E+11,20211112,13:06,CYCLE1_DAY4,24 H,299.8748432,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 823,35RSYC,25-Apr-22
C1071040,10561002,92,PF-06863135,T,6216408040,6.21641E+11,20211108,13:30,CYCLE1_DAY1,0 H,42.85639877,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 712,31RSYC,23-Apr-22
C1071040,10561002,92,PF-06863135,T,6216408040,6.21641E+11,20211109,0:30,CYCLE1_DAY1,6 H,917.306109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 711,31RSYC,23-Apr-22
C1071040,10561002,92,PF-06863135,T,6216898573,6.2169E+11,20211115,14:20,CYCLE1_DAY8,0 H,603.5628688,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 739,32RSYC,23-Apr-22
C1071040,10561002,92,PF-06863135,T,6216898575,6.2169E+11,20211122,9:45,CYCLE1_DAY15,0 H,234.8880057,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 740,32RSYC,23-Apr-22
C1071040,10561002,92,PF-06863135,T,6216898580,6.2169E+11,20211206,10:45,CYCLE2_DAY1,0 H,784.6941199,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1406,96RSYC,12-May-22
C1071040,10561002,92,PF-06863135,T,6217026166,6.21703E+11,20220104,11:00,CYCLE3_DAY1,0 H,470.9852522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1775,71RSYC,7-May-22
C1071040,10561002,92,PF-06863135,T,6216898588,6.2169E+11,20220201,10:00,CYCLE4_DAY1,0 H,197.872371,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1774,71RSYC,7-May-22
C1071040,10561002,92,PF-06863135,T,6216898591,6.2169E+11,20220426,11:30,CYCLE7_DAY1,0 H,798.2172407,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1995,115RSYC,25-Jul-22
C1071040,10561002,92,PF-06863135,T,6216408062,6.21641E+11,20220719,10:35,CYCLE10_DAY1,0 H,966.6602217,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2049,132RSYC,10-Nov-22
C1071040,10561002,92,PF-06863135,T,6218590819,6.21859E+11,20221013,15:30,CYCLE13_DAY1,0 H,716.4257302,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2123,131RSYC,9-Nov-22
C1071040,10561002,92,PF-06863135,T,6219498865,6.2195E+11,20230103,8:40,CYCLE16_DAY1,0 H,506.7513339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2179,140RSYC,22-Mar-23
C1071040,10561002,92,PF-06863135,T,6220036109,6.22004E+11,20230328,9:40,CYCLE19_DAY1,0 H,443.3905021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2228,142RSYC,18-May-23
C1071040,10561002,92,PF-06863135,T,6220036106,6.22004E+11,20230620,10:00,CYCLE22_DAY1,0 H,718.0305539,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2260,144RSYC,27-Nov-23
C1071040,10561002,92,PF-06863135,T,6220036105,6.22004E+11,20230911,10:55,CYCLE25_DAY1,0 H,610.7975676,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2309,147RSYC,29-Feb-24
C1071040,10561002,92,PF-06863135,T,6221375068,6.22138E+11,20231207,10:30,CYCLE28_DAY1,0 H,152.0317802,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2348,148RSYC,27-Mar-24
C1071040,10561002,92,PF-06863135,T,6221375069,6.22138E+11,20240229,10:15,CYCLE31_DAY1,0 H,651.3805416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2370,152RSYC,9-Apr-24
C1071040,10561002,92,PF-06863135,T,6216898596,6.2169E+11,20211112,13:00,CYCLE1_DAY4,0 H,475.222475,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 741,32RSYC,23-Apr-22
C1071040,10931002,93,PF-06863135,T,6517472606,6.51747E+11,20211108,14:15,CYCLE1_DAY1,0 H,88.56031517,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 853,36RSYC,25-Apr-22
C1071040,10931002,93,PF-06863135,T,6517472606,6.51747E+11,20211108,21:17,CYCLE1_DAY1,6 H,488.3825754,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 852,36RSYC,25-Apr-22
C1071040,10931002,93,PF-06863135,T,6517472608,6.51747E+11,20211115,12:23,CYCLE1_DAY8,0 H,409.235041,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 855,36RSYC,25-Apr-22
C1071040,10931002,93,PF-06863135,T,6517472608,6.51747E+11,20211115,19:15,CYCLE1_DAY8,6 H,171.2881001,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 854,36RSYC,25-Apr-22
C1071040,10931002,93,PF-06863135,T,6517472611,6.51747E+11,20211122,16:00,CYCLE1_DAY15,0 H,72.4318095,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 689,30RSYC,22-Apr-22
C1071040,10931002,93,PF-06863135,T,6518778272,6.51878E+11,20211129,16:39,CYCLE1_DAY22,0 H,403.5635094,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1146,107RSYC,24-May-22
C1071040,10931002,93,PF-06863135,T,6518778276,6.51878E+11,20211207,10:31,CYCLE2_DAY1,0 H,255.7868393,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1148,107RSYC,24-May-22
C1071040,10931002,93,PF-06863135,T,6518934242,6.51893E+11,20220103,16:45,CYCLE3_DAY1,0 H,852.5553665,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1709,72RSYC,7-May-22
C1071040,10931002,93,PF-06863135,T,6519290787,6.51929E+11,20220131,17:03,CYCLE4_DAY1,0 H,136.6089334,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1710,72RSYC,7-May-22
C1071040,10931002,93,PF-06863135,T,6519290794,6.51929E+11,20220425,16:00,CYCLE7_DAY1,0 H,806.2054615,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1989,114RSYC,25-Jul-22
C1071040,10931002,93,PF-06863135,T,6519290796,6.51929E+11,20220718,16:30,CYCLE10_DAY1,0 H,15.90349316,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2089,129RSYC,21-Oct-22
C1071040,10931002,93,PF-06863135,T,6519290799,6.51929E+11,20221010,17:10,CYCLE13_DAY1,0 H,353.2531972,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2110,131RSYC,9-Nov-22
C1071040,10931002,93,PF-06863135,T,6521929818,6.52193E+11,20230103,17:56,CYCLE16_DAY1,0 H,276.4437253,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2172,140RSYC,22-Mar-23
C1071040,10931002,93,PF-06863135,T,6522161150,6.52216E+11,20230327,15:06,CYCLE19_DAY1,0 H,665.7936951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2221,142RSYC,18-May-23
C1071040,10931002,93,PF-06863135,T,6521929816,6.52193E+11,20230619,14:23,CYCLE22_DAY1,0 H,104.1465315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2267,144RSYC,27-Nov-23
C1071040,10931002,93,PF-06863135,T,6521929819,6.52193E+11,20230913,17:05,CYCLE25_DAY1,0 H,895.1740134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2304,147RSYC,29-Feb-24
C1071040,10931002,93,PF-06863135,T,6524397935,6.5244E+11,20231204,15:21,CYCLE28_DAY1,0 H,313.6555764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2329,148RSYC,27-Mar-24
C1071040,10931002,93,PF-06863135,T,6524397936,6.5244E+11,,,CYCLE31_DAY1,0 H,96.74160368,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2373,152RSYC,9-Apr-24
C1071040,10931002,93,PF-06863135,T,6517472622,6.51747E+11,20211109,15:16,CYCLE1_DAY1,24 H,892.7632303,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 859,36RSYC,25-Apr-22
C1071040,10931002,93,PF-06863135,T,6517472624,6.51747E+11,20211111,10:45,CYCLE1_DAY4,0 H,65.51397273,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 860,36RSYC,25-Apr-22
C1071040,10931002,93,PF-06863135,T,6517472627,6.51747E+11,20211112,11:36,CYCLE1_DAY4,24 H,289.7429494,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 862,36RSYC,25-Apr-22
C1071040,10111002,94,PF-06863135,T,6517559758,6.51756E+11,20211109,12:40,CYCLE1_DAY1,0 H,318.1666723,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 881,19RSYC,19-Apr-22
C1071040,10111002,94,PF-06863135,T,6517559758,6.51756E+11,20211109,19:20,CYCLE1_DAY1,6 H,526.9565609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 880,19RSYC,19-Apr-22
C1071040,10111002,94,PF-06863135,T,6517559761,6.51756E+11,20211116,8:15,CYCLE1_DAY8,0 H,52.8424396,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 882,19RSYC,19-Apr-22
C1071040,10111002,94,PF-06863135,T,6517559763,6.51756E+11,20211123,9:30,CYCLE1_DAY15,0 H,10.01386256,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1028,40RSYC,26-Apr-22
C1071040,10111002,94,PF-06863135,T,6517559765,6.51756E+11,20211130,9:30,CYCLE1_DAY22,0 H,263.9038999,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1029,40RSYC,26-Apr-22
C1071040,10111002,94,PF-06863135,T,6517559767,6.51756E+11,20211207,9:30,CYCLE2_DAY1,0 H,795.6912628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1030,40RSYC,26-Apr-22
C1071040,10111002,94,PF-06863135,T,6517559768,6.51756E+11,20220104,8:55,CYCLE3_DAY1,0 H,629.7211167,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1617,97RSYC,12-May-22
C1071040,10111002,94,PF-06863135,T,6517559770,6.51756E+11,20220201,10:30,CYCLE4_DAY1,0 H,857.2063803,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1618,85RSYC,10-May-22
C1071040,10111002,94,PF-06863135,T,6517559772,6.51756E+11,20220426,10:00,CYCLE7_DAY1,0 H,593.9365781,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1978,114RSYC,25-Jul-22
C1071040,10111002,94,PF-06863135,T,6517559775,6.51756E+11,20211110,13:15,CYCLE1_DAY1,24 H,28.46512139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 883,19RSYC,19-Apr-22
C1071040,10111002,94,PF-06863135,T,6517559777,6.51756E+11,20211112,10:40,CYCLE1_DAY4,0 H,143.1147301,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 884,19RSYC,19-Apr-22
C1071040,11101002,95,PF-06863135,T,6801650230,6.80165E+11,20211110,10:10,CYCLE1_DAY1,0 H,189.1491436,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 640,29RSYC,22-Apr-22
C1071040,11101002,95,PF-06863135,T,6801650230,6.80165E+11,20211110,16:15,CYCLE1_DAY1,6 H,801.8568704,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 641,29RSYC,22-Apr-22
C1071040,11101002,95,PF-06863135,T,6801650232,6.80165E+11,20211118,10:44,CYCLE1_DAY8,0 H,808.196418,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 825,35RSYC,25-Apr-22
C1071040,11101002,95,PF-06863135,T,6801650232,6.80165E+11,20211118,16:54,CYCLE1_DAY8,6 H,327.4765421,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 824,35RSYC,25-Apr-22
C1071040,11101002,95,PF-06863135,T,6801650234,6.80165E+11,20211124,11:21,CYCLE1_DAY15,0 H,417.1942958,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 827,35RSYC,25-Apr-22
C1071040,11101002,95,PF-06863135,T,6801650236,6.80165E+11,20211201,11:35,CYCLE1_DAY22,0 H,155.9820183,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 939,65RSYC,3-May-22
C1071040,11101002,95,PF-06863135,T,6801650238,6.80165E+11,20211208,11:20,CYCLE2_DAY1,0 H,934.1114622,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 955,65RSYC,3-May-22
C1071040,11101002,95,PF-06863135,T,6801741157,6.80174E+11,20220105,11:33,CYCLE3_DAY1,0 H,843.0290515,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1593,59RSYC,1-May-22
C1071040,11101002,95,PF-06863135,T,6801741158,6.80174E+11,20220202,12:08,CYCLE4_DAY1,0 H,873.4499354,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1594,59RSYC,1-May-22
C1071040,11101002,95,PF-06863135,T,6801830279,6.80183E+11,20220427,12:35,CYCLE7_DAY1,0 H,548.8779119,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1962,114RSYC,25-Jul-22
C1071040,11101002,95,PF-06863135,T,6801721367,6.80172E+11,20220720,12:32,CYCLE10_DAY1,0 H,893.7156477,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2072,129RSYC,21-Oct-22
C1071040,11101002,95,PF-06863135,T,6802027132,6.80203E+11,20221012,10:43,CYCLE13_DAY1,0 H,340.4982159,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2118,131RSYC,9-Nov-22
C1071040,11101002,95,PF-06863135,T,6802027133,6.80203E+11,20230104,11:25,CYCLE16_DAY1,0 H,402.2688284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2189,141RSYC,17-May-23
C1071040,11101002,95,PF-06863135,T,6802065578,6.80207E+11,20230329,11:15,CYCLE19_DAY1,0 H,244.7254518,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2237,145RSYC,4-Jan-24
C1071040,11101002,95,PF-06863135,T,6802065579,6.80207E+11,20230621,10:45,CYCLE22_DAY1,0 H,972.5612919,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2274,147RSYC,29-Feb-24
C1071040,11101002,95,PF-06863135,T,6802302903,6.8023E+11,20230913,10:27,CYCLE25_DAY1,0 H,742.8683208,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2298,147RSYC,29-Feb-24
C1071040,11101002,95,PF-06863135,T,6802400458,6.8024E+11,20231206,10:40,CYCLE28_DAY1,0 H,499.4888717,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2343,148RSYC,27-Mar-24
C1071040,11101002,95,PF-06863135,T,6802400459,6.8024E+11,20240228,10:38,CYCLE31_DAY1,0 H,383.2560326,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071040,11101002,95,PF-06863135,T,6801650242,6.80165E+11,20211111,9:15,CYCLE1_DAY1,24 H,871.3566985,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 645,29RSYC,22-Apr-22
C1071040,11101002,95,PF-06863135,T,6801650244,6.80165E+11,20211115,11:28,CYCLE1_DAY4,0 H,362.7440651,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 647,29RSYC,22-Apr-22
C1071040,11101002,95,PF-06863135,T,6801650246,6.80165E+11,20211116,10:17,CYCLE1_DAY4,24 H,428.7308083,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 649,29RSYC,22-Apr-22
C1071040,10461002,96,PF-06863135,T,6216756762,6.21676E+11,20211116,10:30,CYCLE1_DAY1,0 H,308.9065428,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 729,32RSYC,23-Apr-22
C1071040,10461002,96,PF-06863135,T,6216756762,6.21676E+11,20211116,18:30,CYCLE1_DAY1,6 H,178.7584325,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 728,32RSYC,23-Apr-22
C1071040,10461002,96,PF-06863135,T,6217039131,6.21704E+11,20211123,10:27,CYCLE1_DAY8,0 H,968.7916402,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1436,57RSYC,30-Apr-22
C1071040,10461002,96,PF-06863135,T,6217039131,6.21704E+11,20211123,17:30,CYCLE1_DAY8,6 H,701.6123951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 772,33RSYC,24-Apr-22
C1071040,10461002,96,PF-06863135,T,6217233419,6.21723E+11,20211201,11:35,CYCLE1_DAY15,0 H,759.8887878,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1538,58RSYC,1-May-22
C1071040,10461002,96,PF-06863135,T,6216756768,6.21676E+11,20211208,11:05,CYCLE1_DAY22,0 H,102.9683745,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1381,84RSYC,10-May-22
C1071040,10461002,96,PF-06863135,T,6217142651,6.21714E+11,20220114,15:00,END_OF_TRT,,290.9929445,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1814,86RSYC,13-May-22
C1071040,10461002,96,PF-06863135,T,6218478267,6.21848E+11,20211222,11:00,UNPL,9001 H,674.8192299,NG/ML,,Received as 6217340169-04,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1815,92RSYC,12-May-22
C1071040,10461002,96,PF-06863135,T,6216756775,6.21676E+11,20211117,13:00,CYCLE1_DAY1,24 H,590.3904874,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 732,32RSYC,23-Apr-22
C1071040,10461002,96,PF-06863135,T,6216756777,6.21676E+11,20211118,10:25,CYCLE1_DAY4,0 H,841.7844193,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 734,32RSYC,23-Apr-22
C1071040,10461002,96,PF-06863135,T,6216756778,6.21676E+11,20211119,12:15,CYCLE1_DAY4,24 H,70.78083192,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 735,32RSYC,23-Apr-22
C1071040,10461003,97,PF-06863135,T,6217039129,6.21704E+11,20211123,10:37,CYCLE1_DAY1,0 H,761.8357607,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 771,33RSYC,24-Apr-22
C1071040,10461003,97,PF-06863135,T,6217039129,6.21704E+11,20211123,17:30,CYCLE1_DAY1,6 H,699.1524806,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 770,33RSYC,24-Apr-22
C1071040,10461003,97,PF-06863135,T,6217039133,6.21704E+11,20211202,11:30,CYCLE1_DAY8,0 H,356.5321049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1440,96RSYC,12-May-22
C1071040,10461003,97,PF-06863135,T,6217039133,6.21704E+11,20211202,19:00,CYCLE1_DAY8,6 H,958.1337785,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1439,96RSYC,12-May-22
C1071040,10461003,97,PF-06863135,T,6217368116,6.21737E+11,20211210,10:45,CYCLE1_DAY15,0 H,342.6748911,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1822,92RSYC,12-May-22
C1071040,10461003,97,PF-06863135,T,6217368121,6.21737E+11,20211216,10:20,CYCLE1_DAY22,0 H,449.6441759,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1823,92RSYC,12-May-22
C1071040,10461003,97,PF-06863135,T,6216756770,6.21676E+11,20211222,10:10,CYCLE2_DAY1,0 H,278.7961092,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1819,92RSYC,12-May-22
C1071040,10461003,97,PF-06863135,T,6217233436,6.21723E+11,20220119,10:50,CYCLE3_DAY1,0 H,1.554985705,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1820,92RSYC,12-May-22
C1071040,10461003,97,PF-06863135,T,6217340180,6.21734E+11,20220216,9:30,CYCLE4_DAY1,0 H,898.3958308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1821,92RSYC,12-May-22
C1071040,10461003,97,PF-06863135,T,6217647296,6.21765E+11,20220511,9:45,CYCLE7_DAY1,0 H,712.9415863,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2062,132RSYC,10-Nov-22
C1071040,10461003,97,PF-06863135,T,6217647301,6.21765E+11,20220808,6:00,CYCLE10_DAY1,0 H,85.52867227,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2063,132RSYC,10-Nov-22
C1071040,10461003,97,PF-06863135,T,6216756783,6.21676E+11,20220818,12:29,END_OF_TRT,,821.0974033,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2061,132RSYC,10-Nov-22
C1071040,10461003,97,PF-06863135,T,6216756782,6.21676E+11,20211208,9:30,UNPL,9001 H,982.035524,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1383,86RSYC,13-May-22
C1071040,10461003,97,PF-06863135,T,6217039135,6.21704E+11,20211124,12:00,CYCLE1_DAY1,24 H,131.5921011,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 774,33RSYC,24-Apr-22
C1071040,10461003,97,PF-06863135,T,6217283551,6.21728E+11,20211129,10:29,CYCLE1_DAY4,0 H,459.4133544,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1566,59RSYC,1-May-22
C1071040,10461003,97,PF-06863135,T,6217039142,6.21704E+11,20211130,12:10,CYCLE1_DAY4,24 H,258.18619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1443,96RSYC,12-May-22
C1071040,10461004,98,PF-06863135,T,6217039128,6.21704E+11,20211118,10:15,CYCLE1_DAY1,0 H,14.46993375,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 769,33RSYC,24-Apr-22
C1071040,10461004,98,PF-06863135,T,6217039128,6.21704E+11,20211118,18:48,CYCLE1_DAY1,6 H,525.3287117,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 768,33RSYC,24-Apr-22
C1071040,10461004,98,PF-06863135,T,6217233416,6.21723E+11,20211125,10:15,CYCLE1_DAY8,0 H,530.6121928,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 805,34RSYC,24-Apr-22
C1071040,10461004,98,PF-06863135,T,6217233416,6.21723E+11,20211125,17:56,CYCLE1_DAY8,6 H,76.8423243,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 804,34RSYC,24-Apr-22
C1071040,10461004,98,PF-06863135,T,6217233417,6.21723E+11,20211203,8:00,CYCLE1_DAY15,0 H,996.47297,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1537,58RSYC,1-May-22
C1071040,10461004,98,PF-06863135,T,6217233423,6.21723E+11,20211209,10:50,CYCLE1_DAY22,0 H,228.0770284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1825,92RSYC,12-May-22
C1071040,10461004,98,PF-06863135,T,6217340170,6.21734E+11,20211216,10:20,CYCLE2_DAY1,0 H,773.4792611,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1826,92RSYC,12-May-22
C1071040,10461004,98,PF-06863135,T,6217142650,6.21714E+11,20220114,10:50,END_OF_TRT,,471.1092172,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1824,86RSYC,13-May-22
C1071040,10461004,98,PF-06863135,T,6217039134,6.21704E+11,20211119,12:05,CYCLE1_DAY1,24 H,34.54373252,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 773,33RSYC,24-Apr-22
C1071040,10461004,98,PF-06863135,T,6217039139,6.21704E+11,20211122,10:30,CYCLE1_DAY4,0 H,170.6492383,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 776,33RSYC,24-Apr-22
C1071040,10461004,98,PF-06863135,T,6217039140,6.21704E+11,20211123,11:40,CYCLE1_DAY4,24 H,505.7942728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 777,33RSYC,24-Apr-22
C1071040,10461005,99,PF-06863135,T,6217233415,6.21723E+11,20211125,11:08,CYCLE1_DAY1,0 H,211.5406053,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1536,58RSYC,1-May-22
C1071040,10461005,99,PF-06863135,T,6217233415,6.21723E+11,20211125,18:03,CYCLE1_DAY1,6 H,762.6225638,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1535,56RSYC,30-Apr-22
C1071040,10461005,99,PF-06863135,T,6216756765,6.21676E+11,20211202,12:00,CYCLE1_DAY8,0 H,172.9042507,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1379,84RSYC,10-May-22
C1071040,10461005,99,PF-06863135,T,6216756765,6.21676E+11,20211202,18:55,CYCLE1_DAY8,6 H,852.9964533,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1378,84RSYC,10-May-22
C1071040,10461005,99,PF-06863135,T,6217368120,6.21737E+11,20211214,6:00,CYCLE1_DAY22,0 H,263.7469439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1818,92RSYC,12-May-22
C1071040,10461005,99,PF-06863135,T,6217233426,6.21723E+11,20211221,9:40,CYCLE2_DAY1,0 H,482.9432927,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1816,92RSYC,12-May-22
C1071040,10461005,99,PF-06863135,T,6217283548,6.21728E+11,20220118,9:50,CYCLE3_DAY1,0 H,64.32484914,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1817,92RSYC,12-May-22
C1071040,10461005,99,PF-06863135,T,6217647291,6.21765E+11,20220510,11:20,CYCLE7_DAY1,0 H,271.1157115,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2000,115RSYC,25-Jul-22
C1071040,10461005,99,PF-06863135,T,6217647299,6.21765E+11,20220802,14:30,CYCLE10_DAY1,0 H,178.0821073,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2059,132RSYC,10-Nov-22
C1071040,10461005,99,PF-06863135,T,6218022369,6.21802E+11,20220901,12:30,END_OF_TRT,,502.9013363,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2060,132RSYC,10-Nov-22
C1071040,10461005,99,PF-06863135,T,6217039136,6.21704E+11,20211126,10:55,CYCLE1_DAY1,24 H,706.0007896,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1441,96RSYC,12-May-22
C1071040,10461005,99,PF-06863135,T,6217233439,6.21723E+11,20211129,10:15,CYCLE1_DAY4,0 H,358.5689669,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 806,34RSYC,24-Apr-22
C1071040,10461005,99,PF-06863135,T,6217233440,6.21723E+11,20211130,11:50,CYCLE1_DAY4,24 H,699.1409138,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1540,58RSYC,1-May-22
C1071040,10321002,100,PF-06863135,T,6517509071,6.51751E+11,20211110,11:50,CYCLE1_DAY1,0 H,129.0678566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 866,36RSYC,25-Apr-22
C1071040,10321002,100,PF-06863135,T,6517509071,6.51751E+11,20211110,19:30,CYCLE1_DAY1,6 H,318.462738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 865,36RSYC,25-Apr-22
C1071040,10321002,100,PF-06863135,T,6517509072,6.51751E+11,20211117,8:56,CYCLE1_DAY8,0 H,411.7250538,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 868,19RSYC,19-Apr-22
C1071040,10321002,100,PF-06863135,T,6517509072,6.51751E+11,20211117,17:10,CYCLE1_DAY8,6 H,473.1176344,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 867,36RSYC,25-Apr-22
C1071040,10321002,100,PF-06863135,T,6517559955,6.51756E+11,20211124,15:38,CYCLE1_DAY15,0 H,296.0537711,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1040,40RSYC,26-Apr-22
C1071040,10321002,100,PF-06863135,T,6517559957,6.51756E+11,20211202,15:31,CYCLE1_DAY22,0 H,575.9884281,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1042,40RSYC,26-Apr-22
C1071040,10321002,100,PF-06863135,T,6517559960,6.51756E+11,20211209,15:36,CYCLE2_DAY1,0 H,888.8817588,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1043,40RSYC,26-Apr-22
C1071040,10321002,100,PF-06863135,T,6517559961,6.51756E+11,20220106,14:47,CYCLE3_DAY1,0 H,815.915392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1631,85RSYC,10-May-22
C1071040,10321002,100,PF-06863135,T,6517559982,6.51756E+11,20220113,12:21,END_OF_TRT,,168.7932425,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1632,100RSYC,23-May-22
C1071040,10321002,100,PF-06863135,T,6517509083,6.51751E+11,20211111,14:21,CYCLE1_DAY1,24 H,399.9524624,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 870,19RSYC,19-Apr-22
C1071040,10321002,100,PF-06863135,T,6517559969,6.51756E+11,20211113,9:13,CYCLE1_DAY4,0 H,371.5605156,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 885,19RSYC,19-Apr-22
C1071040,10321002,100,PF-06863135,T,6517509087,6.51751E+11,20211114,9:59,CYCLE1_DAY4,24 H,103.3307274,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 871,19RSYC,19-Apr-22
C1071040,11061001,101,PF-06863135,T,6216408243,6.21641E+11,20211110,12:30,CYCLE1_DAY1,0 H,926.9759975,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1328,50RSYC,29-Apr-22
C1071040,11061001,101,PF-06863135,T,6216408243,6.21641E+11,20211110,20:05,CYCLE1_DAY1,6 H,690.3005106,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1327,50RSYC,29-Apr-22
C1071040,11061001,101,PF-06863135,T,6216408246,6.21641E+11,20211115,14:01,CYCLE1_DAY8,0 H,523.2261083,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1330,50RSYC,29-Apr-22
C1071040,11061001,101,PF-06863135,T,6216408246,6.21641E+11,20211115,21:30,CYCLE1_DAY8,6 H,11.8080572,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1329,50RSYC,29-Apr-22
C1071040,11061001,101,PF-06863135,T,6217165073,6.21717E+11,20211123,9:00,CYCLE1_DAY15,0 H,682.8877744,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1489,55RSYC,30-Apr-22
C1071040,11061001,101,PF-06863135,T,6217193496,6.21719E+11,20211130,10:00,CYCLE1_DAY22,0 H,62.45849021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1526,56RSYC,30-Apr-22
C1071040,11061001,101,PF-06863135,T,6217193503,6.21719E+11,20211207,9:00,CYCLE2_DAY1,0 H,6.821232449,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1528,56RSYC,30-Apr-22
C1071040,11061001,101,PF-06863135,T,6216408260,6.21641E+11,20211111,14:05,CYCLE1_DAY1,24 H,968.0260021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1331,50RSYC,29-Apr-22
C1071040,11061001,101,PF-06863135,T,6216408261,6.21641E+11,20211112,11:00,CYCLE1_DAY4,0 H,852.120343,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1332,50RSYC,29-Apr-22
C1071040,11021010,102,PF-06863135,T,6217023819,6.21702E+11,20211110,13:30,CYCLE1_DAY1,0 H,187.1314561,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 751,32RSYC,23-Apr-22
C1071040,11021010,102,PF-06863135,T,6217023828,6.21702E+11,20211116,14:00,CYCLE1_DAY8,0 H,562.4863119,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 756,33RSYC,24-Apr-22
C1071040,11021010,102,PF-06863135,T,6217023828,6.21702E+11,20211116,20:05,CYCLE1_DAY8,6 H,389.3414594,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 755,32RSYC,23-Apr-22
C1071040,11021010,102,PF-06863135,T,6217170439,6.21717E+11,20211124,13:30,CYCLE1_DAY15,0 H,507.6163292,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 792,34RSYC,24-Apr-22
C1071040,11021010,102,PF-06863135,T,6217170450,6.21717E+11,20211202,17:30,CYCLE1_DAY22,0 H,332.1656252,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1503,55RSYC,30-Apr-22
C1071040,11021010,102,PF-06863135,T,6217142693,6.21714E+11,20211208,10:00,END_OF_TRT,,139.5160766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1468,109RSYC,25-May-22
C1071040,11021010,102,PF-06863135,T,6217023849,6.21702E+11,20211112,14:50,CYCLE1_DAY4,0 H,166.6825088,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1428,57RSYC,30-Apr-22
C1071040,11021010,102,PF-06863135,T,6217136155,6.21714E+11,20211113,15:00,CYCLE1_DAY4,24 H,24.86602268,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 788,34RSYC,24-Apr-22
C1071040,10511001,103,PF-06863135,T,6216408006,6.21641E+11,20211129,13:50,CYCLE1_DAY1,0 H,561.5300636,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1308,76RSYC,4-May-22
C1071040,10511001,103,PF-06863135,T,6216408006,6.21641E+11,20211129,19:00,CYCLE1_DAY1,6 H,986.8218748,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1307,49RSYC,29-Apr-22
C1071040,10511001,103,PF-06863135,T,6216408008,6.21641E+11,20211206,12:43,CYCLE1_DAY8,0 H,254.6846707,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1310,49RSYC,29-Apr-22
C1071040,10511001,103,PF-06863135,T,6216408008,6.21641E+11,20211206,19:40,CYCLE1_DAY8,6 H,713.1352619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1309,49RSYC,29-Apr-22
C1071040,10511001,103,PF-06863135,T,6216408010,6.21641E+11,20211213,18:15,CYCLE1_DAY15,0 H,349.8449408,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1311,49RSYC,29-Apr-22
C1071040,10511001,103,PF-06863135,T,6216408029,6.21641E+11,20211201,12:44,UNPL,9001 H,197.1034229,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1315,49RSYC,29-Apr-22
C1071040,10511001,103,PF-06863135,T,6216408021,6.21641E+11,20211130,14:20,CYCLE1_DAY1,24 H,519.6541586,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1312,49RSYC,29-Apr-22
C1071040,10511001,103,PF-06863135,T,6216408023,6.21641E+11,20211202,13:30,CYCLE1_DAY4,0 H,687.8662803,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1313,49RSYC,29-Apr-22
C1071040,10511001,103,PF-06863135,T,6216408026,6.21641E+11,20211203,14:25,CYCLE1_DAY4,24 H,50.53484268,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1314,49RSYC,29-Apr-22
C1071040,10031012,104,PF-06863135,T,6517751562,6.51775E+11,20211115,9:26,CYCLE1_DAY1,0 H,115.4546391,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 900,20RSYC,19-Apr-22
C1071040,10031012,104,PF-06863135,T,6517751562,6.51775E+11,20211115,18:01,CYCLE1_DAY1,6 H,959.212578,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 899,20RSYC,19-Apr-22
C1071040,10031012,104,PF-06863135,T,6518620843,6.51862E+11,20211130,14:20,CYCLE1_DAY15,0 H,904.0166479,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1119,94RSYC,12-May-22
C1071040,10031012,104,PF-06863135,T,6516580433,6.51658E+11,20220114,15:25,END_OF_TRT,,253.3281505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1934,123RSYC,29-Jul-22
C1071040,10031012,104,PF-06863135,T,6518620862,6.51862E+11,20211116,10:35,CYCLE1_DAY1,24 H,445.9555318,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1122,94RSYC,12-May-22
C1071040,10031012,104,PF-06863135,T,6518620866,6.51862E+11,20211117,11:48,CYCLE1_DAY4,0 H,32.22094546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 928,36RSYC,25-Apr-22
C1071040,10031012,104,PF-06863135,T,6518620869,6.51862E+11,20211118,12:52,CYCLE1_DAY4,24 H,442.0865284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1125,94RSYC,12-May-22
C1071040,11041005,105,PF-06863135,T,6216725275,6.21673E+11,20211115,14:00,CYCLE1_DAY1,0 H,191.5393566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 720,31RSYC,23-Apr-22
C1071040,11041005,105,PF-06863135,T,6216725275,6.21673E+11,20211115,23:50,CYCLE1_DAY1,6 H,472.5517474,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 719,31RSYC,23-Apr-22
C1071040,11041005,105,PF-06863135,T,6216725276,6.21673E+11,20211122,10:00,CYCLE1_DAY8,0 H,807.8488432,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 722,31RSYC,23-Apr-22
C1071040,11041005,105,PF-06863135,T,6216725276,6.21673E+11,20211122,19:00,CYCLE1_DAY8,6 H,433.7982151,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 721,31RSYC,23-Apr-22
C1071040,11041005,105,PF-06863135,T,6217133150,6.21713E+11,20211129,8:50,CYCLE1_DAY15,0 H,366.3912793,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1459,54RSYC,30-Apr-22
C1071040,11041005,105,PF-06863135,T,6216923999,6.21692E+11,20211206,8:30,CYCLE1_DAY22,0 H,176.3940747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1419,57RSYC,30-Apr-22
C1071040,11041005,105,PF-06863135,T,6216924004,6.21692E+11,20211213,10:40,CYCLE2_DAY1,0 H,797.5749937,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1421,57RSYC,30-Apr-22
C1071040,11041005,105,PF-06863135,T,6217133164,6.21713E+11,20220110,10:40,CYCLE3_DAY1,0 H,529.3611056,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1761,91RSYC,11-May-22
C1071040,11041005,105,PF-06863135,T,6216924044,6.21692E+11,20220207,10:50,END_OF_TRT,,631.8719309,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1877,86RSYC,13-May-22
C1071040,11041005,105,PF-06863135,T,6216924026,6.21692E+11,20211116,17:50,CYCLE1_DAY1,24 H,703.3145526,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 747,32RSYC,23-Apr-22
C1071040,11041005,105,PF-06863135,T,6216725292,6.21673E+11,20211117,18:30,CYCLE1_DAY4,0 H,222.1814228,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 726,32RSYC,23-Apr-22
C1071040,11041005,105,PF-06863135,T,6216725295,6.21673E+11,20211118,18:35,CYCLE1_DAY4,24 H,663.6778026,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 727,32RSYC,23-Apr-22
C1071040,11061002,106,PF-06863135,T,6217165069,6.21717E+11,20211122,10:00,CYCLE1_DAY8,0 H,614.7472561,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1485,55RSYC,30-Apr-22
C1071040,11061002,106,PF-06863135,T,6217165077,6.21717E+11,20211201,10:00,CYCLE1_DAY15,0 H,778.3506834,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1492,55RSYC,30-Apr-22
C1071040,11061002,106,PF-06863135,T,6217193495,6.21719E+11,20211207,9:00,CYCLE1_DAY22,0 H,177.5325445,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1525,56RSYC,30-Apr-22
C1071040,11061002,106,PF-06863135,T,6217165080,6.21717E+11,20211214,9:00,CYCLE2_DAY1,0 H,982.3158256,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1493,55RSYC,30-Apr-22
C1071040,11061002,106,PF-06863135,T,6217193513,6.21719E+11,20220118,10:00,CYCLE3_DAY1,0 H,461.6322064,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1802,91RSYC,11-May-22
C1071040,11061002,106,PF-06863135,T,6217193522,6.21719E+11,20220215,9:00,CYCLE4_DAY1,0 H,804.2987819,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1803,92RSYC,12-May-22
C1071040,11061002,106,PF-06863135,T,6217193530,6.21719E+11,20220503,10:00,CYCLE7_DAY1,0 H,815.6313353,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1999,115RSYC,25-Jul-22
C1071040,11061002,106,PF-06863135,T,6217193529,6.21719E+11,20220802,9:00,CYCLE10_DAY1,0 H,699.3563958,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2057,132RSYC,10-Nov-22
C1071040,11061002,106,PF-06863135,T,6219811032,6.21981E+11,20230117,9:00,CYCLE16_DAY1,0 H,692.0134579,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2184,141RSYC,17-May-23
C1071040,11061002,106,PF-06863135,T,6219811031,6.21981E+11,20230418,9:00,CYCLE19_DAY1,0 H,989.1412704,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2239,143RSYC,27-Nov-23
C1071040,11061002,106,PF-06863135,T,6219804830,6.2198E+11,20231031,9:00,CYCLE25_DAY1,0 H,447.6914635,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2349,149RSYC,27-Mar-24
C1071040,11061002,106,PF-06863135,T,6219804831,6.2198E+11,,,END_OF_TRT,,85.52936393,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2350,149RSYC,27-Mar-24
C1071040,11061002,106,PF-06863135,T,6217165092,6.21717E+11,20211118,14:00,CYCLE1_DAY4,0 H,15.227317,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1801,91RSYC,11-May-22
C1071040,11061002,106,PF-06863135,T,6217193544,6.21719E+11,20211119,10:00,CYCLE1_DAY4,24 H,382.6764823,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1531,56RSYC,30-Apr-22
C1071040,10921002,107,PF-06863135,T,6217039323,6.21704E+11,20211115,11:36,CYCLE1_DAY1,0 H,303.5464873,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 779,33RSYC,24-Apr-22
C1071040,10921002,107,PF-06863135,T,6217039323,6.21704E+11,20211115,19:46,CYCLE1_DAY1,6 H,411.5588124,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 778,33RSYC,24-Apr-22
C1071040,10921002,107,PF-06863135,T,6216725230,6.21673E+11,20211122,10:56,CYCLE1_DAY8,0 H,514.0139004,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 717,31RSYC,23-Apr-22
C1071040,10921002,107,PF-06863135,T,6216725230,6.21673E+11,20211122,19:00,CYCLE1_DAY8,6 H,884.2922128,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 716,31RSYC,23-Apr-22
C1071040,10921002,107,PF-06863135,T,6216725232,6.21673E+11,20211129,13:44,CYCLE1_DAY15,0 H,856.7223238,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 718,31RSYC,23-Apr-22
C1071040,10921002,107,PF-06863135,T,6216725234,6.21673E+11,20211206,11:45,CYCLE1_DAY22,0 H,135.6116647,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1370,84RSYC,10-May-22
C1071040,10921002,107,PF-06863135,T,6217039356,6.21704E+11,20211116,11:50,CYCLE1_DAY1,24 H,422.356848,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 780,33RSYC,24-Apr-22
C1071040,10921002,107,PF-06863135,T,6217039362,6.21704E+11,20211118,14:02,CYCLE1_DAY4,0 H,486.0153238,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 781,33RSYC,24-Apr-22
C1071040,10921002,107,PF-06863135,T,6217039366,6.21704E+11,20211119,16:00,CYCLE1_DAY4,24 H,90.18174312,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 782,33RSYC,24-Apr-22
C1071040,10081001,108,PF-06863135,T,6518075544,6.51808E+11,20211115,10:36,CYCLE1_DAY1,0 H,475.8178736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 675,30RSYC,22-Apr-22
C1071040,10081001,108,PF-06863135,T,6518075544,6.51808E+11,20211115,23:03,CYCLE1_DAY1,6 H,593.1742903,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 674,30RSYC,22-Apr-22
C1071040,10081001,108,PF-06863135,T,6518075565,6.51808E+11,20211124,12:35,END_OF_TRT,,84.97570066,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1089,87RSYC,13-May-22
C1071040,10081001,108,PF-06863135,T,6518075557,6.51808E+11,20211116,17:03,CYCLE1_DAY1,24 H,175.4713218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 676,30RSYC,22-Apr-22
C1071040,10561006,109,PF-06863135,T,6217026118,6.21703E+11,20211115,14:45,CYCLE1_DAY1,0 H,562.7801013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 763,33RSYC,24-Apr-22
C1071040,10561006,109,PF-06863135,T,6217026118,6.21703E+11,20211115,22:30,CYCLE1_DAY1,6 H,86.44950105,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 762,33RSYC,24-Apr-22
C1071040,10561006,109,PF-06863135,T,6217026120,6.21703E+11,20211123,10:30,CYCLE1_DAY8,0 H,667.4481512,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 765,33RSYC,24-Apr-22
C1071040,10561006,109,PF-06863135,T,6217026120,6.21703E+11,20211123,18:10,CYCLE1_DAY8,6 H,38.59357979,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 764,33RSYC,24-Apr-22
C1071040,10561006,109,PF-06863135,T,6216408045,6.21641E+11,20211206,13:30,CYCLE1_DAY22,0 H,599.1411847,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1318,49RSYC,29-Apr-22
C1071040,10561006,109,PF-06863135,T,6216898581,6.2169E+11,20211220,10:30,CYCLE2_DAY1,0 H,362.1272363,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1407,96RSYC,12-May-22
C1071040,10561006,109,PF-06863135,T,6216408049,6.21641E+11,20220110,10:50,CYCLE3_DAY1,0 H,788.7395474,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1778,71RSYC,7-May-22
C1071040,10561006,109,PF-06863135,T,6216408051,6.21641E+11,20220208,11:20,CYCLE4_DAY1,0 H,774.4609578,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1779,71RSYC,7-May-22
C1071040,10561006,109,PF-06863135,T,6216898592,6.2169E+11,20220502,10:45,CYCLE7_DAY1,0 H,370.5085021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1996,115RSYC,25-Jul-22
C1071040,10561006,109,PF-06863135,T,6218590823,6.21859E+11,20220727,11:15,CYCLE10_DAY1,0 H,74.52201409,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2051,132RSYC,10-Nov-22
C1071040,10561006,109,PF-06863135,T,6219498869,6.2195E+11,20230109,9:45,CYCLE16_DAY1,0 H,252.4847106,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2181,141RSYC,17-May-23
C1071040,10561006,109,PF-06863135,T,6220036104,6.22004E+11,20230403,13:20,CYCLE19_DAY1,0 H,9.711947049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2230,142RSYC,18-May-23
C1071040,10561006,109,PF-06863135,T,6220036099,6.22004E+11,20230627,11:30,CYCLE22_DAY1,0 H,692.0621537,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2277,144RSYC,27-Nov-23
C1071040,10561006,109,PF-06863135,T,6220036107,6.22004E+11,20230919,10:36,CYCLE25_DAY1,0 H,489.4026128,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2310,147RSYC,29-Feb-24
C1071040,10561006,109,PF-06863135,T,6221375071,6.22138E+11,20240305,9:40,CYCLE31_DAY1,0 H,43.84579727,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2371,153RSYC,10-Apr-24
C1071040,10561006,109,PF-06863135,T,6216408057,6.21641E+11,20211119,11:05,CYCLE1_DAY4,0 H,395.3610543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 715,31RSYC,23-Apr-22
C1071040,10561006,109,PF-06863135,T,6216898600,6.2169E+11,20211120,12:00,CYCLE1_DAY4,24 H,886.6996581,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 742,32RSYC,23-Apr-22
C1071040,10161001,110,PF-06863135,T,6517697441,6.5177E+11,20211115,10:06,CYCLE1_DAY1,0 H,521.0856158,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 894,19RSYC,19-Apr-22
C1071040,10161001,110,PF-06863135,T,6517697441,6.5177E+11,20211115,16:58,CYCLE1_DAY1,6 H,672.7448728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 893,19RSYC,19-Apr-22
C1071040,10161001,110,PF-06863135,T,6517697443,6.5177E+11,20211122,8:35,CYCLE1_DAY8,0 H,259.3895804,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 677,30RSYC,22-Apr-22
C1071040,10161001,110,PF-06863135,T,6517697443,6.5177E+11,20211122,15:07,CYCLE1_DAY8,6 H,586.7442709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 895,19RSYC,19-Apr-22
C1071040,10161001,110,PF-06863135,T,6517697446,6.5177E+11,20211129,8:44,CYCLE1_DAY15,0 H,485.1748132,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1057,41RSYC,26-Apr-22
C1071040,10161001,110,PF-06863135,T,6517697447,6.5177E+11,20211206,8:27,CYCLE1_DAY22,0 H,693.9510494,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1058,41RSYC,26-Apr-22
C1071040,10161001,110,PF-06863135,T,6517697449,6.5177E+11,20211213,8:48,CYCLE2_DAY1,0 H,843.9648244,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1060,41RSYC,26-Apr-22
C1071040,10161001,110,PF-06863135,T,6519057405,6.51906E+11,20220110,8:26,CYCLE3_DAY1,0 H,258.4225869,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1602,97RSYC,12-May-22
C1071040,10161001,110,PF-06863135,T,6517697453,6.5177E+11,20220207,9:02,CYCLE4_DAY1,0 H,117.2223737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1601,97RSYC,12-May-22
C1071040,10161001,110,PF-06863135,T,6520019566,6.52002E+11,20220308,8:51,END_OF_TRT,,821.9205206,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1886,86RSYC,13-May-22
C1071040,10161001,110,PF-06863135,T,6517697458,6.5177E+11,20211116,10:00,CYCLE1_DAY1,24 H,624.2995087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 896,19RSYC,19-Apr-22
C1071040,10161001,110,PF-06863135,T,6517697460,6.5177E+11,20211118,9:59,CYCLE1_DAY4,0 H,438.9340583,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 897,19RSYC,19-Apr-22
C1071040,10161001,110,PF-06863135,T,6517697461,6.5177E+11,20211119,11:09,CYCLE1_DAY4,24 H,610.7514416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 898,20RSYC,19-Apr-22
C1071040,11171007,111,PF-06863135,T,6518011605,6.51801E+11,20211115,10:00,CYCLE1_DAY1,0 H,390.1074929,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 913,20RSYC,19-Apr-22
C1071040,11171007,111,PF-06863135,T,6518011605,6.51801E+11,20211115,17:15,CYCLE1_DAY1,6 H,540.9777447,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 912,63RSYC,2-May-22
C1071040,11171007,111,PF-06863135,T,6517764049,6.51776E+11,20211122,10:59,CYCLE1_DAY8,0 H,520.1980791,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 693,30RSYC,22-Apr-22
C1071040,11171007,111,PF-06863135,T,6517764049,6.51776E+11,20211122,17:01,CYCLE1_DAY8,6 H,249.1887673,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 902,20RSYC,19-Apr-22
C1071040,11171007,111,PF-06863135,T,6517764052,6.51776E+11,20211130,10:09,CYCLE1_DAY15,0 H,604.8027774,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1073,41RSYC,26-Apr-22
C1071040,11171007,111,PF-06863135,T,6517764056,6.51776E+11,20211207,7:39,CYCLE1_DAY22,0 H,402.402728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1074,41RSYC,26-Apr-22
C1071040,11171007,111,PF-06863135,T,6517433564,6.51743E+11,20211214,12:19,CYCLE2_DAY1,0 H,15.31695468,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 987,66RSYC,3-May-22
C1071040,11171007,111,PF-06863135,T,6517764065,6.51776E+11,20220111,8:00,CYCLE3_DAY1,0 H,140.0233492,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1727,72RSYC,7-May-22
C1071040,11171007,111,PF-06863135,T,6517433566,6.51743E+11,20220208,11:09,CYCLE4_DAY1,0 H,203.3987367,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1726,72RSYC,7-May-22
C1071040,11171007,111,PF-06863135,T,6517433569,6.51743E+11,20220503,9:00,CYCLE7_DAY1,0 H,469.8465692,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1965,114RSYC,25-Jul-22
C1071040,11171007,111,PF-06863135,T,6520894174,6.52089E+11,20220726,8:46,CYCLE10_DAY1,0 H,929.5209297,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2094,127RSYC,19-Oct-22
C1071040,11171007,111,PF-06863135,T,6521348641,6.52135E+11,20221018,7:15,CYCLE13_DAY1,0 H,888.5450767,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2141,139RSYC,22-Mar-23
C1071040,11171007,111,PF-06863135,T,6520894175,6.52089E+11,20230113,13:00,CYCLE16_DAY1,0 H,127.1299462,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2175,140RSYC,22-Mar-23
C1071040,11171007,111,PF-06863135,T,6521348643,6.52135E+11,20230628,7:15,CYCLE22_DAY1,0 H,194.5599599,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2282,145RSYC,4-Jan-24
C1071040,11171007,111,PF-06863135,T,6517764085,6.51776E+11,20230725,7:15,END_OF_TRT,,120.6048443,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2292,145RSYC,4-Jan-24
C1071040,11171007,111,PF-06863135,T,6518011607,6.51801E+11,20211116,12:18,CYCLE1_DAY1,24 H,661.4575146,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 914,20RSYC,19-Apr-22
C1071040,11171007,111,PF-06863135,T,6517764075,6.51776E+11,20211118,8:00,CYCLE1_DAY4,0 H,893.7785532,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 904,20RSYC,19-Apr-22
C1071040,11171007,111,PF-06863135,T,6517764083,6.51776E+11,20211119,10:15,CYCLE1_DAY4,24 H,294.9454487,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 905,20RSYC,19-Apr-22
C1071040,10251001,112,PF-06863135,T,6517559619,6.51756E+11,20211115,11:00,CYCLE1_DAY1,0 H,21.89860049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 873,19RSYC,19-Apr-22
C1071040,10251001,112,PF-06863135,T,6517559622,6.51756E+11,20211122,12:20,CYCLE1_DAY8,0 H,838.8409554,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 874,19RSYC,19-Apr-22
C1071040,10251001,112,PF-06863135,T,6517559623,6.51756E+11,20211129,8:30,CYCLE1_DAY15,0 H,144.8967157,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1014,39RSYC,26-Apr-22
C1071040,10251001,112,PF-06863135,T,6517559626,6.51756E+11,20211206,10:45,CYCLE1_DAY22,0 H,722.9702831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1016,39RSYC,26-Apr-22
C1071040,10251001,112,PF-06863135,T,6517559627,6.51756E+11,20211213,10:30,CYCLE2_DAY1,0 H,551.5703881,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1017,39RSYC,26-Apr-22
C1071040,10251001,112,PF-06863135,T,6519204945,6.5192E+11,20220111,10:20,CYCLE3_DAY1,0 H,942.0247101,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1668,101RSYC,13-May-22
C1071040,10251001,112,PF-06863135,T,6517559631,6.51756E+11,20220208,12:25,CYCLE4_DAY1,0 H,773.4179018,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1667,101RSYC,13-May-22
C1071040,10251001,112,PF-06863135,T,6517559634,6.51756E+11,20220503,12:10,CYCLE7_DAY1,0 H,455.8558891,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1972,114RSYC,25-Jul-22
C1071040,10251001,112,PF-06863135,T,6517559650,6.51756E+11,20220524,13:10,END_OF_TRT,,920.3721644,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1973,122RSYC,29-Jul-22
C1071040,10251001,112,PF-06863135,T,6517559636,6.51756E+11,20211116,16:43,CYCLE1_DAY1,24 H,713.1139187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 875,19RSYC,19-Apr-22
C1071040,10251001,112,PF-06863135,T,6517559637,6.51756E+11,20211118,12:10,CYCLE1_DAY4,0 H,695.4416193,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 876,19RSYC,19-Apr-22
C1071040,10251001,112,PF-06863135,T,6517559639,6.51756E+11,20211119,12:10,CYCLE1_DAY4,24 H,952.4975108,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 877,64RSYC,3-May-22
C1071040,10151004,113,PF-06863135,T,6518602939,6.5186E+11,20211117,6:00,CYCLE1_DAY1,0 H,839.1814168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 918,20RSYC,19-Apr-22
C1071040,10151004,113,PF-06863135,T,6518602939,6.5186E+11,20211117,18:20,CYCLE1_DAY1,6 H,830.8993415,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 917,20RSYC,19-Apr-22
C1071040,10151004,113,PF-06863135,T,6518602941,6.5186E+11,20211124,9:30,CYCLE1_DAY8,0 H,746.7542865,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1111,67RSYC,8-May-22
C1071040,10151004,113,PF-06863135,T,6518602941,6.5186E+11,20211124,15:19,CYCLE1_DAY8,6 H,46.74184379,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1110,67RSYC,8-May-22
C1071040,10151004,113,PF-06863135,T,6518602942,6.5186E+11,20211201,12:13,CYCLE1_DAY15,0 H,711.0233485,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1112,67RSYC,8-May-22
C1071040,10151004,113,PF-06863135,T,6518602945,6.5186E+11,20211208,11:36,CYCLE1_DAY22,0 H,505.8829667,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1115,97RSYC,12-May-22
C1071040,10151004,113,PF-06863135,T,6518957157,6.51896E+11,20211215,11:20,CYCLE2_DAY1,0 H,909.7070774,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1251,87RSYC,13-May-22
C1071040,10151004,113,PF-06863135,T,6518602951,6.5186E+11,20211118,12:20,CYCLE1_DAY1,24 H,181.9129374,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 922,20RSYC,19-Apr-22
C1071040,10151004,113,PF-06863135,T,6518602957,6.5186E+11,20211119,13:30,CYCLE1_DAY4,0 H,690.1152093,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 926,20RSYC,19-Apr-22
C1071040,10151007,114,PF-06863135,T,6518602936,6.5186E+11,20211116,15:43,CYCLE1_DAY1,0 H,991.4533087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 916,20RSYC,19-Apr-22
C1071040,10151007,114,PF-06863135,T,6518602940,6.5186E+11,20211123,9:30,CYCLE1_DAY8,0 H,585.2187457,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 920,20RSYC,19-Apr-22
C1071040,10151007,114,PF-06863135,T,6518602940,6.5186E+11,20211123,16:40,CYCLE1_DAY8,6 H,416.0287085,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 919,20RSYC,19-Apr-22
C1071040,10151007,114,PF-06863135,T,6518602943,6.5186E+11,20211201,13:10,CYCLE1_DAY15,0 H,591.7434501,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1113,67RSYC,8-May-22
C1071040,10151007,114,PF-06863135,T,6518842177,6.51884E+11,20211208,12:47,CYCLE1_DAY22,0 H,967.2151452,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1165,104RSYC,22-May-22
C1071040,10151007,114,PF-06863135,T,6518957158,6.51896E+11,20211215,12:35,CYCLE2_DAY1,0 H,622.6392483,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1252,47RSYC,28-Apr-22
C1071040,10151007,114,PF-06863135,T,6518602950,6.5186E+11,20211117,14:45,CYCLE1_DAY1,24 H,101.3465243,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 921,20RSYC,19-Apr-22
C1071040,10151007,114,PF-06863135,T,6518602956,6.5186E+11,20211119,13:35,CYCLE1_DAY4,0 H,506.4030138,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 925,20RSYC,19-Apr-22
C1071040,10031011,115,PF-06863135,T,6517473904,6.51747E+11,20211116,13:45,CYCLE1_DAY1,0 H,480.7960159,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 864,36RSYC,25-Apr-22
C1071040,10031011,115,PF-06863135,T,6517473904,6.51747E+11,20211116,21:49,CYCLE1_DAY1,6 H,602.4153194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 863,36RSYC,25-Apr-22
C1071040,10031011,115,PF-06863135,T,6518620839,6.51862E+11,20211129,9:55,CYCLE1_DAY8,0 H,493.5283895,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1118,94RSYC,12-May-22
C1071040,10031011,115,PF-06863135,T,6518620839,6.51862E+11,20211129,15:54,CYCLE1_DAY8,6 H,875.1794431,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1117,94RSYC,12-May-22
C1071040,10031011,115,PF-06863135,T,6517889670,6.51789E+11,20211209,13:40,CYCLE1_DAY15,0 H,118.4562685,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1085,41RSYC,26-Apr-22
C1071040,10031011,115,PF-06863135,T,6518620844,6.51862E+11,20211216,14:20,CYCLE1_DAY22,0 H,700.3998659,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1120,94RSYC,12-May-22
C1071040,10031011,115,PF-06863135,T,6519134610,6.51913E+11,20220120,15:40,CYCLE3_DAY1,0 H,885.8517862,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1622,85RSYC,10-May-22
C1071040,10031011,115,PF-06863135,T,6516580419,6.51658E+11,20220217,12:12,CYCLE4_DAY1,0 H,540.6234086,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1621,85RSYC,10-May-22
C1071040,10031011,115,PF-06863135,T,6519134613,6.51913E+11,20220512,12:28,CYCLE7_DAY1,0 H,178.1278017,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1987,114RSYC,25-Jul-22
C1071040,10031011,115,PF-06863135,T,6518620873,6.51862E+11,20221027,10:10,CYCLE13_DAY1,0 H,552.3298139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2142,139RSYC,22-Mar-23
C1071040,10031011,115,PF-06863135,T,6519134605,6.51913E+11,20230119,13:43,CYCLE16_DAY1,0 H,879.7368469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2193,141RSYC,17-May-23
C1071040,10031011,115,PF-06863135,T,6523047504,6.52305E+11,20230413,10:57,CYCLE19_DAY1,0 H,710.7256163,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2218,142RSYC,18-May-23
C1071040,10031011,115,PF-06863135,T,6521762365,6.52176E+11,20230710,13:46,CYCLE22_DAY1,0 H,137.1189647,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2330,149RSYC,27-Mar-24
C1071040,10031011,115,PF-06863135,T,6522244539,6.52224E+11,20231002,12:49,CYCLE25_DAY1,0 H,947.6453975,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2331,149RSYC,27-Mar-24
C1071040,10031011,115,PF-06863135,T,6523132945,6.52313E+11,,,CYCLE31_DAY1,0 H,918.9758361,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2376,152RSYC,9-Apr-24
C1071040,10031011,115,PF-06863135,T,6518620864,6.51862E+11,20211117,13:55,CYCLE1_DAY1,24 H,758.8824297,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 927,20RSYC,19-Apr-22
C1071040,10031011,115,PF-06863135,T,6517472381,6.51747E+11,20211122,10:14,CYCLE1_DAY4,0 H,368.328346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 989,66RSYC,3-May-22
C1071040,10031011,115,PF-06863135,T,6518620868,6.51862E+11,20211123,11:47,CYCLE1_DAY4,24 H,499.0131687,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1124,94RSYC,12-May-22
C1071040,11081005,116,PF-06863135,T,6801707956,6.80171E+11,20211116,11:00,CYCLE1_DAY1,0 H,416.6737379,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 671,30RSYC,22-Apr-22
C1071040,11081005,116,PF-06863135,T,6801707956,6.80171E+11,20211116,20:40,CYCLE1_DAY1,6 H,480.1219139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 832,35RSYC,25-Apr-22
C1071040,11081005,116,PF-06863135,T,6801707958,6.80171E+11,20211124,10:00,CYCLE1_DAY8,0 H,680.0589417,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 834,35RSYC,25-Apr-22
C1071040,11081005,116,PF-06863135,T,6801707958,6.80171E+11,20211124,19:45,CYCLE1_DAY8,6 H,102.0266985,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 833,35RSYC,25-Apr-22
C1071040,11081005,116,PF-06863135,T,6801707960,6.80171E+11,20211130,10:42,CYCLE1_DAY15,0 H,514.2135781,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 941,65RSYC,3-May-22
C1071040,11081005,116,PF-06863135,T,6801707962,6.80171E+11,20211207,8:45,CYCLE1_DAY22,0 H,660.7292882,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 952,65RSYC,3-May-22
C1071040,11081005,116,PF-06863135,T,6801734181,6.80173E+11,20211214,9:30,CYCLE2_DAY1,0 H,368.3186107,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 953,65RSYC,3-May-22
C1071040,11081005,116,PF-06863135,T,6801701818,6.8017E+11,20220111,9:26,CYCLE3_DAY1,0 H,415.7850757,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1591,59RSYC,1-May-22
C1071040,11081005,116,PF-06863135,T,6801701820,6.8017E+11,20220208,9:50,CYCLE4_DAY1,0 H,735.9721439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1592,59RSYC,1-May-22
C1071040,11081005,116,PF-06863135,T,6801811838,6.80181E+11,20220509,10:16,CYCLE7_DAY1,0 H,584.6307076,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1961,114RSYC,25-Jul-22
C1071040,11081005,116,PF-06863135,T,6801892999,6.80189E+11,20220725,10:02,CYCLE10_DAY1,0 H,879.8363743,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2070,129RSYC,21-Oct-22
C1071040,11081005,116,PF-06863135,T,6801958742,6.80196E+11,20221017,9:53,CYCLE13_DAY1,0 H,913.997972,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2117,131RSYC,9-Nov-22
C1071040,11081005,116,PF-06863135,T,6802068778,6.80207E+11,20230110,9:43,CYCLE16_DAY1,0 H,600.1678106,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2188,141RSYC,17-May-23
C1071040,11081005,116,PF-06863135,T,6802135339,6.80214E+11,20230403,10:05,CYCLE19_DAY1,0 H,594.3740053,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2236,143RSYC,27-Nov-23
C1071040,11081005,116,PF-06863135,T,6802256362,6.80226E+11,20230626,9:43,CYCLE22_DAY1,0 H,235.8805559,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2275,144RSYC,27-Nov-23
C1071040,11081005,116,PF-06863135,T,6802256364,6.80226E+11,20230919,10:16,CYCLE25_DAY1,0 H,548.1641706,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2297,154RSYC,11-Apr-24
C1071040,11081005,116,PF-06863135,T,6802408400,6.80241E+11,20231213,10:37,CYCLE28_DAY1,0 H,160.8890184,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2344,148RSYC,27-Mar-24
C1071040,11081005,116,PF-06863135,T,6802408402,6.80241E+11,20240110,10:50,END_OF_TRT,,854.4088116,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2345,149RSYC,27-Mar-24
C1071040,11081005,116,PF-06863135,T,6801707964,6.80171E+11,20211117,14:50,CYCLE1_DAY1,24 H,986.8423409,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 835,35RSYC,25-Apr-22
C1071040,11081005,116,PF-06863135,T,6801707966,6.80171E+11,20211119,8:50,CYCLE1_DAY4,0 H,410.9798727,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 836,35RSYC,25-Apr-22
C1071040,11081005,116,PF-06863135,T,6801707968,6.80171E+11,20211120,13:50,CYCLE1_DAY4,24 H,575.0063047,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 837,35RSYC,25-Apr-22
C1071040,11021009,117,PF-06863135,T,6217184360,6.21718E+11,20211116,14:10,CYCLE1_DAY1,0 H,154.0168115,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 798,34RSYC,24-Apr-22
C1071040,11021009,117,PF-06863135,T,6217184360,6.21718E+11,20211116,20:25,CYCLE1_DAY1,6 H,434.3511343,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 797,34RSYC,24-Apr-22
C1071040,11021009,117,PF-06863135,T,6217233478,6.21723E+11,20211126,15:30,CYCLE1_DAY8,0 H,756.1495278,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1544,58RSYC,1-May-22
C1071040,11021009,117,PF-06863135,T,6217233478,6.21723E+11,20211126,22:00,CYCLE1_DAY8,6 H,11.77650567,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1543,58RSYC,1-May-22
C1071040,11021009,117,PF-06863135,T,6217170441,6.21717E+11,20211203,13:30,CYCLE1_DAY15,0 H,848.6651156,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1499,55RSYC,30-Apr-22
C1071040,11021009,117,PF-06863135,T,6217170452,6.21717E+11,20211210,13:40,CYCLE1_DAY22,0 H,673.5317535,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1504,55RSYC,30-Apr-22
C1071040,11021009,117,PF-06863135,T,6217170453,6.21717E+11,20211217,13:35,CYCLE2_DAY1,0 H,428.3582297,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1505,55RSYC,30-Apr-22
C1071040,11021009,117,PF-06863135,T,6217170477,6.21717E+11,20220114,13:00,CYCLE3_DAY1,0 H,280.3509855,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1842,93RSYC,12-May-22
C1071040,11021009,117,PF-06863135,T,6217656226,6.21766E+11,20220308,10:30,END_OF_TRT,,695.3856354,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1880,86RSYC,13-May-22
C1071040,11021009,117,PF-06863135,T,6217136152,6.21714E+11,20211117,14:20,CYCLE1_DAY1,24 H,548.838384,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 785,33RSYC,24-Apr-22
C1071040,11021009,117,PF-06863135,T,6217233480,6.21723E+11,20211122,16:00,CYCLE1_DAY4,0 H,911.2333773,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 811,34RSYC,24-Apr-22
C1071040,11021009,117,PF-06863135,T,6217118744,6.21712E+11,20211123,16:30,CYCLE1_DAY4,24 H,161.0782222,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 784,33RSYC,24-Apr-22
C1071040,10151005,118,PF-06863135,T,6518602937,6.5186E+11,20211123,10:05,CYCLE1_DAY1,0 H,111.572652,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1109,67RSYC,8-May-22
C1071040,10151005,118,PF-06863135,T,6518911702,6.51891E+11,20211129,10:00,CYCLE1_DAY8,0 H,82.92364902,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1187,104RSYC,22-May-22
C1071040,10151005,118,PF-06863135,T,6518911702,6.51891E+11,20211129,15:44,CYCLE1_DAY8,6 H,558.8265976,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1186,104RSYC,22-May-22
C1071040,10151005,118,PF-06863135,T,6518957153,6.51896E+11,20211206,10:50,CYCLE1_DAY15,0 H,848.1679265,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1247,47RSYC,28-Apr-22
C1071040,10151005,118,PF-06863135,T,6518957155,6.51896E+11,20211213,10:10,CYCLE1_DAY22,0 H,232.447123,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1249,47RSYC,28-Apr-22
C1071040,10151005,118,PF-06863135,T,6518602953,6.5186E+11,20211124,13:00,CYCLE1_DAY1,24 H,573.6663087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1116,94RSYC,12-May-22
C1071040,11061005,119,PF-06863135,T,6217165063,6.21717E+11,20211119,16:05,CYCLE1_DAY1,0 H,199.7001864,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1482,55RSYC,30-Apr-22
C1071040,11061005,119,PF-06863135,T,6217165072,6.21717E+11,20211126,12:30,CYCLE1_DAY8,0 H,206.0192619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1488,105RSYC,22-May-22
C1071040,11061005,119,PF-06863135,T,6217165074,6.21717E+11,20211202,11:30,CYCLE1_DAY15,0 H,955.3763633,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1490,55RSYC,30-Apr-22
C1071040,11061005,119,PF-06863135,T,6217193498,6.21719E+11,20211209,11:10,CYCLE1_DAY22,0 H,818.7529244,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1527,56RSYC,30-Apr-22
C1071040,11061005,119,PF-06863135,T,6217165088,6.21717E+11,20211123,15:00,CYCLE1_DAY4,0 H,29.841593,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1494,55RSYC,30-Apr-22
C1071040,11061005,119,PF-06863135,T,6217193548,6.21719E+11,20211124,16:10,CYCLE1_DAY4,24 H,678.5985485,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1532,56RSYC,30-Apr-22
C1071040,10741004,120,PF-06863135,T,6517472574,6.51747E+11,20211119,13:45,CYCLE1_DAY1,0 H,569.5679991,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 850,36RSYC,25-Apr-22
C1071040,10741004,120,PF-06863135,T,6517472574,6.51747E+11,20211119,23:45,CYCLE1_DAY1,6 H,476.8807228,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 849,36RSYC,25-Apr-22
C1071040,10741004,120,PF-06863135,T,6517472577,6.51747E+11,20211130,8:45,CYCLE1_DAY8,0 H,86.84838697,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 995,88RSYC,11-May-22
C1071040,10741004,120,PF-06863135,T,6517472577,6.51747E+11,20211130,18:35,CYCLE1_DAY8,6 H,135.1843654,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 994,66RSYC,3-May-22
C1071040,10741004,120,PF-06863135,T,6518693893,6.51869E+11,20211207,12:45,CYCLE1_DAY15,0 H,52.09419285,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1128,94RSYC,12-May-22
C1071040,10741004,120,PF-06863135,T,6519029235,6.51903E+11,20211213,8:57,CYCLE1_DAY22,0 H,950.1794038,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1263,47RSYC,28-Apr-22
C1071040,10741004,120,PF-06863135,T,6519029237,6.51903E+11,20211221,8:23,CYCLE2_DAY1,0 H,966.7761514,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1265,47RSYC,28-Apr-22
C1071040,10741004,120,PF-06863135,T,6518988296,6.51899E+11,20220118,11:26,CYCLE3_DAY1,0 H,723.3242013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1655,100RSYC,23-May-22
C1071040,10741004,120,PF-06863135,T,6519158559,6.51916E+11,20220215,12:04,CYCLE4_DAY1,0 H,297.1384518,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1656,100RSYC,23-May-22
C1071040,10741004,120,PF-06863135,T,6517472588,6.51747E+11,20220510,12:15,CYCLE7_DAY1,0 H,591.2889935,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1969,114RSYC,25-Jul-22
C1071040,10741004,120,PF-06863135,T,6518807210,6.51881E+11,20220804,11:13,CYCLE10_DAY1,0 H,38.77477364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2083,129RSYC,21-Oct-22
C1071040,10741004,120,PF-06863135,T,6520917899,6.52092E+11,20221026,10:18,CYCLE13_DAY1,0 H,237.4016903,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2143,139RSYC,22-Mar-23
C1071040,10741004,120,PF-06863135,T,6521628791,6.52163E+11,20221207,12:47,END_OF_TRT,,171.6770874,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2133,139RSYC,22-Mar-23
C1071040,10741004,120,PF-06863135,T,6517472591,6.51747E+11,20211120,17:40,CYCLE1_DAY1,24 H,378.8700973,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 851,36RSYC,25-Apr-22
C1071040,10741004,120,PF-06863135,T,6517472593,6.51747E+11,20211122,10:10,CYCLE1_DAY4,0 H,994.182031,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1001,39RSYC,26-Apr-22
C1071040,10741004,120,PF-06863135,T,6518693901,6.51869E+11,20211123,15:27,CYCLE1_DAY4,24 H,300.500763,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1133,94RSYC,12-May-22
C1071040,10031013,121,PF-06863135,T,6517751560,6.51775E+11,20211122,11:54,CYCLE1_DAY1,0 H,565.6752533,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1066,41RSYC,26-Apr-22
C1071040,10031013,121,PF-06863135,T,6517751560,6.51775E+11,20211122,18:35,CYCLE1_DAY1,6 H,660.249049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1065,41RSYC,26-Apr-22
C1071040,10031013,121,PF-06863135,T,6518620838,6.51862E+11,20211202,11:20,CYCLE1_DAY8,0 H,425.6985544,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1935,120RSYC,28-Jul-22
C1071040,10031013,121,PF-06863135,T,6518620838,6.51862E+11,20211202,16:55,CYCLE1_DAY8,6 H,23.16163082,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1936,123RSYC,29-Jul-22
C1071040,10031013,121,PF-06863135,T,6516580394,6.51658E+11,20211210,16:45,CYCLE1_DAY15,0 H,569.619613,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1937,123RSYC,29-Jul-22
C1071040,10031013,121,PF-06863135,T,6518620845,6.51862E+11,20211217,14:15,CYCLE1_DAY22,0 H,677.5830347,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1121,94RSYC,12-May-22
C1071040,10031013,121,PF-06863135,T,6518620848,6.51862E+11,20211222,15:33,CYCLE2_DAY1,0 H,459.7656161,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1938,124RSYC,29-Jul-22
C1071040,10031013,121,PF-06863135,T,6517751582,6.51775E+11,20220121,15:42,CYCLE3_DAY1,0 H,94.03463256,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1623,85RSYC,10-May-22
C1071040,10031013,121,PF-06863135,T,6517473941,6.51747E+11,20211123,12:32,CYCLE1_DAY1,24 H,938.1695963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1006,39RSYC,26-Apr-22
C1071040,10031013,121,PF-06863135,T,6517473946,6.51747E+11,20211124,12:30,CYCLE1_DAY4,0 H,668.8364584,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1007,39RSYC,26-Apr-22
C1071040,10031013,121,PF-06863135,T,6518620870,6.51862E+11,20211125,11:45,CYCLE1_DAY4,24 H,311.8023244,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1126,94RSYC,12-May-22
C1071040,11281001,122,PF-06863135,T,6518343087,6.51834E+11,20211119,15:05,CYCLE1_DAY1,0 H,889.0001481,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1094,67RSYC,8-May-22
C1071040,11281001,122,PF-06863135,T,6518343087,6.51834E+11,20211120,0:20,CYCLE1_DAY1,6 H,383.4230533,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1093,67RSYC,8-May-22
C1071040,11281001,122,PF-06863135,T,6518343089,6.51834E+11,20211126,13:13,CYCLE1_DAY8,0 H,447.1543306,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1096,67RSYC,8-May-22
C1071040,11281001,122,PF-06863135,T,6518343089,6.51834E+11,20211126,17:00,CYCLE1_DAY8,6 H,370.3203961,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1095,87RSYC,13-May-22
C1071040,11281001,122,PF-06863135,T,6518343091,6.51834E+11,20211203,11:06,CYCLE1_DAY15,0 H,394.4128269,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1097,67RSYC,8-May-22
C1071040,11281001,122,PF-06863135,T,6518343107,6.51834E+11,20211210,17:35,END_OF_TRT,,521.4214268,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1101,107RSYC,24-May-22
C1071040,11281001,122,PF-06863135,T,6518343099,6.51834E+11,20211120,16:05,CYCLE1_DAY1,24 H,62.335398,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1098,67RSYC,8-May-22
C1071040,11281001,122,PF-06863135,T,6518343100,6.51834E+11,20211122,11:45,CYCLE1_DAY4,0 H,288.9511424,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1099,67RSYC,8-May-22
C1071040,11281001,122,PF-06863135,T,6518343103,6.51834E+11,20211123,14:25,CYCLE1_DAY4,24 H,359.0620648,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1100,67RSYC,8-May-22
C1071040,10561004,123,PF-06863135,T,6217026113,6.21703E+11,20211122,13:20,CYCLE1_DAY1,0 H,174.1860752,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 761,33RSYC,24-Apr-22
C1071040,10561004,123,PF-06863135,T,6217026113,6.21703E+11,20211122,21:00,CYCLE1_DAY1,6 H,343.2509649,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 760,64RSYC,3-May-22
C1071040,10561004,123,PF-06863135,T,6216898571,6.2169E+11,20211129,14:00,CYCLE1_DAY8,0 H,560.8928951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1403,95RSYC,13-May-22
C1071040,10561004,123,PF-06863135,T,6216898571,6.2169E+11,20211129,22:20,CYCLE1_DAY8,6 H,809.8361747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1402,95RSYC,13-May-22
C1071040,10561004,123,PF-06863135,T,6216898576,6.2169E+11,20211206,14:30,CYCLE1_DAY15,0 H,929.532741,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1405,96RSYC,12-May-22
C1071040,10561004,123,PF-06863135,T,6216408046,6.21641E+11,20211213,11:05,CYCLE1_DAY22,0 H,162.668203,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1319,49RSYC,29-Apr-22
C1071040,10561004,123,PF-06863135,T,6216898582,6.2169E+11,20211221,10:45,CYCLE2_DAY1,0 H,741.3939465,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1408,96RSYC,12-May-22
C1071040,10561004,123,PF-06863135,T,6216408050,6.21641E+11,20220117,13:20,CYCLE3_DAY1,0 H,688.4020801,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1776,71RSYC,7-May-22
C1071040,10561004,123,PF-06863135,T,6216408052,6.21641E+11,20220216,12:35,CYCLE4_DAY1,0 H,691.4995674,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1777,71RSYC,7-May-22
C1071040,10561004,123,PF-06863135,T,6216408054,6.21641E+11,20220512,10:00,CYCLE7_DAY1,0 H,82.70176031,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1992,115RSYC,25-Jul-22
C1071040,10561004,123,PF-06863135,T,6216898603,6.2169E+11,20220803,12:00,CYCLE10_DAY1,0 H,740.6895437,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2050,132RSYC,10-Nov-22
C1071040,10561004,123,PF-06863135,T,6218590830,6.21859E+11,20221025,11:15,CYCLE13_DAY1,0 H,911.838662,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2153,139RSYC,22-Mar-23
C1071040,10561004,123,PF-06863135,T,6219498867,6.2195E+11,20230116,13:30,CYCLE16_DAY1,0 H,505.475454,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2180,140RSYC,22-Mar-23
C1071040,10561004,123,PF-06863135,T,6220036100,6.22004E+11,20230412,12:40,CYCLE19_DAY1,0 H,955.4455318,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2229,142RSYC,18-May-23
C1071040,10561004,123,PF-06863135,T,6220036101,6.22004E+11,20230719,10:20,CYCLE22_DAY1,0 H,987.3540392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2278,147RSYC,29-Feb-24
C1071040,10561004,123,PF-06863135,T,6220036103,6.22004E+11,20231019,15:25,CYCLE25_DAY1,0 H,356.5004863,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2317,147RSYC,29-Feb-24
C1071040,10561004,123,PF-06863135,T,6222181788,6.22218E+11,20240111,12:15,CYCLE28_DAY1,0 H,489.1196119,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2351,152RSYC,9-Apr-24
C1071040,10561004,123,PF-06863135,T,6216408055,6.21641E+11,20211123,15:00,CYCLE1_DAY1,24 H,713.4286636,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 714,31RSYC,23-Apr-22
C1071040,10561004,123,PF-06863135,T,6217026189,6.21703E+11,20211126,14:00,CYCLE1_DAY4,24 H,363.4057698,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1433,57RSYC,30-Apr-22
C1071040,10291001,125,PF-06863135,T,6217232417,6.21723E+11,20211122,14:10,CYCLE1_DAY1,0 H,426.9766034,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1534,56RSYC,30-Apr-22
C1071040,10291001,125,PF-06863135,T,6217232417,6.21723E+11,20211122,20:51,CYCLE1_DAY1,6 H,484.5911393,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1533,56RSYC,30-Apr-22
C1071040,10291001,125,PF-06863135,T,6216407838,6.21641E+11,20211129,10:13,CYCLE1_DAY8,0 H,839.3773109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1294,84RSYC,10-May-22
C1071040,10291001,125,PF-06863135,T,6216407838,6.21641E+11,20211129,19:40,CYCLE1_DAY8,6 H,451.5944149,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1293,84RSYC,10-May-22
C1071040,10291001,125,PF-06863135,T,6216407840,6.21641E+11,20211206,8:10,CYCLE1_DAY15,0 H,520.5375814,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1295,84RSYC,10-May-22
C1071040,10291001,125,PF-06863135,T,6217232422,6.21723E+11,20211213,13:12,CYCLE1_DAY22,0 H,89.85139069,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1748,90RSYC,11-May-22
C1071040,10291001,125,PF-06863135,T,6216407844,6.21641E+11,20211220,8:46,CYCLE2_DAY1,0 H,150.1461058,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1746,90RSYC,11-May-22
C1071040,10291001,125,PF-06863135,T,6216407846,6.21641E+11,20220117,8:20,CYCLE3_DAY1,0 H,724.9235325,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1747,90RSYC,11-May-22
C1071040,10291001,125,PF-06863135,T,6217230872,6.21723E+11,20220214,8:38,CYCLE4_DAY1,0 H,850.7934314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1876,80RSYC,4-May-22
C1071040,10291001,125,PF-06863135,T,6218182028,6.21818E+11,20220331,10:30,END_OF_TRT,,926.5470499,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1916,123RSYC,29-Jul-22
C1071040,10291001,125,PF-06863135,T,6217183327,6.21718E+11,20211123,15:40,UNPL,9001 H,353.2503913,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1516,56RSYC,30-Apr-22
C1071040,10291001,125,PF-06863135,T,6217183332,6.21718E+11,20211124,16:30,UNPL,9002 H,82.1744932,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1517,56RSYC,30-Apr-22
C1071040,10291001,125,PF-06863135,T,6216407851,6.21641E+11,20211123,15:40,CYCLE1_DAY1,24 H,123.5536448,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1296,49RSYC,29-Apr-22
C1071040,10291001,125,PF-06863135,T,6217262392,6.21726E+11,20211125,8:20,CYCLE1_DAY4,0 H,75.47972994,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1548,58RSYC,1-May-22
C1071040,10291001,125,PF-06863135,T,6217262394,6.21726E+11,20211126,13:14,CYCLE1_DAY4,24 H,117.6366904,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1549,58RSYC,1-May-22
C1071040,11021008,126,PF-06863135,T,6217233477,6.21723E+11,20211122,17:15,CYCLE1_DAY1,0 H,786.7103461,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 808,34RSYC,24-Apr-22
C1071040,11021008,126,PF-06863135,T,6217233477,6.21723E+11,20211122,23:30,CYCLE1_DAY1,6 H,515.2667145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 807,34RSYC,24-Apr-22
C1071040,11021008,126,PF-06863135,T,6217023824,6.21702E+11,20211202,15:55,CYCLE1_DAY8,0 H,141.7840354,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1427,57RSYC,30-Apr-22
C1071040,11021008,126,PF-06863135,T,6217023824,6.21702E+11,20211202,23:45,CYCLE1_DAY8,6 H,299.5793824,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1426,57RSYC,30-Apr-22
C1071040,11021008,126,PF-06863135,T,6217170438,6.21717E+11,20211208,13:30,CYCLE1_DAY15,0 H,594.4669143,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1498,110RSYC,25-May-22
C1071040,11021008,126,PF-06863135,T,6216756805,6.21676E+11,20211215,15:35,CYCLE1_DAY22,0 H,774.9874732,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1385,81RSYC,4-May-22
C1071040,11021008,126,PF-06863135,T,6217023838,6.21702E+11,20211222,17:00,CYCLE2_DAY1,0 H,104.4770887,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1843,93RSYC,12-May-22
C1071040,11021008,126,PF-06863135,T,6216756820,6.21676E+11,20220224,10:35,END_OF_TRT,,773.3373716,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1881,109RSYC,25-May-22
C1071040,11021008,126,PF-06863135,T,6217170509,6.21717E+11,20211123,17:30,CYCLE1_DAY1,24 H,550.4770088,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 796,34RSYC,24-Apr-22
C1071040,11021008,126,PF-06863135,T,6217136156,6.21714E+11,20211126,18:30,CYCLE1_DAY4,24 H,749.3000674,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1466,54RSYC,30-Apr-22
C1071040,10401002,127,PF-06863135,T,6518727314,6.51873E+11,20211123,9:26,CYCLE1_DAY1,0 H,924.9426794,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 692,30RSYC,22-Apr-22
C1071040,10401002,127,PF-06863135,T,6518727314,6.51873E+11,20211123,16:48,CYCLE1_DAY1,6 H,373.448215,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 691,30RSYC,22-Apr-22
C1071040,10401002,127,PF-06863135,T,6518727316,6.51873E+11,20211130,8:42,CYCLE1_DAY8,0 H,475.6287379,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1139,94RSYC,12-May-22
C1071040,10401002,127,PF-06863135,T,6518727316,6.51873E+11,20211130,15:15,CYCLE1_DAY8,6 H,962.5599447,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1138,94RSYC,12-May-22
C1071040,10401002,127,PF-06863135,T,6518926328,6.51893E+11,20211214,9:30,CYCLE1_DAY22,0 H,753.7615939,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1196,105RSYC,22-May-22
C1071040,10401002,127,PF-06863135,T,6518926331,6.51893E+11,20211222,16:01,CYCLE2_DAY1,0 H,923.4015611,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1197,105RSYC,22-May-22
C1071040,10401002,127,PF-06863135,T,6519180202,6.51918E+11,20220119,10:50,CYCLE3_DAY1,0 H,14.67213154,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1723,72RSYC,7-May-22
C1071040,10401002,127,PF-06863135,T,6517560306,6.51756E+11,20220216,8:19,CYCLE4_DAY1,0 H,570.2371988,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1722,72RSYC,7-May-22
C1071040,10401002,127,PF-06863135,T,6517560309,6.51756E+11,20220511,12:12,CYCLE7_DAY1,0 H,749.3888759,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1981,114RSYC,25-Jul-22
C1071040,10401002,127,PF-06863135,T,6518806949,6.51881E+11,20220817,7:35,CYCLE10_DAY1,0 H,699.2083442,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2092,127RSYC,19-Oct-22
C1071040,10401002,127,PF-06863135,T,6520956319,6.52096E+11,20221109,8:04,CYCLE13_DAY1,0 H,549.3210065,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2144,139RSYC,22-Mar-23
C1071040,10401002,127,PF-06863135,T,6521647793,6.52165E+11,20230201,7:44,CYCLE16_DAY1,0 H,678.330969,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2194,141RSYC,17-May-23
C1071040,10401002,127,PF-06863135,T,6521647794,6.52165E+11,20230426,11:23,CYCLE19_DAY1,0 H,757.9151947,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2248,143RSYC,27-Nov-23
C1071040,10401002,127,PF-06863135,T,6523034190,6.52303E+11,20230719,10:12,CYCLE22_DAY1,0 H,488.3164954,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2283,145RSYC,4-Jan-24
C1071040,10401002,127,PF-06863135,T,6524124734,6.52412E+11,20231025,7:42,CYCLE25_DAY1,0 H,864.0758542,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2332,149RSYC,27-Mar-24
C1071040,10401002,127,PF-06863135,T,6524124735,6.52412E+11,20240117,8:50,CYCLE28_DAY1,0 H,952.7055381,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2356,148RSYC,27-Mar-24
C1071040,10401002,127,PF-06863135,T,6518712782,6.51871E+11,20211124,9:20,CYCLE1_DAY1,24 H,561.9466659,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1137,94RSYC,12-May-22
C1071040,10401002,127,PF-06863135,T,6518712786,6.51871E+11,20211126,10:40,CYCLE1_DAY4,0 H,659.2823709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 690,30RSYC,22-Apr-22
C1071040,10401002,127,PF-06863135,T,6517560314,6.51756E+11,20211127,11:30,CYCLE1_DAY4,24 H,163.6550783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1053,40RSYC,26-Apr-22
C1071040,10101006,128,PF-06863135,T,6518706273,6.51871E+11,20211123,10:40,CYCLE1_DAY1,0 H,153.4349517,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 685,30RSYC,22-Apr-22
C1071040,10101006,128,PF-06863135,T,6518706273,6.51871E+11,20211123,17:55,CYCLE1_DAY1,6 H,978.2292362,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 686,30RSYC,22-Apr-22
C1071040,10101006,128,PF-06863135,T,6518558179,6.51856E+11,20211130,8:33,CYCLE1_DAY8,0 H,771.1074469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1108,67RSYC,8-May-22
C1071040,10101006,128,PF-06863135,T,6518706279,6.51871E+11,20211207,9:35,CYCLE1_DAY15,0 H,341.9694365,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1134,94RSYC,12-May-22
C1071040,10101006,128,PF-06863135,T,6518447644,6.51845E+11,20211215,10:32,CYCLE1_DAY22,0 H,92.92723359,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1103,67RSYC,8-May-22
C1071040,10101006,128,PF-06863135,T,6518447645,6.51845E+11,20211221,13:00,CYCLE2_DAY1,0 H,416.1221166,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1104,67RSYC,8-May-22
C1071040,10101006,128,PF-06863135,T,6517559663,6.51756E+11,20220119,9:56,CYCLE3_DAY1,0 H,148.9089549,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1615,97RSYC,12-May-22
C1071040,10101006,128,PF-06863135,T,6517559666,6.51756E+11,20220216,10:44,CYCLE4_DAY1,0 H,865.8546505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1616,97RSYC,12-May-22
C1071040,10101006,128,PF-06863135,T,6517559668,6.51756E+11,20220511,9:18,CYCLE7_DAY1,0 H,870.5087443,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1975,114RSYC,25-Jul-22
C1071040,10101006,128,PF-06863135,T,6521315622,6.52132E+11,20221026,13:00,CYCLE13_DAY1,0 H,80.09351737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2145,143RSYC,27-Nov-23
C1071040,10101006,128,PF-06863135,T,6521315620,6.52132E+11,20230412,11:55,CYCLE19_DAY1,0 H,388.187412,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2216,142RSYC,18-May-23
C1071040,10101006,128,PF-06863135,T,6522542259,6.52254E+11,20230705,10:36,CYCLE22_DAY1,0 H,400.4706013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2284,145RSYC,4-Jan-24
C1071040,10101006,128,PF-06863135,T,6524996224,6.525E+11,,,CYCLE31_DAY1,0 H,764.8941039,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2374,152RSYC,9-Apr-24
C1071040,10101006,128,PF-06863135,T,6526011931,6.52601E+11,20240124,11:54,UNPL,9001 H,668.6384033,NG/ML,,Received as 6524145852-02; visit revised from C28D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2357,148RSYC,27-Mar-24
C1071040,10101006,128,PF-06863135,T,6518558185,6.51856E+11,20211124,11:56,CYCLE1_DAY1,24 H,250.1014116,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 684,30RSYC,22-Apr-22
C1071040,10101006,128,PF-06863135,T,6518706291,6.51871E+11,20211126,10:50,CYCLE1_DAY4,0 H,156.3556953,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 687,30RSYC,22-Apr-22
C1071040,10131001,129,PF-06863135,T,6517559687,6.51756E+11,20211123,13:56,CYCLE1_DAY1,0 H,22.90987439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1022,39RSYC,26-Apr-22
C1071040,10131001,129,PF-06863135,T,6517559687,6.51756E+11,20211123,20:05,CYCLE1_DAY1,6 H,833.2968742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1021,39RSYC,26-Apr-22
C1071040,10131001,129,PF-06863135,T,6517559690,6.51756E+11,20211130,12:35,CYCLE1_DAY8,0 H,525.0384089,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1024,39RSYC,26-Apr-22
C1071040,10131001,129,PF-06863135,T,6517559690,6.51756E+11,20211130,18:49,CYCLE1_DAY8,6 H,801.6321012,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1023,39RSYC,26-Apr-22
C1071040,10131001,129,PF-06863135,T,6517559692,6.51756E+11,20211206,8:54,CYCLE1_DAY15,0 H,819.4648873,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1025,39RSYC,26-Apr-22
C1071040,10131001,129,PF-06863135,T,6517559693,6.51756E+11,20211213,8:12,CYCLE1_DAY22,0 H,212.7901826,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1026,40RSYC,26-Apr-22
C1071040,10131001,129,PF-06863135,T,6517559695,6.51756E+11,20211220,8:07,CYCLE2_DAY1,0 H,856.4248009,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1027,40RSYC,26-Apr-22
C1071040,10131001,129,PF-06863135,T,6517559697,6.51756E+11,20220117,7:59,CYCLE3_DAY1,0 H,35.7851343,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1619,85RSYC,10-May-22
C1071040,10131001,129,PF-06863135,T,6517559700,6.51756E+11,20220215,9:39,CYCLE4_DAY1,0 H,830.2649591,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1620,85RSYC,10-May-22
C1071040,10131001,129,PF-06863135,T,6517559701,6.51756E+11,20220509,8:05,CYCLE7_DAY1,0 H,636.5013949,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1977,114RSYC,25-Jul-22
C1071040,10131001,129,PF-06863135,T,6520266800,6.52027E+11,20220801,8:26,CYCLE10_DAY1,0 H,593.935477,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2080,129RSYC,21-Oct-22
C1071040,10131001,129,PF-06863135,T,6517559703,6.51756E+11,20211124,13:51,CYCLE1_DAY1,24 H,474.3370651,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 688,30RSYC,22-Apr-22
C1071040,10801002,130,PF-06863135,T,6517433487,6.51743E+11,20211129,11:26,CYCLE1_DAY1,0 H,542.0784983,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 969,66RSYC,3-May-22
C1071040,10801002,130,PF-06863135,T,6517433487,6.51743E+11,20211129,17:41,CYCLE1_DAY1,6 H,45.25044491,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 968,65RSYC,3-May-22
C1071040,10801002,130,PF-06863135,T,6518789961,6.51879E+11,20211206,10:09,CYCLE1_DAY8,0 H,165.2137989,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1152,107RSYC,24-May-22
C1071040,10801002,130,PF-06863135,T,6518789961,6.51879E+11,20211206,16:13,CYCLE1_DAY8,6 H,464.0185835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1151,107RSYC,24-May-22
C1071040,10801002,130,PF-06863135,T,6517433492,6.51743E+11,20211213,9:22,CYCLE1_DAY15,0 H,386.9577776,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 974,66RSYC,3-May-22
C1071040,10801002,130,PF-06863135,T,6518918013,6.51892E+11,20211220,10:26,CYCLE1_DAY22,0 H,266.7620822,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1190,105RSYC,22-May-22
C1071040,10801002,130,PF-06863135,T,6518918015,6.51892E+11,20211227,10:19,CYCLE2_DAY1,0 H,570.5241282,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1191,105RSYC,22-May-22
C1071040,10801002,130,PF-06863135,T,6517433517,6.51743E+11,20220110,14:10,END_OF_TRT,,52.70302323,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1650,100RSYC,23-May-22
C1071040,10801002,130,PF-06863135,T,6517433503,6.51743E+11,20211130,11:40,CYCLE1_DAY1,24 H,56.1648894,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 977,66RSYC,3-May-22
C1071040,10801002,130,PF-06863135,T,6517433506,6.51743E+11,20211202,11:43,CYCLE1_DAY4,0 H,249.6885116,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 978,66RSYC,3-May-22
C1071040,10801002,130,PF-06863135,T,6517433507,6.51743E+11,20211203,11:00,CYCLE1_DAY4,24 H,566.0386099,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 979,66RSYC,3-May-22
C1071040,11001001,131,PF-06863135,T,6216170946,6.21617E+11,20211123,11:15,CYCLE1_DAY1,0 H,618.25341,NG/ML,,Received as 6216170971-08,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1289,76RSYC,4-May-22
C1071040,11001001,131,PF-06863135,T,6216170946,6.21617E+11,20211123,18:01,CYCLE1_DAY1,6 H,339.8872508,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1277,89RSYC,11-May-22
C1071040,11001001,131,PF-06863135,T,6217163742,6.21716E+11,20211203,12:15,CYCLE1_DAY8,0 H,471.7553082,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1477,55RSYC,30-Apr-22
C1071040,11001001,131,PF-06863135,T,6217163742,6.21716E+11,20211203,17:45,CYCLE1_DAY8,6 H,240.9854791,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1476,110RSYC,25-May-22
C1071040,11001001,131,PF-06863135,T,6217163744,6.21716E+11,20211210,16:20,CYCLE1_DAY15,0 H,459.1840204,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1478,55RSYC,30-Apr-22
C1071040,11001001,131,PF-06863135,T,6216170952,6.21617E+11,20211217,14:00,CYCLE1_DAY22,0 H,795.0784468,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1785,71RSYC,7-May-22
C1071040,11001001,131,PF-06863135,T,6217163751,6.21716E+11,20211224,11:50,CYCLE2_DAY1,0 H,362.4323746,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1786,71RSYC,7-May-22
C1071040,11001001,131,PF-06863135,T,6216170962,6.21617E+11,20211124,12:20,CYCLE1_DAY1,24 H,344.2938398,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1284,89RSYC,11-May-22
C1071040,11001001,131,PF-06863135,T,6216170965,6.21617E+11,20211129,10:01,CYCLE1_DAY4,0 H,789.1078989,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1287,89RSYC,11-May-22
C1071040,11001001,131,PF-06863135,T,6217183920,6.21718E+11,20211130,15:00,CYCLE1_DAY4,24 H,493.0041883,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1519,56RSYC,30-Apr-22
C1071040,11001002,132,PF-06863135,T,6216170947,6.21617E+11,20211123,11:45,CYCLE1_DAY1,0 H,1.305000737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1279,76RSYC,4-May-22
C1071040,11001002,132,PF-06863135,T,6216170947,6.21617E+11,20211123,18:15,CYCLE1_DAY1,6 H,477.0501201,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1278,89RSYC,11-May-22
C1071040,11001002,132,PF-06863135,T,6216170949,6.21617E+11,20211130,11:30,CYCLE1_DAY8,0 H,94.56723374,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1281,89RSYC,11-May-22
C1071040,11001002,132,PF-06863135,T,6216170949,6.21617E+11,20211130,17:15,CYCLE1_DAY8,6 H,282.0769895,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1280,89RSYC,11-May-22
C1071040,11001002,132,PF-06863135,T,6217163745,6.21716E+11,20211207,13:00,CYCLE1_DAY15,0 H,175.3615608,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1479,55RSYC,30-Apr-22
C1071040,11001002,132,PF-06863135,T,6217163748,6.21716E+11,20211214,10:30,CYCLE1_DAY22,0 H,629.4335376,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1480,55RSYC,30-Apr-22
C1071040,11001002,132,PF-06863135,T,6216170954,6.21617E+11,20211221,12:15,CYCLE2_DAY1,0 H,890.0305022,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1787,71RSYC,7-May-22
C1071040,11001002,132,PF-06863135,T,6217468784,6.21747E+11,20220120,13:00,CYCLE3_DAY1,0 H,677.1740609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1788,71RSYC,7-May-22
C1071040,11001002,132,PF-06863135,T,6216170963,6.21617E+11,20211124,12:20,CYCLE1_DAY1,24 H,861.5340516,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1285,89RSYC,11-May-22
C1071040,11001002,132,PF-06863135,T,6216170964,6.21617E+11,20211125,11:01,CYCLE1_DAY4,0 H,51.26853648,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1286,89RSYC,11-May-22
C1071040,11001002,132,PF-06863135,T,6217183957,6.21718E+11,20211126,12:15,CYCLE1_DAY4,24 H,222.2912169,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1520,56RSYC,30-Apr-22
C1071040,10371002,133,PF-06863135,T,6216407903,6.21641E+11,20211123,11:45,CYCLE1_DAY1,0 H,447.9321446,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 708,31RSYC,23-Apr-22
C1071040,10371002,133,PF-06863135,T,6216407903,6.21641E+11,20211123,19:04,CYCLE1_DAY1,6 H,560.1417145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 707,31RSYC,23-Apr-22
C1071040,10371002,133,PF-06863135,T,6216407905,6.21641E+11,20211130,12:35,CYCLE1_DAY8,0 H,779.5971847,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1300,49RSYC,29-Apr-22
C1071040,10371002,133,PF-06863135,T,6216407905,6.21641E+11,20211130,18:45,CYCLE1_DAY8,6 H,567.7836523,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1299,49RSYC,29-Apr-22
C1071040,10371002,133,PF-06863135,T,6216407908,6.21641E+11,20211207,13:00,CYCLE1_DAY15,0 H,987.4606062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1301,49RSYC,29-Apr-22
C1071040,10371002,133,PF-06863135,T,6216407910,6.21641E+11,20211214,13:30,CYCLE1_DAY22,0 H,209.2629992,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1302,49RSYC,29-Apr-22
C1071040,10371002,133,PF-06863135,T,6216407912,6.21641E+11,20211227,12:55,CYCLE2_DAY1,0 H,251.7392952,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1303,49RSYC,29-Apr-22
C1071040,10371002,133,PF-06863135,T,6216407914,6.21641E+11,20220117,13:25,CYCLE3_DAY1,0 H,443.2427714,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1798,91RSYC,11-May-22
C1071040,10371002,133,PF-06863135,T,6216407916,6.21641E+11,20220214,8:55,CYCLE4_DAY1,0 H,613.6827137,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1799,91RSYC,11-May-22
C1071040,10371002,133,PF-06863135,T,6216407918,6.21641E+11,20220509,11:55,CYCLE7_DAY1,0 H,22.15249594,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1991,114RSYC,25-Jul-22
C1071040,10371002,133,PF-06863135,T,6216407926,6.21641E+11,20220801,13:15,CYCLE10_DAY1,0 H,219.4458551,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2056,132RSYC,10-Nov-22
C1071040,10371002,133,PF-06863135,T,6219054603,6.21905E+11,20221024,12:55,CYCLE13_DAY1,0 H,110.7033224,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2154,140RSYC,22-Mar-23
C1071040,10371002,133,PF-06863135,T,6219054602,6.21905E+11,20230116,13:25,CYCLE16_DAY1,0 H,284.7432499,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2176,140RSYC,22-Mar-23
C1071040,10371002,133,PF-06863135,T,6219054604,6.21905E+11,20230412,12:00,CYCLE19_DAY1,0 H,891.5185338,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2232,142RSYC,18-May-23
C1071040,10371002,133,PF-06863135,T,6220666023,6.22067E+11,20230710,9:10,CYCLE22_DAY1,0 H,653.2521194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2279,144RSYC,27-Nov-23
C1071040,10371002,133,PF-06863135,T,6220666022,6.22067E+11,20231002,13:20,CYCLE25_DAY1,0 H,848.7993906,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2318,147RSYC,29-Feb-24
C1071040,10371002,133,PF-06863135,T,6220666026,6.22067E+11,20231227,13:30,CYCLE28_DAY1,0 H,51.46980634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2352,148RSYC,27-Mar-24
C1071040,10371002,133,PF-06863135,T,6222511475,6.22251E+11,,,CYCLE31_DAY1,0 H,500.3879321,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071040,10371002,133,PF-06863135,T,6216407919,6.21641E+11,20211124,13:05,CYCLE1_DAY1,24 H,0.184783878,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 709,31RSYC,23-Apr-22
C1071040,10371002,133,PF-06863135,T,6216407922,6.21641E+11,20211126,12:50,CYCLE1_DAY4,0 H,935.4828161,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1304,49RSYC,29-Apr-22
C1071040,10371002,133,PF-06863135,T,6216407923,6.21641E+11,20211127,12:55,CYCLE1_DAY4,24 H,443.5282169,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1305,49RSYC,29-Apr-22
C1071040,11061004,134,PF-06863135,T,6217193486,6.21719E+11,20211122,15:00,CYCLE1_DAY1,0 H,995.353823,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1524,56RSYC,30-Apr-22
C1071040,11061004,134,PF-06863135,T,6217165070,6.21717E+11,20211129,10:00,CYCLE1_DAY8,0 H,851.6527718,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1487,55RSYC,30-Apr-22
C1071040,11061004,134,PF-06863135,T,6217165070,6.21717E+11,20211129,20:00,CYCLE1_DAY8,6 H,849.2407052,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1486,55RSYC,30-Apr-22
C1071040,11061004,134,PF-06863135,T,6217165076,6.21717E+11,20211207,10:30,CYCLE1_DAY15,0 H,691.2861021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1491,55RSYC,30-Apr-22
C1071040,11061004,134,PF-06863135,T,6217193504,6.21719E+11,20211220,9:00,CYCLE2_DAY1,0 H,475.001722,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1800,91RSYC,11-May-22
C1071040,11061004,134,PF-06863135,T,6217193533,6.21719E+11,20211124,17:00,CYCLE1_DAY1,24 H,380.8220071,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1529,56RSYC,30-Apr-22
C1071040,11061004,134,PF-06863135,T,6217165091,6.21717E+11,20211125,13:00,CYCLE1_DAY4,0 H,78.92394206,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1495,55RSYC,30-Apr-22
C1071040,10101005,135,PF-06863135,T,6518706272,6.51871E+11,20211124,10:25,CYCLE1_DAY1,0 H,977.5797923,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 683,30RSYC,22-Apr-22
C1071040,10101005,135,PF-06863135,T,6518706272,6.51871E+11,20211124,20:10,CYCLE1_DAY1,6 H,720.8206185,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 682,30RSYC,22-Apr-22
C1071040,10101005,135,PF-06863135,T,6518558178,6.51856E+11,20211201,8:00,CYCLE1_DAY8,0 H,275.8318183,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1107,67RSYC,8-May-22
C1071040,10101005,135,PF-06863135,T,6518558178,6.51856E+11,20211201,16:20,CYCLE1_DAY8,6 H,798.4204224,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1106,67RSYC,8-May-22
C1071040,10101005,135,PF-06863135,T,6518447643,6.51845E+11,20211208,8:00,CYCLE1_DAY15,0 H,198.6506991,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1102,67RSYC,8-May-22
C1071040,10101005,135,PF-06863135,T,6518706281,6.51871E+11,20211215,11:05,CYCLE1_DAY22,0 H,785.8582672,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1135,94RSYC,12-May-22
C1071040,10101005,135,PF-06863135,T,6518922661,6.51892E+11,20211221,12:32,CYCLE2_DAY1,0 H,653.2496108,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1195,105RSYC,22-May-22
C1071040,10101005,135,PF-06863135,T,6518877336,6.51888E+11,20220119,8:50,CYCLE3_DAY1,0 H,447.3611942,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1614,97RSYC,12-May-22
C1071040,10101005,135,PF-06863135,T,6517559665,6.51756E+11,20220214,8:05,CYCLE4_DAY1,0 H,325.7101497,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1613,97RSYC,12-May-22
C1071040,10101005,135,PF-06863135,T,6517559667,6.51756E+11,20220510,9:13,CYCLE7_DAY1,0 H,222.620934,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1974,114RSYC,25-Jul-22
C1071040,10101005,135,PF-06863135,T,6517559684,6.51756E+11,20220524,13:40,END_OF_TRT,,982.4251052,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1976,114RSYC,25-Jul-22
C1071040,10101005,135,PF-06863135,T,6518558184,6.51856E+11,20211125,12:25,CYCLE1_DAY1,24 H,464.9644194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 681,30RSYC,22-Apr-22
C1071040,10101005,135,PF-06863135,T,6518706293,6.51871E+11,20211128,13:20,CYCLE1_DAY4,0 H,595.6216207,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1136,94RSYC,12-May-22
C1071040,10101005,135,PF-06863135,T,6518447648,6.51845E+11,20211129,12:30,CYCLE1_DAY4,24 H,620.6574824,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1105,87RSYC,13-May-22
C1071040,10461006,136,PF-06863135,T,6217039130,6.21704E+11,20211124,9:45,CYCLE1_DAY1,0 H,323.3610587,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1435,57RSYC,30-Apr-22
C1071040,10461006,136,PF-06863135,T,6217039130,6.21704E+11,20211124,18:20,CYCLE1_DAY1,6 H,538.7579377,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1434,57RSYC,30-Apr-22
C1071040,10461006,136,PF-06863135,T,6217039132,6.21704E+11,20211202,11:30,CYCLE1_DAY8,0 H,59.76213535,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1438,57RSYC,30-Apr-22
C1071040,10461006,136,PF-06863135,T,6217039132,6.21704E+11,20211202,18:40,CYCLE1_DAY8,6 H,698.8287011,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1437,57RSYC,30-Apr-22
C1071040,10461006,136,PF-06863135,T,6217283550,6.21728E+11,20211125,12:20,CYCLE1_DAY1,24 H,62.43615506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 812,34RSYC,24-Apr-22
C1071040,10461006,136,PF-06863135,T,6217039138,6.21704E+11,20211129,10:23,CYCLE1_DAY4,0 H,378.5544307,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 775,33RSYC,24-Apr-22
C1071040,10461006,136,PF-06863135,T,6217039141,6.21704E+11,20211130,15:00,CYCLE1_DAY4,24 H,707.8798219,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1442,108RSYC,24-May-22
C1071040,10161004,137,PF-06863135,T,6518935555,6.51894E+11,20211124,9:25,CYCLE1_DAY1,0 H,838.6106044,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1226,87RSYC,13-May-22
C1071040,10161004,137,PF-06863135,T,6518935555,6.51894E+11,20211124,16:38,CYCLE1_DAY1,6 H,665.0635856,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1225,46RSYC,28-Apr-22
C1071040,10161004,137,PF-06863135,T,6517697444,6.5177E+11,20211202,10:21,CYCLE1_DAY8,0 H,132.1017713,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1055,40RSYC,26-Apr-22
C1071040,10161004,137,PF-06863135,T,6517697444,6.5177E+11,20211202,16:58,CYCLE1_DAY8,6 H,420.3994252,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1054,40RSYC,26-Apr-22
C1071040,10161004,137,PF-06863135,T,6517697445,6.5177E+11,20211208,10:20,CYCLE1_DAY15,0 H,703.484654,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1056,41RSYC,26-Apr-22
C1071040,10161004,137,PF-06863135,T,6517697448,6.5177E+11,20211216,10:03,CYCLE1_DAY22,0 H,554.7900046,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1059,41RSYC,26-Apr-22
C1071040,10161004,137,PF-06863135,T,6517697450,6.5177E+11,20211222,10:19,CYCLE2_DAY1,0 H,40.72914133,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1061,41RSYC,26-Apr-22
C1071040,10161004,137,PF-06863135,T,6519082806,6.51908E+11,20220118,10:54,CYCLE3_DAY1,0 H,836.4677441,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1605,97RSYC,12-May-22
C1071040,10161004,137,PF-06863135,T,6517697471,6.5177E+11,20220225,8:47,END_OF_TRT,,83.26496577,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1888,87RSYC,13-May-22
C1071040,10161004,137,PF-06863135,T,6517697457,6.5177E+11,20211125,10:55,CYCLE1_DAY1,24 H,408.5557049,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1062,41RSYC,26-Apr-22
C1071040,10161004,137,PF-06863135,T,6517697459,6.5177E+11,20211127,11:03,CYCLE1_DAY4,0 H,942.7435411,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1063,41RSYC,26-Apr-22
C1071040,10161004,137,PF-06863135,T,6518935578,6.51894E+11,20211128,10:06,CYCLE1_DAY4,24 H,447.0566615,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1241,47RSYC,28-Apr-22
C1071040,10251004,138,PF-06863135,T,6519212001,6.51921E+11,20211217,12:30,CYCLE1_DAY1,0 H,471.824731,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1272,76RSYC,4-May-22
C1071040,10251004,138,PF-06863135,T,6519212001,6.51921E+11,20211217,18:30,CYCLE1_DAY1,6 H,625.0465048,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1675,101RSYC,13-May-22
C1071040,10251004,138,PF-06863135,T,6519158571,6.51916E+11,20211227,7:33,CYCLE1_DAY8,0 H,363.1500737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1269,89RSYC,11-May-22
C1071040,10251004,138,PF-06863135,T,6519158571,6.51916E+11,20211227,17:09,CYCLE1_DAY8,6 H,155.7225593,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1268,89RSYC,11-May-22
C1071040,10251004,138,PF-06863135,T,6517559624,6.51756E+11,20220104,8:00,CYCLE1_DAY15,0 H,122.8517281,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1672,101RSYC,13-May-22
C1071040,10251004,138,PF-06863135,T,6519138066,6.51914E+11,20220111,9:30,CYCLE1_DAY22,0 H,976.8696647,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1673,101RSYC,13-May-22
C1071040,10251004,138,PF-06863135,T,6519158572,6.51916E+11,20220118,11:50,CYCLE2_DAY1,0 H,134.0973054,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1674,109RSYC,25-May-22
C1071040,10251004,138,PF-06863135,T,6517559630,6.51756E+11,20220215,13:30,CYCLE3_DAY1,0 H,923.3928186,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1671,101RSYC,13-May-22
C1071040,10251004,138,PF-06863135,T,6519204946,6.5192E+11,20220315,13:25,CYCLE4_DAY1,0 H,177.0516753,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1901,81RSYC,4-May-22
C1071040,10251004,138,PF-06863135,T,6519204948,6.5192E+11,20220906,10:11,CYCLE10_DAY1,0 H,569.5738376,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2086,129RSYC,21-Oct-22
C1071040,10251004,138,PF-06863135,T,6517559649,6.51756E+11,20230207,11:50,END_OF_TRT,,962.5650288,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2195,141RSYC,17-May-23
C1071040,10251004,138,PF-06863135,T,6520939733,6.52094E+11,20220621,12:35,UNPL,9001 H,775.351415,NG/ML,,Received as 6517559633-04,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2268,145RSYC,4-Jan-24
C1071040,10251004,138,PF-06863135,T,6519211968,6.51921E+11,20211218,12:35,CYCLE1_DAY1,24 H,19.15675067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1271,89RSYC,11-May-22
C1071040,10251004,138,PF-06863135,T,6519206322,6.51921E+11,20211220,11:14,CYCLE1_DAY4,0 H,710.1834325,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1270,89RSYC,11-May-22
C1071040,10251004,138,PF-06863135,T,6519219388,6.51922E+11,20211221,8:40,CYCLE1_DAY4,24 H,850.5358681,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1273,89RSYC,11-May-22
C1071040,10161002,139,PF-06863135,T,6518935553,6.51894E+11,20211129,10:34,CYCLE1_DAY1,0 H,692.460606,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1222,87RSYC,13-May-22
C1071040,10161002,139,PF-06863135,T,6518935553,6.51894E+11,20211129,17:11,CYCLE1_DAY1,6 H,324.7038131,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1221,46RSYC,28-Apr-22
C1071040,10161002,139,PF-06863135,T,6518935558,6.51894E+11,20211206,8:49,CYCLE1_DAY8,0 H,107.0285171,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1230,46RSYC,28-Apr-22
C1071040,10161002,139,PF-06863135,T,6518935558,6.51894E+11,20211206,15:54,CYCLE1_DAY8,6 H,45.83644512,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1229,46RSYC,28-Apr-22
C1071040,10161002,139,PF-06863135,T,6518935563,6.51894E+11,20211213,8:21,CYCLE1_DAY15,0 H,97.45335826,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1234,46RSYC,28-Apr-22
C1071040,10161002,139,PF-06863135,T,6518935571,6.51894E+11,20211220,8:02,CYCLE1_DAY22,0 H,799.9997379,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1236,47RSYC,28-Apr-22
C1071040,10161002,139,PF-06863135,T,6519057401,6.51906E+11,20211229,9:27,CYCLE2_DAY1,0 H,77.10328559,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1267,89RSYC,11-May-22
C1071040,10161002,139,PF-06863135,T,6519057403,6.51906E+11,20220126,8:30,CYCLE3_DAY1,0 H,468.431629,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1603,97RSYC,12-May-22
C1071040,10161002,139,PF-06863135,T,6517697472,6.5177E+11,20220228,10:57,END_OF_TRT,,325.0876102,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1887,87RSYC,13-May-22
C1071040,10161002,139,PF-06863135,T,6518935574,6.51894E+11,20211130,11:48,CYCLE1_DAY1,24 H,631.4079215,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1238,47RSYC,28-Apr-22
C1071040,10161002,139,PF-06863135,T,6518981611,6.51898E+11,20211202,10:31,CYCLE1_DAY4,0 H,424.955281,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1259,47RSYC,28-Apr-22
C1071040,10161002,139,PF-06863135,T,6517697462,6.5177E+11,20211203,10:02,CYCLE1_DAY4,24 H,975.5766157,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1064,41RSYC,26-Apr-22
C1071040,10711001,140,PF-06863135,T,6216408107,6.21641E+11,20211130,10:40,CYCLE1_DAY1,0 H,412.9341364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1321,76RSYC,4-May-22
C1071040,10711001,140,PF-06863135,T,6216408107,6.21641E+11,20211130,16:40,CYCLE1_DAY1,6 H,153.5923514,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1320,49RSYC,29-Apr-22
C1071040,10711001,140,PF-06863135,T,6216408110,6.21641E+11,20211210,9:00,CYCLE1_DAY8,0 H,818.7975476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1323,49RSYC,29-Apr-22
C1071040,10711001,140,PF-06863135,T,6216408110,6.21641E+11,20211210,18:00,CYCLE1_DAY8,6 H,579.2065822,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1322,49RSYC,29-Apr-22
C1071040,10711001,140,PF-06863135,T,6216408138,6.21641E+11,20211222,12:30,END_OF_TRT,,948.4259742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1326,108RSYC,24-May-22
C1071040,10711001,140,PF-06863135,T,6216408124,6.21641E+11,20211201,10:40,CYCLE1_DAY1,24 H,274.4993354,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1324,49RSYC,29-Apr-22
C1071040,10711001,140,PF-06863135,T,6216408126,6.21641E+11,20211203,12:50,CYCLE1_DAY4,0 H,943.9457131,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1325,49RSYC,29-Apr-22
C1071040,10031014,141,PF-06863135,T,6517473908,6.51747E+11,20211206,10:18,CYCLE1_DAY1,0 H,820.1919669,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1005,39RSYC,26-Apr-22
C1071040,10031014,141,PF-06863135,T,6517473908,6.51747E+11,20211206,16:40,CYCLE1_DAY1,6 H,316.6870326,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1004,39RSYC,26-Apr-22
C1071040,10031014,141,PF-06863135,T,6516580387,6.51658E+11,20211223,9:43,CYCLE1_DAY8,0 H,784.921798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1939,123RSYC,29-Jul-22
C1071040,10031014,141,PF-06863135,T,6516580387,6.51658E+11,20211223,16:12,CYCLE1_DAY8,6 H,235.8228216,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1940,123RSYC,29-Jul-22
C1071040,10031014,141,PF-06863135,T,6518620842,6.51862E+11,20211229,11:57,CYCLE1_DAY15,0 H,80.63156154,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1941,123RSYC,29-Jul-22
C1071040,10031014,141,PF-06863135,T,6517751574,6.51775E+11,20220105,11:08,CYCLE1_DAY22,0 H,299.3157886,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1942,123RSYC,29-Jul-22
C1071040,10031014,141,PF-06863135,T,6517751579,6.51775E+11,20220113,10:20,CYCLE2_DAY1,0 H,223.0835747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1943,124RSYC,29-Jul-22
C1071040,10031014,141,PF-06863135,T,6516580412,6.51658E+11,20220209,12:05,CYCLE3_DAY1,0 H,931.9856545,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1624,85RSYC,10-May-22
C1071040,10031014,141,PF-06863135,T,6518620856,6.51862E+11,20220309,12:32,CYCLE4_DAY1,0 H,908.8205457,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1893,81RSYC,4-May-22
C1071040,10031014,141,PF-06863135,T,6517751595,6.51775E+11,20220601,10:20,CYCLE7_DAY1,0 H,585.9579239,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2012,122RSYC,29-Jul-22
C1071040,10031014,141,PF-06863135,T,6517751598,6.51775E+11,20220825,9:53,CYCLE10_DAY1,0 H,49.75352554,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2081,131RSYC,9-Nov-22
C1071040,10031014,141,PF-06863135,T,6517472383,6.51747E+11,20211207,9:13,CYCLE1_DAY1,24 H,853.7080992,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 990,86RSYC,13-May-22
C1071040,10031014,141,PF-06863135,T,6517472382,6.51747E+11,20211214,11:50,CYCLE1_DAY4,0 H,623.542643,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1966,126RSYC,1-Aug-22
C1071040,10031014,141,PF-06863135,T,6517473939,6.51747E+11,20211215,12:38,CYCLE1_DAY4,24 H,30.49293875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1971,114RSYC,25-Jul-22
C1071040,10931003,142,PF-06863135,T,6518778264,6.51878E+11,20211129,15:10,CYCLE1_DAY1,0 H,573.5659467,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1143,95RSYC,13-May-22
C1071040,10931003,142,PF-06863135,T,6518778264,6.51878E+11,20211129,21:17,CYCLE1_DAY1,6 H,703.3169762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1142,95RSYC,13-May-22
C1071040,10931003,142,PF-06863135,T,6518778267,6.51878E+11,20211206,13:22,CYCLE1_DAY8,0 H,475.2682822,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1145,95RSYC,13-May-22
C1071040,10931003,142,PF-06863135,T,6518778267,6.51878E+11,20211206,19:15,CYCLE1_DAY8,6 H,627.3172947,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1144,95RSYC,13-May-22
C1071040,10931003,142,PF-06863135,T,6518934232,6.51893E+11,20211213,13:47,CYCLE1_DAY15,0 H,446.43649,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1208,46RSYC,28-Apr-22
C1071040,10931003,142,PF-06863135,T,6518934233,6.51893E+11,20211220,12:18,CYCLE1_DAY22,0 H,813.0533902,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1209,46RSYC,28-Apr-22
C1071040,10931003,142,PF-06863135,T,6518934238,6.51893E+11,20211227,14:16,CYCLE2_DAY1,0 H,58.0985219,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1712,72RSYC,7-May-22
C1071040,10931003,142,PF-06863135,T,6518934244,6.51893E+11,20220126,13:23,CYCLE3_DAY1,0 H,44.51470009,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1713,72RSYC,7-May-22
C1071040,10931003,142,PF-06863135,T,6519290804,6.51929E+11,20220216,9:59,END_OF_TRT,,919.935864,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1714,122RSYC,29-Jul-22
C1071040,10931003,142,PF-06863135,T,6518934248,6.51893E+11,20211130,15:17,CYCLE1_DAY1,24 H,101.8305219,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1210,46RSYC,28-Apr-22
C1071040,10931003,142,PF-06863135,T,6518934251,6.51893E+11,20211202,14:15,CYCLE1_DAY4,0 H,341.0128681,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1213,46RSYC,28-Apr-22
C1071040,10931003,142,PF-06863135,T,6518934254,6.51893E+11,20211203,14:30,CYCLE1_DAY4,24 H,692.7305085,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1216,87RSYC,13-May-22
C1071040,10801003,143,PF-06863135,T,6518789960,6.51879E+11,20211206,11:15,CYCLE1_DAY1,0 H,410.9324103,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1150,107RSYC,24-May-22
C1071040,10801003,143,PF-06863135,T,6518789960,6.51879E+11,20211206,17:45,CYCLE1_DAY1,6 H,158.3118599,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1149,87RSYC,13-May-22
C1071040,10801003,143,PF-06863135,T,6517433489,6.51743E+11,20211213,10:40,CYCLE1_DAY8,0 H,713.7197694,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 971,66RSYC,3-May-22
C1071040,10801003,143,PF-06863135,T,6517433489,6.51743E+11,20211213,17:10,CYCLE1_DAY8,6 H,211.2775762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 970,66RSYC,3-May-22
C1071040,10801003,143,PF-06863135,T,6518918011,6.51892E+11,20211220,10:10,CYCLE1_DAY15,0 H,30.04529006,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1189,105RSYC,22-May-22
C1071040,10801003,143,PF-06863135,T,6518789966,6.51879E+11,20211227,8:40,CYCLE1_DAY22,0 H,241.1942757,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1153,107RSYC,24-May-22
C1071040,10801003,143,PF-06863135,T,6518789967,6.51879E+11,20220103,9:40,CYCLE2_DAY1,0 H,334.5925335,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1651,100RSYC,23-May-22
C1071040,10801003,143,PF-06863135,T,6519494494,6.51949E+11,20220215,8:18,END_OF_TRT,,471.3963491,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1652,100RSYC,23-May-22
C1071040,10801003,143,PF-06863135,T,6518918024,6.51892E+11,20211207,12:00,CYCLE1_DAY1,24 H,650.7420433,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1192,105RSYC,22-May-22
C1071040,10801003,143,PF-06863135,T,6518918028,6.51892E+11,20211209,13:17,CYCLE1_DAY4,0 H,13.83412741,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1193,105RSYC,22-May-22
C1071040,10801003,143,PF-06863135,T,6518918029,6.51892E+11,20211210,13:32,CYCLE1_DAY4,24 H,585.1835521,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1194,105RSYC,22-May-22
C1071040,10741002,144,PF-06863135,T,6518931447,6.51893E+11,20211130,10:45,CYCLE1_DAY1,0 H,626.2914028,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1199,105RSYC,22-May-22
C1071040,10741002,144,PF-06863135,T,6518931447,6.51893E+11,20211130,18:19,CYCLE1_DAY1,6 H,889.1481574,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1198,105RSYC,22-May-22
C1071040,10741002,144,PF-06863135,T,6518935637,6.51894E+11,20211208,9:05,CYCLE1_DAY8,0 H,121.5751084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1244,47RSYC,28-Apr-22
C1071040,10741002,144,PF-06863135,T,6518935637,6.51894E+11,20211208,17:40,CYCLE1_DAY8,6 H,451.7356894,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1243,47RSYC,28-Apr-22
C1071040,10741002,144,PF-06863135,T,6517472578,6.51747E+11,20211214,9:58,CYCLE1_DAY15,0 H,966.479801,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 996,39RSYC,26-Apr-22
C1071040,10741002,144,PF-06863135,T,6518693896,6.51869E+11,20211222,9:27,CYCLE1_DAY22,0 H,89.91747378,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1130,94RSYC,12-May-22
C1071040,10741002,144,PF-06863135,T,6519029236,6.51903E+11,20211229,10:47,CYCLE2_DAY1,0 H,680.310322,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1264,47RSYC,28-Apr-22
C1071040,10741002,144,PF-06863135,T,6517472605,6.51747E+11,20220126,10:05,END_OF_TRT,,628.3480611,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1657,100RSYC,23-May-22
C1071040,10741002,144,PF-06863135,T,6517472590,6.51747E+11,20211201,12:28,CYCLE1_DAY1,24 H,783.0580492,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 999,39RSYC,26-Apr-22
C1071040,10741002,144,PF-06863135,T,6518693900,6.51869E+11,20211203,9:32,CYCLE1_DAY4,0 H,632.4458016,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1132,94RSYC,12-May-22
C1071040,10741002,144,PF-06863135,T,6517472594,6.51747E+11,20211204,12:23,CYCLE1_DAY4,24 H,421.4976088,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1002,39RSYC,26-Apr-22
C1071040,10051001,145,PF-06863135,T,6216725161,6.21673E+11,20211130,11:04,CYCLE1_DAY1,0 H,507.1411482,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1344,50RSYC,29-Apr-22
C1071040,10051001,145,PF-06863135,T,6216725161,6.21673E+11,20211130,17:40,CYCLE1_DAY1,6 H,661.8378473,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1343,87RSYC,13-May-22
C1071040,10051001,145,PF-06863135,T,6216725163,6.21673E+11,20211207,10:30,CYCLE1_DAY8,0 H,779.9447099,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1347,50RSYC,29-Apr-22
C1071040,10051001,145,PF-06863135,T,6216725163,6.21673E+11,20211207,17:15,CYCLE1_DAY8,6 H,562.4255379,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1346,50RSYC,29-Apr-22
C1071040,10051001,145,PF-06863135,T,6216725165,6.21673E+11,20211215,10:30,CYCLE1_DAY15,0 H,808.1977797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1349,50RSYC,29-Apr-22
C1071040,10051001,145,PF-06863135,T,6216725169,6.21673E+11,20211229,11:30,CYCLE2_DAY1,0 H,480.453655,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1740,90RSYC,11-May-22
C1071040,10051001,145,PF-06863135,T,6216725170,6.21673E+11,20220128,11:00,CYCLE3_DAY1,0 H,978.4254558,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1741,90RSYC,11-May-22
C1071040,10051001,145,PF-06863135,T,6217930298,6.21793E+11,20220225,10:00,CYCLE4_DAY1,0 H,60.69812171,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1742,90RSYC,11-May-22
C1071040,10051001,145,PF-06863135,T,6216725182,6.21673E+11,20220812,10:00,CYCLE10_DAY1,0 H,789.8498267,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2046,132RSYC,10-Nov-22
C1071040,10051001,145,PF-06863135,T,6217309165,6.21731E+11,20221028,10:30,CYCLE13_DAY1,0 H,733.8820514,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2155,140RSYC,22-Mar-23
C1071040,10051001,145,PF-06863135,T,6218988074,6.21899E+11,20220603,12:00,UNPL,9001 H,677.7046114,NG/ML,,Received as 6217930299-09,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2017,115RSYC,25-Jul-22
C1071040,10051001,145,PF-06863135,T,6216725177,6.21673E+11,20211201,11:40,CYCLE1_DAY1,24 H,133.0843894,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1351,50RSYC,29-Apr-22
C1071040,10051001,145,PF-06863135,T,6216725179,6.21673E+11,20211203,10:30,CYCLE1_DAY4,0 H,323.586354,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1353,50RSYC,29-Apr-22
C1071040,10051001,145,PF-06863135,T,6216725180,6.21673E+11,20211204,11:10,CYCLE1_DAY4,24 H,886.4177747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1354,50RSYC,29-Apr-22
C1071040,10461007,146,PF-06863135,T,6217283542,6.21728E+11,20211130,11:10,CYCLE1_DAY1,0 H,65.52591102,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1562,58RSYC,1-May-22
C1071040,10461007,146,PF-06863135,T,6217283542,6.21728E+11,20211130,17:45,CYCLE1_DAY1,6 H,941.7365473,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1561,58RSYC,1-May-22
C1071040,10461007,146,PF-06863135,T,6217283543,6.21728E+11,20211206,8:00,CYCLE1_DAY8,0 H,777.5135,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1564,58RSYC,1-May-22
C1071040,10461007,146,PF-06863135,T,6217283543,6.21728E+11,20211206,18:14,CYCLE1_DAY8,6 H,187.1811253,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1563,58RSYC,1-May-22
C1071040,10461007,146,PF-06863135,T,6217368115,6.21737E+11,20211213,10:50,CYCLE1_DAY15,0 H,872.2266619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1829,92RSYC,12-May-22
C1071040,10461007,146,PF-06863135,T,6217340171,6.21734E+11,20211227,14:05,CYCLE2_DAY1,0 H,244.6266929,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1828,92RSYC,12-May-22
C1071040,10461007,146,PF-06863135,T,6217142649,6.21714E+11,20220112,16:45,END_OF_TRT,,490.3770329,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1827,86RSYC,13-May-22
C1071040,10461007,146,PF-06863135,T,6217233438,6.21723E+11,20211201,12:18,CYCLE1_DAY1,24 H,699.0532506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1539,58RSYC,1-May-22
C1071040,10461007,146,PF-06863135,T,6217133173,6.21713E+11,20211202,11:15,CYCLE1_DAY4,0 H,490.7736879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1462,54RSYC,30-Apr-22
C1071040,10461007,146,PF-06863135,T,6217133177,6.21713E+11,20211203,11:35,CYCLE1_DAY4,24 H,551.1936438,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1463,54RSYC,30-Apr-22
C1071040,11001005,147,PF-06863135,T,6217163736,6.21716E+11,20211130,11:00,CYCLE1_DAY1,0 H,247.1163756,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1471,54RSYC,30-Apr-22
C1071040,11001005,147,PF-06863135,T,6217163736,6.21716E+11,20211130,17:00,CYCLE1_DAY1,6 H,89.67855022,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1470,54RSYC,30-Apr-22
C1071040,11001005,147,PF-06863135,T,6217163741,6.21716E+11,20211206,10:15,CYCLE1_DAY8,0 H,533.9624126,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1475,105RSYC,22-May-22
C1071040,11001005,147,PF-06863135,T,6217163741,6.21716E+11,20211206,18:20,CYCLE1_DAY8,6 H,432.3227908,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1474,54RSYC,30-Apr-22
C1071040,11001005,147,PF-06863135,T,6216170950,6.21617E+11,20211213,9:30,CYCLE1_DAY15,0 H,862.7974171,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1282,89RSYC,11-May-22
C1071040,11001005,147,PF-06863135,T,6216170953,6.21617E+11,20211220,9:35,CYCLE1_DAY22,0 H,976.3456499,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1789,71RSYC,7-May-22
C1071040,11001005,147,PF-06863135,T,6217163753,6.21716E+11,20211227,9:30,CYCLE2_DAY1,0 H,478.6719608,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1790,71RSYC,7-May-22
C1071040,11001005,147,PF-06863135,T,6217468785,6.21747E+11,20220124,10:30,CYCLE3_DAY1,0 H,785.6976643,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1792,71RSYC,7-May-22
C1071040,11001005,147,PF-06863135,T,6217366245,6.21737E+11,20220222,11:20,CYCLE4_DAY1,0 H,131.4750599,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1791,71RSYC,7-May-22
C1071040,11001005,147,PF-06863135,T,6216170961,6.21617E+11,20220516,11:15,CYCLE7_DAY1,0 H,572.6931377,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2054,132RSYC,10-Nov-22
C1071040,11001005,147,PF-06863135,T,6217183911,6.21718E+11,20220808,11:00,CYCLE10_DAY1,0 H,46.73816985,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2055,132RSYC,10-Nov-22
C1071040,11001005,147,PF-06863135,T,6219556971,6.21956E+11,20221031,13:35,CYCLE13_DAY1,0 H,156.480496,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2164,140RSYC,22-Mar-23
C1071040,11001005,147,PF-06863135,T,6216170951,6.21617E+11,20211201,11:00,CYCLE1_DAY1,24 H,767.1066155,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1283,89RSYC,11-May-22
C1071040,11001005,147,PF-06863135,T,6216170967,6.21617E+11,20211202,15:00,CYCLE1_DAY4,0 H,848.4185614,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1288,84RSYC,10-May-22
C1071040,11001005,147,PF-06863135,T,6217163749,6.21716E+11,20211203,11:00,CYCLE1_DAY4,24 H,408.6126567,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1481,55RSYC,30-Apr-22
C1071040,10901004,148,PF-06863135,T,6519266723,6.51927E+11,20211130,12:00,CYCLE1_DAY1,0 H,815.5198319,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2096,141RSYC,17-May-23
C1071040,10901004,148,PF-06863135,T,6519266723,6.51927E+11,20211130,19:20,CYCLE1_DAY1,6 H,839.7884848,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1902,81RSYC,4-May-22
C1071040,10901004,148,PF-06863135,T,6517433524,6.51743E+11,20211209,11:00,CYCLE1_DAY8,0 H,451.6752147,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 981,66RSYC,3-May-22
C1071040,10901004,148,PF-06863135,T,6517433524,6.51743E+11,20211209,16:30,CYCLE1_DAY8,6 H,513.5442245,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 980,66RSYC,3-May-22
C1071040,10901004,148,PF-06863135,T,6518828367,6.51883E+11,20211214,11:20,CYCLE1_DAY15,0 H,129.9906989,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1162,108RSYC,24-May-22
C1071040,10901004,148,PF-06863135,T,6517433527,6.51743E+11,20211221,12:50,CYCLE1_DAY22,0 H,533.8346686,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 983,66RSYC,3-May-22
C1071040,10901004,148,PF-06863135,T,6517433530,6.51743E+11,20211228,16:40,CYCLE2_DAY1,0 H,541.6969756,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1678,101RSYC,13-May-22
C1071040,10901004,148,PF-06863135,T,6517433532,6.51743E+11,20220125,11:30,CYCLE3_DAY1,0 H,449.3877854,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1677,101RSYC,13-May-22
C1071040,10901004,148,PF-06863135,T,6519231707,6.51923E+11,20220222,13:25,CYCLE4_DAY1,0 H,316.344314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1679,101RSYC,13-May-22
C1071040,10901004,148,PF-06863135,T,6517433535,6.51743E+11,20220517,11:33,CYCLE7_DAY1,0 H,416.6002322,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1964,114RSYC,25-Jul-22
C1071040,10901004,148,PF-06863135,T,6518807251,6.51881E+11,20220809,12:22,CYCLE10_DAY1,0 H,893.6471818,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2087,127RSYC,19-Oct-22
C1071040,10901004,148,PF-06863135,T,6518807252,6.51881E+11,20221101,15:00,CYCLE13_DAY1,0 H,813.4988207,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2146,139RSYC,22-Mar-23
C1071040,10901004,148,PF-06863135,T,6522393540,6.52239E+11,20230124,15:45,CYCLE16_DAY1,0 H,493.7883316,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2249,143RSYC,27-Nov-23
C1071040,10901004,148,PF-06863135,T,6522242183,6.52224E+11,20230418,14:00,CYCLE19_DAY1,0 H,755.6203078,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2220,142RSYC,18-May-23
C1071040,10901004,148,PF-06863135,T,6522242179,6.52224E+11,20230711,13:05,CYCLE22_DAY1,0 H,210.7271027,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2285,145RSYC,4-Jan-24
C1071040,10901004,148,PF-06863135,T,6525460187,6.52546E+11,20240228,13:41,END_OF_TRT,,209.3204513,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2365,152RSYC,9-Apr-24
C1071040,10901004,148,PF-06863135,T,6517433548,6.51743E+11,20211210,11:22,UNPL,9002 H,736.0764271,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 986,86RSYC,13-May-22
C1071040,10901004,148,PF-06863135,T,6515447313,6.51545E+11,20211201,13:10,CYCLE1_DAY1,24 H,770.5245013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1676,109RSYC,25-May-22
C1071040,10901004,148,PF-06863135,T,6517433540,6.51743E+11,20211203,14:55,CYCLE1_DAY4,0 H,342.6437808,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 984,88RSYC,11-May-22
C1071040,10901004,148,PF-06863135,T,6517433542,6.51743E+11,20211204,14:20,CYCLE1_DAY4,24 H,222.5745337,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 985,66RSYC,3-May-22
C1071040,10041001,149,PF-06863135,T,6216725194,6.21673E+11,20211201,8:00,CYCLE1_DAY1,0 H,262.183101,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1357,76RSYC,4-May-22
C1071040,10041001,149,PF-06863135,T,6216725194,6.21673E+11,20211201,18:25,CYCLE1_DAY1,6 H,239.1652846,NG/ML,11,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1356,84RSYC,10-May-22
C1071040,10041001,149,PF-06863135,T,6216725196,6.21673E+11,20211209,7:45,CYCLE1_DAY8,0 H,50.31266826,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1359,84RSYC,10-May-22
C1071040,10041001,149,PF-06863135,T,6216725196,6.21673E+11,20211209,19:40,CYCLE1_DAY8,6 H,706.2212711,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1358,84RSYC,10-May-22
C1071040,10041001,149,PF-06863135,T,6216725199,6.21673E+11,20211216,8:00,CYCLE1_DAY15,0 H,627.7259614,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1360,84RSYC,10-May-22
C1071040,10041001,149,PF-06863135,T,6216725200,6.21673E+11,20211223,7:30,CYCLE1_DAY22,0 H,649.6765084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1361,84RSYC,10-May-22
C1071040,10041001,149,PF-06863135,T,6216725203,6.21673E+11,20211230,9:30,CYCLE2_DAY1,0 H,258.5067661,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1737,72RSYC,7-May-22
C1071040,10041001,149,PF-06863135,T,6216725204,6.21673E+11,20220127,9:00,CYCLE3_DAY1,0 H,820.8113981,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1738,90RSYC,11-May-22
C1071040,10041001,149,PF-06863135,T,6216725207,6.21673E+11,20220224,9:35,CYCLE4_DAY1,0 H,999.8617892,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1739,90RSYC,11-May-22
C1071040,10041001,149,PF-06863135,T,6216725208,6.21673E+11,20220519,9:30,CYCLE7_DAY1,0 H,161.8882513,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1993,115RSYC,25-Jul-22
C1071040,10041001,149,PF-06863135,T,6217233005,6.21723E+11,20220811,9:10,CYCLE10_DAY1,0 H,750.0269402,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2045,132RSYC,10-Nov-22
C1071040,10041001,149,PF-06863135,T,6216725210,6.21673E+11,20211202,13:30,CYCLE1_DAY1,24 H,842.6556332,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1362,84RSYC,10-May-22
C1071040,10041001,149,PF-06863135,T,6216725213,6.21673E+11,20211206,7:05,CYCLE1_DAY4,0 H,24.19493875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1363,84RSYC,10-May-22
C1071040,10161006,150,PF-06863135,T,6518935552,6.51894E+11,20211201,9:14,CYCLE1_DAY1,0 H,399.5340013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1220,87RSYC,13-May-22
C1071040,10161006,150,PF-06863135,T,6518935552,6.51894E+11,20211201,17:42,CYCLE1_DAY1,6 H,469.655779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1219,87RSYC,13-May-22
C1071040,10161006,150,PF-06863135,T,6518935560,6.51894E+11,20211208,9:35,CYCLE1_DAY8,0 H,983.2674237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1232,46RSYC,28-Apr-22
C1071040,10161006,150,PF-06863135,T,6518935560,6.51894E+11,20211208,16:52,CYCLE1_DAY8,6 H,315.5121002,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1231,46RSYC,28-Apr-22
C1071040,10161006,150,PF-06863135,T,6518935562,6.51894E+11,20211215,10:07,CYCLE1_DAY15,0 H,787.7431083,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1233,46RSYC,28-Apr-22
C1071040,10161006,150,PF-06863135,T,6518935569,6.51894E+11,20211222,10:15,CYCLE1_DAY22,0 H,871.3252214,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1235,46RSYC,28-Apr-22
C1071040,10161006,150,PF-06863135,T,6518972840,6.51897E+11,20211230,10:15,CYCLE2_DAY1,0 H,887.7007381,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1604,97RSYC,12-May-22
C1071040,10161006,150,PF-06863135,T,6518935573,6.51894E+11,20211202,11:50,CYCLE1_DAY1,24 H,9.460769915,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1237,47RSYC,28-Apr-22
C1071040,10161006,150,PF-06863135,T,6518981610,6.51898E+11,20211204,10:16,CYCLE1_DAY4,0 H,10.48417905,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1258,47RSYC,28-Apr-22
C1071040,10161006,150,PF-06863135,T,6518935581,6.51894E+11,20211205,11:40,CYCLE1_DAY4,24 H,17.03120755,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1242,47RSYC,28-Apr-22
C1071040,10901005,151,PF-06863135,T,6518772457,6.51877E+11,20211202,16:35,CYCLE1_DAY1,0 H,416.0606208,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1141,95RSYC,13-May-22
C1071040,10901005,151,PF-06863135,T,6518772457,6.51877E+11,20211202,23:45,CYCLE1_DAY1,6 H,135.8694461,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1140,95RSYC,13-May-22
C1071040,10901005,151,PF-06863135,T,6518877869,6.51888E+11,20211203,17:30,CYCLE1_DAY1,24 H,483.1652037,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1177,104RSYC,22-May-22
C1071040,10461008,152,PF-06863135,T,6217133144,6.21713E+11,20211202,10:55,CYCLE1_DAY1,0 H,580.0609219,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1456,54RSYC,30-Apr-22
C1071040,10461008,152,PF-06863135,T,6217133144,6.21713E+11,20211202,18:32,CYCLE1_DAY1,6 H,631.6215639,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1455,54RSYC,30-Apr-22
C1071040,10461008,152,PF-06863135,T,6217368118,6.21737E+11,20211214,6:00,CYCLE1_DAY15,0 H,455.0713356,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1833,93RSYC,12-May-22
C1071040,10461008,152,PF-06863135,T,6217233424,6.21723E+11,20211221,6:00,CYCLE1_DAY22,0 H,283.4294331,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1831,92RSYC,12-May-22
C1071040,10461008,152,PF-06863135,T,6217233428,6.21723E+11,20211228,10:20,CYCLE2_DAY1,0 H,211.6047795,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1832,93RSYC,12-May-22
C1071040,10461008,152,PF-06863135,T,6217142648,6.21714E+11,20220111,12:10,END_OF_TRT,,498.881415,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1830,86RSYC,13-May-22
C1071040,10461008,152,PF-06863135,T,6217133170,6.21713E+11,20211203,11:15,CYCLE1_DAY1,24 H,830.3391125,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1461,54RSYC,30-Apr-22
C1071040,10461008,152,PF-06863135,T,6217368128,6.21737E+11,20211206,10:54,CYCLE1_DAY4,0 H,164.7033749,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1579,59RSYC,1-May-22
C1071040,10461008,152,PF-06863135,T,6217283552,6.21728E+11,20211207,11:20,CYCLE1_DAY4,24 H,313.7663986,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1567,97RSYC,12-May-22
C1071040,10921005,153,PF-06863135,T,6216725229,6.21673E+11,20211202,11:35,CYCLE1_DAY1,0 H,563.4670029,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1367,76RSYC,4-May-22
C1071040,10921005,153,PF-06863135,T,6216725229,6.21673E+11,20211202,21:55,CYCLE1_DAY1,6 H,442.655125,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1366,84RSYC,10-May-22
C1071040,10921005,153,PF-06863135,T,6216725231,6.21673E+11,20211210,11:31,CYCLE1_DAY8,0 H,463.5119426,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1369,84RSYC,10-May-22
C1071040,10921005,153,PF-06863135,T,6216725231,6.21673E+11,20211210,17:53,CYCLE1_DAY8,6 H,608.3274264,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1368,84RSYC,10-May-22
C1071040,10921005,153,PF-06863135,T,6217039333,6.21704E+11,20211217,12:46,CYCLE1_DAY15,0 H,671.6539872,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1447,54RSYC,30-Apr-22
C1071040,10921005,153,PF-06863135,T,6216725235,6.21673E+11,20211223,16:30,CYCLE1_DAY22,0 H,22.48932611,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1371,84RSYC,10-May-22
C1071040,10921005,153,PF-06863135,T,6216725236,6.21673E+11,20211230,12:23,CYCLE2_DAY1,0 H,407.8951377,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1753,91RSYC,11-May-22
C1071040,10921005,153,PF-06863135,T,6216725239,6.21673E+11,20220127,12:59,CYCLE3_DAY1,0 H,130.3599979,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1754,91RSYC,11-May-22
C1071040,10921005,153,PF-06863135,T,6217039355,6.21704E+11,20220224,15:50,CYCLE4_DAY1,0 H,285.1633751,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1755,91RSYC,11-May-22
C1071040,10921005,153,PF-06863135,T,6217142484,6.21714E+11,20220818,14:30,CYCLE10_DAY1,0 H,524.2601762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2048,132RSYC,10-Nov-22
C1071040,10921005,153,PF-06863135,T,6219074084,6.21907E+11,20221110,11:05,CYCLE13_DAY1,0 H,801.6019733,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2156,140RSYC,22-Mar-23
C1071040,10921005,153,PF-06863135,T,6219074083,6.21907E+11,20230427,13:10,END_OF_TRT,,952.5956413,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2238,143RSYC,27-Nov-23
C1071040,10921005,153,PF-06863135,T,6216725253,6.21673E+11,20211203,12:00,UNPL,9001 H,471.6164881,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1374,108RSYC,24-May-22
C1071040,10921005,153,PF-06863135,T,6216725244,6.21673E+11,20211203,15:20,CYCLE1_DAY1,24 H,726.4273218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1372,84RSYC,10-May-22
C1071040,10921005,153,PF-06863135,T,6216725247,6.21673E+11,20211207,10:35,CYCLE1_DAY4,0 H,135.4715987,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1373,84RSYC,10-May-22
C1071040,10921005,153,PF-06863135,T,6217039367,6.21704E+11,20211208,15:10,CYCLE1_DAY4,24 H,821.7106115,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1450,54RSYC,30-Apr-22
C1071040,11021013,154,PF-06863135,T,6217233476,6.21723E+11,20211202,16:30,CYCLE1_DAY1,0 H,848.707623,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1542,58RSYC,1-May-22
C1071040,11021013,154,PF-06863135,T,6217233476,6.21723E+11,20211202,23:25,CYCLE1_DAY1,6 H,72.25737136,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1541,58RSYC,1-May-22
C1071040,11021013,154,PF-06863135,T,6217280311,6.21728E+11,20211213,15:00,CYCLE1_DAY8,0 H,672.353672,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1555,58RSYC,1-May-22
C1071040,11021013,154,PF-06863135,T,6217280311,6.21728E+11,20211213,21:35,CYCLE1_DAY8,6 H,806.9701625,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1554,58RSYC,1-May-22
C1071040,11021013,154,PF-06863135,T,6217170437,6.21717E+11,20211220,16:05,CYCLE1_DAY15,0 H,306.2471473,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1497,55RSYC,30-Apr-22
C1071040,11021013,154,PF-06863135,T,6217170451,6.21717E+11,20211227,14:40,CYCLE1_DAY22,0 H,332.9669106,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1854,93RSYC,12-May-22
C1071040,11021013,154,PF-06863135,T,6217023834,6.21702E+11,20220103,14:00,CYCLE2_DAY1,0 H,622.9086081,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1853,93RSYC,12-May-22
C1071040,11021013,154,PF-06863135,T,6217170474,6.21717E+11,20220131,13:50,CYCLE3_DAY1,0 H,380.0574406,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1855,93RSYC,12-May-22
C1071040,11021013,154,PF-06863135,T,6217170489,6.21717E+11,20220228,14:30,CYCLE4_DAY1,0 H,47.25735223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1883,80RSYC,4-May-22
C1071040,11021013,154,PF-06863135,T,6217656228,6.21766E+11,20220628,13:00,END_OF_TRT,,793.8102368,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2043,128RSYC,21-Oct-22
C1071040,11021013,154,PF-06863135,T,6217170507,6.21717E+11,20211203,16:25,CYCLE1_DAY1,24 H,141.5200894,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1512,56RSYC,30-Apr-22
C1071040,11021013,154,PF-06863135,T,6217184365,6.21718E+11,20211208,11:30,CYCLE1_DAY4,24 H,620.631435,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1522,56RSYC,30-Apr-22
C1071040,10151008,155,PF-06863135,T,6518957152,6.51896E+11,20211207,16:37,CYCLE1_DAY1,0 H,392.6239124,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1246,87RSYC,13-May-22
C1071040,10151008,155,PF-06863135,T,6518911699,6.51891E+11,20211215,10:06,CYCLE1_DAY8,0 H,724.7639368,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1183,104RSYC,22-May-22
C1071040,10151008,155,PF-06863135,T,6518911699,6.51891E+11,20211215,16:20,CYCLE1_DAY8,6 H,742.6673867,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1182,104RSYC,22-May-22
C1071040,10151008,155,PF-06863135,T,6518957154,6.51896E+11,20211221,10:40,CYCLE1_DAY15,0 H,591.7819523,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1248,47RSYC,28-Apr-22
C1071040,10151008,155,PF-06863135,T,6518957156,6.51896E+11,20211228,9:57,CYCLE1_DAY22,0 H,399.8865472,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1250,47RSYC,28-Apr-22
C1071040,10151008,155,PF-06863135,T,6518842178,6.51884E+11,20220104,10:40,CYCLE2_DAY1,0 H,559.7615516,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1662,101RSYC,13-May-22
C1071040,10151008,155,PF-06863135,T,6518911726,6.51891E+11,20220201,11:56,CYCLE3_DAY1,0 H,329.2051641,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1663,101RSYC,13-May-22
C1071040,10151008,155,PF-06863135,T,6517560134,6.51756E+11,20220301,9:55,CYCLE4_DAY1,0 H,908.8937938,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1898,81RSYC,4-May-22
C1071040,10151008,155,PF-06863135,T,6518957177,6.51896E+11,20220525,9:02,CYCLE7_DAY1,0 H,963.9957017,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1986,114RSYC,25-Jul-22
C1071040,10151008,155,PF-06863135,T,6518957179,6.51896E+11,20211208,16:00,CYCLE1_DAY1,24 H,457.8353975,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1254,47RSYC,28-Apr-22
C1071040,10151008,155,PF-06863135,T,6518957181,6.51896E+11,20211210,12:43,CYCLE1_DAY4,0 H,673.8461963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1256,47RSYC,28-Apr-22
C1071040,10021004,156,PF-06863135,T,6603529934,6.60353E+11,20211203,9:00,CYCLE1_DAY1,0 H,779.165362,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 946,65RSYC,3-May-22
C1071040,10021004,156,PF-06863135,T,6603529934,6.60353E+11,20211203,17:15,CYCLE1_DAY1,6 H,488.1436352,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 947,65RSYC,3-May-22
C1071040,10021004,156,PF-06863135,T,6603324912,6.60332E+11,20211213,9:15,CYCLE1_DAY8,0 H,565.5080869,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 945,65RSYC,3-May-22
C1071040,10021004,156,PF-06863135,T,6603529937,6.60353E+11,20211220,12:10,CYCLE1_DAY15,0 H,70.75446634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 948,65RSYC,3-May-22
C1071040,10021004,156,PF-06863135,T,6603626210,6.60363E+11,20211229,9:38,CYCLE1_DAY22,0 H,839.5368647,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1588,59RSYC,1-May-22
C1071040,10021004,156,PF-06863135,T,6603578696,6.60358E+11,20211204,11:43,CYCLE1_DAY1,24 H,950.6264916,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 949,,
C1071040,10021004,156,PF-06863135,T,6603529964,6.60353E+11,20211206,9:40,CYCLE1_DAY4,0 H,700.4189676,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1586,59RSYC,1-May-22
C1071040,10021004,156,PF-06863135,T,6603529965,6.60353E+11,20211207,11:45,CYCLE1_DAY4,24 H,580.3740475,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1587,59RSYC,1-May-22
C1071040,10971001,157,PF-06863135,T,6216725127,6.21673E+11,20211203,14:30,CYCLE1_DAY1,0 H,431.1761431,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1334,50RSYC,29-Apr-22
C1071040,10971001,157,PF-06863135,T,6216725127,6.21673E+11,20211203,21:45,CYCLE1_DAY1,6 H,832.1421325,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1333,50RSYC,29-Apr-22
C1071040,10971001,157,PF-06863135,T,6216725129,6.21673E+11,20211210,9:30,CYCLE1_DAY8,0 H,978.0855582,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1336,50RSYC,29-Apr-22
C1071040,10971001,157,PF-06863135,T,6216725129,6.21673E+11,20211210,17:00,CYCLE1_DAY8,6 H,373.7537588,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1335,50RSYC,29-Apr-22
C1071040,10971001,157,PF-06863135,T,6216725133,6.21673E+11,20211223,11:30,CYCLE1_DAY22,0 H,271.7614877,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1337,50RSYC,29-Apr-22
C1071040,10971001,157,PF-06863135,T,6216725135,6.21673E+11,20211230,13:40,CYCLE2_DAY1,0 H,9.124601476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1809,92RSYC,12-May-22
C1071040,10971001,157,PF-06863135,T,6216725137,6.21673E+11,20220127,13:45,CYCLE3_DAY1,0 H,476.26627,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1810,92RSYC,12-May-22
C1071040,10971001,157,PF-06863135,T,6216725142,6.21673E+11,20211204,16:30,CYCLE1_DAY1,24 H,245.4409835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1338,50RSYC,29-Apr-22
C1071040,10971001,157,PF-06863135,T,6216725144,6.21673E+11,20211206,13:00,CYCLE1_DAY4,0 H,207.9528126,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1339,50RSYC,29-Apr-22
C1071040,10971001,157,PF-06863135,T,6216725146,6.21673E+11,20211207,15:00,CYCLE1_DAY4,24 H,265.8140217,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1340,50RSYC,29-Apr-22
C1071040,11041006,158,PF-06863135,T,6217133142,6.21713E+11,20211206,9:00,CYCLE1_DAY1,0 H,739.5557553,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1454,54RSYC,30-Apr-22
C1071040,11041006,158,PF-06863135,T,6217133142,6.21713E+11,20211206,22:15,CYCLE1_DAY1,6 H,344.4213803,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1453,54RSYC,30-Apr-22
C1071040,11041006,158,PF-06863135,T,6217133145,6.21713E+11,20211213,9:00,CYCLE1_DAY8,0 H,415.7653444,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1458,54RSYC,30-Apr-22
C1071040,11041006,158,PF-06863135,T,6217133145,6.21713E+11,20211213,19:00,CYCLE1_DAY8,6 H,785.1562037,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1457,54RSYC,30-Apr-22
C1071040,11041006,158,PF-06863135,T,6216725278,6.21673E+11,20211220,12:00,CYCLE1_DAY15,0 H,227.5179263,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1375,84RSYC,10-May-22
C1071040,11041006,158,PF-06863135,T,6216725281,6.21673E+11,20211227,9:35,CYCLE1_DAY22,0 H,295.499421,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1762,91RSYC,11-May-22
C1071040,11041006,158,PF-06863135,T,6217133155,6.21713E+11,20220103,11:45,CYCLE2_DAY1,0 H,89.26451959,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1764,91RSYC,11-May-22
C1071040,11041006,158,PF-06863135,T,6217133161,6.21713E+11,20220131,12:10,CYCLE3_DAY1,0 H,988.786546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1765,91RSYC,11-May-22
C1071040,11041006,158,PF-06863135,T,6216725305,6.21673E+11,20220207,11:29,END_OF_TRT,,921.9631702,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1763,109RSYC,25-May-22
C1071040,11041006,158,PF-06863135,T,6217133169,6.21713E+11,20211207,16:15,CYCLE1_DAY1,24 H,327.96796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1460,54RSYC,30-Apr-22
C1071040,11041006,158,PF-06863135,T,6216924030,6.21692E+11,20211208,8:15,CYCLE1_DAY4,0 H,310.4103875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1423,57RSYC,30-Apr-22
C1071040,11041006,158,PF-06863135,T,6216924035,6.21692E+11,20211209,17:05,CYCLE1_DAY4,24 H,245.0180612,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1424,57RSYC,30-Apr-22
C1071040,10921004,159,PF-06863135,T,6216725228,6.21673E+11,20211206,11:55,CYCLE1_DAY1,0 H,358.7239629,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1365,76RSYC,4-May-22
C1071040,10921004,159,PF-06863135,T,6216725228,6.21673E+11,20211206,18:49,CYCLE1_DAY1,6 H,423.9845389,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1364,84RSYC,10-May-22
C1071040,10921004,159,PF-06863135,T,6217039329,6.21704E+11,20211213,13:16,CYCLE1_DAY8,0 H,970.502178,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1445,96RSYC,12-May-22
C1071040,10921004,159,PF-06863135,T,6217039329,6.21704E+11,20211213,20:33,CYCLE1_DAY8,6 H,545.7924568,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1444,96RSYC,12-May-22
C1071040,10921004,159,PF-06863135,T,6217039332,6.21704E+11,20211220,16:07,CYCLE1_DAY15,0 H,328.0286249,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1446,54RSYC,30-Apr-22
C1071040,10921004,159,PF-06863135,T,6217039339,6.21704E+11,20211227,15:56,CYCLE1_DAY22,0 H,333.2911212,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1448,54RSYC,30-Apr-22
C1071040,10921004,159,PF-06863135,T,6217039345,6.21704E+11,20220103,16:06,CYCLE2_DAY1,0 H,348.3130536,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1751,91RSYC,11-May-22
C1071040,10921004,159,PF-06863135,T,6217039353,6.21704E+11,20220131,14:55,CYCLE3_DAY1,0 H,421.0726874,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1752,91RSYC,11-May-22
C1071040,10921004,159,PF-06863135,T,6216725259,6.21673E+11,20220216,14:30,END_OF_TRT,,925.6046713,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1750,109RSYC,25-May-22
C1071040,10921004,159,PF-06863135,T,6217039371,6.21704E+11,20211207,17:00,UNPL,9001 H,306.7036546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1451,105RSYC,22-May-22
C1071040,10921004,159,PF-06863135,T,6217039357,6.21704E+11,20211207,12:05,CYCLE1_DAY1,24 H,328.8676699,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1449,54RSYC,30-Apr-22
C1071040,11301001,160,PF-06863135,T,6216756836,6.21676E+11,20211213,12:53,CYCLE1_DAY1,0 H,173.9499443,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1387,95RSYC,13-May-22
C1071040,11301001,160,PF-06863135,T,6216756836,6.21676E+11,20211213,20:19,CYCLE1_DAY1,6 H,217.7129346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1386,95RSYC,13-May-22
C1071040,11301001,160,PF-06863135,T,6216756838,6.21676E+11,20211220,17:12,CYCLE1_DAY8,0 H,245.3091738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1391,95RSYC,13-May-22
C1071040,11301001,160,PF-06863135,T,6216756838,6.21676E+11,20211221,1:00,CYCLE1_DAY8,6 H,720.6491443,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1390,95RSYC,13-May-22
C1071040,11301001,160,PF-06863135,T,6216756840,6.21676E+11,20211228,15:45,CYCLE1_DAY15,0 H,965.250284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1864,80RSYC,4-May-22
C1071040,11301001,160,PF-06863135,T,6217347400,6.21735E+11,20220104,14:30,CYCLE1_DAY22,0 H,815.6338014,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1865,80RSYC,4-May-22
C1071040,11301001,160,PF-06863135,T,6216756848,6.21676E+11,20211214,14:30,CYCLE1_DAY1,24 H,974.5108946,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1394,95RSYC,13-May-22
C1071040,11301001,160,PF-06863135,T,6217347402,6.21735E+11,20211216,13:00,CYCLE1_DAY4,0 H,550.1659398,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1575,59RSYC,1-May-22
C1071040,11301001,160,PF-06863135,T,6217347403,6.21735E+11,20211217,12:57,CYCLE1_DAY4,24 H,277.0587726,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1576,97RSYC,12-May-22
C1071040,11001006,161,PF-06863135,T,6217163737,6.21716E+11,20211206,12:00,CYCLE1_DAY1,0 H,610.858774,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1473,54RSYC,30-Apr-22
C1071040,11001006,161,PF-06863135,T,6217163737,6.21716E+11,20211206,19:00,CYCLE1_DAY1,6 H,390.283843,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1472,54RSYC,30-Apr-22
C1071040,11001006,161,PF-06863135,T,6217163747,6.21716E+11,20211228,9:30,CYCLE1_DAY22,0 H,25.21481584,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1796,71RSYC,7-May-22
C1071040,11001006,161,PF-06863135,T,6216170955,6.21617E+11,20220104,10:00,CYCLE2_DAY1,0 H,988.5864269,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1793,71RSYC,7-May-22
C1071040,11001006,161,PF-06863135,T,6216170956,6.21617E+11,20220201,11:45,CYCLE3_DAY1,0 H,581.5348297,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1794,71RSYC,7-May-22
C1071040,11001006,161,PF-06863135,T,6217366241,6.21737E+11,20220301,11:40,CYCLE4_DAY1,0 H,620.8885672,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1878,80RSYC,4-May-22
C1071040,11001006,161,PF-06863135,T,6217366226,6.21737E+11,20220104,17:30,UNPL,9002 H,65.28602727,NG/ML,,Visit revised from C1D8,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1797,71RSYC,7-May-22
C1071040,11001006,161,PF-06863135,T,6217183915,6.21718E+11,20211207,13:00,CYCLE1_DAY1,24 H,257.5304723,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1518,56RSYC,30-Apr-22
C1071040,11001006,161,PF-06863135,T,6216170966,6.21617E+11,20211209,9:50,CYCLE1_DAY4,0 H,920.5037503,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1795,71RSYC,7-May-22
C1071040,11001006,161,PF-06863135,T,6217183961,6.21718E+11,20211210,12:15,CYCLE1_DAY4,24 H,888.8146432,NG/ML,,Received as 6216170972-08,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1290,87RSYC,13-May-22
C1071040,10981005,162,PF-06863135,T,6517769655,6.51777E+11,20211206,9:10,CYCLE1_DAY1,0 H,692.8203032,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1078,41RSYC,26-Apr-22
C1071040,10981005,162,PF-06863135,T,6517769655,6.51777E+11,20211206,18:00,CYCLE1_DAY1,6 H,989.7238967,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1077,41RSYC,26-Apr-22
C1071040,10981005,162,PF-06863135,T,6517769659,6.51777E+11,20211216,8:39,CYCLE1_DAY8,0 H,700.2164012,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1080,41RSYC,26-Apr-22
C1071040,10981005,162,PF-06863135,T,6517769659,6.51777E+11,20211216,16:35,CYCLE1_DAY8,6 H,998.8307493,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1079,41RSYC,26-Apr-22
C1071040,10981005,162,PF-06863135,T,6517769665,6.51777E+11,20211223,10:00,CYCLE1_DAY15,0 H,681.8473913,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1081,41RSYC,26-Apr-22
C1071040,10981005,162,PF-06863135,T,6517769667,6.51777E+11,20211230,10:20,CYCLE1_DAY22,0 H,374.1487716,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1720,125RSYC,31-Jul-22
C1071040,10981005,162,PF-06863135,T,6517768785,6.51777E+11,20220203,9:07,CYCLE3_DAY1,0 H,629.9725965,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1719,72RSYC,7-May-22
C1071040,10981005,162,PF-06863135,T,6517768788,6.51777E+11,20220303,13:50,CYCLE4_DAY1,0 H,116.2365329,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1906,81RSYC,4-May-22
C1071040,10981005,162,PF-06863135,T,6518807320,6.51881E+11,20220817,9:05,CYCLE10_DAY1,0 H,242.8656225,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2091,127RSYC,19-Oct-22
C1071040,10981005,162,PF-06863135,T,6520972523,6.52097E+11,20221108,9:25,CYCLE13_DAY1,0 H,671.0962245,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2147,139RSYC,22-Mar-23
C1071040,10981005,162,PF-06863135,T,6522975588,6.52298E+11,20230404,9:28,END_OF_TRT,,672.6324824,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2224,142RSYC,18-May-23
C1071040,10981005,162,PF-06863135,T,6520939738,6.52094E+11,20220531,10:20,UNPL,9001 H,328.3526815,NG/ML,,Received as 6517769687-04,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2015,115RSYC,25-Jul-22
C1071040,10981005,162,PF-06863135,T,6517755818,6.51776E+11,20211207,13:55,CYCLE1_DAY1,24 H,351.789805,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1070,41RSYC,26-Apr-22
C1071040,10981005,162,PF-06863135,T,6517755821,6.51776E+11,20211209,6:00,CYCLE1_DAY4,0 H,212.7076759,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1071,41RSYC,26-Apr-22
C1071040,10981005,162,PF-06863135,T,6517755825,6.51776E+11,20211210,12:10,CYCLE1_DAY4,24 H,336.292224,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1072,41RSYC,26-Apr-22
C1071040,10931005,163,PF-06863135,T,6518934226,6.51893E+11,20211206,14:20,CYCLE1_DAY1,0 H,685.7498575,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1203,105RSYC,22-May-22
C1071040,10931005,163,PF-06863135,T,6518934226,6.51893E+11,20211206,20:40,CYCLE1_DAY1,6 H,466.6272779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1202,105RSYC,22-May-22
C1071040,10931005,163,PF-06863135,T,6518934229,6.51893E+11,20211213,11:11,CYCLE1_DAY8,0 H,380.4379646,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1205,105RSYC,22-May-22
C1071040,10931005,163,PF-06863135,T,6518934229,6.51893E+11,20211213,17:00,CYCLE1_DAY8,6 H,752.6654409,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1204,105RSYC,22-May-22
C1071040,10931005,163,PF-06863135,T,6518934230,6.51893E+11,20211221,16:27,CYCLE1_DAY15,0 H,914.689267,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1206,46RSYC,28-Apr-22
C1071040,10931005,163,PF-06863135,T,6518934234,6.51893E+11,20211229,15:00,CYCLE1_DAY22,0 H,4.335384135,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1716,72RSYC,7-May-22
C1071040,10931005,163,PF-06863135,T,6518934237,6.51893E+11,20220104,14:00,CYCLE2_DAY1,0 H,125.6872366,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1715,72RSYC,7-May-22
C1071040,10931005,163,PF-06863135,T,6518778282,6.51878E+11,20220201,15:20,CYCLE3_DAY1,0 H,923.3251561,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1711,72RSYC,7-May-22
C1071040,10931005,163,PF-06863135,T,6518934247,6.51893E+11,20220301,14:35,CYCLE4_DAY1,0 H,290.5066279,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1905,81RSYC,4-May-22
C1071040,10931005,163,PF-06863135,T,6517472620,6.51747E+11,20220524,15:36,CYCLE7_DAY1,0 H,386.5482391,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1970,114RSYC,25-Jul-22
C1071040,10931005,163,PF-06863135,T,6518807286,6.51881E+11,20220816,14:50,CYCLE10_DAY1,0 H,20.16617264,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2090,127RSYC,19-Oct-22
C1071040,10931005,163,PF-06863135,T,6521929820,6.52193E+11,20230718,11:50,CYCLE22_DAY1,0 H,678.1998875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2286,148RSYC,27-Mar-24
C1071040,10931005,163,PF-06863135,T,6518934250,6.51893E+11,20211207,14:30,CYCLE1_DAY1,24 H,483.4449609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1212,87RSYC,13-May-22
C1071040,10931005,163,PF-06863135,T,6518934252,6.51893E+11,20211209,13:51,CYCLE1_DAY4,0 H,611.7109907,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1214,46RSYC,28-Apr-22
C1071040,10931005,163,PF-06863135,T,6518934256,6.51893E+11,20211210,14:10,CYCLE1_DAY4,24 H,745.5119784,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1218,46RSYC,28-Apr-22
C1071040,10251002,164,PF-06863135,T,6517559620,6.51756E+11,20211206,12:55,CYCLE1_DAY1,0 H,847.1991859,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1012,39RSYC,26-Apr-22
C1071040,10251002,164,PF-06863135,T,6517559620,6.51756E+11,20211206,19:00,CYCLE1_DAY1,6 H,220.8239715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1011,39RSYC,26-Apr-22
C1071040,10251002,164,PF-06863135,T,6517559621,6.51756E+11,20211213,11:35,CYCLE1_DAY8,0 H,163.8523004,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1013,39RSYC,26-Apr-22
C1071040,10251002,164,PF-06863135,T,6515447223,6.51545E+11,20211220,8:45,CYCLE1_DAY15,0 H,239.6216482,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 961,65RSYC,3-May-22
C1071040,10251002,164,PF-06863135,T,6517559625,6.51756E+11,20211227,8:24,CYCLE1_DAY22,0 H,663.9657947,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1015,39RSYC,26-Apr-22
C1071040,10251002,164,PF-06863135,T,6517559628,6.51756E+11,20220103,9:30,CYCLE2_DAY1,0 H,294.5163939,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1669,101RSYC,13-May-22
C1071040,10251002,164,PF-06863135,T,6517559629,6.51756E+11,20220201,8:40,CYCLE3_DAY1,0 H,119.7684657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1670,101RSYC,13-May-22
C1071040,10251002,164,PF-06863135,T,6517559632,6.51756E+11,20220301,9:20,CYCLE4_DAY1,0 H,857.023735,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1900,81RSYC,4-May-22
C1071040,10251002,164,PF-06863135,T,6519204947,6.5192E+11,20220524,8:10,CYCLE7_DAY1,0 H,221.2072834,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1988,114RSYC,25-Jul-22
C1071040,10251002,164,PF-06863135,T,6517559641,6.51756E+11,20220816,7:55,CYCLE10_DAY1,0 H,412.7903864,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2085,127RSYC,19-Oct-22
C1071040,10251002,164,PF-06863135,T,6521799628,6.5218E+11,20221108,8:35,CYCLE13_DAY1,0 H,571.7804848,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2148,139RSYC,22-Mar-23
C1071040,10251002,164,PF-06863135,T,6521699573,6.5217E+11,20230505,13:30,CYCLE19_DAY1,0 H,39.08882224,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2250,143RSYC,27-Nov-23
C1071040,10251002,164,PF-06863135,T,6521699574,6.5217E+11,20230801,10:50,CYCLE22_DAY1,0 H,634.4085161,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2293,145RSYC,4-Jan-24
C1071040,10251002,164,PF-06863135,T,6517559635,6.51756E+11,20211207,13:20,CYCLE1_DAY1,24 H,358.4411664,NG/ML,12; Damaged sample tube,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1018,,
C1071040,10251002,164,PF-06863135,T,6517559638,6.51756E+11,20211209,9:15,CYCLE1_DAY4,0 H,840.3536944,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1019,39RSYC,26-Apr-22
C1071040,10251002,164,PF-06863135,T,6517559640,6.51756E+11,20211210,12:10,CYCLE1_DAY4,24 H,82.37217941,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1020,39RSYC,26-Apr-22
C1071040,10561008,165,PF-06863135,T,6217026117,6.21703E+11,20211207,12:00,CYCLE1_DAY1,0 H,27.10826886,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1431,57RSYC,30-Apr-22
C1071040,10561008,165,PF-06863135,T,6217026117,6.21703E+11,20211207,18:45,CYCLE1_DAY1,6 H,20.09418365,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1430,57RSYC,30-Apr-22
C1071040,10561008,165,PF-06863135,T,6216408041,6.21641E+11,20211213,12:20,CYCLE1_DAY8,0 H,544.8800605,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1317,49RSYC,29-Apr-22
C1071040,10561008,165,PF-06863135,T,6216408041,6.21641E+11,20211213,19:15,CYCLE1_DAY8,6 H,118.8993482,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1316,49RSYC,29-Apr-22
C1071040,10561008,165,PF-06863135,T,6216898574,6.2169E+11,20211220,15:35,CYCLE1_DAY15,0 H,553.5649447,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1404,96RSYC,12-May-22
C1071040,10561008,165,PF-06863135,T,6217026145,6.21703E+11,20220103,16:10,CYCLE2_DAY1,0 H,310.1332691,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1782,71RSYC,7-May-22
C1071040,10561008,165,PF-06863135,T,6216898586,6.2169E+11,20220201,9:50,CYCLE3_DAY1,0 H,15.33398724,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1780,71RSYC,7-May-22
C1071040,10561008,165,PF-06863135,T,6216898589,6.2169E+11,20220301,10:50,CYCLE4_DAY1,0 H,813.2451736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1781,71RSYC,7-May-22
C1071040,10561008,165,PF-06863135,T,6216898590,6.2169E+11,20220524,11:30,CYCLE7_DAY1,0 H,822.1183281,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1994,122RSYC,29-Jul-22
C1071040,10561008,165,PF-06863135,T,6216898602,6.2169E+11,20220816,14:30,CYCLE10_DAY1,0 H,445.4509226,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2052,132RSYC,10-Nov-22
C1071040,10561008,165,PF-06863135,T,6218590818,6.21859E+11,20221107,13:30,CYCLE13_DAY1,0 H,964.282249,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2157,140RSYC,22-Mar-23
C1071040,10561008,165,PF-06863135,T,6219498870,6.2195E+11,20230407,11:00,END_OF_TRT,,573.5849181,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2231,142RSYC,18-May-23
C1071040,10561008,165,PF-06863135,T,6216898594,6.2169E+11,20211208,12:45,CYCLE1_DAY1,24 H,732.4632099,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1409,96RSYC,12-May-22
C1071040,10561008,165,PF-06863135,T,6216898597,6.2169E+11,20211210,12:10,CYCLE1_DAY4,0 H,883.3591058,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1410,96RSYC,12-May-22
C1071040,10561008,165,PF-06863135,T,6216898599,6.2169E+11,20211211,13:30,CYCLE1_DAY4,24 H,321.7340168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1411,96RSYC,12-May-22
C1071040,10931004,166,PF-06863135,T,6518934225,6.51893E+11,20211207,16:50,CYCLE1_DAY1,0 H,246.1049291,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1201,105RSYC,22-May-22
C1071040,10931004,166,PF-06863135,T,6518934225,6.51893E+11,20211207,23:04,CYCLE1_DAY1,6 H,155.4664526,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1200,105RSYC,22-May-22
C1071040,10931004,166,PF-06863135,T,6518934231,6.51893E+11,20211221,13:50,CYCLE1_DAY15,0 H,805.5338847,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1207,46RSYC,28-Apr-22
C1071040,10931004,166,PF-06863135,T,6517472612,6.51747E+11,20211228,13:28,CYCLE1_DAY22,0 H,250.3098721,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1003,39RSYC,26-Apr-22
C1071040,10931004,166,PF-06863135,T,6518778285,6.51878E+11,20220524,10:50,CYCLE7_DAY1,0 H,940.6682288,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1984,114RSYC,25-Jul-22
C1071040,10931004,166,PF-06863135,T,6518934249,6.51893E+11,20211208,16:55,CYCLE1_DAY1,24 H,171.1203469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1211,46RSYC,28-Apr-22
C1071040,10931004,166,PF-06863135,T,6518934253,6.51893E+11,20211210,13:00,CYCLE1_DAY4,0 H,137.8531655,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1215,46RSYC,28-Apr-22
C1071040,10931004,166,PF-06863135,T,6518934255,6.51893E+11,20211211,12:26,CYCLE1_DAY4,24 H,592.4364962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1217,87RSYC,13-May-22
C1071040,10741003,167,PF-06863135,T,6518693889,6.51869E+11,20211207,12:50,CYCLE1_DAY1,0 H,552.5823234,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1127,94RSYC,12-May-22
C1071040,10741003,167,PF-06863135,T,6519029233,6.51903E+11,20211215,10:15,CYCLE1_DAY8,0 H,659.7478364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1261,47RSYC,28-Apr-22
C1071040,10741003,167,PF-06863135,T,6519029233,6.51903E+11,20211215,17:37,CYCLE1_DAY8,6 H,949.0714398,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1260,47RSYC,28-Apr-22
C1071040,10741003,167,PF-06863135,T,6519029234,6.51903E+11,20211223,8:48,CYCLE1_DAY15,0 H,948.011786,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1262,47RSYC,28-Apr-22
C1071040,10741003,167,PF-06863135,T,6518693895,6.51869E+11,20211228,10:00,CYCLE1_DAY22,0 H,443.1463505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1129,94RSYC,12-May-22
C1071040,10741003,167,PF-06863135,T,6518988295,6.51899E+11,20220105,17:00,CYCLE2_DAY1,0 H,438.9427181,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1658,109RSYC,25-May-22
C1071040,10741003,167,PF-06863135,T,6519123788,6.51912E+11,20220202,11:38,CYCLE3_DAY1,0 H,701.8223279,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1659,109RSYC,25-May-22
C1071040,10741003,167,PF-06863135,T,6517472587,6.51747E+11,20220302,13:41,CYCLE4_DAY1,0 H,182.5037621,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1897,81RSYC,4-May-22
C1071040,10741003,167,PF-06863135,T,6517472589,6.51747E+11,20220525,13:01,CYCLE7_DAY1,0 H,324.6603868,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2014,122RSYC,29-Jul-22
C1071040,10741003,167,PF-06863135,T,6520917900,6.52092E+11,20221122,12:40,CYCLE13_DAY1,0 H,961.4855234,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2134,139RSYC,22-Mar-23
C1071040,10741003,167,PF-06863135,T,6520917901,6.52092E+11,20230215,13:04,CYCLE16_DAY1,0 H,509.1320834,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2196,141RSYC,17-May-23
C1071040,10741003,167,PF-06863135,T,6522652197,6.52265E+11,20230517,13:12,CYCLE19_DAY1,0 H,840.2914456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2251,145RSYC,4-Jan-24
C1071040,10741003,167,PF-06863135,T,6522652198,6.52265E+11,20230816,12:35,CYCLE22_DAY1,0 H,798.6116656,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2302,147RSYC,29-Feb-24
C1071040,10741003,167,PF-06863135,T,6523537652,6.52354E+11,20231108,13:15,CYCLE25_DAY1,0 H,49.92741698,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2333,149RSYC,27-Mar-24
C1071040,10741003,167,PF-06863135,T,6524974340,6.52497E+11,20240207,13:33,CYCLE28_DAY1,0 H,608.3706043,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2358,148RSYC,27-Mar-24
C1071040,10741003,167,PF-06863135,T,6518807209,6.51881E+11,20220824,11:10,UNPL,9001 H,379.8623026,NG/ML,,Visit revised from C10D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2084,129RSYC,21-Oct-22
C1071040,10741003,167,PF-06863135,T,6517472592,6.51747E+11,20211210,7:45,CYCLE1_DAY4,0 H,92.75125858,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1000,39RSYC,26-Apr-22
C1071040,10741003,167,PF-06863135,T,6519029241,6.51903E+11,20211211,10:25,CYCLE1_DAY4,24 H,871.3657097,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1266,89RSYC,11-May-22
C1071040,11041007,168,PF-06863135,T,6216923988,6.21692E+11,20211209,11:00,CYCLE1_DAY1,0 H,877.8793175,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1415,96RSYC,12-May-22
C1071040,11041007,168,PF-06863135,T,6216923988,6.21692E+11,20211209,21:15,CYCLE1_DAY1,6 H,416.1642339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1414,96RSYC,12-May-22
C1071040,11041007,168,PF-06863135,T,6216923992,6.21692E+11,20211220,14:00,CYCLE1_DAY8,0 H,457.595127,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1417,57RSYC,30-Apr-22
C1071040,11041007,168,PF-06863135,T,6216923992,6.21692E+11,20211220,21:20,CYCLE1_DAY8,6 H,700.6384781,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1416,57RSYC,30-Apr-22
C1071040,11041007,168,PF-06863135,T,6217338965,6.21734E+11,20220106,14:50,CYCLE1_DAY22,0 H,503.3107609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1769,71RSYC,7-May-22
C1071040,11041007,168,PF-06863135,T,6216725282,6.21673E+11,20220112,14:45,CYCLE2_DAY1,0 H,58.02457248,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1766,91RSYC,11-May-22
C1071040,11041007,168,PF-06863135,T,6216924016,6.21692E+11,20220208,12:46,CYCLE3_DAY1,0 H,873.3052053,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1767,91RSYC,11-May-22
C1071040,11041007,168,PF-06863135,T,6216924019,6.21692E+11,20220310,14:45,CYCLE4_DAY1,0 H,699.838696,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1908,123RSYC,29-Jul-22
C1071040,11041007,168,PF-06863135,T,6217133181,6.21713E+11,20220317,15:15,END_OF_TRT,,907.5277402,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1909,120RSYC,28-Jul-22
C1071040,11041007,168,PF-06863135,T,6216924025,6.21692E+11,20211210,15:15,CYCLE1_DAY1,24 H,932.3966911,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1422,57RSYC,30-Apr-22
C1071040,11041007,168,PF-06863135,T,6217133176,6.21713E+11,20211215,14:30,CYCLE1_DAY4,0 H,678.2041425,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1768,71RSYC,7-May-22
C1071040,11041007,168,PF-06863135,T,6217133178,6.21713E+11,20211216,15:30,CYCLE1_DAY4,24 H,22.62813592,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1464,54RSYC,30-Apr-22
C1071040,10321005,169,PF-06863135,T,6517559952,6.51756E+11,20211209,11:25,CYCLE1_DAY1,0 H,317.1709061,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1035,40RSYC,26-Apr-22
C1071040,10321005,169,PF-06863135,T,6517559952,6.51756E+11,20211209,17:30,CYCLE1_DAY1,6 H,531.2903119,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1034,66RSYC,3-May-22
C1071040,10321005,169,PF-06863135,T,6517559953,6.51756E+11,20211216,10:06,CYCLE1_DAY8,0 H,980.6039213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1037,40RSYC,26-Apr-22
C1071040,10321005,169,PF-06863135,T,6517559953,6.51756E+11,20211216,17:27,CYCLE1_DAY8,6 H,271.916773,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1036,40RSYC,26-Apr-22
C1071040,10321005,169,PF-06863135,T,6517509075,6.51751E+11,20211222,14:52,CYCLE1_DAY15,0 H,159.5560234,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1009,66RSYC,3-May-22
C1071040,10321005,169,PF-06863135,T,6517509076,6.51751E+11,20211229,14:37,CYCLE1_DAY22,0 H,896.667714,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1633,85RSYC,10-May-22
C1071040,10321005,169,PF-06863135,T,6517509079,6.51751E+11,20220106,13:29,CYCLE2_DAY1,0 H,363.9150695,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1634,100RSYC,23-May-22
C1071040,10321005,169,PF-06863135,T,6517509091,6.51751E+11,20220111,1:14,END_OF_TRT,,668.6445791,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1635,100RSYC,23-May-22
C1071040,10321005,169,PF-06863135,T,6517559967,6.51756E+11,20211210,11:35,CYCLE1_DAY1,24 H,822.2986797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1044,107RSYC,24-May-22
C1071040,10321005,169,PF-06863135,T,6517509085,6.51751E+11,20211212,9:05,CYCLE1_DAY4,0 H,906.4060383,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1010,39RSYC,26-Apr-22
C1071040,10321005,169,PF-06863135,T,6517559972,6.51756E+11,20211213,10:04,CYCLE1_DAY4,24 H,789.5300064,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1048,66RSYC,3-May-22
C1071040,10051002,170,PF-06863135,T,6216725160,6.21673E+11,20211209,13:15,CYCLE1_DAY1,0 H,655.6577577,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1342,50RSYC,29-Apr-22
C1071040,10051002,170,PF-06863135,T,6216725160,6.21673E+11,20211209,19:15,CYCLE1_DAY1,6 H,762.8763404,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1341,50RSYC,29-Apr-22
C1071040,10051002,170,PF-06863135,T,6216725162,6.21673E+11,20211217,12:00,CYCLE1_DAY8,0 H,194.4427986,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1345,50RSYC,29-Apr-22
C1071040,10051002,170,PF-06863135,T,6216725164,6.21673E+11,20211223,10:00,CYCLE1_DAY15,0 H,288.5008028,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1348,50RSYC,29-Apr-22
C1071040,10051002,170,PF-06863135,T,6216725166,6.21673E+11,20211231,10:30,CYCLE1_DAY22,0 H,96.9106264,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1743,90RSYC,11-May-22
C1071040,10051002,170,PF-06863135,T,6216725168,6.21673E+11,20220110,10:00,CYCLE2_DAY1,0 H,275.1395207,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1744,90RSYC,11-May-22
C1071040,10051002,170,PF-06863135,T,6216725183,6.21673E+11,20220211,7:00,CYCLE3_DAY1,0 H,739.8181436,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1745,90RSYC,11-May-22
C1071040,10051002,170,PF-06863135,T,6217930297,6.21793E+11,20220311,10:00,CYCLE4_DAY1,0 H,826.847796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1875,80RSYC,4-May-22
C1071040,10051002,170,PF-06863135,T,6217930300,6.21793E+11,20220606,12:00,CYCLE7_DAY1,0 H,577.7742714,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2018,115RSYC,25-Jul-22
C1071040,10051002,170,PF-06863135,T,6217309164,6.21731E+11,20220901,13:00,CYCLE10_DAY1,0 H,229.4664191,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2047,132RSYC,10-Nov-22
C1071040,10051002,170,PF-06863135,T,6219609252,6.21961E+11,20221116,9:40,END_OF_TRT,,896.5501254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2158,140RSYC,22-Mar-23
C1071040,10051002,170,PF-06863135,T,6216725176,6.21673E+11,20211210,13:20,CYCLE1_DAY1,24 H,352.797482,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1350,50RSYC,29-Apr-22
C1071040,10051002,170,PF-06863135,T,6216725178,6.21673E+11,20211213,11:00,CYCLE1_DAY4,0 H,874.2751141,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1352,50RSYC,29-Apr-22
C1071040,10051002,170,PF-06863135,T,6216725181,6.21673E+11,20211214,12:05,CYCLE1_DAY4,24 H,420.4427918,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1355,50RSYC,29-Apr-22
C1071040,11021012,171,PF-06863135,T,6217283562,6.21728E+11,20211209,10:00,CYCLE1_DAY1,0 H,188.253713,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1571,59RSYC,1-May-22
C1071040,11021012,171,PF-06863135,T,6217283562,6.21728E+11,20211209,23:05,CYCLE1_DAY1,6 H,886.1733502,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1570,59RSYC,1-May-22
C1071040,11021012,171,PF-06863135,T,6217280300,6.21728E+11,20211220,17:20,CYCLE1_DAY8,0 H,288.1638336,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1551,58RSYC,1-May-22
C1071040,11021012,171,PF-06863135,T,6217280300,6.21728E+11,20211220,23:20,CYCLE1_DAY8,6 H,273.507419,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1550,58RSYC,1-May-22
C1071040,11021012,171,PF-06863135,T,6217023833,6.21702E+11,20211227,13:55,CYCLE1_DAY15,0 H,207.9071403,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1850,93RSYC,12-May-22
C1071040,11021012,171,PF-06863135,T,6217170444,6.21717E+11,20220103,14:00,CYCLE1_DAY22,0 H,939.9941172,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1851,93RSYC,12-May-22
C1071040,11021012,171,PF-06863135,T,6216756808,6.21676E+11,20220110,16:05,CYCLE2_DAY1,0 H,118.4893279,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1849,93RSYC,12-May-22
C1071040,11021012,171,PF-06863135,T,6217170473,6.21717E+11,20220207,13:30,CYCLE3_DAY1,0 H,203.5845747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1852,93RSYC,12-May-22
C1071040,11021012,171,PF-06863135,T,6217170483,6.21717E+11,20220307,13:45,CYCLE4_DAY1,0 H,543.0354432,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1882,80RSYC,4-May-22
C1071040,11021012,171,PF-06863135,T,6217170498,6.21717E+11,20220530,13:45,CYCLE7_DAY1,0 H,66.77561687,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2021,115RSYC,25-Jul-22
C1071040,11021012,171,PF-06863135,T,6217142670,6.21714E+11,20220823,14:00,CYCLE10_DAY1,0 H,241.4597564,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2065,132RSYC,10-Nov-22
C1071040,11021012,171,PF-06863135,T,6218384025,6.21838E+11,20221114,14:30,CYCLE13_DAY1,0 H,441.943415,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2165,140RSYC,22-Mar-23
C1071040,11021012,171,PF-06863135,T,6219958816,6.21996E+11,20230206,14:30,CYCLE16_DAY1,0 H,696.1330233,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2211,142RSYC,18-May-23
C1071040,11021012,171,PF-06863135,T,6219958823,6.21996E+11,20230406,16:00,END_OF_TRT,,421.0960285,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2233,142RSYC,18-May-23
C1071040,11021012,171,PF-06863135,T,6217170503,6.21717E+11,20211210,17:00,CYCLE1_DAY1,24 H,100.1671399,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1510,56RSYC,30-Apr-22
C1071040,11021012,171,PF-06863135,T,6217280324,6.21728E+11,20211214,11:00,CYCLE1_DAY4,0 H,456.5068139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1558,58RSYC,1-May-22
C1071040,11021012,171,PF-06863135,T,6217280337,6.21728E+11,20211215,17:40,CYCLE1_DAY4,24 H,568.909102,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1560,58RSYC,1-May-22
C1071040,11021015,172,PF-06863135,T,6217360199,6.21736E+11,20211209,10:00,CYCLE1_DAY1,0 H,196.7587356,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1578,59RSYC,1-May-22
C1071040,11021015,172,PF-06863135,T,6217360199,6.21736E+11,20211209,23:30,CYCLE1_DAY1,6 H,703.1302111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1577,59RSYC,1-May-22
C1071040,11021015,172,PF-06863135,T,6217280308,6.21728E+11,20211220,17:15,CYCLE1_DAY8,0 H,873.0011675,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1553,58RSYC,1-May-22
C1071040,11021015,172,PF-06863135,T,6217280308,6.21728E+11,20211220,23:15,CYCLE1_DAY8,6 H,287.9403091,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1552,58RSYC,1-May-22
C1071040,11021015,172,PF-06863135,T,6216756803,6.21676E+11,20211227,14:20,CYCLE1_DAY15,0 H,350.2094362,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1860,80RSYC,4-May-22
C1071040,11021015,172,PF-06863135,T,6216756806,6.21676E+11,20220104,15:30,CYCLE1_DAY22,0 H,990.8600628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1861,80RSYC,4-May-22
C1071040,11021015,172,PF-06863135,T,6217170455,6.21717E+11,20220111,15:50,CYCLE2_DAY1,0 H,838.0366888,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1863,80RSYC,4-May-22
C1071040,11021015,172,PF-06863135,T,6217023848,6.21702E+11,20220211,13:10,CYCLE3_DAY1,0 H,874.7253857,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1862,80RSYC,4-May-22
C1071040,11021015,172,PF-06863135,T,6217170491,6.21717E+11,20220311,15:40,CYCLE4_DAY1,0 H,418.5456503,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1910,123RSYC,29-Jul-22
C1071040,11021015,172,PF-06863135,T,6217170496,6.21717E+11,20220603,14:00,CYCLE7_DAY1,0 H,632.6511242,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2023,115RSYC,25-Jul-22
C1071040,11021015,172,PF-06863135,T,6217142671,6.21714E+11,20220826,17:00,CYCLE10_DAY1,0 H,978.0020069,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2106,131RSYC,9-Nov-22
C1071040,11021015,172,PF-06863135,T,6219958815,6.21996E+11,20230210,12:50,CYCLE16_DAY1,0 H,889.282143,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2197,141RSYC,17-May-23
C1071040,11021015,172,PF-06863135,T,6219265231,6.21927E+11,20230509,15:00,CYCLE19_DAY1,0 H,652.4406218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2242,143RSYC,27-Nov-23
C1071040,11021015,172,PF-06863135,T,6221060211,6.22106E+11,20230731,14:47,CYCLE22_DAY1,0 H,191.5496211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2295,145RSYC,4-Jan-24
C1071040,11021015,172,PF-06863135,T,6221060212,6.22106E+11,20231023,15:30,CYCLE25_DAY1,0 H,538.381273,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2319,147RSYC,29-Feb-24
C1071040,11021015,172,PF-06863135,T,6217170510,6.21717E+11,20211210,17:30,CYCLE1_DAY1,24 H,117.3212877,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1514,56RSYC,30-Apr-22
C1071040,11021015,172,PF-06863135,T,6217280322,6.21728E+11,20211214,10:15,CYCLE1_DAY4,0 H,489.6454607,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1557,58RSYC,1-May-22
C1071040,11021015,172,PF-06863135,T,6217233482,6.21723E+11,20211215,18:00,CYCLE1_DAY4,24 H,590.9945162,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1546,58RSYC,1-May-22
C1071040,10151009,173,PF-06863135,T,6518957151,6.51896E+11,20211214,13:00,CYCLE1_DAY1,0 H,392.2891793,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1245,87RSYC,13-May-22
C1071040,10151009,173,PF-06863135,T,6518911700,6.51891E+11,20211221,9:45,CYCLE1_DAY8,0 H,315.6346275,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1185,104RSYC,22-May-22
C1071040,10151009,173,PF-06863135,T,6518911700,6.51891E+11,20211221,16:28,CYCLE1_DAY8,6 H,607.107638,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1184,104RSYC,22-May-22
C1071040,10151009,173,PF-06863135,T,6518911704,6.51891E+11,20211228,10:33,CYCLE1_DAY15,0 H,841.2715089,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1188,104RSYC,22-May-22
C1071040,10151009,173,PF-06863135,T,6518911712,6.51891E+11,20220104,10:13,CYCLE1_DAY22,0 H,217.3068029,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1665,101RSYC,13-May-22
C1071040,10151009,173,PF-06863135,T,6518911713,6.51891E+11,20220111,12:40,CYCLE2_DAY1,0 H,860.5308259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1666,101RSYC,13-May-22
C1071040,10151009,173,PF-06863135,T,6518842179,6.51884E+11,20220208,11:35,CYCLE3_DAY1,0 H,66.16698877,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1664,101RSYC,13-May-22
C1071040,10151009,173,PF-06863135,T,6518957171,6.51896E+11,20220308,11:45,CYCLE4_DAY1,0 H,637.4422066,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1899,81RSYC,4-May-22
C1071040,10151009,173,PF-06863135,T,6521544921,6.52154E+11,20230718,12:30,UNPL,9001 H,198.9948427,NG/ML,,Visit revised from C22D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2287,148RSYC,27-Mar-24
C1071040,10151009,173,PF-06863135,T,6518957178,6.51896E+11,20211215,15:02,CYCLE1_DAY1,24 H,754.6025734,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1253,47RSYC,28-Apr-22
C1071040,10151009,173,PF-06863135,T,6518957180,6.51896E+11,20211217,11:35,CYCLE1_DAY4,0 H,934.7342368,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1255,47RSYC,28-Apr-22
C1071040,10901007,174,PF-06863135,T,6518877855,6.51888E+11,20211210,11:00,CYCLE1_DAY1,0 H,877.7510798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1170,104RSYC,22-May-22
C1071040,10901007,174,PF-06863135,T,6518877855,6.51888E+11,20211210,17:50,CYCLE1_DAY1,6 H,812.8146347,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1169,104RSYC,22-May-22
C1071040,10901007,174,PF-06863135,T,6518877858,6.51888E+11,20211217,13:00,CYCLE1_DAY8,0 H,22.2908193,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1174,104RSYC,22-May-22
C1071040,10901007,174,PF-06863135,T,6518877858,6.51888E+11,20211217,19:00,CYCLE1_DAY8,6 H,207.0609549,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1173,104RSYC,22-May-22
C1071040,10901007,174,PF-06863135,T,6517433525,6.51743E+11,20211223,11:28,CYCLE1_DAY15,0 H,85.87179832,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 982,66RSYC,3-May-22
C1071040,10901007,174,PF-06863135,T,6518828368,6.51883E+11,20211230,14:57,CYCLE1_DAY22,0 H,548.4906145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1680,101RSYC,13-May-22
C1071040,10901007,174,PF-06863135,T,6519019919,6.51902E+11,20220203,11:21,CYCLE3_DAY1,0 H,979.0191139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1681,101RSYC,13-May-22
C1071040,10901007,174,PF-06863135,T,6517433533,6.51743E+11,20220303,12:10,CYCLE4_DAY1,0 H,234.5750893,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1903,81RSYC,4-May-22
C1071040,10901007,174,PF-06863135,T,6518807250,6.51881E+11,20220818,10:16,CYCLE10_DAY1,0 H,114.2206195,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2088,127RSYC,19-Oct-22
C1071040,10901007,174,PF-06863135,T,6518877868,6.51888E+11,20211211,11:50,CYCLE1_DAY1,24 H,943.495708,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1176,104RSYC,22-May-22
C1071040,10901007,174,PF-06863135,T,6518877870,6.51888E+11,20211213,15:05,CYCLE1_DAY4,0 H,417.8724485,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1178,104RSYC,22-May-22
C1071040,10901007,174,PF-06863135,T,6518805056,6.51881E+11,20211214,15:10,CYCLE1_DAY4,24 H,361.5658017,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1160,108RSYC,24-May-22
C1071040,11061006,175,PF-06863135,T,6217165064,6.21717E+11,20211213,14:30,CYCLE1_DAY1,0 H,437.550355,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1484,55RSYC,30-Apr-22
C1071040,11061006,175,PF-06863135,T,6217165064,6.21717E+11,20211213,20:00,CYCLE1_DAY1,6 H,392.5257265,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1483,55RSYC,30-Apr-22
C1071040,11061006,175,PF-06863135,T,6217356187,6.21736E+11,20211220,9:00,CYCLE1_DAY8,0 H,676.2547962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1808,92RSYC,12-May-22
C1071040,11061006,175,PF-06863135,T,6217193491,6.21719E+11,20211227,10:00,CYCLE1_DAY15,0 H,162.8081706,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1805,92RSYC,12-May-22
C1071040,11061006,175,PF-06863135,T,6217193500,6.21719E+11,20220103,10:00,CYCLE1_DAY22,0 H,446.9823509,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1806,92RSYC,12-May-22
C1071040,11061006,175,PF-06863135,T,6217165067,6.21717E+11,20220124,8:00,END_OF_TRT,,688.0210729,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1804,86RSYC,13-May-22
C1071040,11061006,175,PF-06863135,T,6217193534,6.21719E+11,20211214,9:00,CYCLE1_DAY1,24 H,825.7224229,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1530,56RSYC,30-Apr-22
C1071040,11061006,175,PF-06863135,T,6217266048,6.21727E+11,20211217,16:00,CYCLE1_DAY4,24 H,848.1606425,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1807,92RSYC,12-May-22
C1071040,11301002,176,PF-06863135,T,6217347397,6.21735E+11,20211213,16:30,CYCLE1_DAY1,0 H,586.2225147,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1868,80RSYC,4-May-22
C1071040,11301002,176,PF-06863135,T,6217347397,6.21735E+11,20211213,23:00,CYCLE1_DAY1,6 H,883.2204958,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1867,80RSYC,4-May-22
C1071040,11301002,176,PF-06863135,T,6217347398,6.21735E+11,20211220,16:20,CYCLE1_DAY8,0 H,389.8582512,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1573,59RSYC,1-May-22
C1071040,11301002,176,PF-06863135,T,6217347398,6.21735E+11,20211220,23:00,CYCLE1_DAY8,6 H,319.1661206,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1572,59RSYC,1-May-22
C1071040,11301002,176,PF-06863135,T,6217347399,6.21735E+11,20211228,14:45,CYCLE1_DAY15,0 H,809.501214,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1866,80RSYC,4-May-22
C1071040,11301002,176,PF-06863135,T,6217347401,6.21735E+11,20211214,16:55,CYCLE1_DAY1,24 H,894.3679824,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1574,59RSYC,1-May-22
C1071040,11301002,176,PF-06863135,T,6216756850,6.21676E+11,20211216,16:30,CYCLE1_DAY4,0 H,404.2691491,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1396,95RSYC,13-May-22
C1071040,11301002,176,PF-06863135,T,6216756853,6.21676E+11,20211217,16:55,CYCLE1_DAY4,24 H,382.833713,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1399,95RSYC,13-May-22
C1071040,10161007,177,PF-06863135,T,6518935554,6.51894E+11,20211213,10:59,CYCLE1_DAY1,0 H,913.1985629,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1224,87RSYC,13-May-22
C1071040,10161007,177,PF-06863135,T,6518935554,6.51894E+11,20211213,18:30,CYCLE1_DAY1,6 H,243.9681609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1223,46RSYC,28-Apr-22
C1071040,10161007,177,PF-06863135,T,6518935557,6.51894E+11,20211221,9:43,CYCLE1_DAY8,0 H,10.69927025,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1228,46RSYC,28-Apr-22
C1071040,10161007,177,PF-06863135,T,6518935557,6.51894E+11,20211221,16:07,CYCLE1_DAY8,6 H,208.6072638,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1227,46RSYC,28-Apr-22
C1071040,10161007,177,PF-06863135,T,6518935564,6.51894E+11,20211228,8:58,CYCLE1_DAY15,0 H,759.1415653,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1607,97RSYC,12-May-22
C1071040,10161007,177,PF-06863135,T,6518935567,6.51894E+11,20220103,10:15,CYCLE1_DAY22,0 H,986.6616083,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1608,97RSYC,12-May-22
C1071040,10161007,177,PF-06863135,T,6519158770,6.51916E+11,20220110,9:30,CYCLE2_DAY1,0 H,984.9738927,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1609,97RSYC,12-May-22
C1071040,10161007,177,PF-06863135,T,6517697451,6.5177E+11,20220207,10:10,CYCLE3_DAY1,0 H,579.4260565,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1606,97RSYC,12-May-22
C1071040,10161007,177,PF-06863135,T,6518914774,6.51891E+11,20220308,15:11,END_OF_TRT,,865.2065608,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1889,87RSYC,13-May-22
C1071040,10161007,177,PF-06863135,T,6518935576,6.51894E+11,20211214,12:44,CYCLE1_DAY1,24 H,611.8068447,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1239,47RSYC,28-Apr-22
C1071040,10161007,177,PF-06863135,T,6518972843,6.51897E+11,20211216,12:10,CYCLE1_DAY4,0 H,803.4638961,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1257,47RSYC,28-Apr-22
C1071040,10161007,177,PF-06863135,T,6518935577,6.51894E+11,20211217,13:06,CYCLE1_DAY4,24 H,13.70207603,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1240,47RSYC,28-Apr-22
C1071040,10321004,178,PF-06863135,T,6517559951,6.51756E+11,20211214,9:10,CYCLE1_DAY1,0 H,250.9309321,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1033,40RSYC,26-Apr-22
C1071040,10321004,178,PF-06863135,T,6517559951,6.51756E+11,20211214,18:48,CYCLE1_DAY1,6 H,813.7292905,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1032,40RSYC,26-Apr-22
C1071040,10321004,178,PF-06863135,T,6517559954,6.51756E+11,20211221,9:08,CYCLE1_DAY8,0 H,15.43122824,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1039,40RSYC,26-Apr-22
C1071040,10321004,178,PF-06863135,T,6517559954,6.51756E+11,20211221,18:09,CYCLE1_DAY8,6 H,262.1523116,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1038,40RSYC,26-Apr-22
C1071040,10321004,178,PF-06863135,T,6517559956,6.51756E+11,20211227,15:30,CYCLE1_DAY15,0 H,596.1921374,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1041,40RSYC,26-Apr-22
C1071040,10321004,178,PF-06863135,T,6517559958,6.51756E+11,20220103,14:48,CYCLE1_DAY22,0 H,881.033078,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1636,85RSYC,10-May-22
C1071040,10321004,178,PF-06863135,T,6517559959,6.51756E+11,20220110,13:55,CYCLE2_DAY1,0 H,790.0248273,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1637,85RSYC,10-May-22
C1071040,10321004,178,PF-06863135,T,6519136785,6.51914E+11,20220207,14:33,CYCLE3_DAY1,0 H,854.441321,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1638,85RSYC,10-May-22
C1071040,10321004,178,PF-06863135,T,6518150045,6.51815E+11,20220307,11:56,CYCLE4_DAY1,0 H,737.4098518,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1895,81RSYC,4-May-22
C1071040,10321004,178,PF-06863135,T,6517559981,6.51756E+11,20220502,12:56,END_OF_TRT,,866.1642732,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1979,114RSYC,25-Jul-22
C1071040,10321004,178,PF-06863135,T,6517559968,6.51756E+11,20211215,12:58,CYCLE1_DAY1,24 H,173.7492734,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1045,40RSYC,26-Apr-22
C1071040,10321004,178,PF-06863135,T,6517559970,6.51756E+11,20211217,9:36,CYCLE1_DAY4,0 H,848.5016372,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1046,40RSYC,26-Apr-22
C1071040,10321004,178,PF-06863135,T,6517559971,6.51756E+11,20211218,13:08,CYCLE1_DAY4,24 H,114.0304769,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1047,40RSYC,26-Apr-22
C1071040,11021014,179,PF-06863135,T,6217283561,6.21728E+11,20211214,10:00,CYCLE1_DAY1,0 H,49.66990439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1569,59RSYC,1-May-22
C1071040,11021014,179,PF-06863135,T,6217283561,6.21728E+11,20211214,23:20,CYCLE1_DAY1,6 H,294.1538988,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1568,110RSYC,25-May-22
C1071040,11021014,179,PF-06863135,T,6217280306,6.21728E+11,20211223,17:00,CYCLE1_DAY8,0 H,442.9225725,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2022,122RSYC,29-Jul-22
C1071040,11021014,179,PF-06863135,T,6217280306,6.21728E+11,20211223,23:30,CYCLE1_DAY8,6 H,320.8311495,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1859,80RSYC,4-May-22
C1071040,11021014,179,PF-06863135,T,6217170442,6.21717E+11,20211230,13:40,CYCLE1_DAY15,0 H,800.1979547,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1857,93RSYC,12-May-22
C1071040,11021014,179,PF-06863135,T,6217136147,6.21714E+11,20220106,13:45,CYCLE1_DAY22,0 H,724.5467728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1856,93RSYC,12-May-22
C1071040,11021014,179,PF-06863135,T,6217170454,6.21717E+11,20220113,14:00,CYCLE2_DAY1,0 H,566.3335515,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1858,80RSYC,4-May-22
C1071040,11021014,179,PF-06863135,T,6217170497,6.21717E+11,20220602,16:30,CYCLE7_DAY1,0 H,208.948048,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2044,128RSYC,21-Oct-22
C1071040,11021014,179,PF-06863135,T,6217004156,6.217E+11,20220825,13:44,CYCLE10_DAY1,0 H,898.2202703,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2105,134RSYC,11-Nov-22
C1071040,11021014,179,PF-06863135,T,6218384028,6.21838E+11,20221124,15:40,CYCLE13_DAY1,0 H,591.3919719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2166,140RSYC,22-Mar-23
C1071040,11021014,179,PF-06863135,T,6219958819,6.21996E+11,20230216,14:50,CYCLE16_DAY1,0 H,829.3475179,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2198,141RSYC,17-May-23
C1071040,11021014,179,PF-06863135,T,6219265228,6.21927E+11,20230511,14:22,CYCLE19_DAY1,0 H,102.8519229,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2241,143RSYC,27-Nov-23
C1071040,11021014,179,PF-06863135,T,6221060210,6.22106E+11,20230817,13:59,CYCLE22_DAY1,0 H,606.1952642,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2296,145RSYC,4-Jan-24
C1071040,11021014,179,PF-06863135,T,6221060209,6.22106E+11,20231109,15:00,CYCLE25_DAY1,0 H,338.8107122,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2353,150RSYC,28-Mar-24
C1071040,11021014,179,PF-06863135,T,6221060215,6.22106E+11,20240201,15:15,CYCLE28_DAY1,0 H,572.8678976,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2362,152RSYC,9-Apr-24
C1071040,11021014,179,PF-06863135,T,6217170508,6.21717E+11,20211215,17:20,CYCLE1_DAY1,24 H,647.0062124,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1513,56RSYC,30-Apr-22
C1071040,11021014,179,PF-06863135,T,6217023852,6.21702E+11,20211220,17:25,CYCLE1_DAY4,0 H,105.8522409,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1429,57RSYC,30-Apr-22
C1071040,11021014,179,PF-06863135,T,6217280336,6.21728E+11,20211221,17:25,CYCLE1_DAY4,24 H,602.6180739,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1559,97RSYC,12-May-22
C1071040,10901009,180,PF-06863135,T,6518805047,6.51881E+11,20211214,17:25,CYCLE1_DAY1,0 H,552.3879536,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1155,107RSYC,24-May-22
C1071040,10901009,180,PF-06863135,T,6518805047,6.51881E+11,20211215,0:40,CYCLE1_DAY1,6 H,265.0934835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1154,107RSYC,24-May-22
C1071040,10901009,180,PF-06863135,T,6518805051,6.51881E+11,20211220,10:40,CYCLE1_DAY8,0 H,237.1615786,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1159,108RSYC,24-May-22
C1071040,10901009,180,PF-06863135,T,6518805051,6.51881E+11,20211220,16:04,CYCLE1_DAY8,6 H,977.7114139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1158,108RSYC,24-May-22
C1071040,10901009,180,PF-06863135,T,6518883085,6.51888E+11,20211228,10:02,CYCLE1_DAY15,0 H,285.5711842,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1181,104RSYC,22-May-22
C1071040,10901009,180,PF-06863135,T,6518877863,6.51888E+11,20220104,9:47,CYCLE1_DAY22,0 H,89.40948863,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1693,106RSYC,23-May-22
C1071040,10901009,180,PF-06863135,T,6517433529,6.51743E+11,20220111,11:59,CYCLE2_DAY1,0 H,652.1327322,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1692,106RSYC,23-May-22
C1071040,10901009,180,PF-06863135,T,6518877872,6.51888E+11,20211217,8:40,CYCLE1_DAY4,0 H,772.1861765,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1179,104RSYC,22-May-22
C1071040,10901009,180,PF-06863135,T,6518805057,6.51881E+11,20211218,10:32,CYCLE1_DAY4,24 H,868.5723921,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1161,108RSYC,24-May-22
C1071040,11021011,181,PF-06863135,T,6217417530,6.21742E+11,20211215,10:30,CYCLE1_DAY1,0 H,438.8769614,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1581,59RSYC,1-May-22
C1071040,11021011,181,PF-06863135,T,6217417530,6.21742E+11,20211215,22:00,CYCLE1_DAY1,6 H,179.2053223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1580,59RSYC,1-May-22
C1071040,11021011,181,PF-06863135,T,6217280305,6.21728E+11,20211223,17:00,CYCLE1_DAY8,0 H,376.1582232,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2020,122RSYC,29-Jul-22
C1071040,11021011,181,PF-06863135,T,6217280305,6.21728E+11,20211224,0:00,CYCLE1_DAY8,6 H,609.7344658,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1848,93RSYC,12-May-22
C1071040,11021011,181,PF-06863135,T,6216756804,6.21676E+11,20211230,15:25,CYCLE1_DAY15,0 H,399.1160321,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1844,93RSYC,12-May-22
C1071040,11021011,181,PF-06863135,T,6217136145,6.21714E+11,20220106,14:20,CYCLE1_DAY22,0 H,273.6754673,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1845,93RSYC,12-May-22
C1071040,11021011,181,PF-06863135,T,6217170458,6.21717E+11,20220113,11:20,CYCLE2_DAY1,0 H,745.7145856,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1846,93RSYC,12-May-22
C1071040,11021011,181,PF-06863135,T,6217170475,6.21717E+11,20220210,13:30,CYCLE3_DAY1,0 H,557.8705501,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1847,93RSYC,12-May-22
C1071040,11021011,181,PF-06863135,T,6217170487,6.21717E+11,20220310,15:15,CYCLE4_DAY1,0 H,226.7931763,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1911,123RSYC,29-Jul-22
C1071040,11021011,181,PF-06863135,T,6217170500,6.21717E+11,20220609,15:50,CYCLE7_DAY1,0 H,335.9797871,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2042,131RSYC,9-Nov-22
C1071040,11021011,181,PF-06863135,T,6218384032,6.21838E+11,20220905,15:40,CYCLE10_DAY1,0 H,509.2825942,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2104,131RSYC,9-Nov-22
C1071040,11021011,181,PF-06863135,T,6219265227,6.21927E+11,20221128,14:45,CYCLE13_DAY1,0 H,518.6011152,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2167,140RSYC,22-Mar-23
C1071040,11021011,181,PF-06863135,T,6219958820,6.21996E+11,20230220,14:20,CYCLE16_DAY1,0 H,120.0446282,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2199,141RSYC,17-May-23
C1071040,11021011,181,PF-06863135,T,6219958822,6.21996E+11,20230515,14:00,CYCLE19_DAY1,0 H,635.5649261,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2240,143RSYC,27-Nov-23
C1071040,11021011,181,PF-06863135,T,6219958826,6.21996E+11,20230829,16:10,END_OF_TRT,,194.4864994,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2312,147RSYC,29-Feb-24
C1071040,11021011,181,PF-06863135,T,6217170505,6.21717E+11,20211216,16:00,CYCLE1_DAY1,24 H,562.8787765,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1511,56RSYC,30-Apr-22
C1071040,11021011,181,PF-06863135,T,6217280321,6.21728E+11,20211220,17:30,CYCLE1_DAY4,0 H,812.6460074,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1556,58RSYC,1-May-22
C1071040,11021011,181,PF-06863135,T,6217233483,6.21723E+11,20211221,17:30,CYCLE1_DAY4,24 H,721.8016046,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1547,97RSYC,12-May-22
C1071040,10901010,182,PF-06863135,T,6518877856,6.51888E+11,20211217,12:10,CYCLE1_DAY1,0 H,639.2835853,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1172,104RSYC,22-May-22
C1071040,10901010,182,PF-06863135,T,6518877856,6.51888E+11,20211217,18:59,CYCLE1_DAY1,6 H,999.0543924,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1171,104RSYC,22-May-22
C1071040,10901010,182,PF-06863135,T,6518805050,6.51881E+11,20211223,9:46,CYCLE1_DAY8,0 H,489.5345355,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1157,107RSYC,24-May-22
C1071040,10901010,182,PF-06863135,T,6518805050,6.51881E+11,20211223,16:00,CYCLE1_DAY8,6 H,472.6374391,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1156,107RSYC,24-May-22
C1071040,10901010,182,PF-06863135,T,6519057380,6.51906E+11,20211230,14:55,CYCLE1_DAY15,0 H,247.601576,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1695,109RSYC,25-May-22
C1071040,10901010,182,PF-06863135,T,6519057382,6.51906E+11,20220113,14:40,CYCLE2_DAY1,0 H,711.0771941,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1696,109RSYC,25-May-22
C1071040,10901010,182,PF-06863135,T,6519231708,6.51923E+11,20220310,15:10,CYCLE4_DAY1,0 H,437.3070974,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1904,81RSYC,4-May-22
C1071040,10901010,182,PF-06863135,T,6518807260,6.51881E+11,20220526,14:39,END_OF_TRT,,800.542529,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1985,122RSYC,29-Jul-22
C1071040,10901010,182,PF-06863135,T,6517433531,6.51743E+11,20220217,12:00,UNPL,9001 H,76.21618001,NG/ML,,Visit revised; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1694,109RSYC,25-May-22
C1071040,10901010,182,PF-06863135,T,6518877867,6.51888E+11,20211218,13:25,CYCLE1_DAY1,24 H,926.4313706,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1175,104RSYC,22-May-22
C1071040,10901010,182,PF-06863135,T,6518828370,6.51883E+11,20211220,8:45,CYCLE1_DAY4,0 H,676.341634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1163,108RSYC,24-May-22
C1071040,10901010,182,PF-06863135,T,6518877875,6.51888E+11,20211221,14:33,CYCLE1_DAY4,24 H,536.6025401,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1180,87RSYC,13-May-22
C1071040,10031016,183,PF-06863135,T,6517473906,6.51747E+11,20211228,10:35,CYCLE1_DAY1,0 H,219.7105723,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1944,112RSYC,25-Jul-22
C1071040,10031016,183,PF-06863135,T,6517473906,6.51747E+11,20211228,18:22,CYCLE1_DAY1,6 H,17.33446086,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1945,118RSYC,27-Jul-22
C1071040,10031016,183,PF-06863135,T,6516580389,6.51658E+11,20220106,12:30,CYCLE1_DAY8,0 H,791.4734349,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1946,123RSYC,29-Jul-22
C1071040,10031016,183,PF-06863135,T,6516580389,6.51658E+11,20220106,18:30,CYCLE1_DAY8,6 H,201.9252141,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1947,123RSYC,29-Jul-22
C1071040,10031016,183,PF-06863135,T,6519134602,6.51913E+11,20220112,14:34,CYCLE1_DAY15,0 H,992.5710536,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1948,122RSYC,29-Jul-22
C1071040,10031016,183,PF-06863135,T,6519134603,6.51913E+11,20220119,13:25,CYCLE1_DAY22,0 H,431.47689,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1626,85RSYC,10-May-22
C1071040,10031016,183,PF-06863135,T,6516580401,6.51658E+11,20220126,12:34,CYCLE2_DAY1,0 H,586.1190137,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1625,85RSYC,10-May-22
C1071040,10031016,183,PF-06863135,T,6518620857,6.51862E+11,20220323,8:30,CYCLE4_DAY1,0 H,561.0355954,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1949,124RSYC,29-Jul-22
C1071040,10031016,183,PF-06863135,T,6518620861,6.51862E+11,20220615,10:30,CYCLE7_DAY1,0 H,390.8517416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2097,137RSYC,18-Nov-22
C1071040,10031016,183,PF-06863135,T,6519134615,6.51913E+11,20220907,10:44,CYCLE10_DAY1,0 H,947.3913816,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2082,129RSYC,21-Oct-22
C1071040,10031016,183,PF-06863135,T,6519134617,6.51913E+11,20221109,9:05,END_OF_TRT,,909.0779055,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2149,139RSYC,22-Mar-23
C1071040,10031016,183,PF-06863135,T,6518620867,6.51862E+11,20211231,15:13,UNPL,9001 H,140.8876339,NG/ML,,Visit revised from C7D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1950,124RSYC,29-Jul-22
C1071040,10031016,183,PF-06863135,T,6517472378,6.51747E+11,20211229,11:05,CYCLE1_DAY1,24 H,189.7667137,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1951,122RSYC,29-Jul-22
C1071040,10031016,183,PF-06863135,T,6517751599,6.51775E+11,20220104,16:23,CYCLE1_DAY4,24 H,325.6277435,NG/ML,9,Visit and time point revised; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071040,10031015,184,PF-06863135,T,6518620835,6.51862E+11,20211220,13:56,CYCLE1_DAY1,0 H,303.8122734,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1952,112RSYC,25-Jul-22
C1071040,10031015,184,PF-06863135,T,6518620835,6.51862E+11,20211220,21:00,CYCLE1_DAY1,6 H,543.1656311,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1953,122RSYC,29-Jul-22
C1071040,10031015,184,PF-06863135,T,6518620840,6.51862E+11,20211228,13:38,CYCLE1_DAY8,0 H,730.889829,NG/ML,,Visit revised from C7D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1955,124RSYC,29-Jul-22
C1071040,10031015,184,PF-06863135,T,6519134604,6.51913E+11,20220113,16:03,CYCLE1_DAY22,0 H,486.8013658,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1954,122RSYC,29-Jul-22
C1071040,10031015,184,PF-06863135,T,6519134609,6.51913E+11,20220217,13:10,CYCLE3_DAY1,0 H,886.0799213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1627,85RSYC,10-May-22
C1071040,10031015,184,PF-06863135,T,6517751589,6.51775E+11,20220316,10:45,CYCLE4_DAY1,0 H,492.8470281,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1894,81RSYC,4-May-22
C1071040,10031015,184,PF-06863135,T,6519134618,6.51913E+11,20220411,13:28,END_OF_TRT,,366.8542957,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1956,124RSYC,29-Jul-22
C1071040,10031015,184,PF-06863135,T,6517473938,6.51747E+11,20211221,13:15,CYCLE1_DAY1,24 H,783.0927319,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1957,122RSYC,29-Jul-22
C1071040,10031015,184,PF-06863135,T,6517472380,6.51747E+11,20211224,14:29,CYCLE1_DAY4,0 H,863.4009619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1958,126RSYC,1-Aug-22
C1071040,10031015,184,PF-06863135,T,6517473950,6.51747E+11,20211225,15:44,CYCLE1_DAY4,24 H,864.614394,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1959,124RSYC,29-Jul-22
C1071040,11301003,185,PF-06863135,T,6216756837,6.21676E+11,20211220,14:48,CYCLE1_DAY1,0 H,541.2499643,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1389,95RSYC,13-May-22
C1071040,11301003,185,PF-06863135,T,6216756837,6.21676E+11,20211220,22:30,CYCLE1_DAY1,6 H,341.3641226,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1388,95RSYC,13-May-22
C1071040,11301003,185,PF-06863135,T,6216756839,6.21676E+11,20211227,14:27,CYCLE1_DAY8,0 H,525.1067339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1393,95RSYC,13-May-22
C1071040,11301003,185,PF-06863135,T,6216756839,6.21676E+11,20211227,20:36,CYCLE1_DAY8,6 H,84.28294232,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1392,95RSYC,13-May-22
C1071040,11301003,185,PF-06863135,T,6216756841,6.21676E+11,20220103,15:21,CYCLE1_DAY15,0 H,514.1805767,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1869,80RSYC,4-May-22
C1071040,11301003,185,PF-06863135,T,6216756843,6.21676E+11,20220110,15:00,CYCLE1_DAY22,0 H,301.1693046,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1870,80RSYC,4-May-22
C1071040,11301003,185,PF-06863135,T,6217542182,6.21754E+11,20220117,14:00,CYCLE2_DAY1,0 H,45.42889493,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1872,80RSYC,4-May-22
C1071040,11301003,185,PF-06863135,T,6217339265,6.21734E+11,20220215,15:15,CYCLE3_DAY1,0 H,297.9161261,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1871,80RSYC,4-May-22
C1071040,11301003,185,PF-06863135,T,6217542186,6.21754E+11,20220315,11:00,CYCLE4_DAY1,0 H,586.558779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1884,80RSYC,4-May-22
C1071040,11301003,185,PF-06863135,T,6216756849,6.21676E+11,20211221,16:32,CYCLE1_DAY1,24 H,811.2721319,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1395,95RSYC,13-May-22
C1071040,11301003,185,PF-06863135,T,6216756851,6.21676E+11,20211223,11:04,CYCLE1_DAY4,0 H,192.6125982,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1397,95RSYC,13-May-22
C1071040,11301003,185,PF-06863135,T,6216756852,6.21676E+11,20211224,12:22,CYCLE1_DAY4,24 H,70.8164944,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1398,108RSYC,24-May-22
C1071040,10901008,186,PF-06863135,T,6518877857,6.51888E+11,20211231,11:27,CYCLE1_DAY1,0 H,196.2174213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1689,102RSYC,20-May-22
C1071040,10901008,186,PF-06863135,T,6518877857,6.51888E+11,20211231,18:45,CYCLE1_DAY1,6 H,432.6654193,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1688,106RSYC,23-May-22
C1071040,10901008,186,PF-06863135,T,6518805052,6.51881E+11,20220107,10:20,CYCLE1_DAY8,0 H,57.08110908,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1683,101RSYC,13-May-22
C1071040,10901008,186,PF-06863135,T,6518805052,6.51881E+11,20220107,16:31,CYCLE1_DAY8,6 H,587.6970586,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1684,101RSYC,13-May-22
C1071040,10901008,186,PF-06863135,T,6519019918,6.51902E+11,20220114,15:24,CYCLE1_DAY15,0 H,734.2254476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1691,106RSYC,23-May-22
C1071040,10901008,186,PF-06863135,T,6517433528,6.51743E+11,20220120,14:23,CYCLE1_DAY22,0 H,772.3658931,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1682,101RSYC,13-May-22
C1071040,10901008,186,PF-06863135,T,6520346778,6.52035E+11,20220203,14:14,UNPL,9001 H,286.319874,NG/ML,,Received as 6518828369-07,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1687,106RSYC,23-May-22
C1071040,10901008,186,PF-06863135,T,6518805053,6.51881E+11,20220101,12:40,CYCLE1_DAY1,24 H,640.4684868,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1685,101RSYC,13-May-22
C1071040,10901008,186,PF-06863135,T,6518877871,6.51888E+11,20220103,11:29,CYCLE1_DAY4,0 H,220.9015801,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1690,106RSYC,23-May-22
C1071040,10901008,186,PF-06863135,T,6518805058,6.51881E+11,20220104,11:25,CYCLE1_DAY4,24 H,960.1356987,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1686,106RSYC,23-May-22
C1071040,10901011,187,PF-06863135,T,6517433456,6.51743E+11,20220103,13:30,CYCLE1_DAY1,0 H,304.9162352,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1698,109RSYC,25-May-22
C1071040,10901011,187,PF-06863135,T,6517433456,6.51743E+11,20220103,20:20,CYCLE1_DAY1,6 H,38.18591595,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1697,109RSYC,25-May-22
C1071040,10901011,187,PF-06863135,T,6517433458,6.51743E+11,20220111,12:02,CYCLE1_DAY8,0 H,984.6062519,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1700,109RSYC,25-May-22
C1071040,10901011,187,PF-06863135,T,6517433458,6.51743E+11,20220111,18:37,CYCLE1_DAY8,6 H,820.4285428,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1699,109RSYC,25-May-22
C1071040,10901011,187,PF-06863135,T,6519138599,6.51914E+11,20220118,12:01,CYCLE1_DAY15,0 H,297.5983839,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1706,109RSYC,25-May-22
C1071040,10901011,187,PF-06863135,T,6519057381,6.51906E+11,20220125,13:00,CYCLE1_DAY22,0 H,664.3228314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1704,109RSYC,25-May-22
C1071040,10901011,187,PF-06863135,T,6519138601,6.51914E+11,20220201,14:20,CYCLE2_DAY1,0 H,205.690508,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1707,109RSYC,25-May-22
C1071040,10901011,187,PF-06863135,T,6517433551,6.51743E+11,20220222,11:36,END_OF_TRT,,481.1388478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1702,109RSYC,25-May-22
C1071040,10901011,187,PF-06863135,T,6518805055,6.51881E+11,20220104,14:20,CYCLE1_DAY1,24 H,738.1766352,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1703,109RSYC,25-May-22
C1071040,10901011,187,PF-06863135,T,6519057385,6.51906E+11,20220106,14:25,CYCLE1_DAY4,0 H,874.8521269,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1705,109RSYC,25-May-22
C1071040,10901011,187,PF-06863135,T,6517433537,6.51743E+11,20220107,15:45,CYCLE1_DAY4,24 H,577.4910244,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1701,109RSYC,25-May-22
C1071040,10321006,188,PF-06863135,T,6519136767,6.51914E+11,20220106,11:26,CYCLE1_DAY1,0 H,867.4486095,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1642,85RSYC,10-May-22
C1071040,10321006,188,PF-06863135,T,6519136767,6.51914E+11,20220106,18:31,CYCLE1_DAY1,6 H,881.2339781,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1641,85RSYC,10-May-22
C1071040,10321006,188,PF-06863135,T,6519136771,6.51914E+11,20220113,7:40,CYCLE1_DAY8,0 H,925.3663926,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1644,85RSYC,10-May-22
C1071040,10321006,188,PF-06863135,T,6519136771,6.51914E+11,20220113,18:52,CYCLE1_DAY8,6 H,549.8897078,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1643,85RSYC,10-May-22
C1071040,10321006,188,PF-06863135,T,6518722091,6.51872E+11,20220120,14:51,CYCLE1_DAY15,0 H,864.0900335,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1639,85RSYC,10-May-22
C1071040,10321006,188,PF-06863135,T,6519136778,6.51914E+11,20220127,14:42,CYCLE1_DAY22,0 H,731.3159672,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1648,100RSYC,23-May-22
C1071040,10321006,188,PF-06863135,T,6518722095,6.51872E+11,20220203,13:59,CYCLE2_DAY1,0 H,654.5872013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1640,85RSYC,10-May-22
C1071040,10321006,188,PF-06863135,T,6518150042,6.51815E+11,20220303,14:30,CYCLE3_DAY1,0 H,316.1415442,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1896,81RSYC,4-May-22
C1071040,10321006,188,PF-06863135,T,6517559965,6.51756E+11,20220623,13:56,CYCLE7_DAY1,0 H,72.36872345,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2031,128RSYC,21-Oct-22
C1071040,10321006,188,PF-06863135,T,6518807507,6.51881E+11,20220923,11:25,CYCLE10_DAY1,0 H,653.0160187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2109,131RSYC,9-Nov-22
C1071040,10321006,188,PF-06863135,T,6518807505,6.51881E+11,20221215,11:09,CYCLE13_DAY1,0 H,700.2474459,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2135,139RSYC,22-Mar-23
C1071040,10321006,188,PF-06863135,T,6519136790,6.51914E+11,20220107,13:01,CYCLE1_DAY1,24 H,432.7873826,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1645,85RSYC,10-May-22
C1071040,10321006,188,PF-06863135,T,6519136793,6.51914E+11,20220109,9:45,CYCLE1_DAY4,0 H,995.6095577,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1646,100RSYC,23-May-22
C1071040,10321006,188,PF-06863135,T,6519136795,6.51914E+11,20220110,11:09,CYCLE1_DAY4,24 H,252.4295993,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1647,85RSYC,10-May-22
C1071040,11281002,189,PF-06863135,T,6518343086,6.51834E+11,20220107,15:45,CYCLE1_DAY1,0 H,950.9555109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1731,72RSYC,7-May-22
C1071040,11281002,189,PF-06863135,T,6518343086,6.51834E+11,20220107,22:18,CYCLE1_DAY1,6 H,382.5755118,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1730,72RSYC,7-May-22
C1071040,11281002,189,PF-06863135,T,6518343088,6.51834E+11,20220117,8:55,CYCLE1_DAY8,0 H,227.0936363,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1735,72RSYC,7-May-22
C1071040,11281002,189,PF-06863135,T,6518343088,6.51834E+11,20220117,17:54,CYCLE1_DAY8,6 H,446.4678911,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1734,72RSYC,7-May-22
C1071040,11281002,189,PF-06863135,T,6518343090,6.51834E+11,20220124,8:40,CYCLE1_DAY15,0 H,111.6914208,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1733,72RSYC,7-May-22
C1071040,11281002,189,PF-06863135,T,6518343093,6.51834E+11,20220131,8:30,CYCLE1_DAY22,0 H,912.5735535,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1732,72RSYC,7-May-22
C1071040,11281002,189,PF-06863135,T,6519452615,6.51945E+11,20220307,9:45,CYCLE3_DAY1,0 H,794.167797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1907,81RSYC,4-May-22
C1071040,11281002,189,PF-06863135,T,6520815984,6.52082E+11,20220628,7:11,CYCLE7_DAY1,0 H,619.8391675,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2095,127RSYC,19-Oct-22
C1071040,11281002,189,PF-06863135,T,6520815985,6.52082E+11,20220920,10:30,CYCLE10_DAY1,0 H,472.2886971,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2101,132RSYC,10-Nov-22
C1071040,11281002,189,PF-06863135,T,6520815987,6.52082E+11,20221213,7:35,CYCLE13_DAY1,0 H,473.860877,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2136,139RSYC,22-Mar-23
C1071040,11281002,189,PF-06863135,T,6522253824,6.52225E+11,20230307,7:54,CYCLE16_DAY1,0 H,132.9437932,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2207,142RSYC,18-May-23
C1071040,11281002,189,PF-06863135,T,6522253826,6.52225E+11,20230530,7:25,CYCLE19_DAY1,0 H,393.9682404,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2269,144RSYC,27-Nov-23
C1071040,11281002,189,PF-06863135,T,6522253825,6.52225E+11,20230825,7:26,CYCLE22_DAY1,0 H,808.347261,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2306,147RSYC,29-Feb-24
C1071040,11281002,189,PF-06863135,T,6522253827,6.52225E+11,20231201,8:08,CYCLE25_DAY1,0 H,144.0950436,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2334,149RSYC,27-Mar-24
C1071040,11281002,189,PF-06863135,T,6525647210,6.52565E+11,,,CYCLE28_DAY1,0 H,808.2769201,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2375,152RSYC,9-Apr-24
C1071040,11281002,189,PF-06863135,T,6518343098,6.51834E+11,20220108,16:25,CYCLE1_DAY1,24 H,824.5984545,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1728,72RSYC,7-May-22
C1071040,11281002,189,PF-06863135,T,6518343101,6.51834E+11,20220110,14:10,CYCLE1_DAY4,0 H,204.0569009,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1729,72RSYC,7-May-22
C1071040,11281002,189,PF-06863135,T,6519452620,6.51945E+11,20220111,14:53,CYCLE1_DAY4,24 H,85.46245989,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1736,72RSYC,7-May-22
